Document aQ4Yz5KDog6BnqJG9Ng4r7DR
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
AR226-3198
DuPont-5368
TRADE SECRET
Study Title H -24516: Sbchronic Toxicity - 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Volume 2 o f 5
Laboratory Project ID : DuPont-5386
Test Guidelines: U.S. EPA Health Effects Test Guidelines OPPTS 870.3100 (1998)
Author: Gregory S. Ladies, Ph.D ., D.A.B.T.
Study Completed on: December 3,2001
Performing Laboratory: E.I. du Pont de N em ours and Company Haskell Laboratory for Toxicology and Industrial Medicine
Elkton Road, P.O. Box 50 Newark, Delaware 19714-0050
Work Request Number:
3
Service Code Number:
Sponsor Study Number:
Page 317 of 1500 Company Sanitized. Does not contain TSCA CBI
H -24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5368
TABLE 44
MICROSCOPIC OBSERVATIONS IN MALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS
I LESION INCIDENCE (NUMERIC)
TREATMENT (mg/kg/day)
0 I
25 100 250
III V
VII
DIGESTIVE SYSTEM LIVER NO ABNORMALITY DETECTED NECROSIS, FOCAL. INFLAMMATION, SUBACUTE/CHRONIC.
HYPERTROPHY, HEPATOCYTE, CENTRILOBULAR.
(10) (10) (10) (ID
643272
643311 643259
643260
643309
643143 643173 643224 643174
643150 643179 643243 643193
643185 643180 643247 643194
643189 643228 643250 643201
643204 643240 643257 643215
643205 643264 643275 643252
643235 643290 643311 643259
643241 643292 643314 643260
643288 643308 643318 643298
643300
643315
643175 643174
643224 643193
643243 643194
643247 643201
643257 643215
643275 643252
643311 643259
643314 643260
643318 643298
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
318
Company SanWzed. Oses no! contain TSC CBf
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5368
TABLE 44 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN MALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS DIGESTIVE SYSTEM
TREATMENT (mg/kg/day)
LESION INCIDENCE (NUMERIC) 0 25 100 250 I III V VII
LIVER HYPERTROPHY, HEPATOCYTE, CENTRILOBULAR.
FATTY CHANGE, MEDIAN CLEFT.
FATTY CHANGE, CENTRILOBULAR.
(10) (10) (10) (11) 643309 643315
643189 643180 643250 643300 643264 643257 643189 643180 643224 643174
643290 643243 643259 643257 643309 643275 643311 643318
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
319
Oempany Sanitized. Does not contain TSCA CBI
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5368
TABLE 44 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN MALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS DIGESTIVE SYSTEM
| LESION INCIDENCE (NUMERIC)
TREATMENT (mg/kg/day)
0 I
25 100 250
III V
VII
PANCREAS NO ABNORMALITY DETECTED
INFLAMMATION, SUBACUTE/CHRONIC. ATROPHY.
(10) 643143 643150 643185 643189 643204 643205 643235
643241 643288 643241 643300
(1) (11) 643175 643174
643193 643194 643201 643215 643260 643298 643309 643315 643252
643259
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
320 otttpisnjp Sanitized. D ees not contain TSCA CBf
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5368
TABLE 44 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN MALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS
i LESION INCIDENCE (NUMERIC)
TREATMENT (mg/kg/day)
0 I
25 100 250
III V
VII
DIGESTIVE SYSTEM
ESOPHAGUS NO ABNORMALITY DETECTED '
INFLAMMATION, SUBACUTE/CHRONIC. EDEMA.
(10) 643143 643150 643185 643189 643204 643205 643235 643241 643288 643300
(1) (11) 643174 643193 643194 643201 643215 643252 643260 643298 643315
643175 643259 643309 643309
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
321
Comparty Sanitized. Does not contain TSCA CM
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5368
TABLE 44 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN MALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS DIGESTIVE SYSTEM
TREATMENT (mg/kg/day)
LESION INCIDENCE (NUMERIC) 0 25 100 250 I III V VII
STOMACH NO ABNORMALITY DETECTED
(10) 643143 643150 643185 643189 643204 643205 643235 643241 643288 643300
(1) (11) 643175 643174
643193 643194 643201 643215 643252 643259 643260 643298 643309 643315
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
322 Conii*iny SsfiWzsff, Does no! contain TSCA CBI
H -24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5368
TABLE 44 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN MALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS DIGESTIVE SYSTEM
TREATMENT (mg/kg/day)
LESION INCIDENCE (NUMERIC)
0 25 100 250
I
III 'V
VII
DUODENUM NO ABNORMALITY DETECTED
'
(10) 643143 643150 643185 643189 643204 643205 643235 643241 643288 643300
(1) (11) 643175 643174
643193 643194 643201 643215 643252 643259 643260 643298 643309 643315
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
323
Company SanRteed. Does no! contain TSCA CBI
H -24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5368
TABLE 44 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN MALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS DIGESTIVE SYSTEM
LESION INCIDENCE (NUMERIC)
"
TREATMENT (mg/kg/day)
0 I
25 100 250
III V
VII
JEJUNUM NO ABNORMALITY DETECTED
(10) 643143 643150 643185 643189 643204 643205 643235 643241 643288 643300
(1) (11) 643175 643174
643193 643194 643201 643215 643252 643259 643260 643298 643309 643315
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
324 Conmany San*t!zed. Doe* no* contain TSCA CBI
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5368
TABLE 44 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN MALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS DIGESTIVE SYSTEM
TREATMENT (mg/kg/day)
LESION INCIDENCE (NUMERIC) 0 25 100 250 I III V VII
ILEUM NO ABNORMALITY DETECTED
(10)' 643143 643150 643185 643189 643204 643205 643235 643241 643288 643300
(1) (11) 643175 643174
643193 643194 643201 643215 643252 643259 643260 643298 643309 643315
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
325
Comoany Sanitized. Does not contain TSCA CBt
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5368
TABLE 44 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN MALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS DIGESTIVE SYSTEM
| LESION INCIDENCE (NUMERIC)
TREATMENT (mg/kg/day)
0 I
25 100 250
III V
VII
CECUM NO ABNORMALITY DETECTED
(10) 643143 643150 643185 643189 643204 643205 643235 643241 643288 643300
(1) (11) 643175 643174
643193 643194 643201 643215 643252 643259 643260 643298 643309 643315
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
326
Comnany Sanitized. Does not contain TSCA CBI
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5368
TABLE 44 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN MALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS DIGESTIVE SYSTEM
TREATMENT (mg/kg/day)
LESION INCIDENCE (NUMERIC) 0 25 100 250 I III V VII
COLON NO ABNORMALITY DETECTED
(10) 643143 643150 643185 643189 643204 643205 643235 643241 643288 643300
(1) (ID 643175 643174
643193 643194 643201 643215 643252 643259 643260 643298 643309 643315
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
327
Company Sanitized. Does not contain TSCA CBI
H -24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5368
TABLE 44 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN MALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS DIGESTIVE SYSTEM
i LESION INCIDENCE (NUMERIC)
TREATMENT (mq/kg/day)
0 I
25 100 III >v
250 VII
RECTUM NO ABNORMALITY DETECTED
(10) 643143 643150 643185 643189 643204 643205 643235 643241 643288 643300
(1) (11) 643175 643174
643193 643194 643201 643215 643252 643259 643260 643298 643309 643315
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
328 Sonipanjr Sanitised. Does not contain TSCACBI
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5368
TABLE 44 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN MALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS DIGESTIVE SYSTEM
| LESION INCIDENCE (NUMERIC)
1 O 11
1 1 1
TREATMENT (mg/kg/day)
H
25 100 250
III V
VII
SALIVARY GLANDS NO ABNORMALITY DETECTED
-
(10) 643143 643150 643185 643189 643204 643205 643235 643241 643288 643300
(1) (11) 643175 643174
643193 643194 643201 643215 643252 643259 643260 643298 643309 643315
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
329
Company Sanitized. Does not contain TSCA CBf
H -24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5368
TABLE 44 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN MALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESION INCIDENCE (NUMERIC)
LESIONS
TREATMENT (mg/kg/day)
0 I
25 100 250
III V
VII
URINARY SYSTEM KIDNEYS NO ABNORMALITY DETECTED
NEPHROPATHY, CHRONIC PROGRESSIVE.
HYPERTROPHY, TUBULAR.
(10) (10) (10) (11) 643143 643173 643224
643185 643179 643243
643189 643240 643250
643205 643264 643257
643235 643272 643318
643288 643290
643308
643150 643180 643175 643193
643204 643228 643247 643194
643241 643292 643311 643215
643300
643314 643252
643298
643309
643275 643174
643193
643194
643201
643215
643252
643259
643260
643298
643309
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
330
omPaft5r Sanlffeed. Does not contain TSCA CBI
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5368
TABLE 44 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN MALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS
| LESION INCIDENCE (NUMERIC)
TREATMENT (mg/kg/day)
0 I
25 100 250
III V
VII
URINARY SYSTEM
KIDNEYS HYPERTROPHY, TUBULAR. HYDRONEPHROSIS, UNILATERAL. HYDRONEPHROSIS, BILATERAL.
(10)
(10)
(10)
(11) 643315
643259 643174
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
331
Company Sanitized. Does not contain TSCA CB1
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5368
TABLE 44 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN MALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS URINARY SYSTEM
TREATMENT (mg/kg/day)
LESION INCIDENCE (NUMERIC) 0 25 100 250 I III V VII
URINARY BLADDER NO ABNORMALITY DETECTED
(10) 643143 643150 643185 643189 643204 643205 643235 643241 643288 643300
(1) (11) 643175 643174
643193 643194 643201 643215 643252 643259 643260 643298 643309 643315
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
332
Cnmnoov
fkM* not contain TSCA CBt
H -24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5368
TABLE 44 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN MALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS
| LESION INCIDENCE (NUMERIC)
TREATMENT (mg/kg/day)
0 I
25 100 250
III 'V
VII
RESPIRATORY SYSTEM
LUNGS NO ABNORMALITY DETECTED
INFLAMMATION, SUBACUTE/CHRONIC. INFLAMMATION, GRANULOMATOUS.
(10) 643143 643150 643185 643189 643235 643241 643288 643300 643204 643205
(1) (11) 643174 643194 643201 643215 643252 643259 643298 643315 643260 643309
643175 643193
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
333
Company Sanitized. Does not contain TSCA CBI
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5368
TABLE 44 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN MALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS RESPIRATORY SYSTEM
| LESION INCIDENCE (NUMERIC)
1
i
1 1o w 1
TREATMENT (mg/kg/day)
25 100 250
III V
VII
TRACHEA NO ABNORMALITY DETECTED
(10) 643143 643150 643185 643189 643204 643205 643235 643241 643288 643300
(1) (11) 643175 643174
643193 643194 643201 643215 643252 643259 643260 643298 643309 643315
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
334
Company Sanitized. Does not contain TSCA CBI
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5368
TABLE 44 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN MALE RATS LISTING INDIVIDUAL ANIMALS AFFECTED-
NEOPLASTIC AND NON-NEOPLASTIC (90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS RESPIRATORY SYSTEM
TREATMENT (mg/kg/day)
LESION INCIDENCE (NUMERIC) 0 25 100 250 I III V VII
PHARYNX/LARYNX
(10)
(1) (11)
NO ABNORMALITY DETECTED
643143
643175 643174
643150
643193
643185
643194
643189
643201
643204
643215
643205
643252
643235
643259
643241
643260
643288
643298
643300
643315
HEMORRHAGE.
643309
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
335
Company Sanitized. Does not contain TSCACBI
H -24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5368
TABLE 44 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN MALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS
TREATMENT (mg/kg/day)
LESION INCIDENCE (NUMERIC) 0 25 100 250 I III V VII
RESPIRATORY SYSTEM NOSE NO ABNORMALITY DETECTED
INFLAMMATION, SUBACUTE/CHRONIC. HYPERPLASIA/HYPERTROPHY, TRANSITIONAL CELL, EPITHELIUM DEGENERATION/NECROSIS, RESPIRATORY, EPITHELIUM. DEGENERATION, AMELOBLASTS.
(10) (10) (10) (ID 643143 643173 643224 643150 643179 643243 643185 643180 643250 643189 643228 643314 643204 643240 643205 643264 643235 643272 643241 643290 643288 643292 643300 643308
643175 643201 643309
643309 643315
643175 643247 643174 643257 643193 643275 643194 643311 643201 643318 643215
643252 643259 643260
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
336
Company Sanitized. Does not contain TSCA CBf
H -24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5368
TABLE 44 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN MALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS RESPIRATORY SYSTEM
| LESION INCIDENCE (NUMERIC)
TREATMENT (mg/kg/day)
0 I
25 100 250
III V
VII
NOSE DEGENERATION, AMELOBLASTS.
(10)
(10)
(10)
(11) 643298 643309 643315
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
337
Company Sanitized. Does not contain TSCA CB
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5368
TABLE 44 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN MALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS CARDIOVASCULAR SYSTEM
TREATMENT (mg/kg/day)
LESION INCIDENCE (NUMERIC) 0 25 100 250 I III V VII
HEART NO ABNORMALITY DETECTED
CARDIOMYOPATHY. INFLAMMATION, SUBACUTE/CHRONIC.
(10) 643143 643150 643185 643241 643288
643189 643204 643205 643235 643300
(1) ' (ID 643174 643193 643201 643215 643252 643260 643298 643309 643194 643259 643315
643175
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
338
Company SanRfeed. Does no! confata TSCA CB!
H -24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5368
TABLE 44 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN MALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS CARDIOVASCULAR SYSTEM
TREATMENT (mg/kg/day)
LESION INCIDENCE (NUMERIC) 0 25 100 250 I III V VII
AORTA NO ABNORMALITY DETECTED
(10) 643143 643150 643185 643189 643204 643205 643235 643241 643288 643300
(1) (11) 643175 643174
643193 643194 643201 643215 643252 643259 643260 643298 643309 643315
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
339
Company Sanitized. Does not contain TSCA CBI
H -24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5368
TABLE 44 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN MALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS LYMPHATIC AND HEMATOPOIETIC SYSTEM
| LESION INCIDENCE (NUMERIC)
TREATMENT (mg/kg/day)
0 I
25 100 250
III V
VII
SPLEEN NO ABNORMALITY DETECTED
(10) 643143 643150 643185 643189 643204 643205 643235 643241 643288 643300
(1) (11) 643175 643174
643193 643194 643201 643215 643252 643259 643260 643298 643309 643315
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
340
Company Sanitized. Does not contain TSCA CBf
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5368
TABLE 44 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN MALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS
TREATMENT (mg/kg/day)
LESION INCIDENCE (NUMERIC) 0 25 100 250 I III V VII
LYMPHATIC AND HEMATOPOIETIC SYSTEM
THYMUS NO ABNORMALITY DETECTED
ATROPHY.
(10) 643143 643150 643185 643189 643204 643205 643235 643241 643288 643300
(11) 643174 643193 643194 643201 643215 643252 643259 643260 643298 643315 643309
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
341
Company Sanitized. Does not contain TSCA CBI
H -24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5368
TABLE 44 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN MALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS LYMPHATIC AND HEMATOPOIETIC SYSTEM
TREATMENT (mg/kg/day)
LESION INCIDENCE (NUMERIC) 0 25 100 250 I III y VII
MANDIBULAR LYMPH NODE NO ABNORMALITY DETECTED
(10) 643143 643150 643185 643189 643204 643205 643235 643241 643288 643300
(U (11) 643175 643174
643193 643194 643201 643215 643252 643259 643260 643298 643309 643315
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
342
Company Sanitized. Does not contain TSCA CBI
H -24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5368
TABLE 44 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN MALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS LYMPHATIC AND HEMATOPOIETIC SYSTEM
TREATMENT (mg/kg/day)
LESION INCIDENCE (NUMERIC) 0 25 100 250 I III V VII
MESENTERIC LYMPH NODE NO ABNORMALITY DETECTED
(10) 643143 643150 643185 643189 643204 643205 643235 643241 643288 643300
(1) (11) 643175 643174
643193 643194 643201 643215 643252 643259 643260 643298 643309 643315
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
343
Company Sanitized. Does not contain TSCA CBi
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5368
TABLE 44 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN MALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS LYMPHATIC AND HEMATOPOIETIC SYSTEM
| LESION INCIDENCE (NUMERIC)
TREATMENT (mg/kg/day)
0 I
25 100 250
III V
VII
BONE MARROW NO ABNORMALITY DETECTED -
HYPERPLASIA, GRANULOCYTIC.
(10) 643143 643150 643185 643189 643204 643205 643235 643241 643288 643300
(1) (11) 643174 643193 643194 643201 643215 643252
643259 643260 643298 643315 643175 643309
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
344
Company Sanitized Does not oonta'n TSCA CBf
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5368
TABLE 44 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN MALE RATS LISTING INDIVIDUAL ANIMALS AFFECTED-
NEOPLASTIC AND NON-NEOPLASTIC (90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS ENDOCRINE SYSTEM
| LESION INCIDENCE (NUMERIC)
TREATMENT (mg/kg/day)
0 I
25 100 250
III V
VII
PITUITARY GLAND NO ABNORMALITY DETECTED
(10) 643143
(1) (11) 643175 643174
643150
643193
643185
643194
643189
643201
643204
643215
643205
643252
643235
643259
643241
643260
643288
643298
643300
643309
643315
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
345
Company Sanitized. Boss not contain TSCACBI
H -24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5368
TABLE 44 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN MALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS
| LESION INCIDENCE (NUMERIC)
TREATMENT (mg/kg/day)
0 I
25 100 250
III V
VII
ENDOCRINE SYSTEM THYROID GLAND NO ABNORMALITY DETECTED INFLAMMATION, SUBACUTE/CHRONIC. HYPERTROPHY, FOLLICULAR.
ALTERATION, COLLOID.
(10) (10) (10) (11)
643150 643179 643175
643235
643224 643174
643318 643193
643194
643201
643252
643259
643260
643298
643309
643315
643143 643173 643224 643174
643185 643180 643243 643193
643189 643228 643247 643194
643204 643240 643250 643201
643205 643264 643257 643215
643235 643272 643275 643252
643241 643290 643311 643259
643288 643292 643314 643260
643300 643308 643318 643298
643309
643315
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
346
Company Sanitized. Does not contain TSCA CBI
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5368
TABLE 44 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN MALE RATS LISTING INDIVIDUAL ANIMALS AFFECTED-
NEOPLASTIC AND NON-NEOPLASTIC (90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS ENDOCRINE SYSTEM
TREATMENT (mg/.kg/day)
LESION INCIDENCE (NUMERIC) 0 25 100 250 I III V VII
PARATHYROID GLANDS NO ABNORMALITY DETECTED
(8) 643143 643150 643185 643204 643205 643235 643241 643300
(10) 643174 643193 643194 643201 643215 643252 643259 643260 643298 643315
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
347
OBipany Sanitized. Does not contain TSCA CBI
H -24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5368
TABLE 44 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN MALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS ENDOCRINE SYSTEM
| LESION INCIDENCE (NUMERIC)
TREATMENT (mg/kg/day)
0 I
25 100 250
III V
VII
ADRENAL GLANDS NO ABNORMALITY DETECTED
(10) 643143 643150 643185 643189 643204 643205 643235 643241 643288 643300
(1) (11) 643175 643174
643193 643194 643201 643215 643252 643259 643260 643298 643309 643315
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
348
Company Sanitized. Does not contain TSCACBI
H -24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5368
TABLE 44 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN MALE RATS LISTING INDIVIDUAL ANIMALS AFFECTED-
NEOPLASTIC AND NON-NEOPLASTIC (90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS NERVOUS SYSTEM
TREATMENT (mg/kg/day)
LESION INCIDENCE (NUMERIC) 0 25 100 250 I III V VII
BRAIN NO ABNORMALITY DETECTED
(10) 643143 643150 643185 643189 643204 643205 643235 643241 643288 643300
(1) (11) 643175 643174
643193 643194 643201 643215 643252 643259 643260 643298 643309 643315
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
349 Company Sanitized. Does not contain TSCA CBI
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5368
TABLE 44 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN MALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS NERVOUS SYSTEM
| LESION INCIDENCE (NUMERIC)
TREATMENT (mg/kg/day)
0 I
25 100 250
III V
VII
SPINAL CORD NO ABNORMALITY DETECTED
(10) 643143 643150 643185 643189 643204 643205 643235 643241 643288 643300
(1) (11) 643175 643174
643193 643194 643201 643215 643252 643259 643260 643298 643309 643315
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
350 Cw**pany Sanitized. Does not contain TSCA CBf
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5368
TABLE 44 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN MALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS
LESION INCIDENCE (NUMERIC)
TREATMENT 0 (mg/kg/day).
I
25 100 250
III V
VII
NERVOUS SYSTEM
SCIATIC NERVE NO ABNORMALITY DETECTED
(1 0 )
643143 643150 643185 643189 643204 643205 643235 643241 643288 643300
(11) 643174 643193 643194 643201 643215 643252 643259 643260 643298 643309 643315
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
351
Company Sanitized. Does not contain TSCA CBf
H -24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5368
TABLE 44 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN MALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS
| LESION INCIDENCE (NUMERIC)
TREATMENT (mg/kg/day)
0 I
25 100 250
III V
VII
MUSCULAR AND SKELETAL SYSTEM
SKELETAL MUSCLE NO ABNORMALITY DETECTED
(10) 643143 643150 643185 643189 643204 643205 643235 643241 643288 643300
(1) (11) 643175 643174
643193 643194 643201 643215 643252 643259 643260 643298 643309 643315
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
352
Company Sanitized. Does not contain TSCCM
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations ................
... ................ -- ----
DuPont-5368 ----- ----------------------
TABLE 44 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN MALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS
TREATMENT (mg/kg/day)
LESION INCIDENCE (NUMERIC) 0 25 100 250 I III V VII
MUSCULAR AND SKELETAL SYSTEM
FEMUR/KNEE JOINT NO ABNORMALITY DETECTED
(10) 643143 643150 643185 643189 643204 643205 643235 643241 643288 643300
(1) (11) 643175 643174
643193 643194 643201 643215 643252
643259 643260 643298 643309 643315
Figure"in~parentheses is number of animals microscopically
g][ehis tlSSUS
The absence of a number indicates the lesion specified was not identified
Company Sanitized. Does not contain TSCA CBt
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5368
TABLE 44 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN MALE RATS LISTING INDIVIDUAL ANIMALS AFFECTED-
NEOPLASTIC AND NON-NEOPLASTIC (90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS
| LESION INCIDENCE (NUMERIC)
TREATMENT (mg/kg/day)
0 I
25 100 250
III V
VII
MUSCULAR AND SKELETAL SYSTEM
STERNUM NO ABNORMALITY DETECTED
(10) 643143 643150 643185 643189 643204 643205 643235 643241 643288 643300
(1) (11) 643175 643174
643193 643194 643201 643215 643252 643259 643260 643298 643309 643315
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
354
Company Sanitized. Does not contain TSCA CEIf
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5368 --------
TABLE 44 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN MALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS
TREATMENT (mg/kg/day)
LESION INCIDENCE (NUMERIC) 0 25 100 250 I III V VII
MUSCULAR AND SKELETAL SYSTEM MANDIBLE NO ABNORMALITY DETECTED
DEGENERATION, AMELOBLASTS.
(10) (10)
(9)
643143 643173 643224
643150 643179 643243
643185 643180 643247
643189 643228 643250
643204 643240 643257
643205 643264 643311
643235 643272 643314
643241 643290 643318
(10)
643288 643292
643300 643308 643275 643174
643193
643194
643201
643215
643252
643259
643260
643298
643315
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
355
Company SanWzed. Does not contain TSCACBS
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5368
TABLE 44 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN MALE RATS LISTING INDIVIDUAL ANIMALS AFFECTED-
NEOPLASTIC AND NON-NEOPLASTIC (90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS
TREATMENT (mg/kg/day)
LESION INCIDENCE (NUMERIC) 0 25 100 250 I III V VII
REPRODUCTIVE SYSTEM
TESTES NO ABNORMALITY DETECTED
SPERMATID RETENTION, SEMINIFEROUS TUBULES.
(10) 643143 643150 643185 643189 643204 643205 643235 643241 643288 643300
(1) (11) 643174 643193 643194 643201 643215 643252 643259 643260 643298 643309 643315
643175
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
356
eempany Sanitized. Pees net eontain TSCACB!
TABLE 44 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN MALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATIO )
LESIONS
| LESION
TREATMENT (mg/kg/day)
0 I
25 100 250
III V
VII
REPRODUCTIVE SYSTEM
EPIDIDYMIDES NO ABNORMALITY DETECTED
(10) 643143 643150 643185 643189 643204 643205 643235 643241 643288 643300
(1) (11) 643175 643174
643193 643194 643201 643215 643252 643259 643260 643298 643309 643315
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
Gompanf Sanitized. Does not contain TSCACW
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5368
TABLE 44 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN MALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS
TREATMENT (mg/kg/day)
LESION INCIDENCE (NUMERIC) 0 25 100 250 I III V VII
REPRODUCTIVE SYSTEM PROSTATE NO ABNORMALITY DETECTED
INFLAMMATION, SUBACUTE/CHRONIC.
(10) 643143 643150 643185 643189 643204 643205 643235 643241 643300
643288
(1) (11) 643174 643193 643194 643201 643215 643252 643259 643260 643298
643309 643175 643315
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
358
Company Sanitized. Does not contain TSCCW
H -24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5368
TABLE 44 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN MALE RATS LISTING INDIVIDUAL ANIMALS AFFECTED-
NEOPLASTIC AND NON-NEOPLASTIC (90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS
| LESION INCIDENCE (NUMERIC)
TREATMENT (mg/kg/day)
0 I
25 100 250
III V
VII
REPRODUCTIVE SYSTEM
SEMINAL VESICLES NO ABNORMALITY DETECTED
(10) 643143 643150 643185 643189 643204 643205 643235 643241 643288 643300
(1) (11) 643175 643174
643193 643194 643201 643215 643252
643259 643260 643298 643309 643315
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
359
Company San*f**ed. Does motcontain TSCA GB!
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5368
TABLE 44 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN MALE RATS LISTING INDIVIDUAL ANIMALS AFFECTED-
NEOPLASTIC AND NON-NEOPLASTIC (90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS
TREATMENT (mg/kg/day)
LESION INCIDENCE (NUMERIC) 0 25 100 250 I III V VII
CUTANEOUS SYSTEM
SKIN NO ABNORMALITY DETECTED
(10) 643143 643150 643185 643189 643204 643205 643235 643241 643288 643300
(1) (11) 643175 643174
643193 643194 643201 643215 643252 643259 643260
643298 643309 643315
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
360
Comoany SanWzed. Does not contain TSCA CB1
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5368
TABLE 44 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN MALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
..........
....
LESION INCIDENCE (NUMERIC)
LESIONS
TREATMENT (mg/kg/day)
25 100 250
III V
VII
SPECIAL SENSES SYSTEM E Y E (S) WITH OPTIC NERVE NO ABNORMALITY DETECTED
OPTIC NERVE NOT PRESENT. FOLD/ROSETTE, RETINAL.
(10 ) 643143 643150 643185 643189 643204 643235 643241 643288 643300
643205
(1 ) (1 1 ) 643175 643174
643194 643201 643215 643252 643259 643260 643298 643315 643252 643309 643193
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
361 Company Sanitized. Does not contain TSCA CBI
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5368
TABLE 44 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN MALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC (ONE-MONTH RECOVERY EVALUATION)
LESIONS
LESION INCIDENCE (NUMERIC)
Males
TREATMENT (mg/kg/day)
0 I
250 VII
DIGESTIVE SYSTEM LIVER
NECROSIS, FOCAL. INFLAMMATION, SUBACUTE/CHRONIC.
HYPERTROPHY, HEPATOCYTE, CENTRILOBULAR.
(10) (10) 643316
643162 643151 643172 643165 643195 643220 643226 643225 643237 643234 643246 643236 643253 643258 643262 643296 643303 643316 643304
643151 643165 643220 643225 643234 643236 643258 643266 643296 643316
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
362
Company Sanitized. Does not contain TSCA CBf
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5368
TABLE 44 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN MALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(ONE-MONTH RECOVERY EVALUATION)
LESIONS
LESION INCIDINCE (NUMERIC)
Males
TREATMENT (mg/kg/day)
250 VII
1
1 1
1
O H1 1
DIGESTIVE SYSTEM
LIVER FOCUS OF CELLULAR ALTERATION, BASOPHILIC. FATTY CHANGE, MEDIAN CLEFT. FATTY CHANGE, CENTRILOBULAR.
(10) (10) 643151
643253 643316 643246
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
363
Company Sanitized. Does not contain TSCA CBI
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5368
TABLE 44 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN MALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(ONE-MONTH RECOVERY EVALUATION)
LESIONS
URINARY SYSTEM KIDNEYS
NO ABNORMALITY DETECTED
NEPHROPATHY, CHRONIC PROGRESSIVE.
HYPERTROPHY, TUBULAR. HYDRONEPHROSIS, UNILATERAL.
LESION INCIDIINCE (NUMERIC)
Males
TREATMENT (mg/kg/day)
0 I
250 VII
(10) (10) 643162 643165 643172 643220 643262 643225 643303 643258 643304 643296 643195 643234 643226 643236 643237 643266 643246 643316 643253
643151 643266 643234
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
364
eumany SanWzed. Does no! contain TSCA 08f
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5368
TABLE 44 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN MALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC (ONE-MONTH RECOVERY EVALUATION)
LESIONS
LESION INCIDENCE (NUMERIC)
Males
TREATMENT (mg/kg/day)
0 I
250 VII
RESPIRATORY SYSTEM NOSE
NO ABNORMALITY DETECTED
ODONTODYSPLASIA. DEGENERATION, AMELOBLASTS.
(1 0 )
( 10)
643172 643266
643195
643226
643237
643246
643253
643262
643303
643304
643162
643151
643165
643220
643225
643234
643236
643258
643296
643316
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
365
Company Sanitized. Does not contain TSCACBt
H -24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5368
TABLE 44 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN MALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC (ONE-MONTH RECOVERY EVALUATION)
LESIONS
LYMPHATIC AND HEMATOPOIETIC SYSTEM SPLEEN
NO ABNORMALITY DETECTED THYMUS
NO ABNORMALITY DETECTED MANDIBULAR LYMPH NODE
ERYTHROCYTOSIS/ERYTHROPHAGOCYTOSIS, SINUS.
LESION INCIDENCE (NUMERIC)
Males
TREATMENT (mg/kg/day)
0 I
250 VII
(l) 643304
(1) (1) 643304 643236
(1) 643304
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
366
'Company Sanitized. Does not contain TSCA CBt
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5368
TABLE 44 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN MALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC (ONE-MONTH RECOVERY EVALUATION)
LESIONS
LESION INCIDE NCE (NUMERIC)
Males
TREATMENT (mg/kg/day)
250 VII
1 1 1 1
O Hl i
ENDOCRINE SYSTEM
THYROID GLAND ALTERATION, COLLOID.
(10) (10) 643162 643151 643172 643165 643195 643220 643226 643225 643237 643234 643246 643236 643253 643258 643262 643266 643303 643296 643304 643316
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
367
Company SanWzed D ow not contain TSCACBf
t
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
IIP
DuPont-5368
TABLE 44 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN MALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC (ONE-MONTH RECOVERY EVALUATION)
LESIONS
LESION INCIDENCE (NUMERIC)
Males
TREATMENT (mg/kg/day)
0 I
250 VII
MUSCULAR AND SKELETAL SYSTEM
MANDIBLE NO ABNORMALITY DETECTED
(10) (10) 643162 643151 643172 643165 643195 643220 643226 643225 643237 643234 643246 643236 643253 643258 643262 643266 643303 643296 643304 643316
is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
368 eomBanirS*nt9e<f. D oes no! contain TSCA CBV
H -24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5368
TABLE 44 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN MALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC (ONE-MONTH RECOVERY EVALUATION)
LESIONS
LESION INCIDI]NCE (NUMERIC)
Males
TREATMENT (mg/kg/day)
0 I
250 VII
REPRODUCTIVE SYSTEM
TESTES DEGENERATION/ATROPHY, SEMINIFEROUS TUBULES, UNILATERAL.
DEGENERATION/ATROPHY, SEMINIFEROUS TUBULES, BILATERAL.
EPIDIDYMIDES NO ABNORMALITY DETECTED OLIGOSPERMIA/GERM CELL DEBRIS, UNILATERAL.
SEMINAL VESICLES NO ABNORMALITY DETECTED
(2 )
( 1)
643226
643253
643220
(2 ) (X) 643226 643253 643220
(1 )
643220
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
369
Company Sanitized. Does not contain TSCA CBi
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5368
TABLE 44 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN MALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(THREE-MONTH RECOVERY EVALUATION)
LESIONS
DIGESTIVE SYSTEM LIVER
NECROSIS, FOCAL. INFLAMMATION, SUBACUTE/CHRONIC.
HYPERTROPHY, HEPATOCYTE, CENTRILOBULAR. FATTY CHANGE, MEDIAN CLEFT. FATTY CHANGE, CENTRILOBULAR.
| LESION INCIDENCE (NUMERIC)
TREATMENT (mg/kg/day)
0 I
25 100 250
III V
VII
(5) 643210
643145 643210 643232 643265 643268
643232
(5) (5) 643169 643283 643206 643159 643149 643169 643152 643181 643178 643206 643283 643286 643295
643152
643149
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
370
Company Sanitized. Does not contain TSCACBI
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5368
TABLE 44 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN MALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(THREE-MONTH RECOVERY EVALUATION)
LESIONS
URINARY SYSTEM KIDNEYS
NO ABNORMALITY DETECTED CALCULUS\CALCULI. NEPHROPATHY, CHRONIC PROGRESSIVE.
INFLAMMATION, SUBACUTE/CHRONIC. HYPERPLASIA, TRANSITIONAL CELL.
TREATMENT (mg/kg/day)
LESION INCIDENCE (NUMERIC) 0 25 100 250 I III V VII
(5) 643232 643265
643145 643210 643268
(5)
643149 643152 643178 643283 643295 643149 643149
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
371
Company Sanitized. Does not contain TSCA CBS
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5368
TABLE 44 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN MALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(THREE-MONTH RECOVERY EVALUATION)
LESIONS
1 LESION INCIDENCE (NUMERIC)
TREATMENT (mg/kg/day)
0 I
25 100 250
III V
VII
RESPIRATORY SYSTEM NOSE
NO ABNORMALITY DETECTED
INFLAMMATION, SUBACUTE/CHRONIC, NASOLACRIMAL DUCT. INFLAMMATION, SUBACUTE/CHRONIC.
HYPERPLASIA/SQUAMOUS METAPLASIA, RESPIRATORY, EPITHELIUM. HYPERPLASIA/HYPERTROPHY, TRANSITIONAL CELL, EPITHELIUM.
FRACTURE/CALLUS, TOOTH. DEGENERATION/NECROSIS, RESPIRATORY, EPITHELIUM. DEGENERATION, AMELOBLASTS. SCHWANNOMA [B].
(5) (5) (5) (5)
643210 643306 643169
643232
643206
643265
643286
643305 643181
643145 643202 643159 643149
643268 643293 643181 643178
643310
643283
643295
643145 643202 643159 643149
643268
643181
643202
643178
643293
643283
643310
643159
643295
643159 643152
643295
643202
[B] Benign tumour
,.
Figure in parentheses is number of animals microscopically examined for this tissue
The absence of a number indicates the lesion specified was not identified
372
Company Sanitized Does not contain TSCA CB1
H -24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5368
TABLE 44 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN MALE RATS LISTING INDIVIDUAL ANIMALS AFFECTED-
NEOPLASTIC AND NON-NEOPLASTIC (THREE-MONTH RECOVERY EVALUATION)
LESIONS ENDOCRINE SYSTEM
| LESION INCIDENCE (NUMERIC)
TREATMENT (mg/kg/day)
0 I
25 100 250
III V
VII
THYROID GLAND ALTERATION, COLLOID.
(5) (5) (5) (5) 643145 643202 643159 643149 643210 643293 643169 643152 643232 643305 643181 643178 643265 643306 643206 643283 643268 643310 643286 643295
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
373
Company Sanitized. Does no* contain TSCACBl
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5368
TABLE 45
MICROSCOPIC OBSERVATIONS IN FEMALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS
TREATMENT (mg/kg/day)
LESIOI> INCIDEINCE (NtIMERIC) 0 25 100 250 II IV VI VIII
DIGESTIVE SYSTEM LIVER
NO ABNORMALITY DETECTED NECROSIS, FOCAL. INFLAMMATION, SUBACUTE/CHRONIC.
-
HYPERTROPHY, HEPATOCYTE, CENTRILOBULAR.
FATTY CHANGE, MEDIAN CLEFT.
(10) (10) (10) (11) 643354 643321 643322 643340
643368
643362
643489
643361 643324 643323 643359
643362 643364 643366 643370
643374 643380 643367 643404
643398 643389 643392 643408
643406 643390 643409 643435
643436 643396 643461 643446
643463 643410 643462 643466
643477 643433 643472
643486 643458 643489
643332
643341
643359
643370
643404
643408
643435
643446
643466
643374 643458
N=ll in Group VIII reflects one reproduction designated animal that died on test day 53. Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
374 *e" n P"V8anllked.
Does notcontain tscacbi
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5368
TABLE 45 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN FEMALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS DIGESTIVE SYSTEM
| LESION INCIDENCE (NUMERIC)
TREATMENT
0
25 100 250
(mg/kg/day)
II IV VI VIII
LIVER FATTY CHANGE, MEDIAN CLEFT.
PANCREAS NO ABNORMA'LITY DETECTED
ATROPHY.
(10) (10) 643398
(10)
(11)
(10)
(1)
643354 643321
643361
643362
643374
643398
643406
643436
643463
643477
643486
(11) 643332 643340 643341 643359 643368 643370 643404 643408 643466
643435 643446
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
375
Oompany Sanitized. Does not contain TSCA CBt
H -24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5368
TABLE 45 (CONTINUED)
M ICROSCOPIC OBSERVATIONS IN FfEM ALE RATS LISTING INDIVIDUAL ANIM ALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS DIGESTIVE SYSTEM ESOPHAGUS
NO ABNORMALITY DETECTED
INFLAMMATION, SUBACUTE/CHRONIC.
| LESION INCIDENCE (NUMERIC)
TREATMENT (mg/kg/day)
0 II
25 100 250
IV VI
VIII
(10)
(1)
643354 643321
643361
643362
643374
643398
643406
643436
643463
643477
643486
(11) 643332 643340 643341 643359 643370 643404 643408 643435 643446 643466 643368
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
376
Company Sanitized. Does not contain TSCA CBI
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5368
TABLE 45 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN FEMALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS
i LESION INCIDENCE (NUMERIC)
TREATMENT
0
25 100 250
(mg/kg/day) II IV VI VIII
DIGESTIVE SYSTEM
STOMACH NO ABNORMALITY DETECTED
(10)
(1)
643354 643321
643361
643362
643374
643398
643406
643436
643463
643477
643486
Fiqure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
......
(11) 643332 643340 643341 643359 643368 643370 643404 643408 643435 643446 643466
__ _____
377
Company Sanitized. Does not contain TSCA CBf
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5368
TABLE 45 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN FEMALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS
DIGESTIVE SYSTEM DUODENUM
NO ABNORMALITY DETECTED
'
| LESION INCIDENCE (NUMERIC)
i 1l 1H 1O H 1
TREATMENT (mg/kg/day)
25 100 250 IV VI VIII
(10)
(1)
643354 643321
643361
643362
643374
643398
643406
643436
643463
643477
643486
(11) 643332 643340 643341 643359 643368 643370 643404 643408 643435 643446 643466
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
378
Company SsniPzed, Coes no! confata TSCA CBf
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5368
TABLE 45 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN FEMALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS DIGESTIVE SYSTEM JEJUNUM
NO ABNORMALITY DETECTED
AUTOLYSIS: NECROPSY AND HISTOLOGY PERFORMED.
i ... -- i
11 11 |1 1 H1 1I O H I1
| LESION INCIDENCE (NUMERIC)
TREATMENT (mg/kg/day)
25 100 250 IV VI VIII
(10)
(1)
643354 643321
643361
643362
643374
643398
643406
643436
643463
643477
643486
(11) 643332 643340 643341 643359 643368 643370 643404 643408 643435 643446 643466 643340 643368
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
379
Company Sanitized. Does not contain TSCA CB!
H -24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5368
TABLE 45 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN FEMALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS
| LESION INCIDENCE (NUMERIC)
1 O1
I1 1 .1- 1I
TREATMENT (mg/kg/day)
25 100 250
IV VI
VIII
H H
DIGESTIVE SYSTEM
ILEUM NO ABNORMALITY DETECTED
(10)
(1)
643354 643321
643361
643362
643374
643398
643406
643436
643463
643477
643486
(11) 643332 643340 643341 643359 643368 643370 643404 643408 643435 643446 643466
Figure in parentheses is number of animals microscopically examined f:or this tissue The absence of a number indicates the lesion specified was not identified
380
Sanitized. Does not contain TSCACBf
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5368
TABLE 45 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN FEMALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS
DIGESTIVE SYSTEM CECUM
NO ABNORMALITY DETECTED
| LESION INCIDENCE (NUMERIC)
1 1 1 1H 1O H 1
TREATMENT (mg/kg/day)
25 100 250 IV VI VIII
(10)
(1)
643354 643321
643361
643362
643374
643398
643406
643436
643463
643477
643486
(11) 643332 643340 643341 643359 643368 643370 643404 643408 643435 643446 643466
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
381
Company Sanitized. Does not contain TSCACBS
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5368
TABLE 45 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN FEMALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
.1 --.... .
1 1 1 lH 1O H 11
LESIONS
| LESION INCIDENCE (NUMERIC)
TREATMENT (mg/kg/day)
25 100 250
IV >VI
VIII
DIGESTIVE SYSTEM
COLON NO ABNORMALITY DETECTED
(10)
(1)
643354 643321
643361
643362
643374
643398
643406
643436
643463
643477
643486
(11) 643332 643340 643341 643359 643368 643370 643404 643408 643435 643446 643466
Figure, in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
382
ftampany Sanitized. Doe* not contain TSCA Cffl
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5368
TABLE 45 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN FEMALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS
i LESION INCIDENCE (NUMERIC)
TREATMENT
0
25 100 250
(mg/kg/day) II IV VI VIII
DIGESTIVE SYSTEM
RECTUM NO ABNORMALITY DETECTED
(10)
(1)
643354 643321
643361
643362
643374
643398
643406
643436
643463
643477
643486
(11) 643332 643340 643341 643359 643368 643370 643404 643408 643435 643446 643466
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
383
.m .M . floes tie* coefafn TSCA CBI
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5368
TABLE 45 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN FEMALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS
DIGESTIVE' SYSTEM SALIVARY GLANDS
NO ABNORMALITY DETECTED
TREATMENT (mg/kg/day)
LESION INCIDENCE (NUMERIC) 0 25 100 250 II IV VI VIII
(10)
(1)
(11)
643354 643321
643332
643361
643340
,
643362
643341
643374
643359
643398
643368
643406
643370
643436
643404
643463
643408
643477
643435
643486
643446
643466
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
384
Company Sanitized. Does not contain TSCA CBI
H -24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5368
TABLE 45 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN FEMALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS
URINARY SYSTEM KIDNEYS
NO ABNORMALITY DETECTED
NEPHROPATHY, CHRONIC PROGRESSIVE.
NECROSIS, TUBULAR. INFLAMMATION, ACUTE. INFARCT. HYPERPLASIA, TRANSITIONAL CELL. HYDRONEPHROSIS, BILATERAL. CYST. AUTOLYSIS: NECROPSY AND HISTOLOGY PERFORMED.
1 LESION INCIDENCE (NUMERIC)
TREATMENT
0
25 100 250
(mg/kg/day)
II IV VI VIII
(10) (10) (10) (11)
643354 643324 643322 643332
643361 643380 643366 643340
643374 643389 643367 643341
643406 643390 643409 643359
643463 643410 643461 643368
643486 643433 643462 643435
643458 643472 643446
643362 643364 643323 643370
643398 643396 643392 643404
643477
643489 643408
643466
643321
643321
643370
643321
&43321
643436
643368
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
385
Company Sanitized Does no! contain TSCA CB
H -24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5368
TABLE 45 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN FEMALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS URINARY SYSTEM URINARY BLADDER
NO ABNORMALITY DETECTED
HYPERPLASIA, SIMPLE, TRANSITIONAL CELL.
| LESION INCIDENCE (NUMERIC)
1i 1 1 1 1H 1O H i
TREATMENT (mg/kg/day)
25 100 250 IV VI VIII
(10)
(1)
643354
643361
643362
643374
643398
643406
643436
643463
643477
643486
643321
(10) 643332 643340 643341 643359 643368 643370 643404 643408 643446 643466
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
386
'Centoatw Sws5?!*i ISoea no* contato TSC CBI
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5368
TABLE 45 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN FEMALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS
TREATMENT (mg/kg/day)
LESION INCIDENCE (NUMERIC) 0 25 100 250 II IV >VI VIII
RESPIRATORY SYSTEM LUNGS
NO ABNORMALITY DETECTED
THROMBUS.
(10) (1) (1) (ID
643354 643321 643392 643332
643361
643340
643362
643341
643374 643398 643406 643436 643477 643486
643359 643368 643370 643404 643408 643435 643446
643466
643463
Figur in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
387
Company Sanitized. Does not contain TSCA CBf
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-G.eneration Reproduction Evaluations
DuPont-5368
TABLE 45 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN FEMALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS
RESPIRATORY SYSTEM TRACHEA
NO ABNORMALITY DETECTED
TREATMENT (mg/kg/day)
LESION INCIDENCE (NUMERIC) 0 25 100 250 II IV VI VIII
(10)
(1)
643354 643321
643361
643362
643374
643398
643406
643436
643463
643477
643486
(11) 643332 643340 643341 643359 643368 643370 643404 643408 643435 643446 643466
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
388
Does not contain TSCA CBI
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5368
TABLE 45 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN FEMALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS
RESPIRATORY SYSTEM PHARYNX /LARYNX
NO ABNORMALITY DETECTED
TREATMENT (mg/kg/day)
LESION INCIDENCE (NUMERIC) 0 25 100 250 II IV VI VIII
(10)
(1)
643354 643321
643361
643362
643374
643398
643406
643436
643463
643477
643486
(11) 643332 643340 643341 643359 643368 643370 643404 643408 643435 643446 643466
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
389
Compan^ Sanitized. Does not contain TSCA CBI
H -24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5368
TABLE 45 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN FEMALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS RESPIRATORY SYSTEM NOSE
NO ABNORMALITY DETECTED
INFLAMMATION, SUBACUTE/CHRONIC. FRACTURE/CALLUS, TOOTH. DEGENERATION, AMELOBLASTS.
*5
TREATMENT (mg/kg/day)
LESI03S INCIDIINCE (NtIMERIC) 0 25 100 250 II IV VI VIII
(10) (10) (10) (11)
643354 643321 643323
643361 643324 643392
643362 643364 643462
643374 643380 643489
643398 643390
643406 643396
643436 643410
643463 643433
643477 643458
643486 643389
643340
643389
643322 643332
643366 643340
643367 643341
643409 643359
643461 643368
643472 643370
643404
643408
643435
643446
F ig u r e i n p a r e n th e s e s i s n u m b e r o f a n im a ls m ic r o s c o p ic a lly e x a m in e d f o r t h i s T he a b se n c e o f a n u m b er in d ic a te s th e le s io n s p e c if ie d w as n o t id e n tif ie d
tis s u e
390
Company Sanitized. Does not contain TSCA CBf
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5368
TABLE 45 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN FEMALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS RESPIRATORY SYSTEM
| LESION INCIDENCE (NUMERIC)
TREATMENT
0
25 100 250
(mg/kg/day)
II IV VI VIII
NOSE DEGENERATION, AMELOBLASTS.
(10)
(10)
(10) (11) 643466
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
391
SanWgetf. Does no! eonWn T S C A W
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5368
TABLE 45 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN FEMALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS CARDIOVASCULAR SYSTEM HEART
NO ABNORMALITY DETECTED
CARDIOMYOPATHY.
TREATMENT (mg/kg/day)
LESION INCIDENCE (NUMERIC) 0 25 100 250 II IV ' VI VIII
(10) 643354 643361 643374 643406 643463 643477 643486
(1)
643362 643321 643398 643436
(11) 643332 643340 643341 643359 643368 643370 643404 643408 643435 643446 643466
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
392
Company Sanitized. Does not contain trca c a t
H -24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5368
TABLE 45 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN FEMALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS
CARDIOVASCULAR SYSTEM AORTA
NO ABNORMALITY DETECTED
TREATMENT (mg/kg/day)
LESION INCIDENCE (NUMERIC) 0 25 100 250 II IV VI VIII
(10)
(1)
643354 643321
643361
643362
643374
643398
643406
643436
643463
643477
643486
(11) 643332 643340 643341 643359 643368 643370 643404 643408 643435 643446 643466
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
393
Company Sanitized. Does not contain TSCA CBS
H -24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5368
TABLE 45 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN FEMALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS LYMPHATIC AND HEMATOPOIETIC SYSTEM SPLEEN
NO ABNORMALITY DETECTED
DEPLETION, LYMPHOID.
,
TREATMENT (mg/kg/day)
l 1 11 H 1O H 1
LESION INCIDENCE (NUMERIC)
25 100 250
IV VI
VIII
(10)
(1)
643354
643361
643362
643374
643398
643406
643436
643463
643477
643486
643321
(10) 643332 643359 643370 643404 643408 643435 643446 643466
643340 643368
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
394
Company Sanitized. Does not contain TSCA CB
]r ' ` H -2 4 5 16: Subchronic Toxicity
90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
IP
DuPont-5368
TABLE 45 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN FEMALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS LYMPHATIC AND HEMATOPOIETIC SYSTEM THYMUS
NO ABNORMALITY DETECTED
ATROPHY.
| LESION INCIDENCE (NUMERIC)
1 O1
1 t 1 1
TREATMENT (mg/kg/day)
H H
25 100 250 IV VI VIII
(10)
(1)
643354
643361
643362
643374
643398
643406
643436
643463
643477
643486
643321
(11) 643332 643341 643359 643370 643404 643408 643435 643446 643466
643340 643368
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
395
Company SanifHzed. Does noi contain TSC CB
H -24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5368
TABLE 45 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN FEMALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS
LYMPHATIC AND HEMATOPOIETIC SYSTEM MANDIBULAR LYMPH NODE
NO ABNORMALITY DETECTED
TREATMENT (mg/kg/day)
LESION INCIDENCE (NUMERIC) 0 25 100 250 II IV VI VIII
(10)
(1)
643354 643321
643361
643362
643374
643398
643406
643436
643463
643477
643486
(l'l) 643332 643340 643341 643359 643368 643370 643404 643408 643435 643446 643466
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
396
Company Sanitized. Does not contain TSCACBI
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5368
TABLE 45 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN FEMALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS
LYMPHATIC AND HEMATOPOIETIC SYSTEM MESENTERIC LYMPH NODE
NO ABNORMALITY DETECTED
11 1M 1O H I
| LESION INCIDENCE (NUMERIC)
TREATMENT (mg/kg/day)
25 100 250
IV VI
VIII
(9) (1) 643354 643321 643361 643362 643374 643398 643406 643436
643463 643477
(9) 643332 643340 643341 643359 643368 643404 643408 643435 643446
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
397
Bompany Sanitized. B ees not contan TSC CBf
u - i t j i u . ouucinomc oxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5368
TABLE 45 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN FEMALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS LYMPHATIC AND HEMATOPOIETIC SYSTEM BONE MARROW
NO ABNORMALITY DETECTED
HYPERPLASIA, GRANULOCYTIC. ATROPHY.
TREATMENT (mg/kg/day)
LESION INCIDENCE (NUMERIC) 0 25 100 250 II IV VI VIII
(10) 643354 643361 643362 643374 643398 643406 643436 643463 643477 643486
(1)
643321
(11) 643332 643340 643341 643359 643370 643404 643408 643435 643446 643466 643368
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
398
olaonllntSCACffl
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5368
TABLE 45 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN FEMALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS
ENDOCRINE SYSTEM PITUITARY GLAND
NO ABNORMALITY DETECTED
TREATMENT (mg/kg/day)
LESION INCIDENCE (NUMERIC) 0 25 100 250 II IV VI VIII
(10)
(1)
643354 643321
643361
643362
643374
643398
643406
643436
643463
643477
643486
(11) 643332 643340 643341 643359 643368 643370 643404 643408 643435 643446 643466
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
399
ompany Sanitized, Does not contain TSCACBf
H -24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5368
TABLE 45 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN FEMALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESION INCIDENCE (NUMERIC)
LESIONS
TREATMENT
0
25 100 250
(mg/kg/day)
II IV VI VIII
ENDOCRINE SYSTEM
THYROID GLAND NO ABNORMALITY DETECTED
HYPERTROPHY, FOLLICULAR. ALTERATION, COLLOID.
(10) (10) (10) (11)
643354 643321 643322 643340
643361 643364 643323 643368
643362 643390 643367 643370
643374 643396 643392
643398
643409
643406
643472
643436
643463
643477
643486
643359
643404
643408
643435
643446
643466
643324 643366 643332
643380 643461 643341
643389 643462 643359
643410 643489 643408
643433
643435
643458
643446
F ig u r e in p a r e n th e s e s i s n u m b e r o f a n im a ls m ic r o s c o p ic a lly e x a m in e d f o r t h i s T he a b se n c e o f a n u m b er in d ic a te s th e le s io n s p e c if ie d w as n o t id e n tif ie d
tis s u e
400 Company Sanitized. Does not contain TSCA CBI
H -24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5368
TABLE 45 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN FEMALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS
| LESION INCIDENCE (NUMERIC)
TREATMENT
0
25 100 250
(mg/kg/day) II IV VI VIII
ENDOCRINE SYSTEM
THYROID GLAND ALTERATION, COLLOID.
PARATHYROID GLANDS NO ABNORMALITY DETECTED
(10)
(10)
(10) (11) 643466
(6) (1) 643354 643321 643362 643374 643406 643436 643463
(7) 643332 643341 643368 643404 643408 643435 643466
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
401 Company Sanitized. Does not contain TSCA CBI
H -24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5368
TABLE 45 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN FEMALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS
TREATMENT (mg/kg/day)
LESION INCIDENCE (NUMERIC) 0 25 100 250 II IV Vi Vili
ENDOCRINE SYSTEM
ADRENAL GLANDS NO ABNORMALITY DETECTED
(10)
(1)
fi41154 643321
643361
643362
643374
643398
643406
643436
643463
643477
643486
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
(11) 643332 643340 643341 643359 643368 643370 643404 643408 643435 643446 643466
--
402
Company Sanitized. Does not contain TSCA CBI
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5368
TABLE 45 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN FEMALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS
TREATMENT (mg/kg/day)
LESION INCIDENCE (NUMERIC) 0 25 100 250 II IV VI VIII
NERVOUS SYSTEM
BRAIN NO ABNORMALITY DETECTED
(10)
(1)
643354 643321
643361
643362
643374
643398
643406
643436
643463
643477
643486
(11) 643332 643340 643341 643359 643368 643370 643404 643408 643435 643446 643466
y examined for this tissue The absence of a number indicates the lesion specified was not identified
403
Company Sanitized. Does not contain TSCA CBI
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5368
TABLE 45 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN FEMALE RATS LISTING INDIVIDUAL ANIMALS AFFECTED-
NEOPLASTIC AND NON-NEOPLASTIC (90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS
TREATMENT (mg/kg/day)
LESION INCIDENCE (NUMERIC) 0 25 100 250 II IV VI VIII
NERVOUS SYSTEM
SPINAL CORD NO ABNORMALITY DETECTED
(10)
(1)
643354 643321
643361
643362
643374
643398
643406
643436
643463
643477
643486
(1 1 ) 643332 643340 643341 643359 643368 643370 643404 643408 643435 643446 643466
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
npnir SunUteed. D m notcoM.fr, JSCA CBf
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5368
TABLE 45 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN FEMALE RATS LISTING INDIVIDUAL ANIMALS AFFECTED-
NEOPLASTIC AND NON-NEOPLASTIC (90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS
NERVOUS SYSTEM SCIATIC NERVE
NO ABNORMALITY DETECTED
| LESION INCIDENCE (NUMERIC)
TREATMENT (mg/kg/day)
0 II
25 100 250
IV VI VIII
----
(10)
(1)
643354 643321
643361
643362
643374
643398
643406
643436
643463
643477
643486
(11) 643332 643340 643341 643359 643368 643370 643404 643408 643435 643446 643466
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
405
Company Sanitized. Doe* not contain TSCA CBI
i
H-24516: Subchronic Toxicity
,.
90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5368 ..... .. .--...
TABLE 45 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN FEMALE RATS LISTING INDIVIDUAL ANIMALS AFFECTED-
NEOPLASTIC AND NON-NEOPLASTIC (90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
-------------------
! LESION INCIDENCE (NUMERIC)
LESIONS
TREATMENT
0
25 100 250
(mg/.kg/day) II IV VI VIII
MUSCULAR AND SKELETAL SYSTEM
SKELETAL MUSCLE NO ABNORMALITY DETECTED
(10)
(1)
643354 643321
643361
643362
643374
643398
643406
643436
643463
643477
643486
(11) 643332 643340 643341 643359 643368 643370 643404 643408 643435 643446 643466
Fiqure"inTparentheses is number of animals microscopically examined for this tissue The9 absence of a number indicates the lesion specified was not identified
406
Company Sanitized. Does not contain TSCA CBI
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5368
TABLE 45 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN FEMALE RATS LISTING INDIVIDUAL ANIMALS AFFECTED-
NEOPLASTIC AND NON-NEOPLASTIC (90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS
TREATMENT (mg/kg/day)
LESION INCIDENCE (NUMERIC) 0 25 100 250 II IV VI VIII
MUSCULAR AND SKELETAL SYSTEM
FEMUR/KNEE JOINT NO ABNORMALITY DETECTED
(10)
(1)
643354 643321
643361
643362
643374
643398
643406
643436
643463
643477
643486
(ID 643332 643340 643341 643359 643368 643370 643404 643408 643435 643446 643466
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
407
Company Sanitized. Does not contain TSCA CBI
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5368
TABLE 45 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN FEMALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION))
LESIONS
TREATMENT (mg/kg/day)
LESION INCIDENCE (NUMERIC) 0 25 100 250 II IV VI VIII
MUSCULAR AND SKELETAL SYSTEM
STERNUM NO ABNORMALITY DETECTED
(10)
(1)
643354 643321
643361
643362
643374
643398
643406
643436
643463
643477
643486
(ID
643332 643340 643341 643359 643368 643370 643404 643408 643435 643446 643466
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
408
Company Sanitized. Does not contain TSCA CBI
H -24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5368
TABLE 45 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN FEMALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS
| LESION INCIDENCE (NUMERIC)
TREATMENT 0
25 100 250
(mg/kg/day) II IV VI VIII
MUSCULAR AND SKELETAL SYSTEM MANDIBLE
NO ABNORMALITY DETECTED
DEGENERATION, AMELOBLASTS.
(10)
(9) (10)
(8)
643354 643324 643322 643404
643361 643364 643323
643362 643380 643366
643374 643389 643367
643398 643390 643392
643406 643396 643409 643436 643410 643461
643463 643433 643462
643477 643458 643472
643486
643489
643332
643341
643359
643370
643435
643446
643466
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
--
409
Company Sanitized. Does not contain TSCA CBI
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5368
TABLE 45 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN FEMALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS
TREATMENT (mg/kg/day)
LESION INCIDENCE (NUMERIC) 0 25 100 250 II IV VI VIII
REPRODUCTIVE SYSTEM
OVARIES NO ABNORMALITY DETECTED
(10)
(1)
643354 643321
643361
643362
643374
643398
643406
643436
643463
643477
643486
(11) 643332 643340 643341 643359 643368 643370 643404 643408 643435 643446 643466
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
410
Do* not conia!" TSCA CBI C o m p l y Sanitized.
H -24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5368
TABLE 45 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN FEMALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS
| LESION INCIDENCE (NUMERIC)
TREATMENT (mg/kg/day)
0 II
25 100 250
IV 'VI
VIII
REPRODUCTIVE SYSTEM UTERUS
NO ABNORMALITY DETECTED
DILATATION, LUMEN.
(10)
(1)
643354 643321
643361
643362
643374
643398
643406
643436
643463
643477
643486
(11) 643340 643359 643368 643370 643404 643408 643446 643466
643332 643341 643435
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
411
Company Sanitized. Does not contain TSCA CBI
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5368
TABLE 45 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN FEMALE RATS LISTING INDIVIDUAL ANIMALS AFFECTED-
NEOPLASTIC AND NON-NEOPLASTIC (90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS
TREATMENT (mg/kg/day)
LESION INCIDENCE (NUMERIC) 0 25 100 250 II IV VI VIII
REPRODUCTIVE SYSTEM
MAMMARY GLAND (FEMALE) NO ABNORMALITY DETECTED
(10)
(1)
643354 643321
643361
643362
643374
643398
643406
643436
643463
643477
643486
(11) 643332 643340 643341 643359 643368 643370 643404 643408 643435 643446 643466
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
412
Company Sanitized. Does not contain TSCA CBI
H -24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5368
TABLE 45 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN FEMALE RATS LISTING INDIVIDUAL ANIMALS AFFECTED-
NEOPLASTIC AND NON-NEOPLASTIC (90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS
TREATMENT (mg/kg/day)
LESION INCIDENCE (NUMERIC) 0 25 100 250 II IV VI VIII
CUTANEOUS SYSTEM
SKIN NO ABNORMALITY DETECTED
(10)
(1)
643354 643321
643361
643362
643374
643398
643406
643436
643463
643477
643486
(11) 643332 643340 643341 643359 643368 643370 643404 643408 643435 643446 643466
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
413
Company Sanitized. Does not contain TSCA CBI
H -24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5368
TABLE 45 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN FEMALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS SPECIAL SENSES SYSTEM
LESION INCIDENCE (NUMERIC)
TREATMENT
0
25 100 250
(mg/kg/day)
II IV VI VIII
EYE(S) WITH OPTIC NERVE NO ABNORMALITY DETECTED
OPTIC NERVE NOT PRESENT. AUTOLYSIS: NECROPSY AND HISTOLOGY PERFORMED.
(10)
(1)
643354 643321
643361
643362
643374
643398
643406
643436
643463
643477
643486
643463 643477
(11) 643332 643340 643341 643359 643368 643370 643404 643408 643435 643446 643466 643370 643446 643466 643340
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
414
Company Sanitized. Does not contain TSCA CBI
H -24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5368
TABLE 45 (CONTINUED)
M ICROSCOPIC OBSERVATIONS IN FEMALE RATS LISTING INDIVIDUAL ANIMALS AFFECTED-
NEOPLASTIC AND NON-NEOPLASTIC (90-DAY EXPOSURE EVALUATION INCLUDING EARLY DEATHS FROM THE REPRODUCTION EVALUATION)
LESIONS
| LESION INCIDENCE (NUMERIC)
1----1 1
1
1H
1O
I
TREATMENT (mg/kg/day)
H
50 250 1000 IV VI VIII
DIGESTIVE SYSTEM
PANCREAS NO ABNORMALITY DETECTED
ATROPHY.
(10)
641240 641245 641249 641283 641293 641384
641257 641290 641335 641344
(10)
641237 641275 641279 641299 641300 641314 641326 641327 641380 641390
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
415
Company Sanitized. Does not contain TSCA CBI
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5368
TABLE 45 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN FEMALE RATS LISTING INDIVIDUAL ANIMALS AFFECTED-
NEOPLASTIC AND NON-NEOPLASTIC (ONE-MONTH RECOVERY EVALUATION)
LESIONS
LESION INCIDENCE (NUMERIC)
Female
TREATMENT (mg/kg/day)
'0 II
250 VIII
DIGESTIVE SYSTEM LIVER
NO ABNORMALITY DETECTED NECROSIS, FOCAL. INFLAMMATION, SUBACUTE/CHRONIC.
FATTY CHANGE, MEDIAN CLEFT.
(10) (10) 643415 643351 643405 643444 643330 643345 643336 643347 643377 643358 643387 643423 643405 643441 643426 643444 643448 643456 643453 643474
643481 643425 643441
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
416
Company Sanitized. Does not contain TSCA CBI
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5368
TABLE 45 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN FEMALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC (ONE-MONTH RECOVERY EVALUATION)
LESIONS
LESION INCIDENCE (NUMERIC)
Female
TREATMENT (mg/kg/day)
0 II
250 VIII
DIGESTIVE SYSTEM
PANCREAS NO ABNORMALITY DETECTED
ESOPHAGUS NO ABNORMALITY DETECTED
STOMACH NO ABNORMALITY DETECTED
DUODENUM NO ABNORMALITY DETECTED
JEJUNUM NO ABNORMALITY DETECTED
(1 )
643336
(1 )
643336
(1 )
643336
(1 )
643336
U) 643336
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
417
Company Sanitized. Does not contain TSCACBI
H -24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5368
TABLE 45 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN FEMALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC (ONE-MONTH RECOVERY EVALUATION)
1 M1 1O HI
LESIONS
LESION INCIDENCE (NUMERIC)
Female
TREATMENT (mg/kg/day)
250 VIII
DIGESTIVE SYSTEM
ILEUM NO ABNORMALITY DETECTED
CECUM NO ABNORMALITY DETECTED
COLON NO ABNORMALITY DETECTED
RECTUM NO ABNORMALITY DETECTED
SALIVARY GLANDS NO ABNORMALITY DETECTED
(l) 643336
(1) 643336
(1) 643336
(1) 643336
(1) 643336
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
418
not contain TSCACBI
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5368
TABLE 45 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN FEMALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC (ONE-MONTH RECOVERY EVALUATION)
LESIONS
URINARY SYSTEM KIDNEYS
NO ABNORMALITY DETECTED
NEPHROPATHY, CHRONIC PROGRESSIVE.
NECROSIS, TUBULAR. MINERALIZATION. INFLAMMATION, ACUTE. HYPERPLASIA, TRANSITIONAL CELL. HYDRONEPHROSIS, BILATERAL. CYST.
LESION INCIDI3NCE (NUMERIC)
Female
TREATMENT (mg/kg/day)
0 II
250 VIII
(10) (10) 643387 643345 643405 643347 643448 643351
643474 643330 643358 643377 643423 643415 643441 643426 643444 643453 643456
643481 643336 643336 643336 643336 643425 643453
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
419
Company Sanitized. Does no! contain TSCA CBI
H -24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5368
TABLE 45 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN FEMALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC (ONE-MONTH RECOVERY EVALUATION)
LESIONS
LESION INCIDEINCE (NUMERIC)
Female
TREATMENT (mg/kg/day)
0 II
250 VIII
URINARY SYSTEM
URINARY BLADDER INFLAMMATION, SUBACUTE/CHRONIC. HYPERPLASIA, SIMPLE, TRANSITIONAL CELL. HEMORRHAGE.
(1) 643336 643336
643336
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
420
Company SanHTzed. Does not contain TSCA CBI
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5368
TABLE 45 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN FEMALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC (ONE-MONTH RECOVERY EVALUATION)
LESIONS
LESION INCIDENCE (NUMERIC)
Female
TREATMENT (mg/kg/day)
0 II
250 VIII
RESPIRATORY SYSTEM
LUNGS NO ABNORMALITY DETECTED
TRACHEA NO ABNORMALITY DETECTED
PHARYNX/LARYNX NO ABNORMALITY DETECTED
(1) 643336
(1) 643336
(1) 643336
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
421
Company Sanitized. Does not contain TSCA CB1
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5368
TABLE 45 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN FEMALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC (ONE-MONTH RECOVERY EVALUATION)
LESION INCIDENCE (NUMERIC)
Female
LESIONS
TREATMENT (mg/kg/day)
0 II
250 VIII
RESPIRATORY SYSTEM NOSE
NO ABNORMALITY DETECTED
SQUAMOUS HYPERPLASIA, NASOLACRIMAL DUCT. INFLAMMATION, SUBACUTE/CHRONIC, NASOLACRIMAL DUCT. DEGENERATION, AMELOBLASTS.
(10) (10) 643330 643351 643336 643423 643377 643474 643387 643405 643425 643426 643448 643453 643415
643456 643345 643347 643358 643441 643444 643456 643481
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
422
"pany Sanitized. Does not contain TSCA CBl
H -24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5368
TABLE 45 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN FEMALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC (ONE-MONTH RECOVERY EVALUATION)
LESIONS
CARDIOVASCULAR SYSTEM HEART
NO ABNORMALITY DETECTED AORTA
NO ABNORMALITY DETECTED
LESION INCIDI;NCE (NUMERIC)
Female
TREATMENT (mg/kg/day)
-0 II
250 VIII
(1) 643336
(1) 643336
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
423
Company Sanitized Does not contain TSCA CBI
H -24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5368
TABLE 45 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN FEMALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC (ONE-MONTH RECOVERY EVALUATION)
LESIONS
LYMPHATIC AND HEMATOPOIETIC SYSTEM
SPLEEN NO ABNORMALITY DETECTED
THYMUS ATROPHY.
MANDIBULAR LYMPH NODE NO ABNORMALITY DETECTED
MESENTERIC LYMPH NODE NO ABNORMALITY DETECTED
BONE MARROW HYPERPLASIA, GRANULOCYTIC.
LESION INCIDIJNCE (NUMERIC)
Female
TREATMENT (mg/kg/day)
0 II
250 VIII
(l) 643336
(1) 643336
(1) 643336
(1) 643336
(1) 643336
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
424
Company Sanitized. Does not contain TSCA CBI
H -24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5368
TABLE 45 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN FEMALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC (ONE-MONTH RECOVERY EVALUATION)
LESIONS
LESION INCIDENCE (NUMERIC)
Female
TREATMENT (mg/kg/day)
0 II
250 VIII
ENDOCRINE SYSTEM PITUITARY GLAND
NO ABNORMALITY DETECTED HYPERPLASIA, DIFFUSE. THYROID GLAND NO ABNORMALITY DETECTED
ALTERATION, COLLOID.
(2) 643336 643415
(10) (10) 643336 643347 643387 643415 643448 643453 643330 643345 643377 643351 643405 643358 643425 643423 643426 643441
643444 643456 643474 643481
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
425
S&nRtzed. Does no!contain TSCA CUT
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5368
TABLE 45 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN FEMALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC (ONE-MONTH RECOVERY EVALUATION)
LESIONS
LESION INCIDEINCE (NUMERIC)
Female
TREATMENT (mg/kg/day)
0 II
250 VIII
ENDOCRINE SYSTEM
PARATHYROID GLANDS NO ABNORMALITY DETECTED
ADRENAL GLANDS NO ABNORMALITY DETECTED
(1) 643336
(1) 643336
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
426
Company Sanitized. Does not contain TSCA CBI
H -24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5368
TABLE 45 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN FEMALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC (ONE-MONTH RECOVERY EVALUATION)
LESIONS
NERVOUS SYSTEM BRAIN
NO ABNORMALITY DETECTED SPINAL CORD .
NO ABNORMALITY DETECTED SCIATIC NERVE
NO ABNORMALITY DETECTED
LESION INCIDI1NCE (NUMERIC)
Female
TREATMENT (mg/kg/day)
0 II
250 VIII
(1) 643336
(1) 643336
(1) 643336
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
427
Ccmnany Sanitized. Does not contain TSCA CB!
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5368
TABLE 45 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN FEMALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC (ONE-MONTH RECOVERY EVALUATION)
LESIONS
LESION INCIDENCE (NUMERIC)
Female
TREATMENT (mg/kg/day)
e ii
250 VIII
MUSCULAR AND SKELETAL SYSTEM
SKELETAL MUSCLE NO ABNORMALITY DETECTED
FEMUR/KNEE JOINT NO ABNORMALITY DETECTED
STERNUM NO ABNORMALITY DETECTED
MANDIBLE NO ABNORMALITY DETECTED
(U 643336
(1) 643336
(1) 643336
(10) (10) 643330 643345 643336 643347 643377 643351 643387 643358 643405 643423 643415 643441 643425 643444 643426 643456 643448 643474 643453 643481
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
428
Company Sanitized. Does not contain TSCA CBI
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5368
TABLE 45 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN FEMALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC (ONE-MONTH RECOVERY EVALUATION)
1 H1 1O Ml
LESIONS
LESION INCIDENCE (NUMERIC)
Female
TREATMENT (mg/kg/day)
250 VIII
REPRODUCTIVE SYSTEM
OVARIES NO ABNORMALITY DETECTED
UTERUS NO ABNORMALITY DETECTED
MAMMARY GLAND (FEMALE) NO ABNORMALITY DETECTED
(U 643336
(1) 643336
(1) 643336
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
429
Company Sanitized. Does not contain TSCA CBI
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5368
TABLE 45 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN FEMALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC (ONE-MONTH RECOVERY EVALUATION)
LESIONS CUTANEOUS SYSTEM
LESION INCIDI3NCE (NUMERIC)
Female
TREATMENT (mg/kg/day)
0 II
250 VIII
SKIN NO ABNORMALITY DETECTED
(I) 643336
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
430
Company Sanitized. Does not contain TSCA CBI
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5368
TABLE 45 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN FEMALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC (ONE-MONTH RECOVERY EVALUATION)
LESIONS SPECIAL SENSES SYSTEM
LESION INCIDI:NCE (NUMERIC)
Female
TREATMENT (mg/kg/day)
0 II
250 VIII
EYE(S) WITH OPTIC NERVE NO ABNORMALITY DETECTED
(1) 643336
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
431
Company Sanitized. Does not contain TSCACBI
H -24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5368
TABLE 45 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN FEMALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(THREE-MONTH RECOVERY EVALUATION)
LESIONS
I LESION INCIDENCE (NUMERIC)
TREATMENT
0
25 100 250
(mg/kg/day) II IV VI VIII
RESPIRATORY SYSTEM NOSE
NO ABNORMALITY DETECTED
INFLAMMATION, SUBACUTE/CHRONIC.
HYPERPLASIA/SQUAMOUS METAPLASIA, TRANSITIONAL CELL.
DEGENERATION, AMELOBLASTS.
(5) 643384 643402
643383 643465 643484 643383 643465 643484
(5) (5) 643373 643487 643382 643412 643360 643356 643381 643450
643360 643356 643381 643388
643450 643329 643356
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
432
Company Sanitized. Does not contain TSCA CBI
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5368
TABLE 45 (CONTINUED)
MICROSCOPIC OBSERVATIONS IN FEMALE RATS LISTING INDIVIDUAL ANIMALS AFFECTEDNEOPLASTIC AND NON-NEOPLASTIC
(THREE-MONTH RECOVERY EVALUATION)
LESIONS
ENDOCRINE SYSTEM THYROID GLAND
NO ABNORMALITY DETECTED ALTERATION, COLLOID.
| LESION INCIDENCE (NUMERIC)
TREATMENT
0
25 100 250
(mg/kg/day) II IV VI VIII
------
(5) (4) (5) (5)
643382
643383 643379 643360 643329
643384 643391 643373 643356
643402 643437 643381 643388
643465 643483 643412 643450
643484
643487
Figure in parentheses is number of animals microscopically examined for this tissue The absence of a number indicates the lesion specified was not identified
433
Company Sanitized. Does not contain TSCA CBI
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5368
TABLE 46
MEAN BODY WEIGHTS AND MEAN BODY WEIGHT GAINS OF Pj MALE RATS
GROUP DOSE (mg/kg/day)
N
TEST DAY
78 85 92 99 106
1-0 III-O V-0 VII-0 0 25 100 250
20 20 20 19
MEAN BODY WEIGHT (grams)
555.6(62.6)3 569.5(63.3) 583.4(64.4) 595.7(63.2) 607.6(64.7)
543.9 (52.9) 555.3(54.7) 568.8(56.5) 582.2(58.0) 590.5(62.5)
547.5 (36.3) 559.3 (39.0) 569.5(40.7) 579.1(45.6) 574.2 (52.3)
495.0 (48.1)* 516.1 (47.0)* 531.1(51.7)* 539.0 (59.8)* 547.2 (65.3)*
GROUP 1-0 III-O V-0 VII-0
DOSE
0
25 100 250
(mg/kg/day) N 20 20 20 19
TEST DAYS
MEAN BODY WEIGHT GAIN (grams)
78-85 85-92 92-99 99-106
13.9 (6.1)a 13.9(6.7) 12.3 (5.5) 12.0(5.0)
11.4(8.5) 13.5(5.8) 13.4(6.4)
8.4(7.5)
11.7(7.3) 10.2(8.0)
9.7(10.3) -5.0(21.7)*
21.2(11.3) 14.9(8.4)
7.9(15.2) 8.3(8.9)*
78-106
52.0(7.1)
46.7(16.5)
26.6(30.1)
a Standard deviation is reported in parentheses.
52.2(32.7)
* Statistically significant difference from control by Jonckheere-Terpstra test (p < 0.05).
434
Company Sanitized. Does not contain TSCA CBI
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5368
TABLE 47
MEAN BODY WEIGHTS AND MEAN BODY WEIGHT GAINS OF Pi FEMALE RATS DURING GESTATION
GROUP DOSE (mg/kg/day)
N
GESTATION DAY
0 7 14 21
II-O 0
13
IV-0 25
16
VI-0 100
15
VIII-0 250
14
MEAN BODY WEIGHT (grams)
305.7 (31.8)a 333.9(33.3) 367.0 (35.1)
453.2 (39.0)c
315.2 (23.3) 344.4(28.1) 370.0(22.4)
454.9(55.4)d
302.1(18.5) 333.4(17.1) 366.0 (19.2)
432.7 (40.0)d
300.3(22.0) 329.2(28.6)
367.2(22.0)^ 444.5(35.5)d
GROUP
DOSE (mg/kg/day)
N
II-O 0
13
IV-0 25
16
VI-0 100
15
VIII-0 250
14
GESTATION DAYS
0-7 7-14 14-21
MEAN BODY WEIGHT GAIN (grams)
28.2 (6.0)a 33.1 (5.4)
86.5 (16.1)c
29.2 (8.8) 25.5(14.2)
82.4 (44. 5) d
31.3(6.9) 32.5(5.0) 71.9 (28.3)d
28.9(23.0) 32.9(6.1)^ 82.0 (33.5)**
0-21
146.1(19.3)C 135.8 (45.7)d 135.1(29.7)d
a Standard deviation is reported in parentheses. b N = 13. c N = 10. d N = 11.
146.2(34.6)d
There were no statistically significant differences from control by Jonckheere-Terpstra test (p < 0.05).
Company Sanitized. Does noi contain TSCA c bi
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5368
TABLE 48
MEAN BODY WEIGHTS AND MEAN BODY WEIGHT GAINS OF Pi FEMALE RATS DURING LACTATION
GROUP DOSE (mg/kg/day)
N
LACTATION naY
0 7 14 21
II-O 0
13
IV-0 25
17
VI-0 100
14
MEAN BODY WEIGHT (grams)
345.5 (36.2)a 346.9(31.0) 360.6(33.4) 351.2 (30.6)
351.6(29.8) 351.3(30.7) 380.9(18.9) 365.9(18.4)
337.2(32.9) 350.0(21.0) 371.4(18.1) 360.4(14.8)
VIII-0 250 13
341.7(21.2) 349.3(25.3) 362.7(28.9) 341.1 (41.2)
GROUP
DOSE (mg/kg/day)
N
II-O 0
13
IV-0 25
17
VI-0 100
14
VIII-0 250
13
LACTATION DAYS
MEAN BODY WEIGHT GAIN (grams)
0-7 7-14 14-21
1.4 (22.1 )a 13.7(20.7)
-9.4(10.9)
-0.3(22.6) 29.6(19.7) -15.0(14.2)
12.8(27.7) 21.4(11.2) -11.1(13.1)
7.6(17.0) 13.3(29.9) -21.5(43.5)
0-21
5.7(20.8)
14.2(21.3)_____ 23.1 (28.5)
a Standard deviation is reported in parentheses.
-0.6(38.4)
* Statistically significant differences from control by Jonckheere-Terpstra test (p < 0.05).
436
Company Sanitized. Does not contain TSCA CBf
H -24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5368
TABLE 49
MEAN DAILY FOOD CONSUMPTION AND MEAN FOOD EFFICIENCY OF Pi FEMALE RATS DURING GESTATION
GROUP
DOSE (mg/kg/day)
N
II-O 0
13
IV-0 25
16
VI-0 100
15
VIII-0 250
14
GESTATION DAYS
MEAN DAILY FOOD CONSUMPTION (grams)
0-7 7-14 14-21
24.8(3.9)a 29.5(3.7)
26.1(5.7)
25.2(2.9) 26.6 (3.2) 27.2(3.4)
25.8 (2.1) 28.4(1.9) 27.0(3.1)
26.8(4.5) 29.2(3.1)
26.5(4.5)*
0-21
26.8(3.6)
26.4(2.7)
27.1(1.8)
a Standard deviation is reported in parentheses. b N = 13.
27.6 (2.5)*
There were no statistically significant differences from control by Jonckheere-Terpstra test (p < 0.05).
GROUP
DOSE (mg/kg/day)
N
II-O 0
13
IV-0 25
16
V I -0 100
15
VIII-0 250
14
GESTATION DAYS
0-7 7-14 14-21
MEAN FOOD EFFICIENCY (grams weiqht qain/qrams food consumed)
0.167 (.046)a 0.162 (.028) 0.553 (.312)
0.163(.039) 0.141 (.072) 0.365 (.238)
0.172 (.031) 0.163 (.022) 0.395 (.178)
0.134(.172) 0.165(.032) 0.440(.206)*
0-21
0.268 (.053)
0.224 (.088)
0.241 (.057)
a Standard deviation is reported in parentheses. b N = 13.
0.254(.056)*
There were no statistically significant differences from control by One-Way Analysis of Variance (p < 0.05).
437
Company Sanitized. Does not contain TSCA CBI
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5368
TABLE 50 SUMMARY OF CLINICAL OBSERVATIONS IN Pi RATS
P i MALE RATS
GROUP DOSE (mg/kg/day)
N
Number of Rats with Observation
1-0 III-O V-0 VII-0 0 25 100 250 20 20 20 19
OBSERVATIONS
Alopecia Colored Discharge Eye(s) Colored Discharge Nose Teeth Clipped Teeth Crooked
102 00 0 000 00 0 000
Total No. of Rats with Masses
000
Statistically significant trend by Cochran-Armitage test; p < 0.05.
1 2 1 5* 1
0
438 SsrtNfeed, Does not contain TSCA CBI
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5368
TABLE 50 (CONTINUED)
SUMMARY OF CLINICAL OBSERVATIONS IN Pi RATS
P1 FEMALE RATS DURING GESTATION
OBSERVATIONS
Alopecia Diarrhea Sore Stained Abdomen Stained Face Stained Perineum Teeth Clipped Weak Wet Perineum Wet Underbody
GROUP DOSE (mg/kg/day)
N
Number of Rats with Observation
II-O
IV-0
VI-0
VIII-0
0 25 100 250
18 19 19 17
1122 00 01 10 00 00 10 00 01 00 11 00 01 00 01 00 01 00 01
Total No. of Rats with Masses
00 00
Note: This table includes clinical observations from pregnant animals only.
P i FEMALE RATS DURING LACTATION
GROUP DOSE (mg/kg/day)
N
OBSERVATIONS
Abnormal Gait or Mobility Alopecia Colored Discharge Nose Discharge Vaginal Opening Hunched Over Teeth Clipped
Number of Rats with Observation
II-O
IV-0
VI-0 VIII-0
0 25 100 250
13 17 14 14
00 1 0 13 4 1 00 1 0 01 1 0 00 10 00 01
Total No. of Rats with Masses
00 00
There were no statistically significant trends by Cochran-Armitage test ;
p < 0.05.
439
Company SanHIzed. Does not contain TRCA CBf
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5368
TABLE 51
MEAN ESTROUS CYCLE PARAMETERS AND PRECOITAL INTERVAL IN Pi FEMALE RATS
Percent Percent Percent
of Days of Days of Days Mean Cycle
Dose
in in in Length
Group (mq/kg/day) N Estrus Diestrus Proestrus
(days)
Mean Precoital Interval
(days)
II-O
0 20 29 60
11 4.7(1.54)3/* 3.8(2.46)c
IV-0
25 19 22
65
13 4.5(0.81)
3.3(2.86)
VI-0
100 20 25
63
12 4.6(0.73)* 2.5(1.31)*
VIII-0
250
18 20
69
12 4.7(1.35)
a Standard deviation is presented in parentheses.
b N=19
c N=18
d N=17
3.6(2.21)d
There were no significant trends (Jonckheere1s test); p < 0.05.
440 r
pa", SanlUzed. Doe* M com,, t s c a ^
H -24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5368
TABLE 52
SUMMARY OF SPERM PARAMETERS IN Pi MALE RATS
Group
I-0
Dose (mg/kg/day)_____ 0
III-O 25
V-0 100
VII-0 250
MOTILITY Percent Motile S.D.
93.3 3.6(10)a
92.2 5.8(10)
93.3 4.0(10)
90.3 6 .1 (10 )
MORPHOLOGY Percent Normal S.D.
98.8 0.8(10)
99.0 1 .1 (10)
99.2 0.7(10)
98.9 1 . 1 (10)
EPIDIDYMAL SPERM (Millions)
Per Cauda
298.7
S.D.
32.3(10)
Per gram Cauda S.D.
1030.9 171.6 (10)
TESTICULAR SPERMATIDS (Millions)
Per Testis
130.1
S.D.
17.1(10)
Per gram Testis S.D.
84.5 12.3(10)
279.8 39.8(10)
998.3 144.3(10)
121.8 13.6(10)
84.5 12.0(10)
278.0 44.9 (10)
949.8 178.4(10)
159.9* 10.3(10)
1 01.1* 9.1(10)
299.2 66.9 (10)
945.7 150.5(10)
146.5* 17.3 (10)
93.2* 9.5 (10)
a Number in group is in parentheses. * statistically significant trend by Jonckheere-Terpstra test; p <0.05.
441
Company Sanitized. Does not contain TSCA CBI
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5368
TABLE 53
SUMMARY OF REPRODUCTIVE INDICES: Pi GENERATION
MATERNAL GROUP II-O
DOSE (mg/kg/day)
0
IV-0 25
MATING INDEX (%) (# copulated/cohoused)
90.0
100.0
(18/20) (20/20)
FERTILITY INDEX (%) (# delivered/copulated)
72.2
85.0
(13/18) (17/20)
GESTATION LENGTH (days)
Number of Implantation Sites per pregnant female
22.3
14.0 (4.53)a
22.2
13.4 (4.58)
VI-0 100
95.0 (19/20)
73.7 (14/19)
22.4
13.9 (2.95)
VIII-0 250
94.7 (18/19)
77.8 (14/18)
22.4
14.1 (2.93)
Implantation Efficiency (%)-b
96.6 (3.33)
90.5
83.4*
84.5*
(13.47) (16.16) (19.10)
a Standard deviation is reported in parentheses. b Number of pups born/number of implantation sites X 100.
There were no statistically significant trends in mating or fertility indices by Cochran-Armitage test; p < 0.05.
There was no statistically significant difference from control in gestation length by One-Way Analysis of Variance; p < 0.05.
* Statistically significant trend by Jonckheere's test; p < 0.05.
442
Company Sanitized. Does not contain TSCA CBI
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5368
TABLE 54
MEAN PUP NUMBERS AND SURVIVAL: Fi GENERATION
MATERNAL GROUP II-0
DOSE (mg/kg/day)
0
^ N 13
IV-0 25 17
VI-0 100 14
VIII-0 250 13
Born Born Alive Day 4 Preculling Day 4 Postculling
Day 7
Day 14
Day 21
MEAN NUMBER OF PUPS/LITTER 14.7 14.6 14.6 8.0
8.0
8.0
8.0
13.4 13.2 12.9
7.6
7.6
7.6
7.6
12.4 11.3 10.0*
6.3 6.3
6.3
6.3
12.5* 12.1* 11.8*
7.5
7.4
7.4
7.4
Born Born Alive Day 4 Preculling Day 4 Postculling
Day 7
Day 14
Day 21
MEAN NUMBER OF MALE PUPS/LITTER 8.7 7.2 5.9 7.1 8.6 7.1 5.4 6.7 8.6 7.1 4.7 6.5 4.2 3.6 3.3 3.6
4.2 3.6 3.3 3.9
4.2 3.6 3.3 3.6 4.2 3.6 3.3 3.6
Born Born Alive Day 4 Preculling Day 4 Postculling
Day 7
Day 14
Day 21
MEAN NUMBER OF FEMALE PUPS/LITTER 6.0 6.1 6.0 6.1 6.0 5.8 3.8 4.0
3.8 4.0
3.8 4.0
3.8 4.0
Sex Ratio (males)
Gestation Indexa Mean % Born Alive 0-4 Day Viability
Lactation Index-t* Litter Survivalc
SURVIVAL (%) 0.59
100.0 99.5
100.0
100.0
100.0
0.50 100.0
99.2 97.6 100.0
100.0
a Percent litters delivered having at least one live pup. b Mean percent survival from day 4 postculling to day 21. c Percent litters born with at least one pup alive on day 21.
6.5 5.9 5.3 3.0 3.0 3.0 3.0
0.50 92.9 88.4 90.6 100.0 92.3
5.5 5.4 5.3 3.8 3.8 3.8 3.8
0.56 100.0
92.4 97.3 92.3 92.3
* Statistically significant trend by Jonckheere-Terpstra test; p < 0.05.
Statistics were performed on combined pups per litter only. Male and female data are presented for information only.
443
Company Sanitized. Does not contain TSCA CBI
H -24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5368
TABLE 55
MEAN PUP WEIGHTS: Fi GENERATION
MATERNAL GROUP DOSE (mg/kg/day)
N
II-O 0 13
IV-0 25 17
V I -0 100 13
VIII-0 250 13
MEAN PUP WEIGHTS (grams)
Day 0 Day 4 Preculling Day 4 Postculling Day 7 Day 14 Day 21
6.9 (0.7)3 11.3 (1.5) 11.4 (1.6) 18.3 (1.9) 37.9 (3.4) 60.9 (6.9)
6.7 (0.6) 11.4 (1.6) 11.4 (1.7) 18.0 (2.2) 37.0 (3.0) 60.3 (5.5)
6.8 (0.7)* 11.9 (1.8) 11.9 (1.9) 18.3 (2.4) 36.1 (3.2) 58.3 (4.3)
6.4 (0.6) 10.1 (1.7) * 10.1 (1.7)* 15.5 (2.1) * 29.5 (3.4) * 45.4 (7.7)*
MEAN MALE PUP WEIGHTS (grams)
Day 0 Day 4 Preculling Day 4 Postculling Day 7 Day 14 Day 21
7.0 (0.7) 11.6 (1.5) 11.7 (1.5) 18.8 (2.0) 38.7 (3.6) 62.5 (7.4)
6.9 (0.7) c 11.5 (1.7) 11.5 (1.7) 18.2 (2.3) 37.7 (3.2) 61.7 (6.2)
6.9 (0.8)* 12.3 (1.9) 12.3 (2.0) 18.9 (2.3) 37.1 (3.1) 60.2 (4.3)
6.7 (0.5) 10.7 (0.8) 10.8 (0.7) 15.7 (2.3) 29.6 (3.8) 45.7 (7.7)
MEAN FEMALE PUP WEIGHTS (grams)
Day 0 Day 4 Preculling Day 4 Postculling Day 7 Day 14 Day 21
6.6 (0.7) 10.9 (1.5) 11.0 (1.6) 17.6 (1.9) 37.0 (3.2) 59.1 (6.3)
6.5 (0.6) c 11.1 (1.8) 11.2 (1.8) 17.6 (2.2) 36.5 (3.0) 59.0 (5.5)
a Standard deviation is reported in parentheses. b N = 12. c N = 14.
6.5 (0.7)* 11.5 (1.7) 11.4 (1.9) 17.5 (2.7) 35.0 (3.6) 56.0 (4.7)
6.2 (0.6) 9.8 (1.7) 9.9 (1.8) 15.3 (2.0) 29.3 (3.1) 45.0 (8.0)
* Statistically significant trends by linea'r contrast of least square means; p < 0.05.
Note: Statistical analyses were conducted on the combined pup weights. Male and female data are presented for information only.
444
Company Sanitized. Does not contain TSCA CBI
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5368
TABLE 56
SUMMARY OF PUP CLINICAL OBSERVATIONS: Fi GENERATION
MATERNAL GROUP II-O
DOSE (mg/kg/day)
0
IV-0 25
VI-0 100
VIII-0 250
OBSERVATIONS
Discharge Nose Weak
0 0 0 3 ( 1)3 0 0 0 2 ( 1)
TOTAL NUMBER OF OBSERVATIONS NUMBER OF LITTERS AFFECTED TOTAL NUMBER OF LITTERS ___
00 0 000 13 17 13
a Numbers outside the parentheses are the number of pups affected; the numbers in parentheses are the number of litters affected.
5 1 13
There were no statistically significant trends by Cochran-Armitage test; p < 0.05.
445
Company Sanitized. Does not conta'n TSCA CBf
H -24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5368
TABLE 57
MEAN BODY WEIGHTS AND MEAN BODY WEIGHT GAINS OF F, MALE RATS
GROUP DOSE (mg/kg/day)
N
DAYS ON
TEST3
1 8 15 22 29 36
1-1 0
13
63.3 (7.5)* 108.7 (12.8) 172.2 (18.0) 236.3 (21.9) 294.7(31.0) 333.4 (33.5)
III-l 25
16
V-l 100
12
MEAN BODY WEIGHT (grams)
62.5(7.0) 103.9(10.3) 163.9(15.3) 224.0(16.9) 278.7(23.6)
331.8 (31.3)c
58.6(5.6) 100.5(8.9) 161.3(13.0) 223.0(11.5) 279.2 (20.4) 310.5(35.5)
VII-1 250
12
47.0 (5.3)* 88.0(6.8)* 144.5 (11.6)* 206.0(11.4)* 264.0(28.4)* 310.2(40.2)*
GROUP
DOSE (mg/kg/day)
N
1-1 0
13
III-l 25
16
V-l 100
12
DAYS ON TEST3
MEAN BODY WEIGHT GAIN (grams)
1-8 8-15 15-22 22-29 29-36
45.3 (6.4)* 63.5 (6.8) 64.1(7.0) 58.4(13.8) 38.7(31.8)
41.5(5.0) 60.0(6.0) 60.1(5.5) 54.7(16.5)
54.6 (20.1)c
41.9 (4.4) 60.8(5.2) 61.7 (5.0) 56.3 (15.6) 31.2(19.3)
1-36
270.1(30.2)
269.7 (28.9)C 251.9(33.3)
a Day of Weaning = Test Day 1. Jb Standard deviation is reported in parentheses, c N = 15.
VII-1 250
12
41.0(7.4) 56.5(6.7)* 61.5(5.7) 58.0(22.5) 46.1(25.5) 263.2(42.3)
* Statistically significant trend by Jonckheere-Terpstra test p < 0.05.
446
Company Sanitized. Does not contain TSCA CBI
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5368
TABLE 58
MEAN BODY WEIGHTS AND MEAN BODY WEIGHT GAINS OF Fi FEMALE RATS
GROUP DOSE (mg/kg/day)
N
DAYS ON
TEST3
1 8 15 22 29 36
II-l 0
13
IV-1 25
17
V I -1 100
12
VIII-1 250
12
57.3 (6.3 )-b 94.0(7.8) 135.8(9.6) 167.5(13.4) 190.0(17.5) 206.4(16.3)
MEAN BODY WEIGHT (grams)
58.6 (6.3) 94.8(8.3) 139.6(13.9) 173.7(21.6) 195.6 (24.2) 218.8 (30.7) c
56.7(4.9) 90.4(7.0) 133.6(8.3) 167.5 (10.8) 191.4 (15.8) 2 1 2 .6( (17.7)
44.7(8.1)* 80.0(9.6)* 124.8(9.1)* 161.7 (9.8) 187.7(13.4) 206.3(13.9)
GROUP
DOSE (mg/kg/day)
N
II-l 0
13
IV-1 25
17
V I -1 100
12
DAYS ON TEST3
1-8 8-15 15-22 22-29 29-36
1-36
36.8 (4,2)b 41.8(6.4) 31.7 (8.4) 22.5 (6.1) 16.4 (7.0)
149.1(17.7)
MEAN BODY WEIGHT GAIN (grams)
36.2(3.8) 44.7(7.1) 34.2(9.1) 21.9(7.7) 22.6 (9.1)c
160.3 (26.7)c
33.7(5.4) 43.2(5.7) 33.9(5.4) 23.9(6.9) 21.1 (4.2)
155.9(16.3)
a Day of Weaning = Test Day 1. b Standard deviation is reported in parentheses,
c N = 16.
VIII-1 250
12
35.2 (6.4) 44.8(4.1) 36.9(5.6) 26.0(8.3) 18.6(13.1) 161.5(18.7)
* Statistically significant trend by Jonckheere-Terpstra test; p < 0.05.
447
Contnsnv S<*nifre d. Does noi cenfsin TSCA CBF
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5368
TABLE 59
SUMMARY OF CLINICAL OBSERVATIONS IN Fi RATS
Fi MALE RATS
GROUP (mg/kg/day)
N
Number of Rats with Given Observation
1-1 III-l V-l VII-1 0 25 100 250 13 16 12 12
OBSERVATIONS
There were no abnormal clinical observations observed in the Fx Male Rats.
Total No. of Rats with Masses
0 0 0________ 0
Fx FEMALE RATS
Number of Rats with Given Observation
GROUP DOSE (mg/kg/day)
N
II-l 0 13
IV-1 25 17
VI-1 100 12
VIII-1 250 12
OBSERVATIONS Alopecia Total No. of Rats with Masses
010 0 000 0
There were no statistically significant trends by Cochran-Armitage test; p < 0.05.
448
Company Sanitized. Does not contain TSCA CBI
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5368
TABLE 60 SUMMARY OF DEVELOPMENTAL LANDMARKS IN Fi RATS
PREPUTIAL SEPARATION - Fi MALE RATS
GROUP 1-1 III-l V-l VII-1
DOSE (mg/kg/day)
0
25 100 250
N 13 16 12 12
AGE (Days)a
39.9 (2.22)
41.5 (2.90)
43.2 (3.16)
42.7 (2.10)
VAGINAL OPENING - Fi FEMALE RATS
GROUP DOSE (mg/kg/day)
N
II-l 0 13
IV-1 25 17
VI-1 100 12
VIII-1 250 12
AGE (Days)a
32.1 (2.43)
32.2 (2.28)
Data summarized as : Mean Standard Deviation
32.1 (1.93)
32.5 (2.58)
a Age was calculated as follows using data presented in Appendix LL: Test day + 20 days = Age (days).
There were no statistically significant trends by linear contrast of least square means (covariate:body weight).
449 Company Sanitized. Does not contain TSCA CBI
QmnnMi VnnlHaoiV Ha m
I Wlf
H -24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
TABLE 61
MEAN FINAL BODY AND ORGAN WEIGHTS FROM MALE RATS - P, ADULTS
GROUP DOSE (MG/KG/DAY)
THYROID
1-0 0
0.021 0.003(12 )
III-O 25
0.020 0.004(17 )
V-0 100
0.022 0.005(14 )
VII-0 250
0.025 0.007(14 )
FINAL BODY
604.692
594.429
557.193
541.471#
62.781(12 ) 57.077(17 ) 61.905(14 ) 65.972(14 )
THYROID/FINAL BODY * 100
0.004 0.000 (12
0.003 0.001(17 )
Data summarized as:
Mean Standard Deviation (n)
Statistical Methods: Trend test (Jonckheere-Terpstra)
# Statistically significant difference at p < 0.05.
0.004 0.001(14 )
0.005# 0.001(14 )
DuPont-5368
450
Company Sanitized. Does not contain TSCA CBf
TABLE 62 MEAN FINAL BODY AND ORGAN WEIGHTS FROM FEMALE RATS - Pi ADULTS
GROUP DOSE (MG/KG/DAY) THYROID
FINAL BODY
II-O 0
0.019 0.004(11 )
351.700 33.050(11 )
IV-0 25
0.021 0.004(17 )
365.888 18.416(17 )
V I -0 100
0.020 0.004(12 )
359.208 15.076(12 )
VIII-0 250
0.022 0.005(12 )
338.008 41.391(12 )
THYROID/FINAL BODY * 100
0.006 0 . 001(11 )
0.006 0.001(17 )
Data summarized as:
Mean. Standard Deviation (n)
Statistical Methods: Trend test (Jonckheere-Terpstra).
No statistically significant difference at p < 0.05.
0.006 0 . 001(12 )
0.006 0 .002(12 )
Company Sanitized. Does not contain TSCACBI
TABLE 63
MEAN FINAL BODY AND ORGAN WEIGHTS FROM MALE RATS - Fi ADULTS
MEAN FINAL BODY AND ABSOLUTE ORGAN WEIGHTS (grams)
GROUP DOSE (MG/KG/DAY)
BRAIN
1-1 0
1.996 0.093(13 )
III-l 25
1.949 0.069(16 )
EPIDIDYMIDES
0.760 0.067(13 )
0.738 0.092(16 )
TESTES
3.300 0.228(13 )
3.154 0.177(16 )
SEMINAL VESICLES
1.200 0.205(13 )
1.074 0.202(16 )
PROSTATE
0.460 0.126(13 )
0.409 0.083(16 )
THYROID
0.019 0.004(13 )
0.017 0.003 (16 )
KIDNEYS
3.283 0.291(13 )
3.154 0.264(16 )
LIVER
17.488 1.869(13 )
16.938 1.829(16 )
FINAL BODY
384.823
372.338
31.437(13 ) 25.695(16 )
V-l 100
1.966 0.106(12 )
0.739 0.048(12 )
3.220 0.254(12 )
1.085 0.257(12 )
0.368 0.087(12 )
0.015 0.004(12 )
3.199 0.293(12 )
17.100 2.729(12 )
376.133 26.968(12 )
VII-1 250
1.978 0.072(12 )
0.686# 0.065(12 )
3.039# 0.439(12 )
1.084 0.187(12 )
0.406 0.116(12 )
0.018 0.004(12 )
3.253 0.270(12 )
16.037# 1.240(12 )
360.375# 36.754(12 )
452
Company Sanitized. Does not contain TSCA CBI
H-24516: Subchronic Toxicity
DuPont-5368
90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations____________________________________ __________________________ ________
TABLE 63 (Continued)
MEAN FINAL BODY AND ORGAN WEIGHTS FROM MALE RATS - Fi ADULTS
MEAN RELATIVE ORGAN WEIGHTS (% of body weight)
GROUP DOSE (MG/KG/DAY)
1-1 III-l 0 25
BRAIN/FINAL BODY * 100 0.521 0.034(13 )
0.525 0.028(16 )
EPIDIDYMIDES/FINAL BODY * 100 0.198 0.014(13 )
0.198 0.019(16 )
TESTES/FINAL BODY * 100 0.860
0.044(13 )
0.848 0.034(16 )
SEMINAL VESICLES/FINAL BODY * 100 0.311 0.037(13 )
0.288 0.045(16 )
PROSTATE/FINAL BODY * 100 0.119 0.029(13 )
0.110 0.020(16 )
THYROID/FINAL BODY * 100 0.005 0.001(13 )
0.005 0.001(16 )
KIDNEYS/FINAL BODY * 100 0.854
0.051(13 )
0.848 0.061(16 )
V-l 100
0.525 0.049(12 )
0.197 0.014(12 )
0.860 0.091(12 )
0.287 0.055(12 )
0.098 0.022(12 )
0.004 0.001(12 )
0.851 0.059(12 )
VII-1 250
0.553 0.048(12 )
0.191 0.015(12 )
0.843 0.077(12 )
0.303 0.057(12 )
0.112 0.024(12 )
0.005 0.001(12 )
0.906 0.068(12 )
Company Sanitized. Does not contain TSCA CBI
TABLE 63 (Continued)
MEAN FINAL BODY AND ORGAN WEIGHTS FROM MALE RATS - F! ADULTS
MEAN RELATIVE ORGAN WEIGHTS (% of body weight)
GROUP DOSE (MG/KG/DAY)
III-l 25
LIVER/FINAL BODY * 100 4.543
n 290(13
4.546 0.327(16 )
V -l
100
4.525 0.479 (12
V II-1
250
4.468 0.329(12 )
M EA N R E L A T IV E O R G A N W E IG H T S ( o r g a n t o b r a i n w e ig h t r a t i o j
GROUP D O S E (M G /K G /D A Y )
LIVER/BRAIN*100
1-1 0
875.891 82.315(13 )
H I-1 25
868.962 90.420(16 )
V -l
100
873.051 149.566(12 )
V II-1
250
811.923 70.037(12 )
KIDNEYS/BRAIN*100 164.486
12.752(13 )
161.723 11.469(16 )
163.152 17.372(12 )
164.691 14.841(12 )
PROSTATE/BRAIN *10 0 23.017
5.990(13 )
20.936 4.034(16 )
18.712 4.085(12 )
20.513 5.677(12 )
SEMINAL VESICLES/BRAIN*100 59.952 8.655(13 )
55.060 10.071(16 )
55.069 12.064(12 )
54.769 9.181(12 )
TESTES/BRAIN*100
165.435 9.973(13 )
161.842 8.064(16 )
164.109 14.137(12 )
153.809 22.378(12 )
Company Sanitized. Does not contain TSCA CB1
TABLE 63 (Continued)
MEAN FINAL BODY AND ORGAN WEIGHTS FROM MALE RATS - F, ADULTS
EPIDIDYMIDES/BRAIN*100
38.113 3.175(13 )
37.831 4.196(16 )
THYROID/BRAIN*100
0.953 0.215(13 )
0.861 0.163(16 )
Data summarized as :
Mean Standard Deviation (n)
Statistical Methods: Trend test (Jonckheere-Terpstra). # Statistically significant difference at p < 0.05.
37.650 2.899(12 )
0.775 0.192(12 )
34.712# 3.437(12 )
0.933 0 .221(12 )
Company Sanitized. Does not contain TSCACBI
H-24516: Subchronic Toxicity
,
90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations________________ . ,
TABLE 64
MEAN FINAL BODY AND ORGAN WEIGHTS FROM FEMALE RATS - Fi ADULTS
MEAN FINAL BODY AND ABSOLUTE ORGAN WEIGHTS (qrams)
GROUP DOSE (MG/KG/DAY)
II-l 0
IV-1 25
BRAIN
1.829 0.061(13 )
1.849 0.082(17 )
UTERUS
0.429 0.087(13 )
0.470 0.140(17 )
THYROID
0.016 0.003(13 )
0.015 0.003(17 )
KIDNEYS
1.886 0.154(13 )
2.038 0.249(17 )
LIVER
9.063 1.385(13 )
9.589 1.727(17 )
FINAL BODY
218.431
226.071
19.969(13 ) 29.359(17 )
V I -1 100
1.799 0.091(12 )
0.450 0.115(12 )
0.016 0.003(12 )
2.051 0.247(12 )
9.593 1.329(12 )
223.750 19.600(12 )
VIII-1 250
1.810 0.057(12 )
0.583 0.604(12 )
0.013 0.002(12 )
2.039 0.211(12 )
9.986 0.958(12 )
222.475 15.014(12 )
DuPont-5368
Company Sanitized. Does not confa'n W i <*bj
TABLE 64 (Continued) MEAN FINAL BODY AND ORGAN WEIGHTS FROM FEMALE RATS - Fi ADULTS
MEAN RELATIVE ORGAN WEIGHTS (% of body weiqht)
GROUP DOSE (MG/KG/DAY)
II-l 0
IV-1 25
BRAIN/FINAL BODY * 100 0.844
0.083(13 )
0.829 0.096(17 )
UTERUS/FINAL BODY * 100 0.198
0.040(13 )
0.210 0.065(17 )
THYROID/FINAL BODY * 100 0.007
0.001(13 )
0.007 0.002(17 )
KIDNEYS/FINAL BODY * 100 0.867 0.079(13 )
0.904 0.052(17 )
LIVER/FINAL BODY * 100 4.136 0.403(13 )
4.227 0.406(17 )
V I -1 100
0.810 0.085(12 )
0.203 0.057(12 )
0.007 0.002(12 )
0.921 0.119(12 )
4.281 0.361(12 )
VIII-1 250
0.817 0.061(12 )
0.258 0.251(12 )
0.006 0.001(12 )
0.917 0.079(12 )
4.492# 0.372(12 )
Misaw PRT.ATTVE ORGAN WEIGHTS (organ to brain weight ratio)
GROUP DOSE (MG/KG/DAY)
LIVER/BRAIN*100
II-l 0
496.052 77.065(13 )
IV-1 25
517.938 86.356(17 )
V I -1 100
534.812 80.407(12 )
VIII-1 250
552.297# 55.783(12 )
Company Sanitized. Does not contain TSCA CBt
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5368 ____________________________ _______________ ___________________________
TABLE 64 (Continued)
MEAN FINAL BODY AND ORGAN WEIGHTS FROM FEMALE RATS - Fi ADULTS
M EA N R E L A T IV E O R G A N W E IG H T S ( o r g a n t o b r a i n w e ig h t r a t i o |
GROUP DOSE (MG/KG/DAY)
II-l 0
IV-1 25
KIDNEYS/BRAIN*100 103.192
8.825(13 )
110.086 11.594(17 )
V I -1 100
114.319# 15.371(12 )
VIII-1 250
112.713# 12.284(12 )
THYROID/BRAIN*100
0.867 0.164(13 )
0.804 0.187(17 )
0.898 0.189(12 )
0.718 0.128(12 )
UTERUS/BRAIN*100
23.473 4.657 (13 )
25.407 7.477(17 )
Data summarized as: Mean Standard Deviation (n)
Statistical Methods : Trend test (Jonckheere-Terpstra) . # Statistically significant difference at p < 0.05.
24.873 5.632(12 )
32.194 33.171(12 )
Company Sanitized. Does not contain TSCA CBI
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
TABLE 65
SITE/LESIO N :
INCIDENCES OF GROSS OBSERVATIONS IN MALE RATS - Pi ADULTS
GROUP DESIGNATION: DOSE (M G/KG/DAY): NUMBER IN GROUP:
1-0 0 20
:====
II II II II II II II 11 II II II II II II
III-O 25 20
V-0 100 20
EPIDIDYMIDES LARGE
0*
a INCIDENCES REFLECT THE NUMBER OF ANIMALS WITH A GIVEN LESIO N .
0
0
II II II 11 II II II II II II II II II II II II II II II II II II II
DuPont-5368
VII-0 250 19 1
459
Company Sanitized. Does not contain TSCACBI
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
------ -----------------
SITE/LESION:
TABLE 66
INCIDENCES OF GROSS OBSERVATIONS IN FEMALE RATS - Pi ADULTS
GROUP DESIGNATION DOSE (MG/KG/DAY):
NUMBER IN GROUP:
II-O 0 20
IV-0 25 20
V I -0 100 20
LIVER DISCOLORATION
STOMACH DISTENDED WITH GAS
SMALL INTESTINE DISTENDED WITH GAS
KIDNEYS DILATATION
UTERUS HEMORRHAGE OBSTRUCTION
ia 0
n0
n0 u
00
,,0 Q0
0 0 0
0
0 0
DuPont-5368 ---------------------------------
VIII-0 250 19
0 1 1 1 1 1
Company Sanitized. Does not contain TSCA CBI
'flip
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5368
S IT E /L E S IO N :
TABLE 67
INCIDENCES OF GROSS OBSERVATIONS IN MALE RATS - Fi PUPS
DAM G R O U P D E S IG N A T IO N : D O SE (M G /K G /D A Y ): N UM BER P U P S /L IT T E R S :
II-O o 1/1
IV-0 25 2/2
V I -0 100 7/3
S_ ----
VIII -0 250 5/3
II II II II II II II II II II II
II II II II II II II II It II II II II II II
II II u II II II
STOM ACH NO M IL K
SPO T
0 ( 0)
2 ( 2)
4 ( 1)
3 ( 3)
P E R IT O N E A L C A V IT Y C A N N IB A L IZ E D
0 ( 0)
0 ( 0)
0 ( 0)
1 ( 1)
LUNGS
NOT EXPANDED
0 ( 0)
2 ( 2)
4 ( 1)
3 ( 3)
TOTAL TO TA L
02
L IT T E R S A FFE C T E D
02
rP UU Pr oS AM F tFt Ei C Tl uE Du ______________________ _________________________________________________________ _______________________________________ _______________________________ ;
1 4
:
3 4
For ach group : The count of
S c r S p B P S S n t V ? t o T S c r e r i n . t i o n .
For ,, o n .ite/taaion, ~
outai*
461 Company Sanitized. Does not contain TSCA CBI
SITE/LESION:
TABLE 68
INCIDENCES OF GROSS OBSERVATIONS IN FEMALE RATS - Fi PUPS
DAM GROUP DESIGNATION: DOSE (MG/KG/DAY): NUMBER PUPS/LITTERS:
II-O 0 0/0
IV-0 25 0/0
VI-0 100 8/3
vm -o
250
4/2
STOMACH NO MILK SPOT
0 ( 0)
0 ( 0)
5 ( 1)
1 ( 1)
LUNGS NOT EXPANDED
0 ( 0)
0 ( 0)
5(
TOTAL TTOTi AAlLl
LITTERS AFFECTED PF UUPP Sb AA Fr gFcE. CL Ti DEDu -------------------------_ ------------------------------------- _
00 00
------------------- --------------------------------------------------------------------------------------- -
1 5
For each group: The count of
1)
.
1 ( 1)
1 1
..
examination.
For each site/lesion:
Numbers outside the parentheses are the number of pups affected Numbers in parentheses are the number of litters affected.
Company Sanitized. Does not contain TSCA CBf
L
SITE/LESION:
TABLE 69
INCIDENCES OF GROSS OBSERVATIONS IN RATS - Fi UNSEXABLE PUPS
DAM GROUP DESIGNATION: DOSE (MG/KG/DAY): NUMBER PUPS/LITTERS:
II-O 0 0/0
IV-0 25 0/0
V I -0 100 0/0
VIII-0 250 13/1
WHOLE BODY AUTOLYSIS
0 ( 0)
0 ( 0)
0(
000
TOTAL TOTAL
LITTERS AFFECTED PUPSB AFFECTED_________
_____________________
_________0________
0 _____________
;
0 _
0) ,
10 (
1 10 ,
For each group, The count of
in S c r p S p PS 5 e r w I n r p . " 0" S?cil examination.
For each elte/teelon, here
Company SanHteed. Does not contain TSCA CBI
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
SITE/LESION
TABLE 70
INCIDENCES OF GROSS OBSERVATIONS IN MALE RATS - Fi WEANLINGS
GROUP DESIGNATION: DOSE (MG/KG/DAY): NUMBER IN GROUP:
1-1 0 42
III-l
25 45
V-l
100 34
KIDNEYS
LARGE SMALL_____
03 0
a INCIDENCES REFLECT THE NUMBER OF ANIMALS WITH A GIVEN LESION.
1 1
0 0
1I1I
II II II II II II II
1I1I
II II
II
I1I1 I1I1
II II II II II II II II II II
DuPont-5368
vu-: 250 35
0 0
H-24516: Subchronic Toxicity
.
DuPont-5368
90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations__________________ ___________ ____________________ _________________________
SITE/LESION:
TABLE 71
INCIDENCES OF GROSS OBSERVATIONS IN FEMALE RATS - F, WEANLINGS
GROUP DESIGNATION: DOSE (MG/KG/DAY): NUMBER IN GROUP:
II-1 0 _36__
VI-1 100 30
VIII-1 250 37
THERE WERE NO GROSS OBSERVATIONS
Company Sanitized. D oes no! contain TSCA CBf
SITE/LESION:
TABLE 72
INCIDENCES OF GROSS OBSERVATIONS IN MALE RATS - Fi ADULTS
GROUP DESIGNATION: DOSE (MG/KG/DAY): NUMBER IN GROUP:
1-1 0 13
III-l 25 16
V-l
100 12
36
VII-1 250
12
0
II
II II II tl II
II II II II II
u II
II II II II II II II H II II
II II 11 II II II
Company Sanitized. Does not contain TSCA CBI
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
TABLE 73
SITE/LESION:
INCIDENCES OF GROSS OBSERVATIONS IN FEMALE RATS - Fi ADULTS
GROUP DESIGNATION: DOSE (MG/KG/DAY): NUMBER IN GROUP:
II-l 0 13
:= = = = =
IV-1 25 17
V I -1 100 12
II 11 II II II II II II II II II II II II II II II II II II II II II II
KIDNEYS DILATATION
0
a INCIDENCES REFLECT THE NUMBER OF ANIMALS WITH A GIVEN LESION.
0
2
II II II II II II II II II II II II II
DuPont-5368
VIII-1 250 12 0
467
Company Sanitized. Does not contain TSCA CBI
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5368
TABLE 74
INCIDENCES AND LESION GRADES OF MICROSCOPIC OBSERVATIONS IN M ALE REPRODUCTION RATS - P! ADULTS
GROUP DESIGNATION: LESION GRADES DOSE (MG/KG/DAY): TISSUE/LESION (P,1,2,3,4) NUMBER IN GROUP:
1-0 0 20
III-O 25 20
V-0 100 20
VII-0 250 19
TESTIS3 TESTES
EPIDIDYMIS3
EPIDIDYMIDES
PROSTATE INFLAMMATION, SUBACUTE/CHRONIC
SEMINAL VESICLES COAGULATING GLAND
OTHER
___
41 32
41 32 73 1
3 3
3 3
6 1 (-,1,
6 6 0
2
3
2
3 5 1 (-,1, 5 5 0
THE NUMBER OF ORGANS EXAMINED FOR EACH GROUP IS UNDERLINED. Tttqton GRADES' P = PRESENT; 1 = MINIMAL; 2 = MILD; 3 = MODERATE; 4 = SEVERE. LESION GRADES'CORRESPOND BY POSITION WITH THE NUMBERS IN PARENTHESES, WHICH INDICATE HOW OFTEN EACH GRAD
GRADES TM h^ pLE: , x 2 , MEANS N0 LESIONS WERE GRADED "PRESENT" (NON-GRADED LESIONS) , 1 LESION WAS GRADED "MINIMAL", 2 LESIONS WERE GRADED "MILD", NO LESIONS WERE GRADED "MODERATE" AND NO LESI
WERE GRADED "SEVERE".
One of the pair available for microscopic examination, Sperm parameter evaluation was performed on the
second of the pair.
468
Company Sanitized. Does not contain TSCA CBI
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5368
TABLE 75
INCIDENCES AND LESION GRADES OF MICROSCOPIC OBSERVATIONS IN FEMALE REPRODUCTION RATS - Pi ADULTS
LESION GRADES TISSUE/LESION (P,1,2,3,4)
GROUP DESIGNATION: DOSE (MG/KG/DAY): NUMBER IN GROUP:
Il-O 0 20
IV-0 25 20
VI-0 100 20
VIII-0 250 19
OVARIES
UTERUS DILATATION, GLAND/LUMEN
VAGINA
OTHER LIVER: NECROSIS, FOCAL SKIN: NO ABNORMALITIES DETECTED
8
8 -
8
2 1 (-,1,1 (1,-,-
3
3 1 (-,1,
3
0
8
8 3 (-,1, 2,-,-)
8
0
5 5
5 0
o THE NUMBER OF ORGANS EXAMINED FOR EACH GROUP IS UNDERLINED.
SisEF'
i l e s io n TM
' grIS ed A
WERE GRADED "SEVERE".
2n i m a l - ,
l e s io n s w ere g ra d ed - m il d - , n o l e s io n s w ere g r a d ed "m o d e r a t e - a n d n o l e s io n s
469
Company Sanitized. Does not contain TSCA CBI
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5368
FIGURES
470
Company Sanitized. Does not contain TSCA CBf
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5368
FIGURES EXPLANATORY NOTES
Critical Dates
Day 74 Male and female rats designated for reproduction evaluations were co-housed. Body weights collected during the cohabitation and post-mating periods are reported in the Reproductive Toxicology section.
Day 90 Recovery period begins for rats designated for one-month and 3-month recovery periods.
Day 91 Male rats designated for the 90-day exposure period were sacrificed.
Day 92 Last day o f test substance administration for female rats designated for the 90-day exposure period.
Day 93 Female rats designated for 90-day exposure period were sacrificed. Day 119 Last day of non-fasted body weight data collection for rats designated for the one-month recovery
period. Day 125 Male and female rats designated for the one-month recovery period were sacrificed Day 175 Last day of non-fasted body weight data collection for rats designated for the 3-month recovery period.
Day 181 Male and female rats designated for 3-month recovery period were sacrificed.
471
SanHtized, 0@s isfcontain JBCA <SBt
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
FIGURE 1 MEAN BODY WEIGHTS OF MALE RATS
DuPont-5368
* On test day 74, male and female rats designated for reproduction evaluations were co-housed. On test day 77, all rats in the 250 mg/kg/day dose group were placed on ground chow.
472
Company SanMzed. Docs not contain TSCA CBI
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
FIGURE 2 MEAN BODY WEIGHTS OF FEMALE RATS
'9 ? DuPont-5368
* On test day 74, male and female rats designated for reproduction evaluations were co-housed. On test day 77, all rats in the 250 mg/kg/day dose group were placed on ground chow.
473
C om pany SanWzed. Does
contain T S C A C B f
H -24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5368
FIGURE 3 MEAN FORELIMB GRIP STRENGTH FOR MALE RATS
Forelimb Grip Strength (kg)
2.00 -I 1.80 1.60 1.40 1.20 1.00 0.80 0.60 0.40 0.20 0.00 -
Baseline
0 mg/kg/day _ _ I I 25 mg/kg/day
100 mgkgday B 2 5 0 mg/kg/day
W eek 13 Assessment Period
Recovery
474
Company Sanitized. Does not contain TSCA CBI
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
FIGURE 4 MEAN FORELIMB GRIP STRENGTH FOR FEMALE RATS
DuPont-5368
1.60
1.40
1.20
Forelimb Grip Strength (kg)
1.00 D 0 mg/kg/day
0.80 0.60
I0.40
H 25 mg/kg/day ^ 100mgkgday
0.20
0.00 Baseline
W eek 13 Assessment Period
Con<Panjr Sanitized. Does no contain TSCA CBf
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
FIGURE 5 MEAN HINDLIMB GRIP STRENGTH FOR MALE RATS
DuPont-5368
Hindlimb Grip Strength (kg)
1= B 2 5 mg/kg/day
1 100 m gkgday
W eek 13 Assessment Period
476
I Recovery
contain TSCACBF
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
FIGURE 6 MEAN HINDLIMB GRIP STRENGTH FOR FEMALE RATS
DuPont-5368
Hindlimb Grip Strength (kg)
0.90 0.80 0.70 0.60 0.50 0.40 0.30 0.20 0.10 0.00
Baseline
0 mg/kg/day H 25 mg/kg/day H 100 m gkgday
M250 mg/kg/day
W eek 13 Assessment Period
Recovery
1
477
Company Sanitized. Does not contain TSCA CBI
J
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5368
FIGURE 7 MOTOR ACTIVITY ASSESSMENT: MEAN DURATION OF MOVEMENTS FOR MALE RATS
2000 n 1800 1600 ^ 1400 o
a 1200 -
c
Baseline
W eek 13 Assessment Period
0 mg/kg/day H 25 mg/kg/day H lOOmgkgday
IM250 mg/kg/day
478
Does no, contain
Recovery
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5368
FIGURE 8 MOTOR ACTIVITY ASSESSMENT: MEAN DURATION OF MOVEMENTS FOR FEMALE RATS
2000 n 1800 1600 -
0 mg/kg/day - 1125 m g/kg/day
H 100 mgkgday 250 mg/kg/day
Duration of Movements (sec)
Baseline
W eek 13 Assessment Period
479
Recovery SanIHzed. Does notcontain TSCA CBf
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5368
FIGURE 9 MOTOR ACTIVITY ASSESSMENT: MEAN NUMBER OF MOVEMENTS FOR MALE RATS
W eek 13 Assessment Period
480
D 0 mg/kg/day
III25 mg/kg/day H 100mgkgday
Company Sanitized. Does not contain TSCA CBI
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5368
FIGURE 10 MOTOR ACTIVITY ASSESSMENT: MEAN NUMBER OF MOVEMENTS FOR FEMALE RATS
Baseline
I
W eek 13 Assessment Period
0 mg/kg/day 11 25 m g/kg/day
1^ 100 mgkgday M250 mg/kg/day
481
Company Sanitized. Does not contain TSCA CBI
Recovery
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5386
APPENDICES
482
Company Sanitized. Does not contain TSCA CB
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5386
APPENDIX A ANALYTICAL DATA
483
Company Sanitized. Does not contain TSCA CI3I
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5386
Table I. Initial Homogeneity and Stability of H-24516 in Dosing Suspensions
Sample Type
mg/mL H-24516
Nominal
Measured
Test Day 0
Homogeneity Control
0.00
n d (a )
Top M id d l e Bottom
2.5 2.30 2.5 2.47 2.5 2.40
M ea n tB); 2.39+0.08
C .V .3%
T op M iddle
Bottom (c )
10 8.97 10 10.2 10 14.0
M e a n tB): H .l + 2 .6
C .V .24%
T op M id d l e B ottom
25 26.8 25 24.8 25 23.5
M ea n t* ): 25.01.6
C.V. 7%
Percent Nominal
92.0 98.8 96.0
(95.6% )
89.7 102.0 140.0
(111.0% )
107.2 99.2 94.0
(100.0% )
Stability^
Test Day 6 Homogeneity Control
T op M iddle B ottom
2.5 2.06 10 8.89 25 24.1
0.00 n d (a )
10 9.26 10 9.58 10 9.23
M ea n t* ): 9.36+0.19 C .V .2% o
82.4 88.9 96.4
92.6 95.8 92.3
(93.6% )
Stability^
10
9.03 90.3
(A) Denotes not detected.
..
(B) The average measured concentration, average percent o f nominal (in parentheses), standard deviation, and
coefficient o f variation of top, middle, and bottom are based on measured concentration for each level.
(C) Duplicate re-analysis o f original sample supports the original analysis and will not be reported.
(D) Stability samples held 5 hours a room temperature.
Company Sanitized. Does not contain TSCA CBf
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5386
Table ELMixing and Stability Study of H-24516 in Dosing Suspensions
Sample Type
mg/mL H-24516
Dose Volume
Nominal
Measured
Homogeneity 7.5 mL/Kg
. Control
0.00 n d (a )
Percent Nominal
--
Top M iddle Bottom
5.0 mL/Kg Control
3.33 2.88 3.33 2.54 3.33 2.67
M earJP): 2.700.2
CV.6%
0.00
n d (a )
86.5 76.3 80.2
(81.1% )
Top M iddle B ottom
Top M iddle Bottom
Top M iddle Bottom
5.0 5.0 5.0
20.0 20.0 20.0
50.0 50.0 50.0
4.53 4.25 4.39
M ea n f i: 4.39+0.14
C. V. 3 %
19.9 17.7 18.6 aW B ) ; i s . r i . i
C.V. 6 %
53.4 52.6 54.0
M ea n f h 53.4+0.7 C.V. 1 %
90.6 85.0 87.8
(87.8% )
99.5 88.5 93.0
(93.5% )
106.8 105.2 108.0
(106.8% )
Stability 7.5 mL/Kg 0-Day Room T emperature 5-Hour Room T emperature 4-Day Refrigerated
3.33 2.70
3.33 2.66 3.33 2.94 3.33 2.88
Meart(C); 2 .9 1 + 0 .0 4
81.1 79.9 88.3 86.5
(87.4% )
C.V. 1%
4-D ay refrigerated/5 Hour RT
3.33
2.74 82.3
(A) Denotes not detected. (B) The average measured concentration, average percent o f nominal (in parentheses), standard deviation, and
coefficient o f variation o f top, middle, and bottom are based on measured concentration for each level. (C) The average measured concentration, average percent o f nominal (in parentheses), standard deviation, and
coefficient o f variation o f duplicate samples are based on measured concentration for each level.
oihpany Sanitized. Does not contain TSCA CBI
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5386
Table II. Mixing and Stability Study of H-24516 in Dosing Suspensions (continued)
Sample Type Dose Volume
mg/mL H-24516
Nominal
Measured
Stability 5.0 mL/Kg 0-Day Room T emperature 5-Hour Room tem perature 2-D ay Refrigerated
5.0 4.39 5.0 4.60 5.0 4.77 5.0 4.76
M ean(C ):^70.01
3-Day R efrigerated
5.0 5.0
C.V. 0.2%
4.74 4.48
M ean(C ): 4.61+0.2
4-D ay Refrigerated 4-Day Refrigerated/5 H our RT
5.0 5.0
C .V .4%
4.81 4.85
Percent Nominal
87.8 92.0 95.4 95.2
(95.4% )
94.8 89.6
(92.2% )
96.1 97.1
0-Day Room T emperature 5-Hour Room T emperature
2-Day Refrigerated
3-Day Refrigerated
4-D ay Refrigerated 4-D ay Refrigerated/5 Hour RT
20.0 18.7 20.0 17.2 20.0 18.7 20.0 18.0
M ea n iQ : TM .30.5
C .V .3%
20.0 39.3 20.0 19.6
M ean (C V ): 29.4+14
C.V. 47%
20.0 19.6 20.0 17.6
93.5 86.0 93.5 90.0
(91.5% )
196.4 97.8
(147.0% )
97.8 88.2
0-Day Room T emperature 5-Hour Room T emperature
2-Day Refrigerated
50.0 53.4 50.0 48.3 50.0 47.3 50.0 48.4
M ea n iQ : 47.9+0.0
106.8 96.6 94.7 96.8
(95.8% )
3-Day Refrigerated
C.V. 2%
50.0 46.5 50.0 46.9
M e a n iQ : 46.7+0.3
93.0 93.8
(93.4% )
4-D ay Refrig era ted 4-D ay Refrigerated/5 H our RT
. 50.0 50.0
C .V .1%
48.9 47.9
97.8 95.7
(A) Denotes not detected.
..
(B) The average measured concentration, average percent of nominal (in parentheses), standard deviation, and
coefficient o f variation o f top, middle, and bottom are based on measured concentration for each level.
(C) The average measured concentration, average percent o f nominal (in parentheses), standard deviation, and
coefficient o f variation of duplicate samples are based on measured concentration for each level.
(D) Result is the mean o f the duplicate re-analysis o f the original sample. Original analysis indicated aliquot error
and will not be reported.
486 . Company SanWred. Doe* not c.n n W n TSCA CBf
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5386
Table III. Final Homogeneity/Concentration Verification of H-24516 in Dosing Suspensions
Sample Type
mg/mL H-24516
Nominal
Measured
Percent Nominal
Test Day 49
Homogeneity Control
0.00
n d (a )
T op M iddle Bottom
T op M iddle B ottom
T op M iddle Bottom
*
3.33 3.33 3.33
13.33 13.33 13.33
33.33 33.33 33.33
2.71 2.99 3.42
M ean*?):
3-04 0 J C.V. 12 %
10.8 12.7 12.8
M eanV ): M eanW :
^ .1 1.1 C.V. 9%
31.0 32.4 33.4 ^.J7.2
C .V .4%
81.4 89.8 102.8
(91.3% )
81.0 95.3 96.3
(90.8% )
92.9 97.1 100.3
(96.8% )
Test Day 91
Control Homogeneity
T op M id d l e Bottom
0.00 n d (a )
. 3.33 3.05 3.33 3.00 3.33 3.01
aW B ) ; 3 .0 2 + 0 .0 3
C.V. 1 %
--
91 .b 90.1 90.4
(90.7% )
Concentration Verification
13.33 13.33
M eaniC):
12.8 12.2
^ .5 0 .4 C .V .3%
96.0 91.5
(93.8% )
33.33 33.33
M ean iO :
32.7 323 ^ .5 0 .i
C.V. 1%
98.1 96.6
(97.5% )
(A) Denotes not detected.
..
(B) The average measured concentration, average percent o f nominal (in parentheses), standard deviation, and
coefficient o f variation o f top, middle, and bottom are based on measured concentration for each level.
(C) The average measured concentration, average percent o f nominal (in parentheses), standard deviation, and
coefficient of variation o f duplicate samples are based on measured concentration for each level.
48Company Sanitized. Does not contain TSCACBI
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Figure 1 Representative Analytical Calibration Curve
DuPont-5386
(a)
0)
(c) . Figure 1: Calibration curve showing linear fit (line) to replicate peak height ratio
measurements (squares) for calibration solutions of H-24516 diluted over a concentration range of 0.0302 to 0.1511 mg/mL. [(a) Retention time = 3.5 minutes, (b) Retention = 4.17 minutes, (c) Retention time = 4.77 minutes.]
488
Company Sanitized. Does not contain TSCA CBI
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5386
Figure 2 Reprsentative High Performance Liquid Chromatography Chromatograms
Figure 2b: Representative GC chromatogram o f 2.5 m g/m L H-24516 dosing solution diluted to a nominal concentration o f 0.06 mg/mL. The measured concentration o f the representative solution is 2.51 mg/mL
489
Company Sanitized. Does not contain TSCA CBt
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5386
Figure 2 (continued) Representative High Performance Liquid Chromatography Chromatograms
Figure 2c: Representative GC chromatogram of 0.0756 mg/mL H-24516 analytical reference solution.
490
Company Sanlttaed. Does not contain TSCA CBf
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5386
APPENDIX B INDIVIDUAL DOSE VOLUMES (ML)
491
Company Sanitized. Does not contain TSCA CB1
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
INDIVIDUAL DOSE VOLUMES (ML)
EXPLANATORY NOTES
DuPont-5386
Critical Dates
Day 74 Male and female rats designated for reproduction evaluations were co housed. Dose volumes administered during the cohabitation and post-mating periods are documented in the study records.
Day 89 Last day o f test substance administration for male and female rats designated for one-month and 3-month recovery periods.
p>ay 9 0 Last day o f test substance administration for male rats designated for the 90day exposure period.
Day 92 Last day o f test substance administration for female rats designated for the 90-day exposure period.
Footnotes
a. Due to error, data are missing. b. Animal may not have received total dose. c. Due to error, rat was dosed with vehicle only. d. On test day 18, all male rats and the first 11 female rats in the 25 mg/kg/day group received
37-39 mg/kg/day.
Abbreviations
AK Accidentally Killed FD Found Dead
SE Sacrificed in extremis
492
Company Sanitized. Does not contain TSCA CBf
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Day 0
Day 1
Male, I - 0 m g/kg/day
643241 2.8 2.8
643300 2.4 2.4
643143 2.4 2.4
643205 2.6 2.6
643235 2.8 2.8
643288 2.5 2.5
643150 2.4 2.4
643189 2.5 2.5
643185 2.5 2.5
643210 2.5 2.5
643268 2.6 2.6
643232 2 .6 2.6
643265 2.4 2.4
643239 2.7 2.7
643270 2.4 2.4
643148 2.5 2.5
643284 2.8 2.8
643229 2.4 2.4
643196 2.1 2.1
643176 2.5 2.5
643218 2.7 2.7
643207 2 . 4 -2.4
643280 2.3 2.3
643271 2.6 2.6
643211 2.5 2.5
643163 2.7 2.7
643197 2.5 2.5
643242 2.4 2.4
643251 2.4 2.4
643155 2.4 2.4
643147 2.5 2.5
643276 2.8 2.8
643237 2.4 2.4
643226 2.5 2.5
643195 2.4 2.4
643246 3.0 3.0
643253 2.4 2.4
643262 2.5 2.5
643172 2.6 2.6
643303 2.3 2.3
643304 2.1 2.1
643162 2.3 2.3
643254
2.2
a
643145
2.5
a
643204
2.7
a
Day 2
2.8 2.4 2.4 2.6 2.8 2.5 2.4 2.5 2.5 2.5 2.6 2.6 2.4 2.7 2.4 2.5 2.8 2.4 2.1 2.5 2.7 2.4 2.3 2.6 2.5 2.7 2.5 2.4 2.4 2.4 2.5 2.8 2.4 2.5 2.4 3.0 2.4 2.5 2.6 2.3 2.1 2.3 2.2
2.5
2.7
Day 3
2.8 2.4 2.4 2.6 2.8 2.5 2.4 2.5 2.5 2.5 2.6 2.6 2.4 2.7 2.4 2.5 2.8 2.4 2.1 2.5 2.7 2.4 2.3 2.6 2.5 2.7 2.5 2.4 2.4 2.4 2.5 2.8 2.4 2.5 2.4 3.0 2.4 2.5 2.6 2.3 2.1 2.3
2.5
2.7
to to to to
INDIVIDUAL DOSE VOLUME,
Day 4
Day 5
Day 6
2.8 2.8 2.8 2.4 2.4 2.4 2.4 2.4 2.4 2.6 2.6 2.6 2.8 2.8 2.8 2.5 2.5 2.5 2.4 2.4 2.4 2.5 2.5 2.5 2.5 2.5 2.5 2.5 2.5 2.5 2.6 2.6 2.6 2.6 2.6 2.6 2.4 2.4 2.4 2.7 2.7 2.7 2.4 2.4 2.4 2.5 2.5 2.5 2.8 2.8 2.8 2.4 2.4 2.4 2.1 2.1 2.1 2.5 2.5 2.5 2.7 2.7 2.7 2.4 2.4 2.4 2.3 2.3 2.3 2.6 2.6 2.6 2.5 2.5 2.5 2.7 2.7 2.7 2.5 2.5 2.5 2.4 2.4 2.4 2.4 2.4 2.4 2.4 2.4 2.4 2.5 2.5 2.5 2.8 2.8 2.8 2.4 2.4 2.4 2.5 2.5 2.5 2.4 2.4 2.4 3.0 3.0 3.0 2.4 2.4 2.4 2.5 2.5 2.5 2.6 2.6 2.6 2.3 2.3 2.3 2.1 2.1 2.1 2.3 2.3 2.3
2.2 2.2
2.5 2.5 2.5
2.7 2.7 2.7
493
S (mL) Day 7
Day 8
Day 9
c
DuPont-5386
Day 10
Day 11
3.5 3.0 2.9 3.1 3.5 3.1 2.9 3.2 3.2 3.0 3.2 3.1 2.9 3.4 2.9 3.0 3.4 2.8 2.6 3.0 3.1 2.9 2.8 3.2 3.1 3.4 3.2 3.1 3.0 2.9 3.1 3.5 2.8 2.9 3.0 3.6 3.0 3.1 3.2 2.9 2.6 2.8
2.7
2.9
3.2
3.5 3.0 2.9 3.1 3.5 3.1 2.9 3.2 3.2 3.0 3.2 3.1 2.9 3.4
2.9
3.0 3.4 2.8 2.6 3.0 3.1 2.9 2.8 3.2 3.1 3.4 3.2 3.1 3.0 2.9 3.1 3.5 2.8 2.9 3.0 3.6 3.0 3.1 3.2 2.9 2.6
2.8
2.7
2.9
3.2
3.5 3.0 2.9 3.1 3.5 3.1 2.9 3.2 3.2 3.0 3.2 3.1 2.9 3.4 2.9 3.0 3.4 2.8 2.6 3.0 3.1 2.9 2.8 3.2 3.1 3 .4 3.2 3.1 3.0 2.9 3.1 3.5 2.8 2.9 3.0 3.6 3.0 3.1 3.2 2.9 2.6
2.8
2.7
2.9
3.2
3.5 3.0 2.9 3.1 3.5 3.1 2.9 3.2 3.2 3.0 3.2 3.1 2.9 3.4 2.9 3.0 3.4
2.8
2.6 3.0 3.1 2.9
2.8
3.2 3.1 3.4 3.2 3.1 3.0 2.9
3.1
3.5 2.8 2.9 3.0 3.6 3.0 3.1 3.2 2.9 2.6 2.8
2.7
2.9
3.2
3.5 3.0 2.9 3.1 3.5 3.1 2.9 3.2 3.2 3.0 3.2 3.1 2.9 3.4 2.9 3.0 3.4
2.8
2.6 3.0 3.1 2.9 2.8 3.2 3.1 3.4 3.2 3.1 3.0
2.9
3.1 3.5 2.8 2.9 3.0 3.6 3.0 3.1 3.2 2.9 2.6
2.8
2.7
2.9
3.2
Company 3*nKh:ed Does not contain TSCA CBI
\
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Day 12
Day 13
Male, I - 0 rag/kg/day
643241 3.5 3.5 643300 3.0 3.0 643143 2.9 2.9 643205 3.1 3.1 643235 3.5 3.5 643288 3.1 3.1 643150 2.9 2.9 643189 3.2 3.2 643185 3.2 3.2 643210 3.0 3.0 643268 3.2 3.2 643232 3.1 3.1 643265 2.9 2.9 643239 3.4 3.4 643270 2.9 2.9 643148 3.0 3.0 643284 3.4 3.4 643229 2.8 2.8 643196 2.6 2.6 643176 3.0 3.0 643218 3.1 3.1 643207 2.9 2 .9 643280 2.8 2.8 643271 3.2 3.2 643211 3.1 3.1 643163 3.4 3.4 643197 3.2 3.2 643242 3.1 3.1 643251 3.0 3.0 643155 2.9 2.9 643147 3.1 3.1
643276 3.5 3.5 643237 2.8 2.8 643226 2 .9 2 .9
643195 3.0 3.0 643246 3.6 3.6 643253 3.0 3.0 643262 3.1 3.1 643172 3.2 3.2 643303 2.9 2.9 643304 2.6 2.6 643162 2.8 2.8 643254 2.7 2.7 643145 2.9 2.9 643204 3.2 3.2
Day 14
4.1 3.5 3.4 3.6 4.1 3.6 3.4 3.8 3.8 3.5 3.8 3.4 3.4 3.8 3.4 3.5 3.9 3.2 3.0 3.5 3.6 3.3 3.4 3.8 3.5 3.9 3.6 3.6 3.5 3.5 3.6 4.2 3.2 3.4 3.5 4.3 3.5 3.7 3.7 3.4 3.0 3.3 3.1 3.3 3.7
INDIVIDUAL DOSE VOLUME!
15 Day 16 Day 17 Day 18
4.1 4.1 4.1 4.1 3.5 3.5 3.5 3.5 3.4 3.4 3.4 3.4 3.6 3.6 3.6 3.6 4.1 4.1 4.1 4.1 3.6 3.6 3.6 3.6 3.4 3.4 3.4 3.4 3.8 3.8 3.8 3.8 3.8 3.8 3.8 3.8 3.5 3.5 3.5 3.5 3.8 3.8 3.8 3.8 3.4 3.4 3.4 3.4 3.4 3.4 3.4 3.4 3.8 3.8 3.8 3.8 3.4 3.4 3.4 3.4 3.5 3.5 3.5 3.5 3.9 3.9 3.9 3.9 3.2 3.2 3.2 3.2 3.0 3.0 3.0 3.0 3.5 3.5 3.5 3.5 3.6 3.6 3.6 3.6 3.3 3.3 3.3 3.3 3.4 3.4 3.4 3.4 3.8 3.8 3.8 3.8 3.5 3.5 3.5 3.5 3.9 3.9 3.9 3.9 3.6 3.6 3.6 3.6 3.6 3.6 3.6 3.6 3.5 3.5 3.5 3.5 3.5 3.5 3.5 3.5 3.6 3.6 3.6 3.6 4.2 4.2 4.2 4.2 3.2 3.2 3.2 3.2 3.4 3.4 3.4 3.4 3.5 3.5 3.5 3.5 4.3 4.3 4.3 4.3 3.5 3.5 3.5 3.5 3.7 3.7 3.7 3.7 3.7 3.7 3.7 3.7 3.4 3.4 3.4 3.4 3.0 3.0 3.0 3.0 3.3 3.3 3.3 3.3 3.1 3.1 3.1 3.1 3.3 3.3 3.3 3.3 3.7 3.7 3.7 3.7
494
3 (mL)
Day 19
Day 20
Day 21
Day 22
DuPont-5386
Day 23
4.1 4.1 4.5 4.5 4.5
3.5 3.5 3.9 3.9 3.9
3.4 3.4 3.8 3.8 3.8
3.6 3.6 4.1 4.1 4.1
4.1 4.1 4.6 4.6 4.6
3.6 3.6 4.1 4.1 4.1
3.4 3.4 3.6 3.6 3.6
3.8 3.8 4.3 4.3 4.3
3.8 3.8 4.2 4.2 4.2
3.5 3.5 3.9 3.9 3.9
3.8 3.8 4.3 4.3 4.3
3.4 3.4 3.8 3.8 3.8
3.4 3.4 4.0 4.0 4.0
3.8 3.8 4.3 4.3 4.3
3.4 3.4 3.8 3.8 3.8
3.5 3.5 3.8 3.8 3.8
3.9 3.9 4.3 4.3 4.3
3.2 3.2 3.5 3.5 3.5
3.0 3.0 3.3 3.3 3.3
3.5 3.5 3.9 3.9 3.9
3.6 3.6 4.0 4.0 4.0
3.3 3.3 3.6 3.6 3.6
3.4 3.4 3.8 3.8 3.8
3.8 3.8 4.3 4.3
3.5 3.5 3. 9 3.9 3 . 9 3 . 9 4.4 4.4
4.3
3.9
4.4
3.6 3.6 4.2 4.2 4.2
3.6 3.6 4.0 4.0 4. 0
3.5 3.5 3.9 3.9 3.9
3.5 3.5 3.9 3.9 3.9
3.6 3.6 4.0 4.0 4.0
4 .2 4 .2 4.7 4.7 4 . 7
3.2 3.2 3.6 3.6 3.6
3 .4 3 .4 3.7 3.7 3.7
3 . 5 3 . 5 3 . 8 3.8 3.8 4 . 3 4 .3 4.7 4.7 4.7
3 . 5 3 . 5 4 . 0 4.0 4 . 0 3.7 3.7 4 . 2 4 . 2 4 . 2 3.7 3.7 4 . 3 4 . 3 4 . 3
3.4 3.4 3.9 3.9 3.9
3.0 3.0 3.4 3.4 3.4
3.3 3.3 3.7 3.7 3.7 3 . 1 3 . 1 3.3 3.3 3.3
3.3 3.3 3.7 3.7 3.7
3.7 3.7 4 . 1 4 . 1 4 . 1
Company Sanitized. Does not contain TSCACBI
H -24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Day 24
Day 25
Male, I - 0 m g/kg/day
643241 4.5 4.5
643300 3.9 3.9 643143 3.8 3.6 643205 4.1 4.1
643235 4.6 4.6 643288 4.1 4.1
643150 3.6 3.6 643189 4.3 4.3 643185 4.2 4.2 643210 3.9 3.9 643268 4.3 4.3 643232 3.8 3.8 643265 4.0 4.0 643239 4.3 4.3 643270 3.8 3.8 643148 3.8 3.8 643284 4.3 4.3 643229 3.5 3.5 643196 3.3 3.3 643176 3.9 3.9 643218 4.0 4.0
643207 3 .6 J3.6 643280 3.8 3.8 643271 4.3 4,3 643211 3.9 3.9 643163 4.4 4.4 643197 4.2 4.2 643242 4.0 4.0 643251 3 .9 3 .9 643155 3.9 3.9 643147 4.0 4.0 643276 4.7 4.7 643237 3.6 3.6 643226 3.7 3.7
643195 3.8 3.8 643246 4.7 4.7 643253 4.0 4.0 643262 4.2 4.2 643172 4.3 4.3 643303 3.9 3.9 643304 3.4 3.4 643162 3.7 3.7 643254 3.3 3.3 643145 3.7 3.7 643204 4.1 4.1
Day 26
4.5 3.9 3.8 4.1 4.6 4.1 3.6 4.3 4.2 3.9 4.3 3.8 4.0 4.3 3.8 3.8 4.3 3.5 3.3 3.9 4.0 3.6 3.8 4.3 3.9 4.4 4.2 4.0 3.9 3.9 4.0 4.7 3.6 3.7 3.8 4.7 4.0 4.2 4.3 3.9 3.4 3.7 3.3 3.7 4.1
Day 27
INDIVIDUAL DOSE VOLUME
Day 28
Day 29
Day 30
4.5 3.9 3.8 4.1 4.6 4.1
3.6 4.3 4.2 3.9 4.3 3.8 4.0 4.3 3.8 3.8 4.3 3.5 3.3 3.9 4.0 3.6 3.8 4.3 3.9 4.4 4.2 4.0
3. 9
3.9 4.0 4.7 3.6 3.7 3.8 4.7
4.0
4.2 4.3 3.9 3.4
3.7 3.3
3.7 4.1
5.0 4.2 4.2 4.5 5.1 4.6 3.8 4.7 4.6 4.3 4.7 4.0 4.2 4.6 4.1 4.1 4.7 3.7 3.5 4.3 4.3 3.9 4.1 4.7 4.2
4.8
4.5 4.3 4.2 4.2 4.3
5.0
3.9
4.0
4.1 5.0 4.3 4.5 4.6 4.3 3.7
3.9 3.7
4.0
4.5
5.0 4.2 4.2 4.5 5.1 4.6 3.8 4.7 4.6 4.3 4.7 4.0 4.2 4.6 4.1 4.1 4.7 3.7 3.5 4.3 4.3
3.9 4.1 4.7 4.2 4.8 4.5
4.3
4.2 4.2 4.3 5.0 3.9 4.0
4.1
5.0 4.3 4.5 4.6 4.3 3.7
3.9 3.7 4.0 4.5
5.0 4.2 4.2 4.5 5.1
4.6 3.8 4.7
4.6 4.3 4.7 4.0 4.2 4.6 4.1 4.1 4.7 3.7 3.5 4.3 4.3 3.9 4.1 4.7 4.2 4.8 4.5 4.3 4.2 4.2
4.3
5.0 3.9 4.0 4.1
5.0
4.3 4.5 4.6 4.3 3.7 3.9 3.7 4.0 4.5
495
S (mL)
Day 31
Day 32
Day 33
Day 34
DuPont-5386
Day 35
5.0 5.0 5.0 5.0 5.2 4.2 4.2 4.2 4.2 4.6 4.2 4.2 4.2 4.2 4.4 4.5 4.5 4.5 4.5 4.7 5.1 5.1 5.1 5.1 5.4 4.6 4.6 4.6 4.6 4.9 3.8 3.8 3.8 3.8 4.1 4.7 4.7 4.7 4.7 4.9
4.6 4.6 4.6 4.6 4.8 4.3 4.3 4.3 4.3 4.4 4.7 4.7 4.7 4.7 5.0 4.0 4.0 4.0 4.0 4.1 4.2 4.2 4.2 4.2 4.4 4.6 4.6 4.6 4.6 4.9 4.1 4.1 4.1 4.1 4.4 4.1 4.1 4.1 4.1 4.5 4.7 4.7 4.7 4.7 5.0 3.7 3.7 3.7 3.7 3.9 3.5 3.5 3.5 3.5 3.7 4.3 4.3 4.3 4.3 4.5 4.3 4.3 4.3 4.3 4.6
3.9 3.9 3.9 3.9 4.2 4.1 4.1 4.1 4.1 4.4 4.7 4.7 4.7 4.7 5.0 4.2 4.2 4.2 4.2 4.5 4.8 4.8 4.8 4.8 5.2 4.5 4.5 4.5 4.5 4.7
4.3 4.3 4.3 4.3 4.6 4.2 4.2 4.2 4.2 4.4 4.2 4.2 4.2 4.2 4.3 4.3 4.3 4.3 4.3 4.6 5.0 5.0 5.0 5.0 5.4 3.9 3.9 3.9 3.9 4.1 4.0 4.0 4.0 4.0 4.1 4.1 4.1 4.1 4.1 4.3
5.0 5.0 5.0 5.0 5.3 4.3 4.3 4.3 4.3 4.6 4.5 4.5 4.5 4.5 4.9 4.6 4.6 4.6 4.6 4.9 4.3 4.3 4.3 4.3 4.7 3.7 3.7 3.7 3.7 3.9 3.9 3.9 3.9 3.9 4.2 3.7 3.7 3.7 3.7 4.0 4.0 4.0 4.0 4.0 4.3
4.5 4.5 4.5 4.5 4.7
Company SanWzed. Does no! contain TSCA CBf
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Day 36
Day 37
Male, I - 0 m g/kg/day
643241 643300 643143 643205 643235 643288 643150 643189 643185 643210 643268 643232 643265 643239 643270 643148 643284 643229 643196 643176 643218 643207 643280 643271 643211 643163 643197 643242 643251 643155 643147 643276 643237
643226 643195 643246 643253 643262 643172 643303 643304
643162 643254 643145 643204
5.2 4.6 4.4 4.7 5.4 4.9 4.1 4.9 4.8 4.4 5.0 4.1 4.4 4.9 4.4 4.5 5.0 3.9 3.7 4.5 4.6 4.2 4.4 5.0 4.5 5.2 4.7 4.6 4.4 4.3 4.6
5.4 4.1 4.1 4.3 5.3 4.6 4.9 4.9 4.7 3.9 4.2 4.0 4.3 4.7
5.2 4.6 4.4 4.7 5.4 4.9 4.1 4.9 4.8 4.4 5.0 4.1 4.4 4.9 4.4 4.5 5.0 3.9 3.7 4.5 4.6 -4.2 4.4 5.0 4.5 5.2 4.7 4.6 4.4 4.3 4.6
5.4 4.1 4.1 4.3 5.3 4.6 4.9 4.9 4.7 3.9 4.2 4.0 4.3 4.7
Day 38
3.9 3.4 3.3 3.5 4.0 3.7 3.1 3.7 3.6 3.3 3.8 3.1 3.3 3.7 3.3 3.3 3.8 2.9 2.8 3.4 3.4 3.2 3.3 3.7 3.3 3.9 3.5 3.5 3.3 3.2 3.5 4.1 3.0
3.1 3.2 4.0 3.4 3.7 3.7 3.5 2.9 3.1 3.0 3.3 3.5
INDIVIDUAL DOSE VOLUMES (mL) 39 Day 40 Day 41
3.9
3.4 3.3 3.5 4.0 3.7
3.1 3.7
3.6 3.3
3.8
3.1 3.3 3.7
3.3 3.3
3.8 2.9 2.8
3.4 3.4
3.2 3.3
3.7 3.3
3.9 3.5 3.5 3.3 3.2 3.5 4.1 3.0 3.1
3.2
4.0 3.4
3.7 3.7
3.5 2.9
3.1 3.0 3.3
3.5
3.9 3.4 3.3
3.5 4.0 3.7
3.1 3.7 3.6
3.3 3.8
3.1
3.3 3.7 3.3 3.3
3.8 2.9 2.8 3.4 3.4
3.2 3.3 3.7
3.3
3.9 3.5 3.5 3.3 3.2 3.5 4.1
3.0 3.1 3.2
4.0 3.4
3.7 3.7
* 3.5 2.9
3.1 3.0 3.3
3.5
3.9
3.4 3.3 3.5 4.0 3.7
3.1 3.7 3.6
3.3 3.8
3.1
3.3 3.7
3.3 3.3 3.8 2.9 2.8 3.4
3.4
3.2 3.3 3.7
3.3 3.9 3.5 3.5 3.3 3.2 3.5 4.1 3.0
3.1 3.2
4.0 3.4 3.7 3.7
3.5
2.9
3.1 3.0 3.3
3.5
42
4.1 3.6 3.5 3.8 4.3 3.9 3.2 3.9 3.8 3.5 3.9 3.2 3.6 3.9 3.5 3.4 4.0 3.1 3.0 3.6 3.6 3.3 3.5 4.0 3.5 4.1 3.7 3.7 3.4 3.4 3.7 4.2 3.2 3.3 3.5 4.2 3.7 3.9 3.9 3.8
3.1 3.2 3.2 3.4
3.7
Day 43
4.1 3.6 3.5 3.8 4.3 3.9 3.2 3.9 3.8 3.5 3.9 3.2 3.6 3.9 3.5 3.4 4.0 3.1 3.0 3.6 3.6 3.3 3.5 4.0 3.5 4.1 3.7 3.7 3.4 3.4 3.7 4.2 3.2 3.3 3.5 4.2 3.7 3.9 3.9 3.8 3.1
3.2 3.2 3.4
3.7
DuPont-5386
Day 44
4.1 3.6 3.5 3.8 4.3 3.9 3.2 3.9 3.8 3.5 3.9 3.2 3.6 3.9 3.5 3.4 4.0 3.1 3.0 3.6 3.6 3.3 3.5 4.0 3.5 4.1 3.7 3.7 3.4 3.4 3.7 4.2 3.2 3.3 3.5 4.2 3.7 3.9 3.9 3.8 3.1 3.2 3.2 3.4 3.7
496
Company Sanitized. Does not contain TSCA CBI
H -24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Day 45
Male, I - 0 mg/kg/day
643241 643300 643143 643205 643235 643288 643150 643189 643185 643210 643268 643232 643265 643239 643270 643148 643284 643229 643196 643176 643218 643207 643280 643271 643211 643163 643197 643242 643251 643155 643147 643276 643237 643226 643195 643246 643253 643262 643172 643303 643304 643162 643254 643145 643204
4.1 3.6 3.5 3.8 4.3 3.9 3.2 3.9 3.8 3.5 3.9 3.2 3.6 3.9 3.5 3.4 4.0 3.1 3.0 3.6 3.6 3.3 3.5 4.0 3.5 4.1 3.7 3.7 3.4 3.4 3.7 4.2 3.2 3.3 3.5 4.2 3.7 3.9 3.9 3.8 3.1 3.2 3.2 3.4 3.7
Day 46
4.1 3.6 3.5 3.8 4.3 3.9 3.2 3.9 3.8 3.5 3.9 3.2 3.6 3.9 3.5 3.4 4.0 3.1 3.0 3.6 3.6 3.3 3.5 4.0 3.5 4.1 3.7 3.7 3.4 3.4 3.7 4.2 3.2 3.3 3.5 4.2 3.7 3.9 3.9 3.8 3.1 3.2
3.2
3.4 3.7
Day 47
INDIVIDUAL DOSE VOLUMES (mL)
Day 4 8
Day 49
Day 50
4.1 3.6 3.5 3.8 4.3 3.9 3.2 3.9 3.8 3.5 3.9 3.2 3.6 3.9 3.5 3.4 4.0 3.1 3.0 3.6 3.6 3.3 3.5 4.0 3.5 4.1 3.7 3.7 3.4 3.4 3.7 4.2 3.2 3.3 3.5 4.2 3.7 3.9 3.9 3.8 3.1 3.2 3.2 3.4 3.7
4.1 3.6 3.5 3.8 4.3 3.9 3.2 3.9 3.8 3.5 3.9 3.2 3.6 3.9 3.5 3.4 4.0 3.1 3.0 3.6 3.6 3.3 3.5 4.0 3.5 4.1 3.7 3.7 3.4 3.4 3.7 4.2 3.2 3.3 3.5 4.2 3.7 3.9 3.9 3.8 3.1 3.2 3.2 3.4 3.7
4.3 3.8 3.6 3.9 4.4 3.9 3.2 3.9 3.9 3.7 4.1 3.4 3.7 4.1 3.6 3.6 4.2 3.2 3.1 3.7 3.8 3.4 3.7 4.2 3.7 4.3 3.9 3.9 3.6 3.7 3.8 4.5 3.3 3.6
3.6 4.3 3.8
4.1
4.0 4.0 3.3 3.3
3.3
3.6 3.8
4.3 3.8 3.6 3.9 4.4 3.9 3.2
3.9 3.9 3.7 4.1 3.4 3.7 4.1 3.6 3.6 4.2 3.2 3.1 3.7 3.8 3.4 3.7 4.2 3.7 4.3 3.9 3.9 3.6 3.7
3.8 4.5 3.3 3.6 3.6 4.3 3.8
4. 1
4.0 4.0 3.3 3.3
3.3
3.6
3.8
Day 51
4.3 3.8 3.6 3.9 4.4 3.9 3.2 3.9 3.9 3.7 4.1 3.4 3.7 4.1 3.6 3.6 4.2 3.2 3.1 3.7 3.8 3.4 3.7 4.2 3.7 4.3 3.9 3.9 3.6 3.7 3.8 4.5 3.3 3.6 3.6 4.3 3.8 4.1 4.0 4.0 3.3 3.3
3.3
3.6
UJ CD
Day 52
4.3 3.8 3.6 3.9 4.4 3.9 3.2 3.9 3.9 3.7' 4.1 3.4 3.7 4.1 3.6 3.6 4.2 3.2 3.1 3.7 3.8 3.4 3.7 4.2 3.7 4.3 3.9 3.9 3.6 3.7 3.8 4.5 3.3 3.6 3.6 4.3 3.8 4.1 4.0
4.0 3.3 3.3 3.3
3.6 3.B
DuPont-5386
Day 53
4.3 3.8 3.6 3.9 4.4 3.9 3.2 3.9 3.9 3.7 4.1 3.4 3.7 4.1 3.6 3.6 4.2 3.2 3.1 3.7 3.8 3.4 3.7 4.2 3.7 4.3 3.9 3.9 3.6 3.7 3.8 4.5
3.3 3.6 3.6
4.3 3.8
4.1 4.0 4.0 3.3 3.3 3.3
3.6 3.8
497
Comnsny SanV ied. Does noi contain TSCA CBI
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Day 54
Male, I - 0 mg/kg/day
643241 643300 643143 643205 643235 643288 643150 643189 643185 643210 643268 643232 643265 643239 643270 643148 643284 643229 643196 643176 643218 643207 643280 643271 643211 643163 643197 643242 643251 643155 643147 643276 643237 643226 643195 643246 643253 643262 643172 643303 643304 643162 643254 643145 643204
4.3 3.8 3.6 3.9 4.4
3.9 3.2 3.9 3.9 3.7 4.1 3.4 3.7 4.1 3.6 3.6 4.2 3.2 3.1 3.7 3.8 3.4 3.7 4.2 3.7 4.3 3.9 3.9 3.6 3.7 3.8 4.5 3.3 3.6 3.6 4.3 3.8 4.1 4.0 4.0 3.3 3.3 3.3 3.6 3.8
Day 55
4 .3 3 .8 3 .6
3.9
4. 4 3.9 3 .2 3.9 3 .9 3 .7
4 .1
3 .4 3 .7 4 .1 3 .6 3 .6 4 .2 3.2 3.1 3.7 3.8 3. 4 3. 7 4. 2 3 .7 4 .3 3.9 3. 9 3 .6 3. 7 3 .8 4 .5 3 .3 3 ..6 3 .6 4. 3 3 .,8 4 ..1 4 ., 0 4 .. 0 3 .. 3 3.,3 3 ..3 3 .6 3 .. 8
INDIVIDUAL DC
56 Day 57
4.4 4.4 4.0 4.0 3.7 3.7 4.0 4.0 4.5 4.5 4.1 4.1 3.3 3.3 4.1 4.1 4.0 4.0 3.7 3.7 4.2 4.2 3.4 3.4 3.7 3.7 4.2 4.2 3.7 3.7 3.7 3.7 4.3 4.3 3.3 3.3 3.2 3.2 3.8 3.8 4.0 4.0 3.5 3.5 3.9 3.9 4.4 4.4 3.8 3.8 4.5 4.5 4.0 4.0 4.1 4.1 3.7 3.7 4.0 4.0 4.0 4.0 4.7 4.7 3.5 3.5 3.7 3.7 3.8 3.8 4.4 4.4 4.0 4.0 4.2 4.2 4.3 4.3 4.1 4.1 3.4 3.4 3.1 3.1 3.4 3.4 3.6 3.6
3.9 3.9
iSE VOLUMES (mL)
Day 58
Day 59
4.4 4.0 3.7 4.0 4.5 4.1
3.3 4.1 4.0 3.7 4.2 3.4 3.7 4.2 3.7 3.7 4.3 3.3 3.2 3.8 4.0 3.5 3.9
4.4
3.8 4.5 4.0 4.1
3.7
4.0 4.0 4.7 3.5 3.7
3.8
4.4
4.0 4.2 4.3 4.1 3.4 3.1 3.4 3.6 3.9
4.4 4.0 3.7 4.0
4.5 4.1 3.3 4.1 4.0 3.7 4.2 3.4 3.7 4.2 3.7 3.7 4.3 3.3 3.2 3.8 4.0 3.5 3.9
4.4
3.8 4.5
4.0
4.1 3.7 4.0 4.0 4.7 3.5 3.7 3.8
4.4 4.0
4.2 4.3 4.1 3.4 3.1 3.4 3.6
3.9
Day 60
4.4 4.0 3.7 4.0 4.5 4.1 3.3 4.1 4.0 3.7 4.2 3.4 3.7 4.2 3.7 3.7 4.3 3.3 3.2 3.8 4.0 3.5 3.9
4.4
3.8 4.5 4.0
4.1
3.7 4.0 4.0 4.7 3.5 3.7 3.8
4,4
4.0 4.2 4.3 4.1 3.4 3.1 3.4 3.6 3.9
Day 61
4.4 4.0 3.7 4.0 4.5 4.1 3.3 4.1 4.0 3.7 4.2 3.4 3.7 4.2 3.7 3.7 4.3 3.3 3.2 3.8 4.0 3.5 3.9
4.4
3.8 4.5 4.0 4.1 3.7 4.0 4.0 4.7
3.5 3.7
3.8
4.4
4.0 4.2 4.3 4.1 3.4 3.1
3.4 3.6 3.9
I>
D uP o n t-5 3 8 6
Day 62
4.4 4.0 3.7 4.0 4.5 4.1 3.3 4.1 4.0 3.7 4.2 3 .4 3.7 4.2 3.7 3.7 4.3 3.3 3.2 3.8 4.0 3.5 3.9
4.4 3.8
4.5 4.0
4.1
3.7 4.0
4.0 4.7
3.5
3.7 3. 8 4.4
4.0 4.2 4.3 4.1
3.4 3. 1 3.4
3.6 3.9
498
Company Sanitized. Does not contain TSCACBI
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
INDIVIDUAL DOSE VOLUMES (mL)
Day 63
Male, I - 0 mg/kg/day
643241 643300 643143 643205 643235 643288 643150 643189 643185 643210 643268 643232 643265 643239 643270 643148 643284 643229 643196 643176 643218 643207 643280 643271 643211 643163 643197 643242 643251 643155 643147 643276 643237 643226 643195 643246 643253 643262 643172 643303 643304 643162 643254 643145 643204
4.6 4.2 3.7 4.1 4.7 4.2 3.5 4.3 4.2 3.8 4.2 3.6 3.7 4.4 3.8 3.8 4.5 3.4 3.3 3.9 4.1 3.6 4.0 4.6 3.9 4.6 4.2 4.3 3.9 4.1 4.0 4.9 3.6 3.9 3.9 4.6
4.1 4.3 4.4 4.3
3.5 3.0 3.5 3.7
4.1
Day 64
4.6 4.2 3.7 4.1 4.7 4.2 3.5 4.3 4.2 3.8 4.2 3.6 3.7 4.4 3.8 3.8 4.5 3.4 3.3 3.9 4.1 3.6 4.0 4.6 3.9 4.6 4.2 4.3 3.9 4.1 4.0 4.9 3.6 3.9 3.9 4.6 4.1 4.3 4.4 4.3 3.5 3.0 3.5 3.7 4.1
Day 65
4.6 4.2 3.7 4.1 4.7 4.2 3.5 4.3 4.2 3.8 4.2 3.6 3.7 4.4 3.8 3.8 4.5 3.4 3.3 3.9 4.1 3.6 4.0 4.6 3.9 4.6 4.2 4.3 3.9 4.1 4.0 4.9 3.6 3.9 3.9 4.6 4.1 4.3 4.4 4.3 3.5 3.0 3.5 3.7 4.1
Day 66
4.6 4.2 3.7 4.1 4.7 4.2 3.5 4.3 4.2 3.8 4.2 3.6 3.7 4.4 3.8 3.8 4.5 3.4 3.3 3.9 4.1 3.6 4.0 4.6 3.9 4.6 4.2 4.3 3.9 4.1 4.0 4.9 3.6 3.9 3.9 4.6 4.1 4.3 4.4 4.3 3.5 3.0 3.5 3.7 4.1
Day 67
4.6 4.2 3.7 4.1 4.7 4.2 3.5 4.3 4.2 3.8 4.2 3.6 3.7 4.4 3.8 3.8 4.5 3.4 3.3 3.9 4.1 3.6 4.0 4.6 3.9 4.6 4.2 4.3 3.9 4.1 4.0 4.9 3.6 3.9 3.9 4.6 4.1 4.3 4.4 4.3 3.5 3.0 3.5 3.7
4.1
Day 68
4.6 4.2 3.7 4.1 4.7 4.2 3.5 4.3 4.2 3.8 4.2 3.6 3.7 4.4 3.8 3.8 4.5 3.4 3.3 3.9 4.1 3.6 4.0 4.6 3.9 4.6 4.2 4.3 3.9 4.1 4.0 4.9 3.6 3.9 3.9 4.6 4.1 4.3 4.4 4.3 3.5 3.0 3.5 3.7
4.1
Day 69
4.6 4.2 3.7 4.1 4.7 4.2 3.5 4.3 4.2 3.8 4.2 3.6 3.7 4.4 3.8 3.8 4.5 3.4 3.3 3.9 4.1 3.6 4.0 4.6 3.9 4.6 4.2 4.3 3.9 4.1 4.0 4.9 3.6 3.9 3.9 4.6 4.1 4.3 4.4 4.3 3.5 3.0 3.5 3.7 4.1
Day 70
4.7 4.3 3.8 4.2 4.7 4.4 3.6 4.4 4.2 4.0 4.4 3.7 3.8 4.5 3.8 3.8 4.7 3.5 3.4 4.0 4.2 3.8 4.2 4.7 4.0 4.8 4.3 4.4 3.9 4.3 4.2 5.1 3.7 4.0 4.1 4.8 4.3 4.4 4.6 4.3 3.6 3.1 3.6 3.8
4.2
DuPont-5386
Day 71
4.7 4.3 3.8 4.2 4.7 4.4 3.6 4.4 4.2 4.0 4.4 3.7 3.8 4.5 3.8 3.8 4.7 3.5 3.4 4.0 4.2 3.8 4.2 4.7 4.0 4.8 4.3 4.4 3.9 4.3 4.2 5.1
3.7
4.0
4.1
4.8 4.3
4.4 4.6
4.3
3.6
3.1
3.6
3.8
4.2
499
Company SanHteed. Does mrt contata TSCA CB1
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Day 72
Male, I - 0 mg/kg/day
643241
643300 643143 643205 643235 643288 643150 643189 643185 643210 643268 643232 643265 643239 643270 643148 643284 643229 643196 643176 643218 643207 643280 643271 643211 643163
643197 643242 643251 643155 643147 643276 643237 643226 643195 643246 643253 643262 643172 643303 643304 643162 643254 643145 643204
4.7
4.3 3.8 4.2 4.7 4.4 3.6 4.4 4.2 4.0 4.4 3.7 3.8 4.5 3.8 3.8 4.7 3.5 3.4 4.0 4.2 3.8 4.2 4.7 4.0 4.8 4.3 4.4
3.9 4.3 4.2 5.1 3.7 4.0 4.1 4.8 4.3 4.4 4.6 4.3 3.6 3.1 3.6 3.8 4.2
Day 73
4.7 4.3 3.8 4.2 4.7 4.4 3.6 4.4 4.2 4.0 4.4 3.7 3.8 4.5 3.8 3.8 4.7 3.5 3.4 4.0 4.2 3.8 4.2 4.7 4.0
4.8 4.2 4.4 3.9 4.3 4.2 5.1 3.7 4.0 4.1 4.8 4.3 4.4 4.6 4.3 3.6 3.1 3.6 3.8 4.2
Day 74
INDIVIDUAL DOSE VOLUMES (mL)
Day 75
Day 76
Day 77
4.7
4.3 3.8 4.2 4.7 4.4 3.6 4.4 4.2 4.0 4.4 3.7 3.8 4.5 3.8 3.8 4.7 3.5 3.4 4.0 4.2 3.8 4.2 4.7 4.0 4.8 4.3 4.4
3.9 4.3 4.2 5.1 3.7 4.0 4.1 4.8 4.3 4.4 4.6 4.3 3.6 3.1 3.6 3.8 4.2
4.7 4.3 3.8 4.2 4.7 4.4 3.6 4.4 4.2 4.0 4.4 3.7 3.8
3.7 4.0 4.1 4.8 4.3 4.4 4.6 4.3 3.6 3.1
3.8 4.2
4.7 4.3 3.8 4.2 4.7 4.4 3.6 4.4 4.2 4.0 4.4 3.7 3.8
3.7 4.0 4.1 4.8 4.3 4.4 4.6 4.3 3.6 3.1
3.8 4.2
4.7 4.4 3.9 4.3 4.8 4.5 3.6 4.5 4.4 4.0 4.3 3.8 3.8
3.8 4.1 4.1 4.8 4.3 4.5 4.7 4.5 3.7 2.8
3.7 4.2
Day 78
Day 79
4.7b
4.4
3.9 4.3 4.8
4.5 3.6 4.5 4.4
4.0 4.3 3.8 3.8
4.7
4.4
3.9 4.3 4.8
4.5 3.6 4.5 4.4
4.0 4.3 3.8 3.8
3.8 4.1 4.1 4.8 4.3 4.5 4.7 4.5 3.7 2.8
3.7 4.2
3.8 4.1 4.1 4.8 4.3 4.5 4.7 4.5 3.7 2.8
3.7 4.2
DuPont-5386
Day 80
4.7 4.4 3.9 4.3 4.8 4.5 3.6 4.5 4.4 4.0 4.3 3.8 3.8
3.8 4.1 4.1 4.8 4.3 4.5 4.7 4.5 3.7 2.8 3.7 4.2
500
Company Smithed. Does noteortM nTSCACBf
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations______________
Day 81
Male, I - 0 mg/kg/day
643241 643300 643143 643205 643235 643288 643150 643189 643185 643210 643268 643232 643265 643239 643270 643148 643284 643229 643196 643176 643218 643207 643280 643271 643211 643163 643197
643242 643251 643155 643147 643276 643237 643226 643195 643246 643253 643262 643172 643303 643304 643162 643254 643145 643204
4.7 4.4 3.9 4.3 4.8 4.5 3.6 4.5 4.4 4.0 4.3 3.8 3.8
3.8 4.1 4.1 4.8 4.3 4.5 4.7 4.5 3.7 2.8 3.7 4.2
Day 82
4.7 4.4 3.9 4.3 4.8 4.5 3.6 4.5 4.4 4.0 4.3 3.8 3.8
3.8 4.1 4.1 4.8 4.3 4.5 4.7 4.5 3.7 2.8 3.7 4.2
Day 83
INDIVIDUAL DOSE VOLUMES ( m L )
Day 84
Day 85
Day 86
4.7 4.8 4.8 4.8 4.4 4.5 4.5 4.5
3 . 9 3.9 3 . 9 3 . 9
4.3 4.4 4.4 4.4
4 . 8 4 . 9 4 . 9 4.9
4.5 4.6 4.6 4.6 3.6 3.6 3.6 3.6 4.5 4.6 4.6 4.6 4.4 4.5 4.5 4.5
4 . 0 4 . 1 4 . 1 4.1
4.3 4.4 4.4 4.4 3.8 3.9 3.9 3.9 3.8 3.8 3.8 3.8
3.8 4.1 4.1
4.8 4.3 4.5
4.7
2.8
3.7 4.2
3.8
4.1
4.2 4.8 4.5 4.5 4.7 4.6 3.8 3.0
3.9 4.4
3.8 4.1 4.2
4.8
4.5 4.5 4.7 4.6 3.8 3.0
3.9 4.4
3.8 4.1 4.2 4.8 4.5 4.5 4.7 4.6 3.8 3.0
3.9 4.4
Day 87
4.8
4.5 3.9 4.4 4.9 4.6 3.6 4.6 4.5 4.1 4.4 3.9 3.8
3.8 4.1 4.2 4.8 4.5 4.5 4.7 4.6 3.8 3.0 3.9 4.4
Day 88
4.8 4.5 3.9 4.4 4.9 4.6 3.6 4.6 4.5 4.1 4.4 3.9 3.8
3.8 4.1 4.2 4.8 4.5 4.5 4.7 4.6 3.8 3.0 3.9 4.4
DuPont-5386
Day 89
4.8 4.5 3.9
4.4
4.9 4.6 3.6 4.6 4.5 4.1 4.4 3.9 3.8
3.8 4.1 4.2 4.8 4.5 4.5 4.7 4.6 3.8 3.0 3.9 4.4
501
Company Sanitized. Does not contain TSCA CBI
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
INDIVIDUAL DOSE VOLUMES (mL)
Day 90
M a le , I - 0 m g /k g /d a y
643241 643300 643143 643205 643235 643288 643150 643189 643185 643210 643268 643232 643265 643239 643270 643148 643284 643229 643196 643176 643218 643207 643280
643271 643211 643163 643197 643242 643251 643155 643147 643276 643237
643226
643195 643246 643253 643262 643172 643303 643304 643162 643254 643145 643204
4.8 4.5 3.9 4.4 5.0 4.5 3.7 4.7 4.6
4.5
DuPont-5386
502
Company Sanitized. Does not contain TSCA CBf
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5386
INDIVIDUAL DOSE VOLUMES (mL)
Day 0
Day 1
Day 2
Day 3
Day 5
Day 6
Day 1
Day 8
Day 9
Day 10
Day 11
M ale, I I I - 25 m g /k g /d a y
643173 643290 643272 643292 643226 643308 643264 643240 643180 643179 643202 643310 643306 643305 643293 643287 643188 643230 643170 643144 643277 643214 643261 643166
643153 643177 643198 643291 643184 643167 643223 643233 643183 643219 643263
2.4 2.1 2.3 2.5 2.8 2.6 2.7 2.5 2.4 2.6 2.3 2.6 2.2 2.7 2.5 2.1 2.6 2.6 2.6 1.9 2.5 2.6 2.6 2.3 2.4
2.4 2.7 2.6 2.4 2.5 2.6 2.4 2.6 2.7 2.3
2.4 2.1 2.3 2.5 2.8 2.6 2.7 2.5 2.4 2.6 2.3 2.6 2.2 2.7 2.5 2.1 2.6 2.6 2.6 1.9 2.5 - 2.6 2.6 2.3 2.4 2.4
2.7 2.6 2.4 2.5 2.6 2.4 2.6 2.7
2.3
2.4 2.1 2.3 2.5 2.8 2.6 2.7 2.5 2.4 2.6 2.3 2.6 2.2 2.7 2.5 2.1 2.6 2.6 2.6 1.9 2.5 2.6 2.6 2.3
2.4 2.4 2.7 2.6 2.4 2.5 2.6 2.4 2.6 2.7
2.3
2.4 2.1 2.3 2.5 2.8 2.6 2.7 2.5 2.4 2.6 2.3 c 2.6 c 2.2 c 2.1 c 2.5 c 2.1 2.6 2.6 2.6 1.9 2.5 2.6 2.6 2.3 2.4
2.4 2.7 2.6 2.4 2.5 2.6 2.4 2.6 2.7
2.3
2.4 2.1 2.3 2.5 2.8 2.6 2.7
2.5 2.4 2.6 2.3 2.6 2.2 2.7 2.5 2.1 2.6 2.6 2.6 1.9 2.5 2.6 2.6 2.3 2.4 2.4 2.7 2.6 2.4
2.5
2.6
2.4
2.6
2.7
2.3
2.4
2.1 2.3 2.5 2.8
2.6 2.7 2.5 2.4 2.6 2.3 2.6 2.2 2.7 2.5 2.1 2.6 2.6 2.6 1.9 2.5 2.6
2.6 2.3 2.4 2.4 2.7 2.6 2.4 2.5 2.6 2.4
2.6
2.7
to u>
2.4 2.1 2.3 2.5 2.8 2.6 2.7 2.5 2.4 2.6 2.3 2.6 2.2 2.7 2.5 2.1 2.6 2.6 2.6 1.9 2.5 2.6 2.6 2.3 2.4 2.4
2.7 2.6 2.4 2.5 2.6 2.4
2.6
2.7
2.3
3.0 2.7 2.8 3.0 3.5 3.3 3.3 3.0 3.0
3.1 2.8 3.2 2.6 3.2 3.0 2.6 3.3 3.1 3.2 2.4 3.1 3.3 3.2 2.8 2.9 3.1
3.4 3.2 3.0 3.2 3.1
2.9
3.2
3.3 2.6
3.0 2.7 2.8 3.0 3.5 3.3 3.3 3.0 3.0 3.1 2.8 3.2 2.6 3.2 3.0 2.6 3.3 3.1 3.2 2.4 3.1 3.3
3.2 2.8 2.9 3.1 3.4 3.2 3.0 3.2 3.1
2.9
3.2
3.3
2.8
3.0 2.7 2.8 3.0 3.5 3.3 3.3 3.0 3.0 3.1 2.8 3.2 2.6 3.2 3.0 2.6 3.3 3.1 3.2 2.4 3.1 3.3 3.2 2.8 2.9
3.1 3.4 3.2 3.0 3.2
3.1 2.9
3.2 3.3
2.8
3.0 2.7 2.8 3.0 3.5 3.3 3.3 3.0 3.0
3.1 2.8 3.2 2.6 3.2 3.0 2.6 3.3 3.1 3.2
2.4 3.1 3.3 3.2 2.8 2.9 3.1 3.4 3.2 3.0 3.2 3.1
2.9
3.2
3.3
2.8
3.0 2.7
2.8 3.0 3.5 3.3
3.3
3.0 3.0
3.1 2.8 3.2 2.6 3.2
3.0 2.6 3.3 3.1 3.2
2.4
3.1 3.3
3.2
2.8 2.9
3.1 3.4 3.2
3.0 3.2 3.1 2. 9
3.2
3.3 2. 8
503
Company Sanitized. Does not contain TSCA CBI
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
INDIVIDUAL DOSE VOLUMES (mL)
Day 12
Day 13
Male, I I I - 25 m g /k g /d a y
643173 643290 643272 643292 643228 643308 643264 643240 643180 643179 643202 643310 643306 643305 643293 643287 643188 643230 643170 643144 643277 643214 643261 643166 643153 643177
643198
643291 643184 643167 643223 643233 643183 643219 643263
3.0 2.7 2.8 3.0 3.5 3.3 3.3 3.0 3.0 3.1 2.8 3.2 2.6 3.2 3.0 2.6 3.3 3.1 3.2 2.4 3.1 3.3 3.2 2.8 2.9 3.1
3.4
3.2 3.0 3.2 3.1 2.9 3.2
3.3
2.8
3.0 2.7 2.8 3.0 3.5 3.3 3.3 3.0 3.0 3.1 2.8 3.2 2.6 3.2 3.0 2.6 3.3 3.1 3.2 2.4 3.1 '3 .3 3.2 2.8 2.9 3.1
3.4 3.2 3.0 3.2 3.1 2.9 3.2
3.3 2.6
Day 14
Day 15
3.5 3.2 3.3 3.5 4.1 3.9 3.9 3.6 3.6 3.7 3.3 3.6 3.0 3.7 3.5 3.0 4.0 3.5 3.7 2.9 3.7 3.7 3.8 3.4 3.5 3.6
4.0
3.8 3.4 3.8 3.6
3.3
3.7
3.8 3.2
3.5 3.2 3.3 3.5 4.1 3.9 3.9 3.6
3.6 3.7 3.3 3.6 3.0 3.7 3.5 3.0 4.0 3.5 3.7 2.9 3.7 3.7 3.8 3.4 3.5 3.6
4.0
3.8 3.4 3.8 3.6
3.3
3.7
3.0
3.2
Day 16
3.5 3.2 3.3 3.5 4.1 3.9 3.9 3.6 3.6 3.7 3.3 3.6 3.0 3.7 3.5 3.0 4.0 3.5 3.7 2.9 3.7 3.7 3.8 3.4 3.5 3.6
4.0 3.8 3.4 3.8 3.6
3.3
3.7
3.8
3.2
Day 17
Day 18d
3.5 3.2 3.3 3.5 4.1 3.9
3.9 3.6
3.6 3.7 3.3 3.6 3.0
3.7 3.5 3.0 4.0 3.5
3.7
2.9 3.7 3.7 3.8 3.4 3.5
3.6
v> 4.0 b
3.8 3.4 3.8 3.6
3. 3
3.7
3.8
3.2
3.5 3.2 3.3 3.5
4.1
3.9 3.9 3.6
3.6 3.7 3.3 3.6 3.0 3.7 3.5 3.0 4.0 3.5 3.7
2.9 3.7 3.7 3.8 3.4
3.5 3.6
4.0
3.8
3.4 3. 8 3.6 3.3
3.7
3.8
3.2
Day 19
3.5 3.2 3.3 3.5 4.1 3.9 3.9 3.6 3.6 3.7 3.3 3.6 3.0 3.7 3.5 3.0 4.0 3.5 3.7 2.9 3.7 3.7 3.8 3.4 3.5 3.6
4.0 3.8 3.4 3.8 3.6
3.3
3.7 3.8 3.2
Day 20
3.5 3.2 3.3 3.5 4.1 3.9 3.9 3.6 3.6 3.7 3.3 3.6 3.0 3.7 3.5 3.0 4.0 3.5 3.7 2.9 3.7 3.7 3.8 3.4 3.5 3.6
4.0 3.8 3.4 3.8 3.6
3.3
3.7 3.8 3.2
Day 21
3.8 3.6 3.5 3.9 4.5 4.2 4.3 3.8 4.0 4.1 3.6 4.1 3.3 4.0 3.9 3.4 4.4
3.8
4.1 3.3 4.2 4.2 4.2 3.7 3.8 4.0
4.5 4.2 3.7 4.2 3.9 3.6 4.0 4.2 3.6
Day 22
3.8 3.6 3.5
3.9
4.5 4.2 4.3 3.8 4.0 4.1 3.6 4.1 3.3 4.0 3.9 3.4 4.4
3.8
4.1 3.3 4.2 4.2 4.2 3.7 3.8 4.0
4.5 4 .2 3.7 4.2 3.9
3.6
4.0 4.2 3.6
i
DuPont-5386
Day 23
3.8 3.6 3.5 3.9 4.5 4.2 4.3 3.8 4.0 4.1 3.6 4.1 3.3 4.0 3.9 3.4 4.4
3.8
4.1
3.3
4.2 4.2 4.2 3.7
3.8
4.0 4.5 4.2
3.7
4.2 3.9
3.6
4.0 4.2 3.6
504
)
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Day 24
Day 25
Male, I I I - 25 m g/kg/day
643173 643290 643272 643292 643228 643308 643264 643240 643180 643179 643202 643310 643306 643305 643293 643287 643188 643230 643170 643144 643277 643214 643261 643166 643153 643177 643198 643291 643184 643167 643223 643233 643183 643219 643263
3.8 3.8 3.6 3.6 3.5 3.5 3.9 3.9 4.5 4.5 4.2 4.2 4.3 4.3 3.8 3.8 4.0 4.0 4.1 4.1 3.6 3.6 4.1 4.1 3.3 3.3 4.0 4.0 3.9 3.9 3.4 3.4 4.4 4.4 3.8 3.8 4.1 4.1 3.3 3.3 4.2 4.2 4.2 - 4.2 4.2 4.2 3.7 3.7 3.8 3.8 4.0 4.0 4.5 4.5 4.2 4.2 3.7 3.7 4.2 4.2 3.9 3.9 3.6 3.6 4.0 4.0 4.2 4.2 3.6 3.6
Day 26
3.8 3.6 3.5 3.9 4.5 4.2 4.3 3.8 4.0 4.1 3.6 4.1 3.3 4.0 3.9 3.4 4.4 3.8 4.1 3.3 4.2 4.2 4.2 3.7 3.8 4.0 4.5 4.2 3.7 4.2 3.9 3.6 4.0 4.2 3.6
Day 27
3.8 3.6 3.5 3.9 4.5 4.2 4.3 3.8 4.0 4.1 3.6 4.1 3.3 4.0 3.9 3.4 4.4 3.8 4.1 3.3 4.2 4.2 4.2 3.7 3.8 4.0 4.5 4.2 3.7 4.2 3.9 3.6 4.0 4.2 3.6
INDIVIDUAL DOSE VOLUMES
Day 28
Day 29
Day 30
4.2 4.2 4.2 4.0 4.0 4.0 3.9 3.9 3.9 4.2 4.2 4.2 4.9 4.9 4.9 4.6 4.6 4.6 4.7 4.7 4.7 4.1 4.1 4.1 4.4 4.4 4.4 4.4 4.4 4.4 3.8 3.8 3.8 4.5 4.5 4.5 3.7 3.7 3.7 4.2 4.2 4.2 4.2 4.2 4.2 3.7 3.7 3.7
4.8 4.8 4.8 4.1 4.1 4.1 4.5 4.5 4.5 3.7 3.7 3.7 4.6 4.6 4.6
4.6 4.6 4.6 4.5 4.5 4.5 4.1 4.1 4.1 4.2 4.2 4.2 4.4 4.4 4.4 4.9 4.9 4.9 4.6 4.6 4.6 3.8 3.8 3.8 4.5 4.5 4.5 4.2 4.2 4.2 3.8 3.8 3.8 4.4 4.4 4.4 4.6 4.6 4.6 3.9 3.9 3.9
505
3 (ml.)
Day 31
Day 32
Day 33
Day 34
DuPont-5386
Day 35
4.2 4.2 4.2 4.2 4.7
4.0 4.0 4.0 4.0 4.3
3.9 3.9 3.9 3.9 4.1
4.2 4.2 4.2 4.2 4.6
4.9 4.9 4.9 4.9 5.4
4.6 4.6 4.6 4.6 5.0
4.7 4.7 4.7 4.7 5.0
4.1 4.1 4.1 4.1 4.3
4.4 4.4 4.4 4.4 4.8
4.4 4.4 4.4 4.4 4.6
3.8 3.8 3.8 3.8 4.1
4.5 4.5 4.5 4.5 4.8
3.7 3.7 3.7 3.7 3.9
4.2 4.2 4.2 4.2 4.6
4.2 4.2 4.2 4.2 4.6
3.7 3.7 3.7 3.7 4.0
4.8 4.8 4.8 4.8 5.1
4.1 4.1 4.1 4.1 4.3
4.5 4.5 4.5 4.5 4.8
3.7 3.7 3.7 3.7 3.9
4.6 4.6 4.6 4.6 4.9
4.6 4.6 4.6 4.6 4.9
4.5 4.5 4,5 4.5 4.9
4 . 1 4 . 1 4 . 1 4 . 1 4.4
4 .2 4 .2 4 .2 4 . 2 4.5 4.4 4.4 4.4 4.4 4 . 7
4.9 4.9 4.9 4.9 5.2
4 .6 4 . 6 4 . 6 4 . 6 4.9
3.8 3.8 3.8 3.8 4.0
4.5 4.5 4.5 4.5 4.9
4 . 2 4 . 2 4 . 2 4 . 2 4.4 3 .8 3 .8 3 .8 3 .8 4.1 4.4 4.4 4.4 4.4 4.8
4.6 4.6 4.6 4.6 4.9
lU ID
3.9 3 . 9
3.9 4.2
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Day 36
Day 37
Male, I I I - 25 m g /k g /d a y
643173 643290 643272 643292 643228 643308 643264 643240 643180 643179 643202 643310 643306 643305 643293 643287 643188 643230 643170 643144 643277 643214 643261 643166 643153 643177 643198
643291 643184 643167 643223 643233 643183 643219 643263
4.7 4.3 4.1 4.6 5.4 5.0 5.0 4.3 4.8 4.6 4.1 4.8 3.9 4.6 4.6 4.0 5.1 4.3 4.8 3.9 4.9
4.9 4.9 4.4 4.5 4.7 5.2 4.9 4.0 4.9 4.4 4.1 4.8 4.9 4.2
4.7 4.3 4.1 4.6 5.4 5.0 5.0 4.3 4.8 4.6 4.1 4.8 3.9 4.6 4.6 4.0 5.1 4.3 4.8 3.9 4.9 - 4.9 4.9 4.4 4.5 4.7 5.2 4.9
4.0 4.9 4.4 4.1 4.8 4.9 4.2
Day 38
3.5 3.2 3.1 3 .4 4.1 3.7 3.8 3.3 3.6 3.5 3.1 3.6 2.9 3.4 3.5 3.0 3.8 3.3 3.6 2.9 3.7 3.7 3.7 3.3 3.4 3.6 3.9 3.7
3.0 3.7 3.3 3.1 3.6 3.7 3.1
INDIVIDUAL DOSE VOLUMES (mL) 39 Day 40 Day 41 D a y 4 2
3.5
3.2 3.1 3.4
4.1 3.7
3.8
3.3
3.6 3.5 3.1 3.6
2.9 3.4 3.5
3.0 3.8 3.3 3.6 2.9 3.7
3.7 3.7
3.3 3.4 3.6 3.9 3.7
3.0 3.7
3.3 3.1 3.6 3.7
3.1
3.5
3.2 3.1 3.4
4.1 3.7
3.8 3.3
3.6
3.5 3.1 3.6
2.9 3.4 3.5 3.0
3.8 3.3 3.6 2.9 3.7
3.7 3.7
3.3 3.4
3.6 3.9 3.7
3.0 3.7 3.3
3.1 3.6 3.7
3.1
3.5 3.2 3.1 3.4
4.1
3.7
3.8 3.3
3.6
3.5 3.1 3.6 2.9 3.4 3.5 3.0
3.8 3.3 3.6 2.9 3.7
3.7 3.7
3.3 3.4
3.6 3.9 3.7
3.0 3.7
3.3
3.1 3.6 3.7
3.1
3.6 3.5 3.3 3.6 4.2
3.9 4.0 3.3 3.8
3.6 3.2 3.7
3.1 3.5
3.6 3.1
3.9 3.3 3.7
3.1
3.9 3.6 3.8 3.4 3.5 3.7 4.0 3.9 3.1 3.8 3.5 3.2 3.8 3.8
3.2
Day 43
3.6 3.5 3.3 3.6 4.2 3.9 4.0 3.3 3.8 3.6 3.2 3.7 3.1 3.5 3.6 3.1 3.9 3.3 3.7 3.1 3.9 3.8 3.8 3.4 3.5 3.7 4.0 3.9
3.1 3.8 3.5 3.2 3.8 3.8 3.2
DuPont-5386
Day 44
3.6 3.5 3.3 3.6 4.2 3.9 4.0 3.3 3.8 3.6 3.2 3.7 3.1 3.5 3.6 3-1 3.9 3.3 3.7 3.1 3.9 3.8 3.8 3.4 3.5 3.7 4.0 3.9 3.1 3.8
3.5 3.2 3.8 3.8 3.2
506
Company Sanitized. Does not contain TSCA CBf
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Day 45
Day 46
Male, I I I - 25 m g/kg/day
643173 643290 643272 643292 643228 643308 643264 643240 643180 643179 643202 643310 643306 643305 643293 643287 643188 643230 643170 643144 643277 643214 643261 643166 643153 643177 643198 643291 643184 643167 643223 643233 643183 643219 643263
3.6 3.5 3.3 3.6 4.2 3.9 4.0 3.3 3.8 3.6 3.2 3.7 3.1 3.5 3.6 3.1 3.9 3.3 3.7 3.1 3.9 3.8 3.8 3.4 3.5 3.7 4.0 3.9 3.1 3.8 3.5 3.2 3.8 3.8 3.2
3.6 3.5 3.3 3.6 4.2 3.9 4.0 3.3 3.8 3.6 3.2 3.7 3.1 3.5 3.6 3.1 3.9 3.3 3.7 3.1 3.9 3.8 3.8 3.4 3.5 3.7 4.0. 3.9 3.1 3.8 3.5 3.2 3.8 3.8 3.2
Day 47
INDIVIDUAL DC
Day 48
3.6 3.6 3.5 3.5 3.3 3.3 3.6 3.6 4.2 4.2 3.9 3.9 4.0 4.0
3.3 3.3 3.8 3.8 3.6 3.6 3.2 3.2 3.7 3.7 3.1 3.1
3.5 3.5
3.6 3.6 3.1 3.1 3.9 3.9 3.3 3.3 3.7 3.7 3.1 3.1 3.9 3.9 3.8 3.8 3.8 3.8
3.4 3.4 3.5 3.5 3.7 3.7 4.0 4.0 3.9 3.9 3.1 3.1 3.8 3.8 3.5 3.5 3.2 3.2 3.8 3.8 3.8 3.8 3.2 3.2
ISE VOLUMES (mL)
Day 4 9
Day 50
3.7 3.7 3.5 3.5 3.3 3.3 3.7 3.7 4.3 4.3 4.0 4.0 4.0 4.0 3.3 3.3 3.9 3.9 3.6 3.6 3.4 3.4 3.8 3.8 3.1 3.1 3.7 3.7 3.7 3.7 3.2 3.2 4.1 4.1 3.5 3.5 3.8 3.8 3.2 3.2 4.0 4.0 3.8 3.8 3.9 3.9 3.6 3.6 3.5 3.5 3.9 3.9 4.2 4.2 4.0 4.0 3.2 3.2 3.8 3.8 3.6 3.6 3.2 3.2 4.0 4.0 4.0 4.0
3 . 4 3.4
Day 51
3.7 3.5 3.3 3.7 4.3 4.0 4.0 3.3 3.9 3.6 3.4 3.8 3.1 3.7 3.7 3.2 4.1 3.5 3.8 3.2 4.0 3. B 3.9
3.6
3.5 3.9 4.2 4.0 3.2 3.8
3.6
3.2 4.0 4.0 3.4
Day 52
3.7 3.5 3.3 3.7 4.3 4.0 4.0 3.3 3.9 3.6 3.4 3.8 3.1 3.7 3.7 3.2 4.1 3.5 3.8 3.2 4.0 3.8 3.9 3.6 3.5 3.9 4.2 4.0 3.2 3.8 3.6
3.2
4.0 4.0
3.4
%
DuPont-5386
Day 53
3.7 3.5 3.3 3.7 4.3 4.0 4.0 3.3 3.9 3.6 3.4 3.8 3.1 3.7 3.7 3.2 4.1 3.5 3.8 3.2 4.0 3.8 3.9 3.6 3.5 3.9
4.2
4.0 3.2 3.8 3.6 3.2 4.0 4.0 3.4
507
D oes not contain TSCA 08
H -24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Day 54
Day 55
Male, I I I - 25 m g/kg/day
643173 643290 643272 643292 643228 643308 643264 643240 643180 643179 643202 643310 643306 643305 643293 643287 643188 643230 643170 643144 643277 643214 643261 643166 643153 643177 643198 643291 643184 643167 643223 643233 643183 643219 643263
3.7 3.5 3.3 3.7 4.3 4.0 4.0 3.3 3.9 3.6 3.4 3.8 3.1 3.7 3.7 3.2 4.1 3.5 3.8 3.2 4.0 3.8 3.9 3.6 3.5 3.9 4.2 4.0 3.2 3.8 3.6 3.2 4.0 4.0 3.4
3.7 3.5 3.3 3.7 4.3 4.0 4.0 3.3
3.9 3.6 3.4 3.8 3.1 3.7 3.7 3.2 4.1 3.5 3.8 3.2 4.0 3.8 3.9 3.6 3.5 3.9 4.2 4.0 3.2 3.8 3.6 3.2 4.0 4.0 3.4
Day 56
INDIVIDUAL DO;
Day 57
3.8 3.8 3.8 3.8 3.4 3.4 3.8 3.8 4.5 4.5 4.1 4.1 4.2 4.2 3.4 3 .4 4.0 4.0 3.7 3.7 3.3 3.3 3.9 3.9 3.2 3.2 3.7 3.7 3.9 3.9 3.3 3.3 4.4 4.4 3.6 3.6 3.9 3.9 3.3 3.3 4.1 4.1 4.0 4.0 4.1 4.1 3.8 3.8 3.7 3.7
4.0 4.0 4.4 4.4 4.1 4.1 3.3 3.3 3.9 3.9 3.7 3.7 2.9 2.9 4.1 4.1 4.1 4.1 3.5 3.5
SE VOLUMES (mL)
Day 58
Day 59
3.8 3.8 3.8 3.8 3.4 3.4 3.8 3.8 4.5 4.5 4.1 4.1 4.2 4.2 3.4 3.4 4.0 4.0 3.7 3.7 3.3 3.3 3.9 3-9 3.2 3.2 3.7 3.7 3.9 3.9 3.3 3.3 4.4 4.4 3.6 3.6 3.9 3.9 3.3 3.3 4.1 4.1 4.0 4.0 4.1 4.1 3.8 3.8 3.7 3.7 4.0 4.0 4.4 4.4 4.1 4.1 3.3 3.3 3.9 3.9 3.7 3.7 2.9 2.9 4.1 4.1 4.1 4.1 3.5 3.5
Day 60
3.8 3.8 3.4 3.8 4.5 4.1 4.2 3.4 4.0 3.7 3.3 3.9 3.2 3.7 3.9 3.3 4.4 3.6 3.9 3.3 4.1 4.0 4.1 3.8 3.7 4.0 4.4 4.1 3.3 3.9 3.7 2.9 4.1 4.1 3.5
Day 61
3.8 3.8 3.4 3.8 4.5 4.1 4.2 3.4 4.0 3.7 3.3 3.9 3.2 3.7 3.9 3.3 4.4 3.6 3.9 3-3 4.1 4.0 4.1 3.8 3.7 4.0 4.4 4.1 3.3 3.9 3.7 2.9 4.1 4.1 3.5
4
DuPont-5386
Day 62
3.8 3.8 3.4 3.8 4.5 4.1 4.2 3.4 4.0 3.7 3.3 3.9 3.2 3.7 3.9 3.3 4.4 3.6 3.9 3.3 4.1 4.0 4.1 3.8 3.7 4.0 4.4 4.1 3.3 3.9 3.7 2.9 4.1 4.1 3.5
508
Company Sanitized. Does not contain TSCA CBI
' ? t,,.,|
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations_______________
Day 63
Day 64
Male, I I I
643173 643290 643272 643292 643228 643308 643264 643240 643180 643179 643202 643310 643306 643305 643293 643287 643188 643230 643170 643144 643277 643214 643261 643166 643153 643177 643198 643291
643184 643167 643223 643233 643183 643219 643263
25 m g/kg/day
3.9 3.9 3.7 3.9 4.7 4.2 4.4 3.5 4.2 3.7 3.4 4.0 3.2 3.8 4.1 3.4 4.5 3.7 4.1 3.4 4.4
4.1 4.3 3.9 3.8 4.1 4.4 4.3 3.2 4.0 3.8 3.3 4.2 4.3
3.6
3.9
3.9 3.7
3.9 4.7
4.2 4.4
3.5 4.2
3.7 3.4
4.0
3.2 3.8
4.1 3.4
4.5 3.7 4.1 3.4 4.4
4.1 4.3 3.9 3.8 4.1
4.4 4.3 3.2 4.0
3.8 3.3 4.2 4.3
3.6
Day 65
INDIVIDUAL DOSE VOLUMES (mL )
Day 66
Day 67
Day 68
3 . 9 3 . 9 3 . 9 3.9
3.9
3.9 3.7
3 . 9 3.9 3.7 3.7
3.9 3.9 3.9 3.9
4.7 4 .7 4 .7 4.7
4.2 4 . 2 4 . 2 4.2
4.4 4 . 4 4 . 4 4.4
3.5 4.2
3 . 5 3.5 4 . 2 4.2
3.7 3 . 7 3 .7 3.7
3.4 3.4 3 . 4 3.4
4.0 4.0 4 .0 4.0
3.2 3.2 3 .2 3.2
3.8 3.8 3 . 8 3.8
4.1 4.1 4 .1 4.1
3.4 3.4 3 . 4 3.4
4.5 4.5 4 .5 4.5
3.7 3 . 7 3 . 7 3. 7
4.1 4.1 4 . 1 4. 1
3.4 3.4 3 . 4 3.4
4.4 4.4 4 . 4 4.4
4.1
4.3
4.1 4.3
4.1 4.3
4.1 4.3
3.9 3.9 3 . 9 3.9
3.8 3.8 3 . 8 3.8
4.1 4.1 4 .1 4.1
4.4 4.4 4 . 4 4.4
4.3 4.3 4 . 3 4.3
3.2 3.2 3 . 2 3.2
4.0 4.0 4 .0 4.0
3.8 3.8 3 . 8 3.8
3.3 3.3 3 . 3 3.3
4.2 4.2 4 .2 4.2
4.3 4.3 4 . 3 4.3
3.6 3 . 6 3 . 6 3.6
Day 69
3.9 3.9 3.7 3.9 4.7 4.2 4.4 3.5 4.2 3.7 3.4 4.0 3.2 3.8 4.1 3.4 4.5 3.7 4.1 3.4 4.4 4.1 4.3 3.9 3.8 4.1 4.4 4.3 3.2 4.0 3.8 3.3 4.2 4.3 3.6
Day 70
4.0 4.0 3.8 4.0 4.8 4.4 4.5 3.6 4.1 3.9 3.4 4.2 3.3 4.0 4.2 3.5 4.6 3.7 4.2 3.6 4.5 4.2 4.4 4.1 3.9 4.2 4.5 4.4 3.3 4.2 3.9 3.5 4.3 4.4 3.7
DuPont-5386
Day 71
4.0 4.0 3.8 4.0 4.8 4.4 4.5 3.6 4.1 3.9 3.4 4.2 3.3 4.0 4.2 3.5 4.6 3.7 4.2 3.6 4.5 4.2 4.4 4.1 3.9 4.2 4.5 4.4 3-3 4.2 3.9 3.5 4.3
4.4
3.7
509
Company Sanitized. Does not contain TSCA CBI
H-24516: Subchronic Toxicity 90-Pay Gavage Study in Rats with One-Generation Reproduction Evaluations
INDIVIDUAL DOSE VOLUMES (mL)
Day 72
Day 73
Male, I I I
643173 643290 643272 643292 643228 643308 643264 643240 643180 643179 643202 643310 643306 643305 643293 643287 643188 643230 643170 643144
643277 643214 643261. 643166 643153 643177 643198 643291 643184 643167 643223 643233 643183 643219 643263
in CN
mg/kg/day
4.0 4.0 3.8 4.0 4.8 4.4 4.5 3.6 4.1 3.9 3.4 4.2 3.3 4.0 4.2 3.5 4.6 3.7 4.2
3.6 4.5 4.2 4.4 4.1 3.9 4.2 4.5 4.4 3.3 4.2 3.9 3.5 4.3 4.4 3.7
4.0 4.0 3.8 4.0 4.8 4.4 4.5 3.6
4.1 3.9 3.4 4.2 3.3 4.0 4.2 3.5 4.6 3.7 4.2 3.6 4.5
4.2 4.4 4.1 3.9 4.2 4.5 4.4 3.3 4.2 3.9 3.5 4.3 4.4 3.7
74
4.0 4.0 3.8 4.0 4.8 4.4 4.5 3.6 4.1 3.9 3.4 4.2 3.3 4.0 4.2 3.5 4.6 3.7 4.2 3.6 4.5 4.2 4.4
4.1 3.9 4.2 4.5 4.4 3.3 4.2 3.9 3.5 4.3 4.4 3.7
Day 75
4.0 4.0 3.8 4.0 4.8 4.4 4.5 3.6 4.1 3.9 3.4 4.2 3.3 4.0 4.2
Day 76
4.0 4.0 3.8 4.0 4.8 4.4 4.5 3.6 4.1 3.9 3.4 4.2 3.3 4.0 4.2
Day 77
4.1 4.1 3.9 4.0 5.0 4.5 4.7 3.7 4.2 3.9 3.5 4.1 3.3 4.0 4.1
Day 78
4.1 4.1 3.9 4.0 5.0 4.5 4.7 3.7 4.2 3.9 3.5 4.1 3.3 4.0 4.1
Day 79
4.1 4.1 3.9 4.0 5.0 4.5 4.7 3.7 4.2 3.9 3.5 4.1 3.3 4.0 4.1
DuPont-5386
Day 80
4.1 4.1 3.9 4.0 5.0 4.5 4.7 3.7 4.2 3.9 3.5 4.1 3.3 4.0 4.1
510
Company SanWzed. Does not contain TSCA CW
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Day 81
Day 82
Day 83
INDIVIDUAL DOSE VOLUMES (mL)
Day 84
Day 85
Day 86
M ale, I I I - 25 m g /k g /d a y
643173 643290 643272 643292 643228 643308 643264 643240 643180 643179 643202 643310 643306 643305 643293 643287 643188 643230 643170 643144 643277 643214 643261
643166 643153 643177 643198 643291 643184 643167 643223 643233 643183 643219 643263
4.1 4.1 3.9 4.0 5.0 4.5 4.7 3.7 4.2 3.9 3.5 4.1 3.3 4.0 4.1
4.1 4.1 3.9 4.0 5.0
4.5 4.7 3.7 4.2 3.9 3.5 4.1
3.3 4.0 4.1
4.1 3.9 4.0 5.0 4.5 4.7
3.7
4.2 3.9 3.5 4.1 3.3 4.0 4.1
4.2 4.0
4.0
5.1 4.7
4.8 3.7
4.3 4.1 3.5 4.2 3.5 4.1 4.2
4.1
4.2
4.0
4.0 5.1 4.7
4.8 3.7 4.3
4.1 3.5 4.2 3.5 4.1 4.2
4.1 4.2 4.0 4.0 5.1 4.7 4.8 3.7 4.3 4.1 3.5 4.2 3.5 4.1 4.2
Day 87
4.1 4.2 4.0 4.0 5.1 4.7 4.8 3.7 4.3 4.1 3.5 4.2 3.5 4.1 4.2
DuPont-5386
Day 88
4.1 4.2 4.0 4.0 5.1 4.7 4.8 3.7 4.3 4.1 3.5 4.2
3.5
4.1 4.2
Day 89
4.1 4.2 4.0 4.0 5.1 4.7 4.8 3.7 4.3 4.1 3.5 4.2 3.5 4.1 4.2
511
Company Sanitized. Does not contain TSCA CB1
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
INDIVIDUAL DOSE VOLUMES (mL)
Day 90
Male, I I I - 25 m g/kg/day
643173 643290 643272 643292 643228 643308 643264 643240 643180 643179 643202 643310 643306 643305 643293 643287 643188 643230 643170 643144 643277 643214 643261
643166 643153 643177 643198 643291 643184 643167 643223 643233 643183 643219 643263
3.9 4.3 4.1 4.1 5.2 4.7 4.9 3.8 4.3 4.1
DuPont-5386
512
Company S sn f'ved. Does not contain TSCA CBI
1
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations ____________
DuPont-5386
Day 0
Day 1
Day 2
Day 3
INDIVIDUAL DOSE VOLUMES (mL)
Day 4
Day 5
Day 6
Day 7
Day 8
Day 9 Day 10 Day 11
Male, V - 100 m g/kg/day
643250 643243 643311 643318 643247 643175 643314 643275 643257 643224 643169 643159 643286 643181 643206 643313 643182 643146 643312 643199 643267 643216
643244 643245 643301 643200 643255 643157 643238 643227 643164 643154 643156 643208 643190
2.3 2.3 2.4 2.6 2.8 2.6 2.6 2.7 2.4 2.5 2.3 2.7 2.1 2.8 2.4 2.1 2.5 2.8 2.4 2.4 2.5 2.7 2.5
2.3 2.6 2.4 2.6 2.4 2.6 2.6 2.5 2.4 2.7 2.5 2.7
2.3 2.3 2.4 2.6 2.8 2.6 2.6 2.7 2.4 2.5 2.3 2.7 2.1 2.8 2.4 2.1 2.5 2.8 2.4 2.4 2.5 2.7
2.5 2.3 2.6 2.4 2.6 2.4 2.6 2.6 2.5 2.4 2.7 2.5 2.7
2.3 2.3 2.4 2.6 2.8 2.6 2.6 2.7 2.4 2.5 2.3 2.7 2.1 2.8 2.4 2.1 2.5 2.8 2.4 2.4 2.5 2.7
2.5 2.3 2.6 2.4 2.6 2.4 2.6 2.6 2.5 2.4 2.7 2.5 2.7
2.3 2.3 2.4 2.6 2.8 2.6 2.6 2.7 2.4
2.5 2.3 2.7 2.1 2.8 2.4 2.1 2.5 2.8 2.4 2.4 2.5 2.7 2.5 2.3 2.6 2.4 2.6 2.4
2.6 2.6 2.5 2.4 2.7 2.5 2.7
2.3 2.3
2.4
2.6 2.8 2.6 2.6
2.7
2.4
2.5
2.3
2.7
2.1 2.8
2.4
2.1
2.5
2.8
2.4
2.4
2.5
2.7
2.5
2.3
2.6
2.4
2.6
2.4
2.6 2.6
2.5 2.4 2.7
2.5
2.7
2.3
2.3
2.4
2.6 2.8 2.6 2.6
2.7
2.4
2.5
2.3
2.7
2.1
2.8 2.4
2.1
2.5 2.8 2.4
2.4 2.5 2.7
2.5
2.3
2.6
2.4
2.6
2.4
2.6
2.6
2.5 2.4 2.7
2.5
2.7
2.3 2.3 2.4
2.6 2.8 2.6 2.6
2.7
2.4
2.5
2.3
2.7
2.1 2.8
2 .4
2.1
2.5
2.8
2.4
2.4
2.5
2.7
2.5
2.3 2.6
2.4
2.6
2.4
2.6 2.6
2.5 2.4 2.7
2.5
2.7
2.8
2.9 3.0 3.2 3.5 3.2 3.3 3.2 3.0
3.0
2.8
3.1 2.5 3.3
2.9
2.7 3.1 3.3 3.0 3.1 3.1 3.4
3.0
2.8
3.1 3.1 3.1 3.0 3.1 3.3 3.3 3.0 3.3 3.0
3.3
2.8
2.9 3.0 3.2 3.5 3.2 3.3 3.2 3.0 3.0
2.8
3.1 2.5 3.3 2.9 2.7 3.1 3.3 3.0 3.1 3.1 3.4
3.0
2.8
3.1 3.1
3.1
3.0 3.1 3.3 3.3 3.0 3.3 3.0
3.3
2.8
2.9 3.0 3.2 3.5 3.2 3.3 3.2 3.0 3.0
2.8
3.1 2.5 3.3 2.9 2.7 3.1 3.3 3.0 3.1 3.1 3.4
3.0 2.8
3.1 3.1 3.1 3.0 3.1 3.3 3.3 3.0 3.3 3.0 3.3
2.8
2.9 3.0 3.2
3.5 3.2 3.3 3.2 3.0 3.0
2.8
3.1 2.5 3.3 2.9 2.7 3.1 3.3 3.0 3.1 3.1 3.4
3.0
2.8
3.1 3.1 3.1 3.0 3.1 3.3 3.3 3.0 3.3 3.0 3.3
2.8
2.9 3.0 3.2 3.5 3.2 3.3 3.1 3.0 3.0
2.8
3.1 2.5 3.3 2.9 2.7
3.1 3.3 3.0 3.1 3.1 3.4 3.0
2.8
3.1 3.1
3.1
3.0 3.1 3.3 3.3 3.0 3.3 3.0 3.3
513
Company Santtbed. Does not contain TSCA CBI
H -24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5386
Male, V
643250 643243 643311 643318 643247 643175 643314 643275 643257 643224 643169 643159 643286 643181 643206 643313 643182 643146 643312 643199 643267 643216 643244 643245 643301 643200 643255
643157 643238 643227 643164 643154 643156 643208 643190
INDIVIDUAL DOSE VOLUMES (mL) 12 D a y 13 D a y 14 D a y 15 D a y 16 D a y 17 D a y 18 D a y 19 D a y 20 Day 21 Day 22 Day 23
) mg/kg/day
2.8 2.9 3.0. 3.2 3.5 3.2 3.3 3.2 3.0 3.0 2.8 3.1 2.5 3.3 2.9 2.7 3.1 3.3 3.0 3.1 3.1
3.4 3.0 2.8 3.1 3.1 3.1 3.0 3.1 3.3 3.3 3.0 3.3 3.0 3.3
2.8 2.9 3.0 3.2 3.5 3.2 3.3 3.2 3.0 3.0 2.8 3.1 2.5 3.3 2.9 2.7 3.1 3.3 3.0 3.1 3.1 3.4
3.0 2.8 3.1 3.1 3.1 3.0 3.1 3.3 3.3 3.0 3.3 3.0 3.3
3.1 3.5 3.6 3.7 4.1 3.7 3.7 3.7 3.5 3.4 3.3 3.6 2.9 3.B 3.2 3.2 3.7 3.7 3.5 3.7 3.7 4.0
3.6 3.1 3.6 3.6 3.7 3.5 3.5 3.8 3.8 3.4 3.8 3.5 3.8
3.1 3.5 3.6 3.7 4.1 3.7 3.7 3.7 3.5 3.4 3.3 3.6 2.9 3.8 3.2 3.2 3.7 3.7 3.5 3.7 3.7 4.0
3.6
3.1 3.6 3.6 3.7 3.5 3.5 3.8 3.8 3.4 3.8 3.5 3.8
3.1 3.5 3.6 3.7 4.1 3.7 3.7 3.7 3.5 3.4 3.3 3.6 2.9 3.8 3.2 3.2 3.7 3.7 3.5 3.7 3.7 4.0
3.6 3.1 3.6 3.6 3.7 3.5 3.5 3.8 3.8 3.4 3.8 3.5 3.8
3.1 3.5 3.6 3.7 4.1 3.7 3.7 3.7 3.5 3.4 3.3 3.6 2.9 3.8 3.2 3.2 3.7 3.7 3.5 3.7 3.7 4.0 3.6
3.1 3.6 3.6 3.7 3.5 3.5 3.8 3.8 3.4 3.8 3.5 3.8
3.1 3.5 3.6 3.7
4.1 3.7 3.7 3.7 3.5 3.4 3.3 3.6 2.9 3.8 3.2 3.2 3.7 3.7 3.5 3.7 3.7 4.0 3.6 3.1 3.6 3.6
3.7 3.5 3.5 3.8 3.8 3.4 3.8 3.5 3.8
3.1 3.5 3.6 3.7 4.1 3.7 3.7 3.7 3.5 3.4 3.3 3.6 2.9 3.8 3.2 3.2 3.7 3.7 3.5 3.7 3.7 4.0 3.6
3.1 3.6 3.6 3.7 3.5 3.5 3.8 3.8 3.4 3.8 3.5 3.8
3.1 3.5 3.6 3.7 4.1 3.7 3.7 3.7 3.5 3.4 3.3 3.6 2.9 3.8 3.2 3.2 3.7 3.7 3.5 3.7 3.7 4.0 3.6
3.1 3.6 3.6 3.7 3.5 3.5 3.8 3.8 3.4 3.8 3.5 3.8
3.5 3.9 3.9 4.3 4.5 4.2 4.1 4.1 3.9 3.7 3.7 3.9 3.3 4.1 3.7 3.6 4.2
4.2 4.2 4.5 3.9 3.5 4.0
4.0 4.2 3.9 4.0 4.1 4.3 3.9 4.3 3.9 4.2
3.5
3.9 3.9 4.3
4.5 4.2 4.1 4.1 3.9 3.7 3.7
3.9 3.3
4.1 3.7 3.6
4.2 4.2
3.8 4.2 4.2
4.5
3.9 3.5 4.0 4.0 4.2
3.9 4.0 4.1
4.3 3.9 4.3 3.9 4.2
3.5
3.9 3.9 4.3
4.5 4.2
4.1 4.1
3.9 3.7 3.7
3.9
3.3 4.1 3.7 3.6
4.2 4.2 3.8 4.2 4.2 4.5
3.9 3.5 4.0 4.0 4.2 3.9 4.0 4.1 4.3 3.9 4.3
3.9 4.2
514
Company Sanitized. Doe* not contain TSCA CBI
)
tw
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5386
Day 24
Day 25
Male, V - 100 m g/kg/da y
643250 643243 643311 643318 643247 643175 643314 643275 643257 643224 643169 643159 643286 643181 643206 643313 643182 643146 643312 643199 643267 643216 643244 643245 643301 643200 643255 643157 643238 643227 643164 643154 643156 643208 643190
3.5 3.9 3.9 4.3 4.5 4.2 4.1 4.1 3.9 3.7 3.7 3.9 3.3 4.1 3.7 3.6 4.2 4.2 3.8 4.2 4.2 4.5 3.9 3.5 4.0 4.0 4.2 3.9 4.0 4.1 4.3 3.9 4.3 3.9 4.2
3.5 3.9 3.9 4.3 4.5 4.2 4.1 4.1 3.9 3.7 3.7 3.9 3.3 4.1 3.7 3.6 4.2 4.2 3.8 4.2 4.2 - 4.5 3.9 3.5 4.0 4.0 4.2 3.9 4.0 4.1 4.3 3.9 4.3 3.9 4.2
Day 26
3.5 3.9 3.9 4.3 4.5 4.2 4.1 4.1 3.9 3.7 3.7 3.9 3.3 4.1 3.7 3.6 4.2 4.2 3.8 4.2 4.2 4.5 3.9 3.5 4.0 4.0 4.2 3.9 4.0 4.1 4.3 3.9 4.3 3.9 4.2
INDIVIDUAL DOSE VOLUMES (mL)
27 Day 28 Day 29 Day 30
31 Day 32 Day 33 Day 34 Day 35
3.5 3.9 3.9 4.3 4.5 4.2 4.1 4.1 3.9 3.7 3.7 3.9 3.3 4.1 3.7 3.6 4.2 4.2 3.8 4.2 4.2 4.5 3.9 3.5 4.0 4.0 4.2 3.9 4.0 4.1 4.3 3.9 4.3 3.9 4.2
3.9 4.2 4.2 4.6 4.6
4.5 4.3
4.5 4.1 4.0 4.0 4.3 3.6 4.4 3.8 3.9 4.6 4.5 4.0 4.7 4.5
4.9 4.3 3.8 4.4 4.4 4.6 4.2 4.1 4.5 4.7 4.2 4.7 4.1
4.5
3.9 4.2 4.2 4.6 4.8 4.5 4.3 4.5 4.1 4.0 4.0 4.3 3.6 4.4 3.8 3.9 4.6 4.5 4.0 4.7 4.5 4.9 4.3 3.8 4.4 4.4 4.6 4.2 4.1 4.5 4.7 4.2 4.7
4.1
4.5
3.9 4.2 4.2 4.6 4.8 4.5 4.3 4.5 4.1
4.0 4.0 4.3 3.6 4.4 3.8 3.9 4.6 4.5 4.0 4.7
4.5 4.9 4.3 3.8 4.4 4.4 4.6 4.2 4.1 4.5 4.7 4.2 4.7 4.1 4.5
3.9 4.2 4.2 4.6 4.8 4.5 4.3 4.5 4.1 4.0 4.0 4.3 3.6 4.4 3.8 3.9 4.6 4.5 4.0 4.7 4.5
4.9 4.3 3.8 4.4 4.4 4.6 4.2 4.1 4.5 4.7 4.2 4.7 4.1
4.5
3.9 4.2 4.2 4.6 4.8 4.5 4.3 4.5 4.1 4.0 4.0 4.3 3.6 4.4 3.8 3.9 4.6 4.5 4.0 4.7 4.5 4.9 4.3 3.8 4.4 4.4 4.6 4.2 4.1 4.5 4.7 4.2 4.7 4.1
4.5
3.9 4.2 4.2 4.6
4.8 4.5 4.3 4.5 4.1 4.0 4.0 4.3 3.6 4.4 3.8 3.9 4.6 4.5 4.0 4.7
4.5
4.9 4.3 3.8 4.4 4.4 4.6 4.2 4.1 4.5 4.7 4.2 4.7 4.1
4.5
3.9 4.2 4.2 4.6 4.8
4.5 4.3 4.5 4.1 4.0 4.0 4.3 3.6 4.4 3.8 3.9 4.6 4.5 4.0 4.7 4.5
4.9 4.3 3.8 4.4 4.4 4.6 4.2 4.1 4.5 4.7 4.2 4.7 4.1 4.5
4.0 4.5 4.4 4.9 5.0 4.8 4.5 4.7 4.4 4.2 4.2 4.7 3.9 4.6 4.0. 4.2 5.0 4.8 4.2 4.8 4.8 5.2 4.5 3.9 4.7 4.7 4.8 4.5 4.3 4.7 5.0 4.4 4.9 4.3
4.8
515 Company Sanitized. Does not contain TSCACBf
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
INDIVIDUAL DOSE VOLUMES (mL)
Day 36
Day 37
Male, V - 100 m g/kg/day
643250 643243 643311 643318 643247 643175 643314 643275 643257 643224 643169 643159 643286 643181 643206 643313 643182 643146 643312 643199 643267 643216
643244 643245 643301 643200 643255 643157 643238 643227 643164 643154 643156 643208 643190
4.0 4.5 4.4 4.9 5.0 4.8 4.5 4.7 4.4 4.2 4.2 4.7 3.9 4.6 4.0 4.2 5.0 4.8 4.2 4.8 4.8 5.2 4.5
3.9 4.7 4.7 4.8 4.5 4.3 4.7 5.0 4.4 4.9 4.3 4.8
5.9 4.5 4.4 4.9 5.0 4.8 4.5 4.7 4.4 4.2 4.2 4.7 3.9 4.6 4.0 4.2 5.0 4.8 4.2 4.8 4.8 5.2 4.5
3.9 4.7 4.7 4.8 4.5 4.3 4.7 5.0 4.4 4.9 4.3 4.8
Day 38
3.0 3.4 3.3 3.7 3.7 3.6 3.4 3.5 3.3 3.2 3.2 3.5 2.9 3.5 3.0 3.2 3.7 3.6 3.1 3.6 3.6 3.9
3.4 2.9 3.5 3.5 3.6 3.4 3.3 3.5 3.7 3.3 3.7 3.3 3.6
Day 39
3.0 3.4 3.3 3.7 3.7 3.6 3.4 3.5 3.3 3.2 3.2 3.5 2.9 3.5 3.0 3.2 3.7 3.6 3.1 3.6 3.6 3.9 3.4 2.9
3.5 3.5 3.6 3.4 3.3 3.5 3.7 3.3 3.7 3.3 3.6
Day 40
3.0 3.4 3.3 3.7 3.7 3.6 3.4 3.5 3.3 3.2 3.2 3.5 2.9 3.5 3.0 3.2 3.7 3.6 3.1 3.6 3.6 3.9 3.4 2.9
3.5 3.5 3.6 3.4 3.3 3.5 3.7 3.3 3.7 3.3 3.6
Day 41
3.0 3.4 3.3 3.7 3.7 3.6 3.4 3.5 3.3 3.2 3.2 3.5 2.9 3.5 3.0 3.2 3.7 3.6 3.1 3.6 3.6 3.9 3.4 2.9
3.5 3.5 3.6 3.4 3.3 3.5 3.7 3.3 3.7 3.3 3.6
Day 42
3.1 3.5 3.5 3.8 3.9 3.8 3.6 3.7 3.4 3.3 3.3 3.6 3.1 3.7 3.1 3.3 3.9 3.7 3.2 3.7 3.8 4.1 3.5
3.0 3.6 3.7 3.8 3.6 3.5 3.8 3.9 3.4 3.9 3.4 3.8
Day 43
3.1 3.5 3.5 3.8 3.9 3.8 3.6 3.7 3.4 3.3 3.3 3.6 3.1 3.7 3.1 3.3 3.9 3.7 3.2 3.7 3.8 4.1 3.5 3.0
3.6 3.7 3.8 3.6 3.5 3.8 3.9 3.4 3.9 3.4 3.8
DuPont-5386
Day 44
3.1 3.5 3.5 3.8 3.9 3.8 3.6 3.7 3.4 3.3 3.3 3.6 3.1 3.7 3.1 3.3 3.9 3.7 3.2 3.7 3.8 4.1 3.5 3.0
3.6 3.7 3.8 3.6 3.5 3.8 3.9 3.4 3.9 3 .4 3.8
516 ' n,t,P, iy Sanitized. Doe*
"o* contain TSCACBI
H-24516; Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Day 4 5
Day 46
M a l e , V -- 1 0 0 m g / k g / d a y
643250 643243 643311 643318 643247 643175 643314 643275 643257 643224 643169 643159 643286 643181 643206 643313 643182 643146 643312 643199 643267 643216 643244 643245 643301 643200 643255 643157 643238 643227 643164 643154 643156 643208 643190
3.1 3.5 3.5 3.8 3.9 3.8 3.6 3.7 3.4 3.3 3.3 3.6 3.1 3.7 3.1 3.3 3.9 3.7 3.2 3.7 3.8 4.1 3.5 3.0 3.6 3.7 3.8 3.6 3.5 3.8 3.9 3 .4 3.9 3.4 3.8
31
35 35
38
39
38 36
37
34
33
33
36 31
37
31
33
39 37
32
37
3e 4i
35
30 3 ,6
37
3 .8
36
3 ,5
3 ,8
3 .9 3 ,4
3 ,9 3 .4
3 .8
INDIVIDUAL DC
47 Day 48
3.1 3.1 3.5 3.5 3.5 3.5 3.8 3.8 3.9 3.9 3.8 3.8 3.6 3.6 3.7 3.7 3.4 3.4 3.3 3.3 3.3 3.3 3.6 3.6 3.1 3.1 3.7 3.7 3.1 3.1 3.3 3.3 3.9 3.9 3.7 3.7 3.2 3.2 3.7 3.7 3.8 3.8 4.1 4.1 3.5 3.5 3.0 3.0 3.6 3.6 3.7 3.7 3.8 3.8 3.6 3.6 3.5 3.5 3.8 3.8 3.9 3.9 3.4 3.4 3.9 3.9 3.4 3.4 3.8 3.8
>SE VOLUMES (mL)
Day 4 9
Day 50
3.2 3.6 3.6 3.9 3.6 3.8 3.7 3.8 3.4
3.3
3.4 3.7 3.3 3.9 3.3 3.5 4.0 3.8 3.3 3.8
4.0
4.2 3.7
3.1 3.8 3.8 4.0 3.8 3.7 4.0 4.1 3.6
4.1
3.6
3.9
3.2 3.6 3.6 3.9 3.6 3.8 3.7
3.8 3.4 3.3 3.4 3.7 3.3 3.9 3.3 3.5 4.0 3.8 3.3 3.8 4.0 4.2 3.7 3.1 3.8 3.8 4.0 3.8 3.7 4.0 4.1 3.6 4.1 3.6 3.9
Day 51
3.2 3.6 3.6 3.9 3.6 3.8 3.7 3.8 3.4 3.3 3.4 3.7 3.3 3.9 3.3 3.5 4.0 3.8 3.3 3.8 4.0 4.2 3.7 3.1 3.8 3.8 4.0 3.8 3.7 4.0
4.1
3.6 4.1 3.6 3.9
Day 52
3.2 3.6 3.6 3.9 3.6 3.8 3.7 3.8 3.4 3.3 3.4 3.7 3.3 3.9 3.3 3.5 4.0 3.8 3.3 3.8 4.0 4.2 3.7 3.1 3.8 3.8 4.0 3.8 3.7 4.0 4.1 3.6 4.1 3.6 3.9
DuPont-5386
Day 53
3.2 3.6 3.6 3.9 3.6 3.8 3.7 3.8 3.4 3.3 3.4 3.7 3.3 3.9 3.3 3.5 4.0 3 .e 3.3 3.8 4.0 4.2 3.7 3.1 3.8 3.8 4.0 3.8 3.7
4.0 4.1
3.6 4.1 3.6 3.9
517
Com pany Sanitized. Does not contain TSCA CBI
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Day 54
Day 55
Male, v - 100 m g/kg/day
643250 643243 643311 643318 643247
643175 643314 643275 643257 643224 643169 643159 643286 643181 643206 643313 643182 643146 643312 643199 643267 643216 643244 643245 643301 643200 643255 643157 643238 643227 643164 643154 643156 643208 643190
3.2 3.6 3.6 3.9 3.6 3.8 3.7 3.8 3.4 3.3 3.4 3.7 3.3 3.9 3.3 3.5 4.0 3.8 3.3 3.8 4.0 4.2 3.7 3.1 3.8 3.8 4.0 3.8 3.7 4.0 4.1 3.6 4.1 3.6 3.9
3.2 3.6 3.6 3.9 3.6 3.8 3.7 3.8 3.4 3.3 3.4 3.7 3.3 3.9 3.3 3.5 4.0 3.8 3.3 3.8 4.0 4.2 3.7 3.1 3.8 3.8 4.0 3.8 3.7 4.0 4.1 3.6 4.1 3.6 3.9
Day 56
INDIVIDUAL DC
Day 57
3.3 3.3 3.7 3.7
3.6 3.6 4.0 4.0
3.8 3.8 4.0 4.0
3.8 3.8 3.9 3.9 3.6 3.6 3.4 3.4 3.4 3.4 3.9 3.9 3.4 3.4 4.0 4.0 3.3 3.3 3.6 3.6 4.1 4.1 4.0 4.0 3.5 3.5 3.9 3.9 4.0 4.0 4.3 4.3 3.7 3.7 3.3 3.3 3.9 3.9 4.0 4.0 4.2 4.2 3.9 3.9 3.8 3.8 4.1 4.1 4.2 4.2 3.7 3.7 4.3 4.3 3.8 3.8 4.0 4.0
) i
ISE VOLUMES (mL)
Day 58
Day 59
3.3 3.3 3.7 3.7 3.6 3.6 4.0 4.0 3.8 3.8 4.0 4.0 3.8 3.8 3.9 3.9 3.6 3.6 3.4 3 .4 3.4 3.4 3.9 3.9 3.4 3.4 4.0 4.0 3.3 3.3 3.6 3.6 4.1 4.1 4.0 4.0 3.5 3.5 3.9 3.9 4.0 4.0 4.3 4.3 3.7 3.7 3.3 3.3 3.9 3.9 4.0 4.0 4.2 4.2 3.9 3.9 3.8 3.8 4.1 4.1 4.2 4.2 3.7 3.7 4.3 4.3 3.8 3.8 4.0 4.0
Day 60
3.3 3.7 3.6 4.0 3.8 4.0 3.8 3.9 3.6 3.4 3.4 3.9 3.4 4.0 3.3 3.6 4.1 4.0 3.5 3.9 4.0 4.3 3.7 3.3 3.9 4.0 4.2 3.9 3.8 4.1 4.2 3.7 4.3 3.8 4.0
Day 61
3.3 3.7 3.6 4.0 3.8 4.0 3.8 3.9 3.6 3.4 3.4 3.9 3.4 4.0 3.3 3.6 4.1 4.0 3.5 3.9 4.0 4.3 3.7 3.3 3.9 4.0 4.2 3.9 3.8 4.1 4.2 3.7 4.3 3.8 4.0
DuPont-5386
Day 62
3.3 3.7 3.6 4.0 3.8 4.0 3.8 3.9 3.6 3.4 3.4 3.9 3.4 4.0 3.3 3.6 4.1 4.0 3.5 3.9 4.0 4.3 3.7 3.3 3.9 4.0 4.2 3.9 3.8 4.1 4.2 3.7 4.3 3.8 4.0
518
Company Sanitized. Does not eontaln TSCA CBt
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
INDIVIDUAL DOSE VOLUMES (mL)
Day 63
Day 64
Male, V - 100 m g/kg/day
643250 643243 643311 643318 643247
643175 643314 643275 643257 643224 643169 643159 643286 643181 643206 643313 643182 643146 643312 643199 643267 643216 643244 643245 643301 643200 643255 643157 643238 643227 643164 643154 643156 643208
643190
3.4 3.9 3.7 4.1 4.0 3.9 3.9 4.1 3.6 3.5 3.4 4.0 3.5 4.1 3.5 3.8 4.3 4.1 3.7 4.0 4.1 4.5 3.9 3.4 4.1 4.1 4.4 4.2 4.0 4.2 4.4
3.8 4.5 3.9 4.3
3.4 3.9 3.7 4.1 4.0 3.9 3.9 4.1 3.6 3.5 3.4 4.0 3.5 4.1 3.5 3.8 4.3 4.1 3.7 4.0 4.1 4.5 3.9 3.4 4.1 4.1 4.4. 4.2 4.0 4.2 4.4 3.8 4.5
3.9 4.3
Day 65
3.4 3.9 3.7 4.1 4.0 3.9 3.9 4.1 3.6 3.5 3.4 4.0 3.5 4.1 3.5 3.8 4.3 4.1 3.7 4.0 4.1 4.5 3.9 3.4 4.1 4.1 4.4 4.2 4.0 4.2 4.4
3.8 4.5 3.9 4.3
Day 66
3.4 3.9 3.7 4.1 4.0 3.9 3.9 4.1 3.6 3.5 3.4 4.0 3.5 4.1 3.5 3.8 4.3 4.1 3.7 4.0 4.1 4.5 3.9 3.4 4.1 4.1 4.4 4.2 4.0 4.2 4.4
3.8 4.5 3.9 4.3
Day 67
3.4 3.9 3.7 4.1 4.0 3.9 3.9 4.1 3.6 3.5 3 .4 4.0 3.5 4.1 3.5 3.8 4.3 4.1 3.7 4.0 4.1 4.5 3.9 3.4 4.1 4.1 4.4 4.2 4.0 4.2 4.4
3.8 4.5 3.9 4.3
Day 68
3.4 3.9 3.7 4.1 4.0 3.9 3.9 4.1 3.6 3.5 3.4 4.0 3.5 4.1 3.5 3.8 4.3 4.1 3.7 4.0 4.1 4.5 3.9 3.4 4.1 4.1 4.4 4.2 4.0 4.2 4.4
3.8 4.5 3.9 4.3
Day 69
3.4 3.9 3.7 4.1 4.0 3.9 3.9 4.1 3.6 3.5 3.4 4.0 3.5 4.1 3.5 3.8 4.3 4.1 3.7 4.0 4.1 4.5 3.9 3.4 4.1 4.1 4.4 4.2 4.0 4.2
4.4 3.8 4.5 3.9 4.3
Day 70
3.5 4.0 3.8 4.2 4.1 3.4 4.0 4.2 3.7 3.5 3.5 4.0 3.6 4.3 3.6 3.8 4.4 4.3 3.8 4.1 4.3 4.6 3.9 3.5 4.2 4.2 4.5 4.3 4.1
4.3 4.5 3.9 4.6 4.0 4.2
D uPont-5386
Day 71
3.5 4.0 3.8 4.2 4.1 3.4 4.0 4.2 3.7 3.5 3.5 4.0 3.6 4.3 3.6 3.8 4.4 4.3 3.8 4.1 4.3 4.6 3.9 3.5 4.2 4.2 4.5 4.3 4.1 4.3
4.5 3.9 4.6 4.0 4.2
519
Company Sanitized. Does not contain TSCA CH
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Day 72
Day 73
Day 74
INDIVIDUAL DOSE VOLUMES (mL)
Day 75
Day 76
77
Day
CO r-
Male, V - 100 m g/kg/day
643250 643243 643311 643318 643247 643175 643314 643275 643257 643224 643169 643159 643286 643181 643206 643313 643182 643146 643312 643199 643267 643216 643244 643245 643301 643200 643255
643157 643238 643227 643164 643154 643156 643208 643190
3.5 4.0 3.8 4.2 4.1 3.4 4.0 4.2 3.7 3.5 3.5 4.0 3.6 4.3 3.6 3.8 4.4 4.3 3.8 4.1 4.3 4.6 3.9 3.5 4.2 4.2 4.5
4.3 4.1 4.3 4.5 3.9 4.6 4.0 4.2
3.5 4.0 3.8 4.2 4.1 3.4 4.0 4.2 3.7 3.5 3.5 4.0 3.6 4.3 3.6 3.8 4.4 4.3 3.8 4.1 4.3 4.6 3.9 3.5 4.2 4.2 4.5
4.3 4.1 4.3 4.5 3.9 4.6 4.0 4.2
3.5 4.0 3.8 4.2 4.1 3.4 4.0 4.2 3.7 3.5 3.5 4.0 3.6 4.3 3.6 3.8 4.4 4.3 3.8 4.1 4.3 4.6 3.9 3.5 4.2 4.2 4.5
4.3 4.1 4.3 4.5 3.9 4.6 4.0 4.2
3.5 4.0 3.8 4.2 4.1 3.4
4.0
4.2 3.7 3.5 3.5 4.0 3.6 4.3 3.6
3.5 4.0 3.8 4.2
4.1
3.4 4.0 4.2 3.7 3.5 3.5 4.0 3.6 4.3 3.6
3.5 3.5 4.1 4.1 3.8 3.8 4.3 4.3 4.2 4.2 AK TEST DAY 7 7 4.0 4.0 4.2 4.2 3.8 3.8 3.6 3.6 3.6 3.6 4.1 4.1 3.7 3.7 4.4 4.4 3.5 3.5
Day 79
3.5 4.1 3.8 4.3 4.2
4.0 4.2 3.8 3.6 3.6 4.1 3.7 4.4 3.5
t'
DuPont-5386
Day 80
3.5 4.1 3.8 4.3 4.2
4.0 4.2 3.8 3.6 3.6 4.1 3.7 4.4 3.5
520
Company Stmltteed. D o e s n ot con tain TSCACW
H -24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
INDIVIDUAL DOSE VOLUMES (mL)
Male, V
643250 643243 643311 643318 643247 643175 643314 643275 643257 643224 643169 643159 643286
643181 643206 643313 643182 643146 643312 643199 643267 643216 643244 643245 643301 643200 643255 643157 643238 643227 643164 643154 643156 643208 643190
Day 81
Day 82
100 m g/kg/day
3.5 3.5 4.1 4.1 3.8 3.8 4.3 4.3 4.2 4.2
4.0 4.2 3.8 3.6 3.6 4.1 3.7
4 .4b 3.5
4.0 4.2 3.8 3.6 3.6 4.1 3.7
4.4
3.5
Day 83
3.5 4.1 3.8 4.3 4.2
4.0 4.2 3.8 3.6 3.6 4.1 3.7 4.4 3.5
Day 84
3.6 4.1 3.9 4.3 4.2
3.6 4.1 3.8 3.7 3.6 4.0 3.8 4.5 3.7
Day 85
3.6 4.1 3.9 4.3 4.2
3.6 4.1 3.8 3.7 3.6 4.0 3.8 4.5 3.7
Day 86
3.6 4.1 3.9 4.3 4.2
3.6 4.1 3.8 3.7 3.6 4.0 3.8 4.5 3.7
Day 87
3.6 4.1 3.9 4.3 4.2
3.6 4.1 3.8 3.7 3.6 4.0 3.8 4.5 3.7
Day 88
3.6 4.1 3.9 4.3 4.2
3.6 4.1 3.8 3.7 3 ,'s 4.0 3.8 4.5 3.7
DuPont-5386
Day 89
3.6 4.1 3.9 4.3 4.2
3.6 4.1 3.8 3.7 3.6 4.0 3.8 4.5 3.7
521
Company Sanitized. Does nof contain T8CA CW
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
INDIVIDUAL DOSE VOLUMES (mL)
Day 90
Male, V - 100 m g/kg/day
643250 643243 643311 643318 643247 643175 643314 643275 643257 643224 643169 643159 643286 643181 643206 643313 643182 643146 643312 643199 643267
643216 643244 643245 643301 643200 643255 643157 643238 643227 643164 643154 643156 643208 643190
3.7 4.2 3.9 4.4 4.3
4.0 4.1 3.9 3.7
DuPont-5386
522
Company Sanitized. Does not contain TSCA CBI
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5386
INDIVIDUAL DOSE VOLUMES (mL)
Day 0
Day 1
Day 2
Day 3
Day 4
Day 5
Day 6
Day 7
Day 8
Day 9
Day 10
Day 11
Male, VII - 250 m g/kg/day
643194 643252 643260 643315 643215 643193 643298 643201 643259 643174 643283 643149 643178
643152
643295 643289 643171 643158 643249 643161 643309 643248 643285 643278 643299 643274 643192 643222 643160 643191 643203 643282 643302 643317
643225 643296 643258 643316 643220 643236 643165 643266 643151 643234 643281
2.4 2.2 2.3 2.4 2.7 2.7 2.5 2.7 2.4 2.8 2.4 2.6 2.3
2.9
2.5 2.1 2.6 2.6 2.5 2.6 2.9 2.6 2.5 2.4 2.4 2.4 2.6 2.6 2.4 2.7 2.5 2.8 2.5 2.5 2.6 2.7 2.3 2.4 2.5 2.5
2.4 2.5 2.3 2.8 2.4
2.4 2.2 2.3 2.4 2.7 2.7 2.5 2.7 2,4 2.8 2.4 2.6 2.3
2.9
2.5 2.1 2.6 2.6 2.5 2.6 2.9 - 2.6 2.5 2.4 2.4 2.4 2.6 2.6 2.4 2.7 2.5 2.8 2.5 2.5 2.6 2.7 2.3 2.4 2.5 2.5
2.4 2.5 2.3 2.8 2.4
2.4 2.2 2.3 2.4 2.7 2.7 2.5 2.7 2.4 2.8 2.4 2.6 2.3
2.9
2.5 2.1 2.6 2.6 2.5 2.6 2.9 2.6 2.5 2.4 2.4 2.4 2.6 2.6 2.4 2.7 2.5 2.8 2.5 2.5 2.6 2.7 2.3 2.4 2.5 2.5 2.4
2.5 2.3 2.8 2.4
2.4 2.2 2.3 2.4 2.7 2.7 2.5 2.7 2.4 2.8 2.4 2.6 2.3
2.9 2.5 2.1 2.6 2.6 2.5 2.6 2.9 2.6 2.5 2.4 2.4 2.4 2.6 2.6 2.4 2.7 2.5 2.8 2.5 2.5 2.6 2.7 2.3 2.4 2.5
2.5 2.4 2.5 2.3 2.8 2.4
2.4 2.2 2.3 2.4 2.7 2.7 2.5 2.7 2.4 2.8 2.4 2.6 2.3
2.9 2.5 2.1 2.6 2.6 2.5 2.6 2.9 2.6 2.5 2.4 2.4 2.4 2.6 2.6 2.4 2.7 2.5 2.8 2.5 2.5 2.6 2.7 2.3 2.4
2.5 2.5 2.4 2.5 2.3 2.8 2.4
2.4 2.2 2.3 2.4 2.7 2.7 2.5 2.7 2.4 2.8 2.4 2.6 2.3
2.9
2.5 2.1 2.6 2.6 2.5 2.6 2.9 2.6 2.5 2.4 2.4 2.4 2.6 2.6 2.4 2.7 2.5 2.8 2.5 2.5 2.6 2.7 2.3 2.4 2.5 2.5
2.4 2.5 2.3 2.8 2.4
2.4 2.2 2.3 2.4 2.7 2.7 2.5 2.7 2.4 2.8 2.4 2.6 2.3
2.9 2.5 2.1 2.6 2.6 2.5 2.6 2.9 2.6 2.5 2.4 2.4 2.4 2.6 2.6 2.4 2.7 2.5 2.8 2.5 2.5 2.6 2.7 2.3 2.4
2.5 2.5 2.4 2.5 2.3 2.8 2.4
3.0 2.9 2.8 2.9 3.3 3.4 3.3 3.3 2.9 3.5 2.9 3.1 2.7
3.5
3.0 2.7 3.3 3.4 3.1 3.2 3.7 3.1 3.1 2.9 3.0 3.0 3.2 3.2 3.0 3.4 3.2 3.5 3.0 3.0 3.3 3.4 3.0 3.0 3.1
3.1 3.0 3.1 2.8 3.4 3.0
3.0 2.9 2.8 2.9 3.3 3.4 3.3 3.3 2.9 3.5 2.9 3.1 2.7
3.5 3.0 2.7 3.3 3.4 3.1 3.2 3.7 3.1 3.1 2.9 3.0 3.0 3.2 3.2 3.0 3.4 3.2 3.5 3.0 3.0 3.3 3.4 3.0 3.0 3.1
3.1 3.0 3.1 2.8 3.4 3.0
3.0 2.9 2.8 2.9 3.3 3.4 3.3 3.3 2.9 3.5 2.9 3.1 2.7
3.5
3.0 2.7 3.3 3.4 3.1 3.2 3.7 3.1 3.1 2.9 3.0 3.0 3.2 3.2 3.0 3.4 3.2 3.5 3.0 3.0 3.3 3.4 3.0 3.0 3.1
3.1 3.0 3.1 2.8 3.4 3.0
3.0 2.9 2.8 2.9 3.3 3.4 3.3 3.3 2.9 3.5 2.9 3.1 2.7
h 3.5 b
3.0 2.7 3.3 3.4 3.1 3.2 3.7 3.1 3.1 2.9 3.0 3.0 3.2 3.2 3.0 3.4 3.2 3.5 3.0 3.0 3.3 3.4 3.0 3.0 3.1 3.1 3.0
3.1 2.8 3.4
3.0
3.0 2.9 2.8 2.9 3.3 3.4 3.3 3.3 2.9 3.5 2.9 3.1 2.7
3.5
3.0 2.7 3.3 3.4 3.1 3.2 3.7 3.1 3.1 2.9 3.0 3.0 3.2 3.2 3.0 3.4 3.2 3.5 3.0 3.0 3.3 3.4 3.0 3.0 3.1 3.1 3.0 3.1 2.8 3 .4 3.0
523
Company Sanitized. Doe* not contata TSCA CBI
i
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Day 12
Day 13
Male, VII - 250 m g/kg/day
643194 643252 643260 643315 643215 643193 643298 643201 643259 643174 643283 643149 643178 643152 643295 643289 643171 643158 643249 643161 643309 643248 643285 643278 643299 643274 643192 643222 643160 643191 643203 643282 643302 643317 643225 643296 643258 643316 643220 643236 643165 643266 643151 643234 643281
3.0 3.0 2.9 2.9 2.8 2.8 2.9 2.9 3.3 3.3 3.4 3.4 3.3 3.3 3.3 3.3 2.9 2.9 3.5 3.5 2.9 2.9 3.1 3.1 2.7 2.7 3.5 3.5 3.0 3.0 2.7 2.7 3.3 3.3 3.4 3.4 3.1 3.1
3.2 3.2 3.7 3.7
3.1 -3.1 3.1 3.1 2.9 2.9
3.0 3.0 3.0 3.0 3.2 3.2 3.2 3.2 3.0 3.0 3.4 3.4 3.2 3.2 3.5 3.5 3.0 3.0 3.0 3.0
3.3 3.3 3.4 3.4 3.0 3.0 3.0 3.0 3.1 3.1 3.1 3.1 3.0 3.0 3.1 3.1 2.8 2.8 3.4 3.4 3.0 3.0
Day 14
3.4 3.3 3.2 3.3 3.7 3.8 3.8 3.8 3.4 3.9 3.4 3.6 3.1 4.1 3.4 3.1 3.9 3.9 3.6 3.6 4.2 3.5 3.5 3.4 3.5 3.5 3.7 3.7 3.3 3.8 3.7 4.1 3.5 3.5 3.7 3.9 3.5 3.5 3.6 3.6 3.5 3.7 3.3 3.8 3.4
INDIVIDUAL DOSE VOLUME
15 Day 16 Day 17 Day 18
3.4 3.4 3.4 3.4 3.3 3.3 3.3 3.3 3.2 3 .2 3.2 3.2 3.3 3.3 3.3 3.3 3.7 3.7 3.7 3.7 3.8 3.8 3.8 3.8 3.8 3.8 3.8 3.8 3.8 3.8 3.8 3.8 3.4 3.4 3.4 3.4 3.9 3.9 3.9 3.9 3.4 3.4 3.4 3.4 3.6 3.6 3.6 3.6 3.1 3.1 3.1 3.1 4.1 4.1 4.1 4.1 3.4 3.4 3.4 3.4 3.1 3.1 3.1 3.1 3.9 3.9 3.9 3.9 3.9 3.9 3.9 3.9 3.6 3.6 3.6 3.6 3.6 3.6 3.6 3.6 4.2 4.2 4.2 4.2 3.5 3.5 3.5 3.5 3.5 3.5 3.5 3.5 3.4 3.4 3.4 3.4 3.5 3.5 3.5 3.5 3.5 3.5 3.5 3.5 3.7 3.7 3.7 3.7 3.7 3.7 3.7 3.7 3.3 3.3 3.3 3.3 3.8 3.8 3.8 3.8 3.7 3.7 3.7 3.7 4.1 4.1 4.1 4.1 3.5 3.5 3.5 3.5 3.5 3.5 3.5 3.5 3.7 3.7 3.7 3.7 3.9 3.9 3.9 3.9 3.5 3.5 3.5 3.5 3.5 3.5 3.5 3.5 3.6 3.6 3.6 3.6 3.6 3.6 3.6 3.6 3.5 3.5 3.5 3.5 3.7 3.7 3.7 3.7 3.3 3.3 3.3 3.3 3.8 3.8 3.8 3.8 3.4 3.4 3.4 3.4
524
S (mL)
Day 19
Day 20
Day 21
Day 22
DuPont-5386
Day 23
3.4 3.3 3.2 3.3 3.7
3.8 3.8 3.8 3.4 3.9 3.4 3.6 3.1
4.1
3 .4 3.1 3.9
3.9
3.6 3.6 4.2 3.5 3.5 3.4 3.5 3.5 3.7 3.7
3.3 3.8 3.7
4.1
3.5 3.5 3.7 3.9 3.5 3.5 3.6 3.6 3.5 3.7 3.3 3.8 3.4
3.4 3.3 3.2 3.3 3.7
3.8 3.8 3.8 3.4
3.9
3.4 3.6 3.1 4.1 3.4 3.1 3.9
3.9 3.6
3.6 4.2
3.5 3.5 3.4 3.5 3.5 3.7 3.7 3.3 3.8 3.7 4.1 3.5 3.5 3.7 3.9 3.5 3.5 3.6 3.6 3.5 3.7 3.3 3.8 3.4
3.8 3.7 3.5 3.7 4.2 4.3 4.2 4.3 3.9 4.5 3.7 4.0 3.4 4.6 3.8 3.5 4.5 4.4 3.9 4.2 4.7
3.9 3.9
3.8 3.9 3.9 4.2 4.1
3.8 4.2 4.2 4.7 3.9 3.9 4.1
4.4 4.0 4.0 4.0 4.1 4.0 4.1 3.6 4.3 3.9
3.8 3.7
3.5
3.7
4.2 4.3 4.2 4.3 3.9 4.5 3.7 4.0 3.4 4.6
3.8
3.5 4.5 4.4 3.9 4.2 4.7
3.9 3.9 3.8 3.9 3.9
4.2
4.1 3.8 4.2 4.2 4.7 3.9 3.9 4.1 4.4 4.0 4.0 4.0 4.1 4.0 4.1 3.6 4.3 3.9
3.8
3.7 3.5 3.7 4.2
4.3 4.2 4.3
3.9 4.5
3.7
4.0 3.4 4.6 3.8 3.5 4.5 4.4 3.9 4.2 4.7
3.9 3.9 3.8 3.9 3.9 4.2 4.1
3.8 4.2 4.2 4.7 3.9 3.9 4.1 4.4 4.0 4.0 4.0 4.1 4.0 4.1 3.6 4.3 3.9
Company Sanitized. Doe* no! contain TSCA CW
H -24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Day 24
Day 25
Male, VII - 250 m g/kg/day
643194 643252 643260 643315 643215 643193 643298 643201
643259 643174 643283 643149 643178 643152 643295 643289 643171 643158 643249 643161 643309 643248 643285 643278 643299 643274 643192 643222 643160 643191 643203 643282 643302 643317 643225 643296 643258 643316 643220 643236 643165 643266 643151 643234 643281
3.8 3.8 3.7 3.7 3.5 3.5 3.7 3.7 4.2 4.2 4.3 4.3 4.2 4.2 4.3 4.3 3.9 3.9 4.5 4.5 3.7 3.7 4.0 4.0 3.4 3.4 4.6 4.6 3.8 3.8 3.5 3.5 4.5 4.5 4.4 4.4 3.9 3.9 4.2 4.2 4.7 4.7 3.9 -3.9 3.9 3.9 3.8 3.8 3.9 3.9 3.9 3.9 4.2 4.2 4.1 4.1 3.8 3.8 4.2 4.2 4.2 4.2 4.7 4.7 3.9 3.9
3.9 3.9 4.1 4.1 4.4 4.4 4.0 4.0 4.0 4.0 4.0 4.0 4.1 4.1 4.0 4.0 4.1 4.1 3.6 3.6 4.3 4.3 3.9 3.9
Day 26
3.8 3.7 3.5 3.7 4.2 4.3 4.2 4.3 3.9 4.5 3.7 4.0 3.4 4.6 3.8 3.5 4.5 4.4 3.9 4.2 4.7 3.9 3.9 3.8 3.9 3.9 4.2 4.1 3.8 4.2 4.2 4.7 3.9 3.9 4.1 4.4 4.0 4.0 4.0 4.1 4.0 4.1 3.6 4.3 3.9
INDIVIDUAL DOSE VOLUMES
27 Day 28 Day 2 9 Day 30
3.8 4.1 4.1 4.1 3.7 4.0 4.0 4.0 3.5 3.8 3.8 3.8 3.7 4.0 4.0 4.0 4.2 4.5 4.5 4.5 4.3 4.6 4.6 4.6 4.2 4.5 4.5 4.5 4.3 4.6 4.6 4.6 3.9 4.3 4.3 4.3 4.5 4.9 4.9 4.9 3.7 4.0 4.0 4.0 4.0 4.4 4.4 4.4 3.4 2.9 2.9 2.9 4.6 5.0 5.0 5.0 3.8 4.1 4.1 4.1 3.5 3.8 3.8 3.8 4.5 4.8 4.8 4.8 4.4 4.6 4.6 4.6 3.9 4.2 4.2 4.2 4.2 4.5 4.5 4.5 4.7 5.0 5.0 5.0 3.9 4.2 4.2 4.2 3.9 4.2 4.2 4.2 3.8 4.1 4.1 4.1 3.9 4.2 4.2 4.2 3.9 4.2 4.2 4.2 4.2 4.6 4.6 4.6 4.1 4.4 4.4 4.4 3.8 4.0 4.0 4.0 4.2 4.4 4.4 4.4 4.2 4.5 4.5 4.5 4.7 5.1 5.1 5.1 3.9 4.2 4.2 4.2 3.9 4.2 4.2 4.2 4.1 4.3 4.3 4.3 4.4 4.7 4.7 4.7 4.0 4.3 4.3 4.3 4.0 4.3 4.3 4.3 4.0 4.3 4.3 4.3 4.1 4.5 4.5 4.5 4.0 4.3 4.3 4.3 4.1 4.5 4.5 4.5 3.6 4.0 4.0 4.0 4.3 4.6 4.6 4.6 3.9 4.2 4.2 4.2
525
(mL)
31
Day 32
Day 33
Day 34
DuPont-5386
Day 35
4.1 4.1 4.1 4.1 4.3 4.0 4.0 4.0 4.0 4.3 3.8 3.8 3.8 3.8 4.0 4.0 4.0 4.0 4.0 4.3 4.5 4.5 4.5 4.5 4.7
4.6 4.6 4.6 4.6 4.8
4.5 4.5 4.5 4.5 4.8
4.6 4.6 4.6 4.6 4.9
4.3 4.3 4.3 4.3 4.5 4.9 4.9 4.9 4.9 5.2
4.0 4.0 4.0 4.0 4.2
4.4 4.4 4.4 4.4 4.7
2.9 2.9 2.9 2.9 3.2 5.0 5.0 5.0 5.0 5.3
4.1 4.1 4.1 4.1 4.3 3.8 3.8 3.8 3.8 4.0
4.8 4.6 4.6 4.8 5.1 4.6 4.6 4.6 4.6 4.9
4.2 4.2 4.2 4.2 4.6
4.5 4.5 4.5 4.5 4.9 5.0 5.0 5.0 5.0 5.3
4.2 4.2 4.2 4.2 4.4 4.2 4.2 4.2 4.2 4.4 4.1 4.1 4.1 4.1 4.3 4.2 4.2 4.2 4.2 4.4 4.2 4.2 4.2 4.2 4.5 4.6 4.6 4.6 4.6 4.9 4.4 4.4 4.4 4.4 4.7 4.0 4.0 4.0 4.0 4.2 4.4 4.4 4.4 4.4 4.6 4.5 4.5 4.5 4.5 4.8 5.1 5.1 5.1 5.1 5.4 4.2 4.2 4.2 4.2 4.5 4.2 4.2 4.2 4.2 4.5 4.3 4.3 4.3 4.3 4.5 4.7 4.7 4.7 4.7 5.0 4.3 4.3 4.3 4.3 4.6 4.3 4.3 4.3 4.3 4.6 4.3 4.3 4.3 4.3 4.5 4.5 4.5 4.5 4.5 4.5 4.3 4.3 4.3 4.3 4.6
4.5 4.5 4.5 4.5 4.8 4.0 4.0 4.0 4.0 4.2 4.6 4.6 4.6 4.6 4.9 4.2 4.2 4.2 4.2 4.5
Company Sanitized. Does not contain TSCACBi
H -24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Day 36
Day 37
Male, VII - 250 mg/kg/day
643194 643252 643260 643315 643215 643193 643298 643201 643259 643174 643283 643149 643178 643152 643295 643289 643171 643158 643249 643161 643309 643248 643205 643278 643299 643274 643192 643222 643160 643191 643203 643282 643302 643317
643225 643296
643258 643316 643220 643236 643165 643266 643151 643234 643281
4.3 4.3 4.0 4.3 4.7 4.8 4.8 4.9 4.5 5.2 4.2 4.7 3.2 5.3 4.3 4.0 5.1 4.9 4.6 4.9 5.3 4.4 4.4 4.3 4.4 4.5 4.9 4.7 4.2 4.6 4.8 5.4 4.5
4.5 4.5 5.0
4.6
4.6 4.5 4.5 4.6 4.8 4.2 4.9 4.5
4.3 4.3 4.0 4.3 4.7 4.8 4.8 4.9 4.5 5.2 4.2 4.7 3.2 5.3 4.3 4.0 5.1 4.9 4.6 4.9 5.3 .4.4 4.4 4.3 4.4 4.5 4.9 4.7 4.2 4.6 4.8
5.4 4.5 4.5 4.5 5.0
4.6 4.6 4.5 4.5 4.6 4.8 4.2 4.9 4.5
Day 38
3.2 3.3 3.0 3.2 3.5 3.6 3.6 3.7 3.4 3.9 3.1 3.5 2.4 4.0 3.2 3.0 3.8 3.7 3.5 3.6 4.0 3.3 3.3 3.2 3.3 3.4 3.7 3.5 3.2 3.5 3.6 4.0
3.3 3.3 3.4 3.7
3.4 3.4 3.4 3.4 3.5 3.6 3.1 3.7 3.4
INDIVIDUAL DOSE VOLUMES (mL)
Day 39
Day 40
Day 41
Day 42
3.2 3.3 3.0 3.2 3.5 3.6 3.6 3.7 3.4 3.9 3.1 3.5 2.4 4.0 3.2 3.0 3.8 3.7 3.5 3.6 4.0 3.3 3.3 3.2 3.3 3.4 3.7 3.5 3.2 3.5 3.6 4.0 3.3 3.3
3.4 3.7
3.4
3.4 3.4 3.4 3.5 3.6 3.1 3.7 3.4
3.2 3.3 3.0 3.2 3.5 3.6 3.6 3.7 3.4 3.9 3.1 3.5 2.4 4.0 3.2 3.0 3.B 3.7 3.5 3.6 4.0 3.3 3.3 3.2 3.3 3.4 3.7 3.5 3.2 3.5 3.6 ' 4.0 3.3 3.3 3.4
3.7
3.4
3.4 3.4 3.4 3.5 3.6 3.1 3.7 3.4
3.2 3.3 3.0 3.2 3.5 3.6 3.6 3.7 3.4 3.9 3.1 3.5 2.4 4.0 3.2 3.0 3.8 3.7 3.5 3.6 4.0 3.3 3.3 3.2 3.3 3.4 3.7 3.5 3.2 3.5 3.6 4.0 3.3 3.3
3.4 3.7
3.4 b
3.4 3.4 3.4 3.5 3.6 3.1 3.7 3.4
3.4 3.4 3.1 3.4 3.6 3.8 3.7 3.9 3.6 4.0 3.2 3.7 2.7 4.1 3.4 3.2 4.0 3.8 3.7 3.7 4.1 3.5 3.4 3.4 3.5 3.5 3.9 3.7 3.3 3.6 3.7 4.2 3.5 3.5 3.6 3.8
2.9
3.5 3.5 3.5 3.6 3.8 3.2
3.8 3.4
Day 43
3.4 3.4 3.1 3.4 3.6 3.8 3.7 3.9 3.6 4.0 3.2 3.7 2.7 4.1 3.4 3.2 4.0 3.8 3.7 3.7 4.1 3.5 3.4 3.4 3.5 3.5 3.9 3.7 3.3 3.6 3.7 4.2 3.5 3.5 3.6 3.8
2.9 3.5 3.5 3.5 3.6 3.8 3.2 3.8 3.4
DuPont-5386
Day 44
3.4 3.4 3.1 3.4 3.6 3.8 3.7 3.9 3.6 , 4.0 3.2 3.7 2.7 4.1 3.4 3.2 4.0
3.7 3.7 4.1 3.5 3.4 3.4
3.5 3.9 3.7 3.3 3.6
4.2 3.5 3.5 3.6 3.8 2.9 3.5 3.5 3.5 3.6 3.8 3.2 3.8 3.4
526
Company Sanitized. Does not contain TSCA CBI
H -24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Day 45
Day 46
Male, VII - 250 m g/kg/day
643194 643252 643260 643315 643215 643193 643298 643201 643259 643174 643283 643149 643178 643152 643295 643289 643171 643158 643249 643161 643309 643248 643285 643270 643299 643274 643192 643222 643160 643191 643203 643282 643302 643317 643225 643296 643258 643316 643220 643236 643165 643266 643151 643234 643281
3.4 3.4 3.1 3.4 3.6 3.8 3.7 3.9 3.6 4.0 3.2 3.7 2.7 4.1 3.4 3.2 4.0 3.8 3.7 3.7 4.1 3.5 3.4 3.4 3.5 3.5 3.9 3.7 3.3 3.6 3.7 4.2 3.5 3.5 3.6 3.8 2.9 3.5 3.5 3.5 3.6
3.8 3.2 3.8 3.4
3.4 3.4 3.1 3.4 3.6 3.8 3.7 3.9 3.6 4.0 3.2 3.7 2.7 4.1 3.4 3.2 4.0 3.8 3.7 3.7 4.1 3.5 3.4 3.4 3.5 3.5 3.9 3.7 3.3 3.6 3.7 4.2 3.5 3.5 3.6 3.8 2.9 3.5 3.5 3.5 3.6
3.8 3.2 3.8 3.4
Day 47
INDIVIDUAL DC
Day 48
3.4 3.4 3.4 3.4 3.1 3.1 3.4 3.4 3.6 3.6 3.8 3.8 3.7 3.7
3.9 3.9 3.6 3.6 4.0 4.0 3.2 3.2 3.7 3.7 2.7 2.7 4.1 4.1 3.4 3.4 3.2 3.2 4.0 4.0 3.8 3.8 3.7 3.7 3.7 3.7 4.1 4.1 3.5 3.5 3.4 3.4 3.4 3.4 3.5 3.5 3.5 3.5 3.9 3.9 3.7 3.7 3.3 3.3 3.6 3.6 3.7 3.7 4.2 4.2 3.5 3.5 3.5 3.5 3.6 3.6 3.8 3.8 2.9 2.9 3.5 3.5 3.5 3.5
3.5 3.5 3.6 3.6 3.8 3.8 3.2 3.2 3.8 3.8 3.4 3.4
iSE VOLUMES (mL)
Day 49
Day 50
3.5 3.5 3.3 3.3 3.1 3.1 3.4 3.4 3.6 3.6 3.8 3.8 3.7 3.7
3.8 3.8 3.5 3.5 4.0 4.0 3.2 3.2 3.8 3.8 2.7 2.7 4.3 4.3 3.4 3.4 3.2 3.2 4.1 4.1 4.0 4.0 3.7 3.7 3.8 3.8 4.2 4.2 3.4 3.4 3.5 3.5 3.4 3.4 3.6 3.6 3.6 3.6 3.9 3.9 3.7 3.7 3.4 3.4 3.7 3.7 3.8 3.8 4.4 4.4 3.6 3.6 3.5 3.5 3.6 3.6 3.9 3.9 3.3 3.3 3.6 3.6 3.5 3.5 3.6 3.6 3.4 3.4
3.9 3.9 3.3 3.3 3.9 3.9 3.6 3.6
Day 51
3.5 3.3 3.1 3.4 3.6 3.8 3.7 3.8 3.5 4.0 3.2 3.8 2.7 4.3 3.4 3.2 4.1 4.0 3.7 3.8 4.2 3.4 3.5 3.4 3.6 3.6 3.9 3.7 3.4 3.7 3.8 4.4 3.6 3.5 3.6 3.9 3.3 3.6 3.5 3.6 3.4 3.9 3.3 3.9 3.6
Day 52
3.5 3.3 3.1 3.4 3.6 3.8 3.7 3.8 3.5 4.0 3.2 3.8 2.7 4.3 3.4 3.2 4.1 4.0 3.7 3.8 4.2 3.4 3.5 3.4 3.6 3.6 3.9 3.7 3.4 3.7 3.8 4.4 3.6 3.5 3.6 3.9 3.3 3.6 3.5 3.6 3.4 3.9 3.3 3.9 3.6
i. '
DuPont-5386
Day 53
3.5 3.3 3.1 3.4 3.6 3.8 3.7 3.8 3.5 4.0 3.2 3.8 2.7 4.3 3.4 3.2 4.1 4.0 3.7 3.8 4.2 3.4 3.5 3.4 3.6 3.6 3.9 3.7 3.4 3.7 3.8 4.4 3.6 3.5 3.6 3.9 3.3 3.6 3.5 3.6 3.4 3.9 3.3 3.9 3.6
527
Company Sanitized. Does not contain TSCA CtH
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Day 54
Day 55
Male, VII - 250 m g/kg/day
643194 643252 643260 643315 643215
643193
643298 643201 643259 643174 643283 643149 643178 643152 643295 643289 643171 643158 643249 643161 643309 643248 643285 643278 643299 643274 643192 643222 643160 643191 643203 643282 643302 643317 643225 643296 643258 643316 643220 643236 643165 643266 643151 643234
643281
3.5 3.3 3.1 3.4 3.6
3.8
3.7 3.8 3.5 4.0 3.2 3.8 2.7 4.3 3.4 3.2 4.1 4.0 3.7 3 .B 4.2 3.4 3.5 3.4 3.6 3.6 3.9 3.7 3.4 3.7 3.8 4.4 3.6 3.5 3.6 3.9 3.3 3.6 3.5 3.6 3.4 3.9 3.3 3.9
3.6
3.5 3.3 3.1 3.4 3.6
3.8
3.7 3.8 3.5 4.0 3.2 3.8 2.7 4.3 3.4 3.2 4.1 4.0 3.7 3.8 4.2 3.4 3.5 3.4 3.6 3.6 3.9 3.7 3.4 3.7 3.8 4.4 3.6 3.5 3.6 3.9 3.3 3.6 3.5 3.6 3.4 3.9 3.3 3.9
3.6
Day 56
INDIVIDUAL DC
Day 57
3.6 3.6 3.4 3.4 3.2 3.2 3.4 3.4 3.7 3.7
3.1 3.1
3.9 3.9 3.8 3 . B
3.5 3.5 4.1 4.1
3.2 3.2 3.9 3.9 2.8 2.8 4.3 4.3 2.9 2.9 2.9 2.9
4.1 4.1 4.1 4.1 3.8 3.8 3.9 3.9 3.7 3.7 3.5 3.5 3.5 3.5 3.6 3.6 3.7 3.7 3.7 3.7 4.0 4.0 3.8 3.8 3.5 3.5 3.7 3.7 3.8 3.8 4.4 4.4 3.6 3.6 3.6 3.6 3.6 3.6 4.0 4.0 3.4 3.4 3.7 3.7 3.5 3.5 3.8 3.8 3.4 3.4 3.9 3.9 3.4 3.4 3.9 3.9
3.7 _
iSE VOLUMES (mL)
Day 58
Day 59
3.6 3.4 3.2 3.4 3.7
3.1
3.9 3.8 3.5 4.1 3.2 3.9 2.8 4.3 2.9 2.9 4.1 4.1 3.8 3.9 3.7 3.5 3.5 3.6 3.7 3.7 4.0 3.8 3.5 3.7 3.8 4.4 3.6 3.6 3.6 4.0 3.4 3.7 3.5 3.8 3.4 3.9 3.4 3.9
3.7
3.6 3.4 3.2 3.4 3.7
3.1
3.9 3.8 3.5 4.1 3.2 3.9 2.8 4.3 2.9 2.9 4.1 4.1 3.8 3.9 3.7 3.5 3.5 3.6 3.7 3.7 4.0 3.8 3.5 3.7 3.8 4.4 3.6 3.6 3.6 4.0 3.4 3.7 3.5 3.8 3.4 3.9 3.4 3.9
3.7
Day 60
3.6 3.4 3.2 3.4 3.7
3.1 3.9 3.8 3.5 4.1 3.2 3.9 2.8 4.3 2.9 2.9 4.1 4.1 3.8 3.9 3.7 3.5 3.5 3.6 3.7 3.7 4.0 3.8 3.5 3.7 3.8 4.4 3.6 3.6 3.6 4.0 3.4 3.7 3.5 3.8 3.4 3.9 3.4 3.9
3.7
Day 61
3.6 3.4 3.2 3.4 3.7
3.1 3.9 3.8 3.5 4.1 3.2 3.9 2.8 4.3 2.9 2.9 4.1 4.1 3.8 3.9 3.7 3.5 3.5 3.6 3.7 3.7 4.0 3.8 3.5 3.7 3.8 4.4 3.6 3.6 3.6 4.0 3.4 3.7 3.5 3.8 3.4 3.9 3.4 3.9
3.7
DuPont-5386
Day 62
3.6 3.4 3.2 3.4 3.7 3.1 3.9 3.8 3.5 4.1 3.2 3.9 2.8 4.3 2.9 2.9 4.1 4.1 3.8 3.9 3.7 3.5 3.5 3.6 3.7 3.7 4.0 3.8 3.5 3.7 3.8 4.4 3.6 3.6 3.6 4.0 3.4 3.7 3.5 3 .8 3.4 3.9 3.4 3.9 3.7
528
Com pany SwiWtwl. P oes not contain TSCA CBI
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Day 63
Day 64
Male, VII - 250 m g/kg/day
643194 643252 643260 643315 643215 643193 643298 643201 643259 643174 643283 643149 643178 643152 643295 643289 643171
643158 643249 643161 643309 643248 643285 643278 643299 643274 643192 643222 643160 643191 643203 643282 643302 643317 643225 643296 643258 643316 643220 643236 643165 643266 643151 643234 643281
3.7 3.6 3.3 3.6 3.7 3.5 4.0 4.0 3.5 4.3 3.2 3.9 2.8 4.4 2.9 3.0 4.1
4.2
3.9 3.6 4.0 3.2 3.4 3.3 3.7 3.8 3.8 3.7 3.6 3.8 3.9 4.3 3.4 3.6 3.7 4.0 3.6 3.8 3.3 3.6 3.3 4.0 3.2 3.7 3.8
3.7 3.6 3.3 3.6 3.7 3.5 4.0 4.0 3.5 4.3 3.2 3.9 2.8 4.4 2.9 3.0 4.1
4.2 3.9 3.6 4.0 3.2 3.4 3.3 3.7 3.8 3.8 3.7 3.6 3.8 3.9 4.3 3.4 3.6 3.7 4.0 3.6 3.8 3.3 3.6 3.3 4.0 3.2 3.7 3.8
INDIVIDUAL DC
65 Day 66
3.7 3.7 3.6 3.6 3.3 3.3 3.6 3.6 3.7 3.7 3.5 3.5 4.0 4.0 4.0 4.0 3.5 3.5 4.3 4.3 3.2 3.2 3.9 3.9 2.8 2.8 4.4 4.4 2.9 2.9 3.0 3.0 4.1 4.1
4.2 4.2 3.9 3.9 3.6 3.6 4.0 4.0 3.2 3.2 3.4 3.4 3.3 3.3 3.7 3.7 3.8 3.8 3.8 3.8 3.7 3.7 3.6 3.6 3.8 3.8 3.9 3.9 4.3 4.3 3.4 3.4 3.6 3.6 3.7 3.7 4.0 4.0 3.6 3.6 3.8 3.8 3.3 3.3 3.6 3.6 3.3 3.3 4.0 4.0 3.2 3.2 3.7 3.7 3.8 3.8
ISE VOLUMES (mL)
67 Day 68
3.7 3.6 3.3 3.6 3.7 3.5 4.0 4.0 3.5 4.3 3.2 3.9 2.8 4.4 2.9 3.0 4.1
4.2
3.9 3.6 4.0 3.2 3.4 3.3 3.7 3.8 3.8 3.7 3.6 3.8 3.9 4.3 3.4 3.6 3.7 4.0 3.6 3.8 3.3 3.6 3.3 4.0 3.2 3.7 3 .8
3.7 3.6 3.3 3.6 3.7 3.5 4.0 4.0 3.5 4.3 3.2 3.9 2.8 4.4 2.9 3.0 4.1
4.2
3.9 3.6 4.0 3.2 3 .4 3.3 3.7 3.8 3.8 3.7 3.6 3.8 3.9 4.3 3.4 3.6 3.7 4.0 3.6 3.8 3.3 3.6 3.3 4.0 3.2 3.7 3.8
i
DuPont-5386
Day 69
3.7 3.6 3.3 3.6 3.7 3.5 4.0 4.0 3.5 4.3 3.2 3.9 2.8 4.4 2.9 3.0 4.1
4.2 3.9 3.6 4.0 3.2 3.4 3.3 3.7 3.8 3.B 3.7 3.6 3.8 3.9 4.3 3.4 3.6 3.7 4.0 3.6 3.8 3.3 3.6 3.3 4,0 3.2 3.7 3.8
Day 70
Day 71
3.8 3.8 2.8 2.8 3.3 3.3 3.7 3.7 3.2 3.2 3.6 3.6 4.0 4.0 4.0 4.0 3.7 3.7 4.3 4.3 3.0 3.0 3.9 3.9 2.8 2.8 4.5 4.5 2.5 2.5 3.2 3.2 3.4 3.4
4.3 4.3 b 3.4 3.4 3.6 3.6 3 . 7 AK T E S T DAY 70 3.0 3.0 3.3 3.3 3.6 3.6 3.6 3.6 3.8 3.8 3.9 3.9 3.9 3.9 3.6 3.6 3.8 3.8 4.0 4.0 3.7 3.7 2.8 2.8 2.9 2.9 3.8 3.8 3.2 3.2 3.6 3.6 3.8 3.8
3.3 3.3
3.8 3.8
3.5 3.5
4.0 4.0 3.2 3.2 3.3 3.3 3.8 3.8
529
Com pany Sanitized. Does not contain TSCA CBI
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations______________
Day 72
Day 73
Male, VII - 250 m g/kg/day
643194 643252 643260 643315 643215 643193 643298 643201 643259 643174 643283 643149 643178 643152 643295 643289 643171 643158 643249 643161 643309 643248 643285 643278 643299 643274 643192 643222 643160 643191 643203 643282 643302 643317 643225 643296 643258 643316 643220 643236
643165 643266 643151 643234 643281
3.8 2.8 3.3 3.7 3.2 3.6 4.0 4.0 3.7 4.3 3.0 3.9 2.8 4.5 2.5 3.2 3.4 4.3 3.4 3.6
3.0 3.3 3.6 3.6 3.8 3.9 3.9 3.6 3.8 4.0 3.7 2.8 2.9 3.8 3.2 3.6 3.8 3.3 3.8 3.5 4.0 3.2 3.3 3.8
3.8 2.8 3.3 3.7 3.2 3.6 4.0 4.0 3.7 4.3 3.0 3.9 2.8 4.5 2.5 3.2 3.4 4.3 3.4 3.6
3.0 3.3 3.6 3.6 3.8 3.9 3.9 3.6 3.8 4.0 3.7 2.8 2.9 3.8 3.2 3.6 3.8 3.3 3.8 3.5 4.0 3.2 3.3 3.8
Day 74
INDIVIDUAL DOSE VOLUMES (mL)
Day 75
Day 76
77
3.8 2.8 3.3 3.7 3.2 3.6 4.0 4.0 3.7 4.3 3.0 3.9 2.8 4.5 2.5 3.2 3.4 4.3 3.4 3.6
3.0 3.3 3.6 3.6 3.8 3.9 3.9 3.6 3.8 4.0 3.7 2.8 2.9 3.8 3.2 3.6 3.8 3.3 3.8 3.5 4.0 3.2 3.3 3.8
3.8 2.8 3.3 3.7 3.2 3.6 4.0 4.0 3.7 4.3 3.0 3.9 2.8 4.5 2.5
3.8 3.2 3.6 3.8 3.3 3.8 3.5 4.0 3.2 3.3
3.8 2.8 3.3 3.7 3.2 3.6 4.0 4.0 3.7 4.3 3.0 3.9 2.8 4.5 2.5
3.8 3.2 3.6 3.8 3.3 3.8 3.5 4.0 3.2 3.3
3.8 3.4 3.4 3.5 3.7 3.8 3.7 4.1 3.4 4.4 3.3 4.0 2.6 4.5 3.2
3.8 3.9 3.1 3.8 3.4 3.6 2.9 3.9 3.0 3.8
Day 78
3. a 3.4 3.4 3.5 3.7 3.8 3.7 4.1 3.4 4.4 3.3 4.0 2.6 4.5 3.2
3.8 3.9 3.1 3.8 3.4 3.6 2.9 3.9 3.0 3.8
Day 79
3.8 3.4 3.4 3.5 3.7 3.8 3.7 4.1 3.4 4.4 3.3 4.0 2.6 4.5 3.2
3.8 3.9 3.1 3.8 3.4 3.6 2.9 3.9 3.0 3.8
DuPont-5386
Day 80
3.8 3.4 3.4 3.5 3.7 3.8 3.7 4.1 3.4 4.4 3.3 4.0 2.6 4.5 .3.2
3.8 3.9 3.1 3.8 3.4 3.6 2.9 3.9 3.0 3.8
530 Company Sanitized. Does not contain TSCA C8I
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Day 81
Day 82
Male, VII - 250 m g/kg/day
643194 643252 643260 643315 643215 643193 643298 643201 643259 643174 643283 643149 643178 643152 643295 643289 643171 643158 643249 643161 643309 643248 643285 643278 643299 643274 643192 643222 643160 643191 643203 643282 643302 643317 643225 643296 643258 643316 643220 643236 643165 643266
643151 643234 643281
u> 00
3.8 3.4 3.4 3.5 3.7 3.7 4.1 3.4 4.4 3.3 4.0 2.6 4.5 3.2
3.8 3.9 3.1 3.8 3.4 3.6 2.9 3.9 3.0 3.8
3.8 3.4 3.4 3.5 3.7 3.8 3.7 4.1 3.4 4.4 3.3 4.0 2.6 4.5 3.2
3.8 3.9 3.1 3.8 3.4 3.6 2.9 3.9 3.0 3.8
INDIVIDUAL DOSE VOLUMES (mL)
83 Day 84 Day 85
86
3 . 8 3 . 9 3 . 9 3.9 3 . 4 3 . 8 3 . 8 3.8 3 . 4 3 . 4 3 . 4 3.4 3 . 5 3 . 7 3 . 7 3.7
3 . 7 3 . 9 3 . 9 3.9 3 .8 4 . 0 4 .0 4.0 3 . 7 4 . 0 4 . 0 4.0 4 . 1 4 . 2 4 .2 4.2 3 .4 3 . 7 3 . 7 3.7
4 . 4 4 . 4 4 . 4 4,4
3 . 3 3 . 3 3 . 3 3.3 4 . 0 4 . 1 4 . 1 4.1 2 . 6 2 . 9 2 . 9 2.9 4 . 5 4 . 7 4 . 7 4.7 3 . 2 3 . 2 3 . 2 3.2
3 .8 4 . 0 4 .0 4.0 3 . 9 4 . 2 4 . 2 4.2 3 . 1 3 . 6 3 . 6 3.6 3 . 8 3 . 9 3 . 9 3.9 3 . 4 3 . 5 3 . 5 3.5 3 . 6 3 . 9 3 . 9 3.9 2 . 9 3 . 6 3 . 6 3.6 3 .9 4 . 1 4 . 1 4.1 3 . 0 3 . 4 3 . 4 3.4 3 . 8 3 . 8 3 . 8 3.8
Day 87
3.9 3.8 3.4 3.7 3.9 4.0 4.0 4.2 3.7 4.4 3.3 4.1 2.9 4.7 3.2
4.0 4.2 3.6 3.9 3.5 3.9 3.6 4.1 3.4 3.8
Day 88
3.9 3.8 3.4 3.7 3.9 4.0 4.0 4.2 3.7 4.* 3.3 4.1 2.9 4.7 3.2
4.0 4.2 3.6 3.9 3.5 3.9 3.6 4.1 3.4 3.6
DuPont-5386
Day 89
3.9 3.8 3.4 3.7 3.9 4.0 4.0 4.2 3.7 4.4 3.3 4.1 2.9 4.7 3.2
4.0 4.2 3.6 3.9 3.5 3.9 3.6 4.1 3.4 3.8
531
Sanitized. Does not contain TOGACBI
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Day 90
Male, VII - 250 m g/kg/day
643194 643252 643260 643315 643215 643193 643298 643201 643259 643174 643283 643149 643178 643152 643295 643289 643171 643158 643249 643161 643309 643248 643285 643278 643299 643274 643192 643222 643160 643191 643203 643282 643302 643317 643225 643296 643258 643316 643220 643236 643165 643266 643151 643234 643281
4.0 4.0 3.5 3.8 4.0 4.2 4.1 4.3 3.8 4.5
INDIVIDUAL DOSE VOLUMES (mL)
DuPont-5386
532
Company Sanitized. Does not contain TSCA CBI
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Day 0
Day 1
Female, II - 0 mg/kg/day
643477 643374 643406 643486 643361 643463 643398 643436 643362
643354 643402 643383 643465 643484 643384 643352 643343 643459 643394 643480 643319 643350 643363 643397 643421 643420 643419 643414 643401 643455 643378 643393 643447 643478 643386 643405 643425 643448 643426 643415 643453 643330 643336 643387 643377
1.7 1.7 1.8 1.8 1.6 1.6 1.8 1.8 1.9 1.9 2.2 2.2 1.7 1.7 1.8 1.8 1.8 1.8 1.6 1.6 1.8 1.8 1.7 1.7 2.1 2.1 1.8 1.8 1.9 1.9 1.9 1.9 1.7 1.7 2.1 2.1 1.9 1.9 2.0 2.0 2.0 2.0 1.9 1.9 2.0 '2.0 1.9 1.9 1.8 1.8 2.1 2.1 2.1 2.1 2.1 2.1 1.8 1.0 1.9 1.9 2.2 2.2 1.9 1.9 1.9 1.9 1.8 1.8 1.8 1.8 2.1 2.1 2.0 2.0 2.1 2.1 1.8 1.8 2.1 2.1 2.0 2.0
1.7 1.7 2.0 2.0 1.9 1.9 2.0 2.0
Day 2
1.7 1,8 1.6 1.8 1.9 2.2 1.7 1.8 1.8 1.6 1.8 1.7 2.1 1.8 1.9 1.9 1,7 2.1 1.9 2.0 2.0 1.9 2.0 1.9 1.8 2.1 2.1 2.1 1.8 1.9 2.2 1.9 1.9 1.8 1.8 2.1 2.0 2.1 1.8 2.1 2.0 1.7 2.0 1.9 2.0
Day 3
1.7 1.8 1.6 1.8 1.9 2.2 1.7 1.0 1.8 1.6 1.8 1.7 2.1 1.8 1.9 1.9 1.7 2.1 1.9 2.0 2.0 1.9 2.0 1.9 1.8 2.1 2.1 2.1 1.8 1.9 2.2 1.9 1.9 1.8 1.8 2.1 2.0 2.1 1.8 2.1 2.0 1.7 2.0 1.9 2.0
INDIVIDUAL DOSE VOLUME
Day 4
Day 5
Day 6
1.7 1.7 1.7 1.8 1.8 1.8 1.6 1.6 1.6 1.8 1.8 1.8 1.9 1.9 1.9 2.2 2.2 2.2 1.7 1.7 1.7 1.8 1.8 1.8 1.8 1.8 1.8 1.6 1.6 1.6 1.8 1.8 1.8 1.7 1.7 1.7 2.1 2.1 2.1 l.B 1.8 1.8 1.9 1.9 1.9 1.9 1.9 1.9 1.7 1.7 1.7 2.1 2.1 2.1 1.9 1.9 1.9 2.0 2.0 2.0 2.0 2.0 2.0 1.9 1.9 1.9 2.0 2.0 2.0 1.9 1.9 1.9 1.8 1.8 1.8 2.1 2.1 2.1 2.1 2.1 2.1 2.1 2.1 2.1 1.8 1.8 1.8 1.9 1.9 1.9 2.2 2.2 2.2 1.9 1.9 1.9 1.9 1.9 1.9 1.8 1.8 1.8 1.8 1.8 1.8 2.1 2.1 2.1 2.0 2.0 2.0 2.1 2.1 2.1 1.8 1.8 1.8 2.1 2.1 2.1 2.0 2.0 2.0 1.7 1.7 1.7 2.0 2.0 2.0 1.9 1.9 1.9 2.0 2.0 2.0
533
S (mL)
Day 7
Day 8
Day 9
DuPont-5386
Day 10
Day 11
2.0 2.1 1.9 1.9 2.1 2.4 1.9 2.0 2.1
1.7 1.9
12 .. 29
1.9 2.2 2.1 1.9 2.3 2.3 2.3 2.3 2.1 2.3 2.3 2.0 2.3 2.4 2.5 1.8 2.1 2.4 2.3 2.2 2.0 2.2 2.4 2.3 2.3 2.1 2.4 2.2 1.9
2.2
2.1 2.2
2.0 2.1
1.9 1.9 2.1
2.4
21 .. 09
2.1
1.7 1.9 1.9 2.2 1.9 2.2 2.1
1.9 2.3 2.3 2.3 2.3 2.1 2.3
22 .. 30
2.3 2.4 2.5 1.8 2.1
2.4 2.3 2.2 2.0
2.2
2.4 2.3 2.3 2.1
22 .. 42
1.9 2.2
22.. 21
2.0
2.1
1.9 1.9 2.1
2.4 1.9 2.0 2.1
1.7
1.9 1.9 2.2 1.9 2.2 2.1
1.9 2.3 2.3 2.3 2.3 2.1
2.3 2.3 2.0 2.3 2.4 2.5 1.8 2.1 2.4 2.3 2.2 2.0 2.2 2.4 2.3 2.3 2.1 2.4
2.2
1.9
2.2 2.1
2.2
2.0 2.1
1.9 1.9
2.1 2.4
21 .. 09
2.1
1.7
1.9 1.9 2.2 1.9 2.2 2.1 1.9 2.3 2.3 2.3 2.3 2.1
2.3
22 .. 30
2.3 2.4 2.5 1.8 2.1 2.4 2.3
22.. 02
2.2
2.4 2.3 2.3 2.1 2.4 2.2
1.9 2.2 2.1 2.2
2.0 2.1 1.9 1.9 2.1 2.4 1.9 2.0 2.1
1.7 1.9 1.9 2.2 1.9 2.2 2.1 1.9 2.3 2.3 2.3 2.3 2.1 2.3 2.3 2.0 2.3 2.4 2.5 1.8
2.1 2 .4 2.3 2.2
22 .. 20
2.4 2.3 2.3 2.1
22 .. 42
1.9 2.2 2.1
2.2
Company Sanitized. Does not contain TSCA CBf
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
D a y 12
D ay 13
F e m a le , I I - 0 mg/k g /d a y
643477 643374 643406 643486 643361 643463 643398 643436 643362 643354 643402 643383 643465 643484 643384 643352
643343 643459 643394 643480 643319 643350
643363 643397 643421 643420 643419 643414 643401 643455 643378 643393 643447 643478 643386 643405 643425 643448 643426 643415 643453
643330 643336 643387 643377
2.0 2.1 1.9 1.9 2.1 2.4 1 .9 2.0 2.1 1.7
1.9 1.9 2.2 1.9 2.2 2.1 1.9 2.3 2.3 2.3 2.3 2.1
2.3 2.3 2.0 2.3 2.4 2.5 1.8 2.1 2.4 2.3 2.2 2.0
2.2 2.4 2.3 2.3 2.1 2.4 2.2
1.9 2.2 2.1 2.2
2.0 2.1 1 .9 1 .9 2.1 2.4 1.9 2.0 2.1 1.7 1.9 1.9 2.2 1.9 2.2 2.1
1.9 2.3 2.3 2.3 2.3
.2 . 1 2.3 2.3 2.0 2.3 2.4 2.5 1.8 2.1 2.4 2.3 2.2 2.0 2.2
2.4 2.3 2.3 2.1 2.4 2.2
1.9 2.2 2.1 2.2
D a y 14
2.1 2.3 2.1 1.9 2.2 2.7 2.1 2.3 2.4 1.9 2.2 2.0 2.4 2.1 2.4 2.3 2.1 2.5 2.4 2.4 2.4 2.2 2.6 2.5 2.2 2.5 2.6 2.6 2.0 2.2 2.7 2.4 2.4 2.1 2.2 2.7 2.4 2.3 2.3 2.6 2.5 2.1 2.5 2.4 2.4
D ay 15
2.1 2.3 2.1 1.9 2.2 2.7 2.1 2.3 2.4 1.9 2.2 2.0 2.4 2.1 2.4 2.3 2.1 2.5 2.4 2.4 2.4 2.2 2.6 2.5 2.2 2.5 2.6 2.6 2.0 2.2 2.7 2.4 2.4 2.1 2.2 2 .7 2.4 2.3 2.3 2.6 2.5 2.1 2.5 2.4 2.4
INDIVIDUAL DOSE VOLUME
D ay 16
D ay 17
D ay 18
2.1 2.3 2.1 1.9 2.2 2.7 2.1 2.3 2.4
1.9 2.2 2.0 2.4 2.1 2.4 2.3 2.1 2.5 2.4 2.4 2.4 2.2 2.6 2.5 2.2 2.5 2.6 2.6 2.0 2.2 2.7 2.4 2.4 2 .1 2.2 2.7 2.4
2.3 2.3 2.6 2 .5
2.1 2.5 2.4 2.4
*
2.1 2.3 2.1 1 .9 2.2 2.7 2.1 2.3 2.4
1.9 2 .2. 2.0 2.4 2.1 2.4 2.3 2.1 2.5 2.4 2.4 2.4 2.2 2.6 2.5 2.2 2.5 2.6 2.6 2.0 2.2 2.7 2.4 2.4 2.1 2-2
2.7 2.4 2.3 2.3 2.6 2.5
2.1 2.5 2.4 2.4
2.1 2.3 2.1 1.9 2.2 2.7 2.1 2 .3 2.4
1.9 2.2 2.0 2.4 2.1 2.4 2.3 2.1 2.5 2.4 2.4 2.4 2.2 2.6 2.5 2.2 2.5 2.6 2.6 2.0 2.2 2.7 2.4 2.4 2.1 2.2 2 .7 2.4 2.3 2.3 2.6 2.5
2.1 2.5 2.4 2.4
534
IS (mL)
D ay 19
D ay 20
D ay 21
D ay 22
DuPont-5386
D ay 23
2.1 2.1 2.4 2.4 2.4
2.3 2.3 2.4 2.4 2.4 2.1 2.1 2.2 2.2 2.2
1 . 9 1 . 9 2 . 1 2 . 1 2 .1
2.2 2 .2 2 .6 2.6 2 .6
2.7 2.7 2.7 2.7 2.7
2.1 2.1 2.3 2.3 2.3
2.3 2.3 2.4 2.4 2.4
2.4 2.4 2.5 2.5 2.5
1.9 1.9 2.1 2.1 2.1
2.2 2.2 2.3 2.3 2.3
2.0 2.0 2.2 2.2 2.2
2 . 4 2 . 4 2 . 7 2 . 7 2 .7
2.1 2.1 2.2 2.2 2.2
2.4 2.4 2.5 2.5 2.5
2.3 2.3 2.5 2.5 2.5
2.1 2.1 2.3 2.3 2.3
2.5
2 .5
2.6
2.6
2 .6
2.4 2.4 2.5 2.5 2.5
2 . 4 2 . 4 2 . 5 2 . 5 2 .5
2.4 2.4 2.7 2.7 2.7
2.2 2.2 2.3 2.3 2.3
2.6 2.6 2.6 2.6 2.6
2.5 2.5 2.6 2.6 2.6
2.2 2.2 2.3 2.3 2.3
2.5 2.5 2.8 2.8 2.8
2 . 6 2 . 6 2 . 9 2 . 9 2 .9
2 . 6 2 . 6 2 . 8 2 . 8 2 .8
2 . 0 2 . 0 2 . 1 2 . 1 2 .1
2.2 2.2 2.4 2 .4 2.4
2.7 2.7 2.9 2.9 2.9
2.4 2.4 2.6 2.6 2.6
2.4 2.4 2.6 2.6 2.6 2.1 2.1 2.3 2.3 2.3
2.2 2.2 2.4 2.4 2.4
2.7 2.7 2.8 2.8 2.8
2.4 2.4 2.7 2.7 2.7 2.3 2.3 2.5 2.5 2.5
2.3 2.3 2.6 2.6 2.6
2.6 2.6 2.7 2.7 2.7
2.5 2.5 2.7 2.7 2.7
2.1 2.1 2.2 2.2 2.2
2.5 2.5 2.7 2.7 2.7
2.4 2.4 2.5 2.5 2.5
2.4 2.4 2.6 2.6 2.6
Company Sanitized. Does not contain TSCACBI
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
D ay 24
D ay 25
F e m a le , I I - 0 mg/k g /d a y
643477 643374 643406 643486 643361
643463 643398 643436 643362 643354 643402 643383 643465 643484 643384 643352 643343 643459 643394 643480 643319 643350 643363 643397 643421 643420 643419 643414 643401 643455 643378 643393 643447 643478 643386 643405 643425 643448 643426 643415 643453
643330 643336 643387 643377
2.4 2.4 2.2 2.1
2.6 2 .7
2.3 2.4 2.5 2.1 2.3 2.2 2.7 2.2 2.5 2.5 2.3 2.6 2.5 2.5 2.7
2.3 2.6 2.6 2.3 2.8 2.9
2.8 2.1 2.4
2.9 2.6 2.6 2.3 2.4 2.8 2.7 2.5 2.6 2.7 2.7
2.2 2 .7
2.5 2.6
2.4 2.4 2.2 2.1
2.6
2.7 2.3 2.4 2.5 2.1 2.3 2.2 2.7 2.2 2.5 2.5 2.3 2.6 2.5 2.5 2.7 .2 . 3 2.6 2.6 2.3 2 .8 2.9
2.8 2.1 2.4 2.9 2.6 2.6 2.3 2.4 2.8 2 .7
2.5 2.6 2.7 2.7
2.2 2.7 2.5
2.6
D ay 26
2.4 2.4 2.2 2 .1 2.6 2.7 2.3 2.4 2.5 2.1 2.3 2.2 2.7 2.2 2.5 2.5 2.3 2.6 2 .5 2.5 2.7 2.3 2.6 2.6 2.3 2.8 2 .9 2.8 2.1 2.4 2.9 2.6 2.6 2.3 2.4 2 .8 2.7 2.5 2.6 2.7 2.7 2.2 2.7 2.5 2.6
INDIVIDUAL DOSE VOLUME
27 D ay 28 D ay 29 D ay 30
2.4 2.4 2.2 2.1 2.6 2.7
2.3 2.4 2.5 2.1 2.3 2.2 2.7 2.2 2.5 2.5 2.3 2.6 2.5 2.5 2.7
2.3 2.6 2 .6 2.3 2 .8 2 .9 2.8 2.1 2.4 2 .9 2.6 2.6 2.3 2.4 2 .8 2.7 2.5 2.6 2.7 2.7
2.2 2.7
2.5
2.6
2.4 2 .5 2.3 2 .1 2.7 2.9 2.4 2.6 2.6 2.2 2.4 2.2 2.8 2.3 2.6 2.6 2.4 2 .7 2.7 2.7 2.7
2.4 2.9 2.7 2.4 2.9 3.1 2.9 2.3 2.6 3.0 2.9 2.7 2.4 2.5 3.0 2.8 2 .7 2.7 3.0 2.8 2.4 2.9 2.7 2.7
2.4 2.5 2.3 2.1 2.7
2.9 2.4 2.6 2.6 2.2 2.4 2.2 2.8 2.3 2.6 2.6 2.4 2.7 2.7 2.7 2.7
2.4 2.9 2.7 2.4 2.9 3.1
2.9 2.3 2.6 3.0 2.9 2.7 2.4 2.5 3.0 2.8 2.7 2.7 3.0 2.8 2.4 2.9 2.7 2.7
2.4 2.5 2.3 2.1
2.7 2.9
2.4
2.6 2.6 2.2 2.4 2.2 2.8 2.3 2.6 2.6 2.4 2 .7 2.7 2.7 2.7 2.4 2.9 2.7 2.4 2.9 3.1 2.9 2.3 2 .6
3.0 2.9 2.7 2.4 2.5 3.0 2.8 2.7 2.7 3.0 2.8 2.4 2.9 2.7 2.7
535
S (mL)
D ay 31
D ay 32
D ay 33
D ay 34
DuPont-5386
D ay 35
2.4 2.5 2.3 2.1 2.7
2.9 2.4 2.6 2.6 2.2 2.4 2.2 2.8 2.3 2.6 2.6 2.4 2.7 2.7 2.7 2.7
2.4 2.9 2.7 2.4 2.9 3.1 2.9 2.3 2.6 3.0 2.9 2.7 2.4 2.5 3.0 2.8 2.7 2.7 3.0 2.8 2.4 2 .9 2.7 2.7
2.4 2.5 2.3 2.1 2.7
2.9 2.4 2.6 2.6 2.2 2.4 2.2 2.8 2.3 2.6 2.6 2.4 2.7 2.7 2.7 2.7 2.4 2 .9 2.7 2.4 2.9 3.1 2.9 2.3 2.6 3.0 2.9 2.7 2.4 2.5 3.0 2.8 2.7 2.7 3 .0 2 .8 2.4 2.9 2.7
2.7
2.4 2.5 2.3 2.1 2.7 2.9 2.4 2.6 2.6
2.2 2.4 2.2 2.8 2.3 2.6 2.6 2.4 2.7 2.7 2.7 2.7
2.4 2.9 2.7 2.4 2.9 3.1 2.9 2.3 2.6 3.0 2.9 2.7 2.4 2.5 3.0 2.8 2.7 2.7 3.0 2.8
2.4 2.9 2.7 2.7
2.4 2.5 2.3 2.1 2.7 2.9 2.4 2.6 2.6 2.2 2.4 2.2 2.8 2.3 2.6 2.6 2.4 2.7 2.7 2.7 2.7 2.4 2.9 2.7 2.4 2.9 3.1 2.9 2.3 2.6 3.0 2.9 2.7 2.4 2.5 3.0 2.8 2.7 2.7 3.0 2.8 2.4 2 .9 2.7 2.7
2.6 2.6 2.4 2.2 2.8 3.1 2.6 2.7 2.8 2.3 2.5 2.4 2.7 2.4 2.8 2.8 2.6 2 .9 2.8 2.9 2.9
2.5 3.0 2.8 2.5 3.2 3.2 3.1 2.3 2.6 3.2 3.0 2.9 2.4
2.5 3.2 2.9 2.8 2.9 3.0 2.9
2.5 3.0 2.9 2.9
Company Sanftfzed. Does not contain TSCA CBI
H-24516: Subchronic Toxicity . 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
D ay 36
Day 37
F e m a le , I I - 0 mg/k g /d a y
643477 643374 643406 643486 643361
643463
643398 643436 643362 643354 643402 643383 643465 643484 643384 643352 643343 643459 643394 643480
643319 643350 643363 643397 643421 643420 643419 643414 643401 643455 643378 643393 643447 643478
643386 643405 643425
643448 643426 643415 643453 643330 643336 643387 643377
2.6 2.6 2.4 2.2 2.8
3.1
2.6 2.7 2.8 2 .3 2.5 2.4 2.7 2.4 2 .8 2.8 2.6 2 .9 2 .8
2.9 2.9 2.5 3.0 2.8 2.5 3.2 3.2 3.1 2.3 2.6 3.2 3.0 2.9 2.4
2.5 3.2 2.9 2 .8
2.9 3.0 2.9 2.5 3.0 2.9
2.9
2.6 2.6 2.4 2.2 2.8
3.1
2.6 2 .7 2.8 2.3 2 .5 2.4 2 .7 2.4 2.8 2.8 2.6 2 .9 2.8 2.9 2.9 2 . 5 3.0 2.8 2.5 3.2 3.2 3.1 2.3 2.6 3.2 3.0 2.9 2.4
2.5 3.2 2.9 2.8 2.9 3.0 2 .9
2.5 3.0 2.9 2.9
D ay 38
2.0 1.9 1.8 1 .7 2.1
2.3 2.0 2.0 2.1 1.7 1 .9 1.8 2.1 1 .8 2.1 2 .1 2.0 2 .1 2.1 2.2 2.2 1.9 2.3 2.1 1 .9 2.4 2.4 2.3 1.8 1.9 2.4 2.3 2.2 1.8 1.9 2.4 2.2 2.1 2.2 2.2 2.2 1.9 2.2 2.2 2.1
INDIVIDUAL DOSE VOLUMES (mL)
Day 39
D ay 40
D ay 41
D ay 42
2.0
1.9 1.8 1.7 2.1
2.3
2.0 2.0 2.1 1.7 1.9 1.8 2.1 1.8 2.1 2.1 2.0 2 .1 2.1 2.2 2.2
1 .9 2.3 2 .1 1.9 2.4 2.4 2.3 1 .8 1.9 2.4 2.3 2.2 1.8
1.9 2.4 2.2 2.1 2.2 2.2 2.2
1.9 2.2 2.2 2.1
2.0 1.9 1.8 1.7 2.1
2.3
2.0 2.0
2.1 1.7 1.9 1.8 2.1 1.8 2 .1 2 .1 2.0 2.1 2.1 2.2 2.2
1 .9 2.3 2.1 1.9 2.4 2.4 2.3 1.8 1 .9 2.4 2.3 2.2 1.8
1.9 2.4 2.2 2.1 2.2 2.2 2.2
1.9 2.2 2.2 2.1
2.0 1.9 1 .8 1.7 2.1
2.3 b
2.0 2.0 2.1 1.7 1.9 1.8 2.1 1.8 2.1 2.1 2.0 2.1 2.1 2.2 2.2 1.9 2.3 2.1 1 .9 2.4 2 .4 2.3 1.8 1.9 2.4 2.3 2.2 1 .8
1.9 2.4 2.2 2.1 2.2 2.2 2.2 1.9 2.2 2.2 2.1
2.0 2.0 1.8 1.7 2.2
2.3
2.0 2.1 2.1 1.8 1.9 1.8 2.2 1.8 2.0 2.1 2.0 2.3 2.1 2.1 2.3 2.0 2.2 2.2 2.0 2.5 2.5 2.4 1.8 2.0 2.4 2.3 2.2 1.9 2.0 2.6 2.2 2.1 2.2 2.3 2.3 2.0 2.3 2.2 2.2
D ay 43
D ay 44
2.0 2.0 1.8 1.7
2.2
2.3
2.0 2.1 2.1 1.8 1.9 1.8 2.2 1.8 2.0 2.1 2 .0 2.3 2.1 2.1 2.3 2.0 2.2 2.2 2.0 2.5 2.5 2.4 1.8 2.0 2.4 2 .3 2.2 1.9
2.0 2.6 2.2 2.1 2.2 2.3 2.3 2.0 2.3 2.2 2.2
2.0 2.0 1.8 1.7 2.2
2.3
2.0 2.1
2.1 1.8 1.9 1.8 2.2 1 .8 2 .0 2.1 2.0 2.3 2.1 2.1 2.3 2.0 2.2 2.2 2.0 2.5 2.5 2.4 1.8 2.0 2.4 2.3 2.2 1.9
2.0 2.6 2.2 2.1 2.2 2.3 2.3 2.0 2.3 2.2 2.2
DuPont-5386
D ay 45
2.0 2.0 1.8 1.7 2.2 2.3 2.0 2.1 2.1 ' 1.8 1.9 1.8 2.2 1.8 2 .0 2.1 2.0 2.3 2.1 2.1 2.3 2.0 2.2 2.2 2.0 2.5 2.5 2.4 1.8 2.0 2.4 2.3 2.2 1.9 2.0 2.6 2.2 2.1 2.2 2.3 2.3 2.0 2.3 2.2 2.2
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Day 46
D ay 47
F e m a le , I I - 0 mg/k g /d a y
643477 643374 643406 643456 643361
643463 643398 643436 643362 643354 643402 643383 643465 643484 643384 643352 643343 643459 643394 643480 643319 643350 643363 643397 643421 643420 643419 643414 643401 643455 643378 643393 643447 643478 643386 643405 643425 643448 643426 643415 643453 643330 643336 643387 643377
2.0
2.0 1.8 1.7 2.2
2.3 2.0 2.1 2.1 1.8 1.9 1.8 2.2 1.8 2.0 2.1 2.0 2.3 2.1 2.1 2.3 2.0 2.2 2.2 2.0 2.5 2.5 2.4 1.8 2.0 2.4 2.3 2.2 1.9 2.0 2.6 2.2 2.1 2.2 2.3 2.3
2.0 2.3 2.2 2.2
2.0
2.0 1.8 1.7 2.2
2.3 2.0 2.1 2.1 1.8 1.9 1.8 2.2 1.8 2.0 2.1 2.0 2.3 2.1 2.1 2.3 2.0 2.2 2.2 2.0 2.5 2.5 2.4 1.8 2.0 2.4 2.3 2.2 1.9 2.0 2.6 2.2 2.1 2.2 2.3 2.3
2.0 2.3 2.2 2.2
Day 4 8
INDIVIDUAL DOSE VOLUMES (mL)
Day 49
D ay 50
D a y 51
D ay 52
2.0 2.0 1.8 1.7 2.2
2.3 2 .0 2.1
2.1 1.8 1.9 1.8 2.2 1.8 2.0 2.1 2.0 2.3 2 .1 2.1 2.3 2.0 2.2 2.2 2.0 2.5 2.5 2.4 1.8 2.0 2.4 2.3 2.2 1 .9 2.0 2.6 2.2 2.1 2.2 2.3 2 .3
2.0 2.3 2.2 2.2
2.0 2.1 1 .9 1.8 2.4
2.3 2.0 2.1 2.1 1.9 2.0 1.9 2.2 1.9 2.1 2.2 2.1 2.4 2.2 2.2 2.3 2.1 2.4 2.3 2.0 2.6 2.6 2 .5 1.8 2.0 2.6 2.4 2.3 2.0 2.0 2.7 2 .3 2.1 2.3 2.4 2.4
2.0 2.4 2.3 2.3
2.0 2.1 1.9 1.8 2.4
2.3 2.0 2.1 2.1 1.9 2.0 1.9 2.2 1.9 2.1 2.2 2.1 2.4 2.2
2.2 2.3 2.1 2.4 2.3 2.0 2.6 2.6 2.5 1.8 2.0 2.6 2.4 2.3 2.0 2.0 2.7 2.3 2.1 2.3 2.4 2.4
2.0 2.4 2.3 2.3
2.0 2.1 1.9 1.8 2.4 2.3 2.0 2.1
2.1 1.9 2.0 1.9 2.2 1.9 2.1 2.2 2.1 2.4 2.2 2.2 2.3
2.1 2.4 2.3 2.0 2.6 2.6 2.5 1.8 2.0 2.6 2.4 2.3 2.0 2.0 2.7 2.3 2.1 2.3 2.4 2.4 2.0 2.4 2.3 2.3
2.0 2.1 1.9 1.8 2.4 2.3 2.0 2.1 2.1 1.9 2.0 1.9 2.2 1.9 2.1 2.2 2.1 2.4 2.2
2.2 2.3
2.1 2.4 2 .3 2.0 2.6 2.6 2.5 1.8 2.0 2.6 2.4 2.3 2.0 2.0 2.7 2.3 2.1 2.3 2.4 2.4
2.0 2.4 2.3 2.3
D ay 53
D ay 54
2.0 2 .1 1.9 1.8 2.4 2.3 2.0 2.1
2.1 1.9 2.0 1.9 2.2 1.9 2.1 2.2 2 .1 2.4 2.2 2.2
2.3
2.1 2.4 2.3 2.0 2.6 2.6 2.5 1.8 2.0 2.6 2.4 2.3 2.0 2.0 2 .7 2.3 2.1 2.3 2.4 2.4
2.0 2.4 2.3 2.3
2.0 2.1 1.9 1.8 2.4 2.3 2.0 2.1 2.1 1 .9 2.0 1.9 2.2 1.9 2.1 2.2 2.1 2.4 2.2 2.2 2.3
2.1 2.4 2.3 2.0 2.6 2.6 2.5 1.8 2.0 2.6 2.4
2.3 2.0 2.0 2.7 2.3 2.1 2.3 2.4 2.4 2.0 2.4 2.3
2.3
DuPont-5386
D ay 55
2.0 2.1 1.9 1.8 2.4 2.3 2.0 2.1 2.1 1.9 2.0 1.9 2.2 1.9 2.1 2.2 2.1 2.4 2.2 2.2 2.3 2.1 2.4 2.3 2.0 2.6 2.6 2.5 1.8 2.0 2.6 2.4 2.3 2.0 2.0 2.7 2.3 2.1 2.3 2.4 2.4 2.0 2.4 2.3 2.3
537
C mpany Santt!zed- Doe* not contabi TSCA CBI
O
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
D ay 56
D ay 57
F e m a le , I I - 0 mg/k g /d a y
643477 643374 643406 643486 643361 643463
643398 643436 643362 643354 643402
643383 643465 643484 643384 643352 643343 643459 643394
643480 643319 643350 643363 643397 643421 643420 643419 643414 643401 643455 643378 643393 643447 643478
643386 643405 643425 643448 643426 643415 643453 643330 643336 643387 643377
2 .0 2.1 1.9 1 .9 2.5 2.5 2.2 2.2
2.2 2.0 2.0 2.1 2.3 1.9 2.1 2.3 2 .1 2.4 2.1 2.3 2.4
2.1 2.5 2.2 2.1 2.6 2.7 2.6 2.0 2.1 2.5 2.5 2.3 2.0
2.1 2.7 2.4 2.3 2.4 2.4 2.4
2.0 2.4 2.4 2.4
2.0 2.1 1 .9 1 .9 2.5 2.5 2.2
2.2 2.2 2.0 2.0 2.1 2.3 1.9 2 .1 2.3 2.1 2.4 2.1 2.3 2.4
2.1 2.5 2.2 2.1 2.6 2.7 2.6 2.0 2.1 2.5 2.5 2.3 2.0 2.1 2.7 2.4 2.3 2.4 2.4 2.4
2.0 2.4 2.4 2.4
INDIVIDUAL DOSE VOLUMES (m L )
58 D a y 59 D ay 60 D ay 61 D a y 62
2.0 2.1 1.9 1 .9 2.5
2.5 2.2 2.2
2.2 2.0
2.0 2.1 2.3 1.9 2 .1 2.3 2.1 2.4 2.1 2.3 2.4
2.1 2.5 2.2 2.1 2.6 2.7 2.6 2.0 2.1 2.5 2 .5 2.3 2.0
2.1 2.7 2.4
2.3 2.4 2.4 2.4 2.0 2.4 2.4 2.4
2.0 2.1 1.9 1 .9 2.5 2.5 2.2
2.2 2.2
2.0 2.0 2.1 2.3 1.9 2.1 2.3 2.1 2.4 2.1 2.3 2.4
2.1 2.5 2.2 2.1 2.6 2.7 2.6 2.0 2 .1 2.5 2.5 2.3 2.0
2.1 2.7 2.4 2.3 2.4 2.4 2.4
2.0 2.4 2.4 2.4
2.0 2.1 1.9 1 .9 2.5 2.5 2.2 2.2 2.2 2.0 2.0 2.1 2.3 1.9 2.1 2.3 2.1 2.4 2.1 2.3 2.4 2.1 2.5 2.2 2.1 2.6 2.7 2.6
2.0 2.1 2.5 2.5 2.3 2.0
2.1 2.7 2.4 2.3 2.4 2.4 2.4
2.0 2.4 2.4 2.4
2.0 2.1 1 .9 1.9 2.5
2.5 2.2 2.2 2.2 2.0 2.0
2.1 2.3 1.9 2.1 2.3 2.1 2.4 2.1 2.3 2.4 2.1 2.5 2.2 2.1 2.6 2.7 2.6 2.0 2.1 2.5 2.5 2.3 2.0
2.1 2.7 2.4 2.3 2.4 2.4 2.4
2.0 2.4 2.4 2.4
2.0 2.1 1.9 1 .9 2.5 2.5 2.2 2.2 2.2 2 .0 2.0 2.1 2.3 1.9 2.1 2.3 2.1 2.4 2.1 2.3 2.4 2.1 2.5 2.2 2.1 2.6 2.7 2.6 2.0
2.1 2.5 2.5 2.3 2.0
2.1 2.7 2.4 2.3 2.4 2.4 2.4
2.0 2.4 2.4 2 .4
D ay 63
2.1 2.2 2.0 2.0 2.6 2.5 2.2 2.2 2.3 2.0 2.0 2.1 2.3 1.9 2.2 2.2 2.0 2.3 2.2 2.2 2.4 2.2 2.5 2.2 2.1 2.7 2.7
2.6 1.9 2.1 2.6 2.5 2.4 2.0 2.1 2.7 2.4 2.3 2.4 2.6 2.4 2.1 2.5 2.4 2.5
D ay 64
2.1 2.2 2.0 2.0 2.6 2.5 2.2 2.2 2.3 2.0 2.0 2.1 2.3 1.9 2.2 2.2 2.0 2.3 2.2 2.2 2.4 2.2 2.5 2.2 2 .1 2.7 2.7 2.6
1.9 2.1 2.6 2.5 2.4 2.0 2.1 2.7 2.4 2.3 2.4 2.6 2.4 2.1 2.5 2.4 2.5
DuPont-5386
D ay 65
2.1 2.2 2.0 2.0 2.6 2.5 2.2 2.2 2.3 2.0 2.0 2.1 2.3 1.9 2.2 2.2 2.0 2 .3 2.2 2.2
2.5 2.2 2 .1 2.7 2.7 2.6 1.9 2.1 2.6 2.5 2.4
2.4 2.3 2.4 2.6 2.4 2.1 2.5 2.4 2.5
538
Company Sanitized. Does not contain TSCA CBf
H -24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
D ay 66
D ay 67
F e m a le , I I - 0 mg/k g /d a y
643477 643374 643406 643486 643361
643463 643398 643436 643362 643354 643402 643383 643465 643484 643384 643352 643343 643459 643394 643480 643319
643350 643363 643397
643421 643420 643419 643414 643401 643455 643378 643393 643447 643478 643386 643405 643425 643448 643426 643415 643453 643330 643336 643387 643377
2 .1 2.2 2.0 2.0 2.6
2.5 2.2 2.2 2.3 2 .0 2.0 2.1 2.3 1.9 2.2 2.2 2 .0 2.3 2.2 2.2 2.4 2.2 2.5 2.2 2 .1 2.7 2 .7 2.6 1.9 2 .1 2.6 2.5 2.4 2.0 2.1 2.7 2.4 2.3
2.4 2.6 2.4
2.1 2.5 2.4 2.5
2.1 2.2 2.0 2 .0 2.6 2.5
2.2 2.2 2.3
2.0 2.0 2.1 2.3 1.9 2.2 2.2 2.0 2 .3 2.2 2.2 2.4
2.2 2.5 2.2 2.1 2.7 2.7 2.6 1.9 2.1 2.6 2.5 2.4 2.0 2.1 2.7
2.4 2.3 2.4 2.6 2.4
2.1 2.5 2.4 2.5
D ay 68
2 .1 2.2 2 .0 2.0 2.6 2.5 2.2 2.2 2.3 2.0 2.0 2.1 2.3 1.9 2.2 2.2 2.0 2.3 2.2 2.2 2.4 2.2 2.5 2.2 2.1 2.7 2.7 2.6 1.9 2.1 2.6 2.5 2.4 2.0 2.1
2.7 2.4 2.3 2.4 2.6 2.4 2.1 2.5 2.4 2.5
INDIVIDUAL DOSE VOLUMES (mL)
Day 69
D ay 70
D ay 71
D ay 72
2.1 2.2 2.0 2.0 2.6 2.5 2.2 2.2 2,3 2.0 2.0 2.1 2.3 1 .9 2.2 2.2 2.0 2.3 2.2 2.2 2.4
2.2 2.5 2.2 2.1 2.7
2.7 2.6 1.9 2 .1 2.6 2.5 2.4 2.0
2.1 2.7
2.4 2.3 2.4
2.6 2.4
2.1 2.5 2.4 2.5
2 .1 2.3 2.1 2.0 2.6
2.5 2.2 2.2 2.3 2.1 2.1 2.2 2.4 1.9 2.2 2.3 2.2 2.4 2.2 2.2 2.4 2.2 2.5 2.3 2.1 2.7 2.7 2 .7 2 .0 2 .1 2.6 2.5 2.4 2.0 2.1 2.8 2.4
2.3 2.5 2.8 2.5
2.1 2.5 2.5 2.5
2 .1 2.3 2.1 2.0 2.6 2.5 2.2 2.2 2.3 2.1 2.1 2.2 2.4 1.9 2.2 2.3 2.2 2.4 2.2 2.2 2.4 2.2 2.5 2.3 2.1 2.7 2.7 2.7 2.0 2.1 2.6 2.5 2.4 2.0
2.1 2.8 2.4 2.3 2.5 2.8 2.5 2 .1 2 .5 2.5 2.5
2.1 2.3 2.1 2.0 2.6 2.5 2.2 2.2 2.3 2.1 2.1 2.2 2.4 1 .9 2.2 2 .3 2.2 2.4 2.2 2.2 2.4 2.2 2.5 2.3 2.1 2.7 2.7 2.7 2.0 2 .1 2.6 2.5 2.4 2.0 2.1
2.8 2.4
2.3 2.5 2.8 2.5 2.1 2.5 2.5 2.5
D ay 73
2 .1 2.3 2 .1 2.0 2.6 2.5 2.2 2.2 2.3 2.1 2.1 2.2 2.4 1.9 2.2 2.3 2.2 2.4 2.2 2.2 2.4 2.2 2.5 2.3 2.1 2.7 2.7 2.7 2.0 2.1 2.6 2.5 2.4 2.0 2.1 2.8
2.4 2.3 2.5 2.8 2.5 2.1 2.5 2.5 2.5
D ay 74
2.1 2.3 2 .1 2.0 2.6 2.5 2.2 2.2 2.3 2.1 2.1 2.2 2.4 1.9 2.2 2.3 2.2 2.4 2.2 2.2 2.4 2.2 2.5 2.3 2 .1 2.7 2.7 2.7 2.0 2 .1 2.6 2.5 2.4 2.0 2.1 2.8 2.4
2.3 2.5 2.8 2.5 2.1 2.5 2.5 2.5
DuPont-5386
D ay 75
2.1 2.3 2.1 2.0 2.6 2.5 2.2 2.2 2.3 2.1 2.1 2.2 2.4 1.9 2.2
2.8 2.4 2.3 2.5 2.8 2.5 2.1 2 .5 2.5 2 .5
539 Company Sanitized. Does not contain T3CA CBI
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
D ay 76
D ay 77
F e m a le , I I - 0 mg/k g /d a y
643477 643374 643406 643486 643361 643463 643398 643436 643362
643354 643402 643383 643465 643484
643384 643352 643343 643459 643394 643480
643319 643350 643363 643397 643421 643420 643419 643414 643401 643455 64337B 643393 643447 643478 643386 643405 643425 643448 643426 643415 643453 643330 643336 643387 643377
2.1 2.3 2.1 2.0 2.6 2.5 2.2 2.2 2.3 2.1 2.1 2.2 2.4 1 .9 2.2
2.8 2.4 2.3 2.5 2.8 2 .5 2.1 2.5 2.5 2.5
2 .1 2 .3 2 .0 2 .0 2.7 2.5 2.2 2.3 2.3 2.1 2.0 2.2 2.4 2.0 2.3
2.7 2.4 2.3 2.6 2.9 2.5 2.1 2.5 2.5 2.6
D ay 78
2.1 2.3 2 .0 2.0 2.7 2.5 2.2 2.3 2.3 2.1 2.0 2.2 2.4 2.0 2.3
2.7 2.4 2.3 2.6 2.9
2.5 2.5 2.6
INDIVIDUAL DOSE VOLUMES (mL)
Day 79
D ay 80
D ay 81
D ay 82
2.1 2.3 2.0 2.0 2.7
2.5 2.2 2.3 2 .3 2.1 2 .0 2.2 2.4 2.0 2.3
2.1 2.3 2.0 2 .0 2.7 2.5 2.2 2.3 2.3
2.1 2.0 2.2 2.4 2.0 2.3
2 .1 2.3 2.0 2.0 2.7
2.5 2.2 2.3 2.3 2.1 2.0 2.2 2.4 2.0 2.3
2.1 2.3 2.0 2.0 2.7 2.5 2.2 2.3 2.3 2.1 2.0 2.2 2.4 2.0 2.3
2.7 2.7 2.7 2.7
2.4 2.4 2.4 2.4
2.3 2.3 2.3 2.3
2.6 2.6 2.6 2.6
2 .9
2.9
2.9
2.9
2.5 2.5 2.5 2.5
2.1 2.1 2.1 2.1
2.5 2.5 2.5 2.5
2.5 2.5
2.6 2.6 2.6 2.6
DuPont-5386
83 D ay 84 D a y 85
2 .1 2.3 2.0 2.0 2.7 2.5 2.2 2.3 2.3
2.1 2.0 2.2 2.4 2.0 2.3
2.2 2.4 2.0 1.9 2 .8
2.6 2.3 2.3 2.4
2.1 2.1 2.2 2.4 2.0 2.3
2.2 2.4 2.0 1.9 2.8 2.6 2.3 2.3 2.4 2.1 2.1 2.2 2.4 2.0 2.3
2.7 2.7 2.7 2.4 2.4 2.4 2.3 2.3 2.3
2.6 2.6
2.9 3.0 3.0 2.5 2.5 2.5
2.2 2.2 2 . 5 2 .5
2.5 2.5 2.5 2.6 2.5 2.5
540
SmiHzed. Does no! contain TSCA CM
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Gneration Reproduction Evaluations
D ay 86
D a y 87
F e m a le , I I - 0 mg/k g /d a y
643477 643374 643406 643486 643361 643463 643398 643436 643362 643354 643402 643383 643465 643484 643384 643352 643343 643459 643394
643480 643319 643350 643363 643397 643421 643420
643419 643414 643401 643455 643378 643393 643447 643478 643386 643405 643425 643448 643426 643415 643453 643330 643336 643387
643377
2.2 2.4 2.0 1.9 2.8 2.6 2.3 2.3 2.4 2 .1 2.1 2.2 2.4 2.0 2.3
2.7 2.4 2.3 2.6 3.0 2 .5 2.2 2.5 2.5 2.5
2.2 2.4 2.0 1 .9 2 .8 2.6 2.3 2.3 2.4 2.1 2 .1 2.2 2.4 2.0 2.3
2.7 2.4 2.3 2.6 3.0 2.5 2.2 2.5 2.5 2.5
D ay 88
2.2 2.4 2.0 1.9 2.8 2.6 2.3 2.3 2.4 2.1 2 .1 2.2 2.4 2.0 2.3
2.7 2.4 2.3 2.6 3.0 2.5 2.2 2.5 2.5 2.5
INDIVIDUAL DOSE VOLUMES (mL)
D ay 89
D ay 90
D ay 91
D a y 92
2.2 2.4 2.0 1.9 2.8 2.6
2.3 2.3 2.4 2.1 2 .1 2.2 2.4 2.0 2.3
2.2 2.4 2.0 1 .9 2.8 2.6 2.3 2.3 2.4 2.1
2.2 2.5 2.1 1.9 3.0
2.6 2.3 2.4 2.3 2.2
2.2 2.5 2.1 1.9 3.0 2.6 2 .3 2.4
2.3 2.2
2.7 2.4 2.3 2.6
3.0 2.5
2.2 2.5 2 .5
2.5
DuPont-5386
541
Company S a n d e d . Does nof contain TSCA CBT
H-245I6: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Day 0
Day 1
Day 2
F e m a le , IV - 25 mg/k g /d a y
643390 643396 643380 643433 643389 643410 643321 643324 643458 643364
643483 643411 643379 643391 643437 643399 643334 643464 643369 643490 643342
643438 643445 643418 643325 643479
643403 643376 643422 643452 643475 643372 643400 643395 643457
1.8 2.0 1.7 1.9 1.8 1.9 1.9
1.8 1.8 1.8 1.8 1.7 2.1 1 .7 1.9 1.8 1.7 2.1 2.0 2 .1 2 .0
2.0 2.3 1.9 2.2 1.9 1.9 1 .9 2.0 2.1 2.2 2.0 1.7 1.9 2.0
1 .8 2.0 1.7 1 .9 1.8 1.9
1.9 1.8 1.8 1.8 1.8
AK TEST 2.1 1.7
1.9 1.8 1.7 2 .1 2.0 2 .1 2.0 2.0 '2.3 1.9 2.2 1.9 1.9 1.9 2.0 2.1 2.2 2.0 1 .7 1.9
2.0
DAY
1.8 2.0 1.7 1 .9 1.8 1.9 1.9 1.8 1.8 1.8 1.8 0 2.1 1.7 1.9 1.8 1.7 2.1 2.0 2.1 2.0
2.0 2.3 1.9 2.2 1.9 1.9 1.9 2.0 2.1 2.2 2.0 1.7 1.9 2.0
Day 3
1.8 2.0 1.7 1.9 1.8 1.9 1.9 1.8 1.8 1.8 1.8
2.1 1.7 1.9 1.8 1.7 2.1 2.0 2.1 2.0 2.0 2.3 1.9 2.2 1.9 1.9 1.9 2.0 2.1 2.2 2.0 1.7 1.9 2.0
IN D I V I D U A L D O S E VOLUME]
Day 4
Day 5
Day 6
1.8 2.0 1.7 1.9 1.8 1.9 1.9 1.8 1.8 1.8 1.8
2.1 1.7 1.9 1.8 1.7 2.1 2.0 2.1 2.0 2.0 2.3 1.9 2.2 1.9 1.9 1.9 2.0 2.1 2.2 2.0 1.7 1.9 2.0
1.8 2.0 1.7 1.9 1.8 1.9 1.9 1.8 1.8 1.8 1.8
2.1 1.7 1.9 1.8 1.7 2.1 2.0 2.1 2.0 2.0 2.3 1.9 2.2 1.9 1.9 1.9 2.0 2.1 2.2 2.0 1.7 1.9 2.0
1.8 2.0 1.7 1.9 1.8 1.9 1.9 1.8 1.8 1.8 1.8
2.1 1.7 1.9 1.8 1.7 2.1 2.0 2.1 2.0 2.0 2.3 1.9 2.2 1.9 1.9 1.9 2.0 2.1 2.2 2.0 1.7 1.9 2.0
542
S (m L ) Day 7
Day 8
Day 9
DuPont-5386
D ay 10
D ay 11
1.9 1.9 1.9 1.9 1.9
2.3 2.3 2.3 2.3 2.3
1 .9
1.9
1.9
1.9
1.9
2.2 2.2 2.2 2.2 2.2
2.1 2.1 2.1 2.1 2.1
2.3 2.3 2.3 2.3 2.3
2.1 2.1 2.1 2.1 2.1
2 . 0 2 . 0 2 . 0 2 . 0 2 .0
1.9 1.9 1.9 1.9 1.9
1.9 1.9 1.9 1.9 1.9
2.0 2.0 2.0 2.0 2.0
2.2 2.2 2.2 2.2 2.2
1.9 1.9 1.9 1.9 1.9
2.0 2.0 2.0 2.0 2.0
2.0 2.0 2.0 2.0 2.0
1.9
1.9
1.9
1 .9
1.9
2.4 2.4 2.4 2.4 2.4
2.2 2.2 2.2 2.2 2.2
2.3 2.3 2.3 2.3 2.3
2.3 2.3 2.3 2.3 2.3
2.2 2.2 2.2 2.2 2.2
2.6 2.6 2.6 2.6 2.6
2.1 2.1 2.1 2.1 2.1
2.5 2.5 2.5 2.5 2.5
2.2 2.2 2.2 2.2 2.2
2.3 2.3 2.3 2.3 2.3
2.2 2.2 2.2 2.2 2.2
2.3 2.3 2.3 2.3 2.3
2.2 2.2 2.2 2.2 2.2
2.5 2.5 2.5 2.5 2.5
2.2 2.2 2.2 2.2 2.2
1.9 1.9 1.9 1.9 1.9
2.1 2.1 2.1 2.1 2.1
2.3 2.3 2.3 2.3 2.3
Company Sanitized. Does not contain TSCA CBI
H -24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
D ay 12
D ay 13
F e m a le , IV - 25 mg/k g /d a y
643390 643396 643380 643433 643389 643410 643321 643324
643458 643364 643483 643411 643379 643391 643437
643399 643334 643464 643369 643490 643342
643438 643445 643418 643325 643479 643403 643376 643422 643452 643475 643372 643400 643395 643457
1.9 2.3 1.9 2.2 2 .1 2.3 2.1 2.0 1.9 1.9 2.0
2.2 1.9 2.0 2.0 1.9 2.4 2.2 2.3 2.3 2.2 2.6 2.1 2.5 2.2 2 .3 2.2 2.3 2.2 2.5 2.2 1 .9 2 .1 2.3
1.9 2.3 1.9 2.2 2.1 2.3 2.1 2.0 1.9 1.9 2.0
2.2 1 .9 2 .0 2.0 1.9 2.4 2.2 2.3 2.3 2.2 2.6 2.1 2.5 2.2 2 .3 2.2 2.3 2.2 2.5 2.2 1.9 2.1 2.3
D ay 14
2.0 2.5 2.3 2.4 2.2 2.4 2.1 2.2 2.2 2.1 2 .1
2.4 2 .1 2.2 2.3 2.1 2.6 2.4 2.5 2.5 2.4 2.7 2.3 2.7 2 .3 2 .5 2.4 2.6 2.4 2 .5 2.4 2.0 2.3 2.5
D ay 15
2.0 2 .5 2 .3 2.4 2.2 2.4 2.1 2.2 2.2 2.1 2 .1
2.4 2.1 2.2 2.3 2.1 2.6 2.4 2.5 2.5 2.4 2.7 2 .3 2 .7 2.3 2.5 2.4 2.6 2.4 2.5 2.4 2.0 2 .3 2.5
INDIVIDUAL DOSE VOLUMES (mL)
D ay 16
D ay 17
Day 18d
D ay 19
2.0 2 .5 2.3 2.4 2.2 2.4 2.1 2.2 2.2 2.1 2.1
2.4 2.1 2.2 2.3 2.1 2.6 2.4 2.5 2.5 2.4 2.7 2 .3 2.7 2.3 2.5 2.4 2.6 2.4 2.5 2.4 2.0 2.3 2.5
2.0 2.5 2.3 2.4 2.2 2.4 2.1 2.2 2.2 2.1 2.1
2.4 2.1 2.2 2.3 2.1 2.6 2.4 2.5 2.5 2.4 2.7 2.3 2.7 2.3 2.5 2.4 2.6 2.4 2.5 2.4 2.0 2.3 2.5
2.0 2.5 2.3 2.4 2.2 2.4 2.1 2.2 2.2 2 .1 2.1
2.4 2.1 2.2 2.3 2 .1 2.6 2.4 2.5 2.5 2.4 2 .7 2.3 2 .7 2.3 2.5 2.4 2.6 2.4 2.5 2.4 2.0 2.3 2.5
2.0 2.5 2.3 2.4 2.2 2.4 2.1 2.2 2.2 2.1 2.1
2.4 2.1 2.2 2.3 2.1 2.6 2.4 2.5 2.5 2.4 2.7 2.3 2 .7 2.3 2.5 2.4 2.6 2.4 2.5 2.4 2.0 2.3 2.5
D ay 20
2.0 2.5 2.3 2.4 2.2 2.4 2.1 2.2 2.2 2.1 2.1
2.4 2.1 2.2 2.3 2.1 2 .6 2.4 2.5 2.5 2.4 2.7 2.3 2.7 2.3 2.5 2.4 2.6 2.4 2.5 2.4 2.0 2.3 2.5
D ay 21
2.2 2 .8 2.5 2.7 2.4 2.6 2.3 2.4 2.3 2.3 2.3
2.7 2.2 2.5 2.4 2.4 2.8 2.6 2.7 2.7 2.5 3.0 2.4 3.0 2.6 2.7 2.6 2 .8 2.7 2.8 2.6 2.1 2.5 2.6
D ay 22
2.2 2.8 2.5 2.7 2.4 2.6 2.3 2.4 2.3 2.3 2.3
2.7 2.2 2.5 2.4 2.4 2.8 2.6 2.7 2.7 2.5 3.0 2.4 3.0 2.6 2 .7 2.6 2.8 2.7 2.8 2.6 2.1 2.5 2.6
DuPont-5386
D ay 23
2.2 2.8 2.5 2.7 2.4 2.6 2.3 2.4 2.3 2.3 2.3
2.7 2.2 2.5 2.4 2.4 2 .8 2.6 2.7 2.7 2.5 3.0 2.4 3.0 2.6 2.7 2.6 2 .8 2.7 2.8 2.6 2.1 2.5 2.6
543
"Pany Santflzed Does not contain TSCA CBT
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations___________________________________________________________ DuPont-5386
D ay 24
D ay 25
D ay 26
F e m a le , IV - 25 mg/k g /d a y
643390 643396 643380 643433 643389 643410 643321 643324 64345B 643364 643483 643411 643379 643391 643437 643399 643334 643464 643369 643490 643342 643438 643445 643418 643325 643479 643403 643376 643422 643452 643475 643372 643400 643395
643457
2.2 2.8 2.5 2.7 2.4 2.6 2.3 2.4 2.3 2.3 2.3
2.7 2.2 2.5 2.4 2.4 2.8 2.6 2.7 2.7 2.5 3.0 2.4 3.0 2.6 2.7 2.6 2.8 2.7 2.8 2.6 2 .1 2.5 2.6
2.2 2.8 2.5 2.7 2.4 2.6 2.3 2.4 2.3 2.3 2.3
2.7 2.2 2.5 2.4 2.4 2.8 2.6 2.7 2.7 2.5 3.0 2.4 3.0 2.6 2.7 2.6 2.8 2.7 2.8 2.6 2 .1 2.5 2.6
2.2 2.8 2.5 2.7 2.4 2.6 2.3 2.4 2.3 2.3 2.3
2.7 2.2 2.5 2.4 2.4 2.8 2.6 2.7 2.7 2.5 3.0 2.4 3 .0 2.6 2.7 2.6 2.8 2.7 2 .8 2 .6 2.1 2.5 2.6
INDIVIDUAL DOSE VOLUMES (mL)
n a t / *5Q
Ifl
2.2 2.8 2.5 2.7 2.4 2.6 2.3 2.4 2.3 2.3 2.3
2.7 2.2 2.5 2.4 2.4 2 .8 2.6 2 .7 2.7 2.5 3.0 2.4 3.0 2.6 2.7 2.6 2.8 2.7 2.8 2.6 2.1 2.5 2.6
2.4 2.8 2.7 2.9 2.4 2.7 2.4 2.6 2.4 2.4 2.3
2.7 2.3 2.5 2.6 2.5 2.9 2.9 2.8 2 .9 2.8 3.1 2.6 3.1 2.6 2.8 2.7 3.0 3.0 2.9 2.8 2 .3 2.6 2.7
2.4 2.8 2.7 2 .9 2.4 2.7 2.4 2.6 2.4 2.4 2.3
2.7 2.3 2.5 2.6 2.5 2.9 2 .9 2 .8 2.9 2.8 3.1 2 .6 3.1 2.6 2.8 2.7 3.0 3.0 2.9 2.8 2.3 2.6 2.7
2.4 2.4 2.8 2.8 2.7 2.7 2.9 2.9 2.4 2.4 2.7 2.7
SB TEST DAY 29 2.6 2.6 2.4 2.4 2.4 2.4 2.3 2.3
2.7
2.3 2.5 2.6 2.5 2 .9 2 .9 2 .8 2.9 2.8 3.1 2.6 3.1 2.6 2 .8 2.7 3 .0 3.0 2 .9 2.8 2.3 2.6 2.7
2.7 2.3 2.5 2.6 2.5 2.9 2.9 2.8 2.9 2.8 3.1 2.6 3.1 2.6 2.8 2.7 3.0 3.0 2.9 2.8 2 .3 2.6
2.7
2.4 2.8 2.7 2 .9 2.4 2.7
2.6 2.4 2.4 2.3
2.7 2.3 2.5 2.6 2.5 2.9 2 .9 2 .8 2.9 2.8 3.1 2.6 3.1 2.6 2.8 2.7 3.0 3.0 2.9 2.8 2.3 2.6 2.7
2.4 2.8 2.7 2.9 2.4 2.7
2.6 2.4 2.4 2.3
2.7 2.3 2.5 2.6 2.5 2.9 2.9 2.8 2.9 2.8 3.1 2.6 3.1 2.6 2.8 2.7 3.0 3.0 2.9 2.8 2.3 2.6 2.7
2.4 2.8 2.7 2 .9 2.4 2.7
2.6 2.4 2.4 2.3
2.7 2.3 2.5 2.6 2.5 2.9 2.9 2.8 2.9 2.8 3.1 2.6 3.1 2.6 2.8 2.7 3.0 3.0 2.9 2.8 2.3 2.6 2.7
2.5 3.0 2 .8 2 .9 2.6 2.9
2.7 2.6 2.5 2.5
2.8 2.4 2.6 2.7 2.6 3 .0 2.9 2.8 3.0 2.9 3.5 2.7 3.2 2.8 3.0 2.7 3.1 3.1 3.0 2.9 2.4 2.7 2.8
544
Company Sanitized. Does not contain TSCA CB!
)
<1
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
D ay 36
Day 37
F e m a le , IV - 25 mg/k g /d a y
643390 643396 643380 643433 643389
643410 643321 643324 643458 643364 643483 643411 643379 643391 643437 643399 643334 643464 643369 643490 643342 643438 643445 643418 643325 643479 643403 643376 643422 643452 643475 643372 643400 643395 643457
2.5 3.0 2.8 2.9 2.6 2.9
2.7 2.6 2.5 2.5
2.8 2.4 2.6 2.7 2.6 3 .0 2.9 2.8 3.0 2.9 3.5 2.7 3.2 2.8 3.0 2.7 3.1 3.1 3.0 2.9 2.4 2.7 2.8
2.5 3.0 2.8 2.9 2.6 2.9
2.7 2.6 2.5 2.5
2.8 2.4 2.6 2.7 2.6 3.0 2.9 2.8 3.0 2.9 3.5 2.7 3.2 2.8 3.0 2.7 3.1 3.1 3.0 2.9 2.4 2.7 2.8
D ay 38
1.9 2.3 2.1 2.2 2.0 2.2
2.0 1.9 1.9 1.9
2.1 1.8 2.0 2.0 2.0 2.3 2.2 2.1 2.2 2.1 2.6 2.0 2.4 2.1 2.2 2.1 2.3 2.3 2.3 2.1 1.8 2.0 2.1
INDIVIDUAL DOSE VOLUMES (mL)
D ay 39
D ay 40
D ay 41
D ay 42
1.9 2.3 2.1 2.2 2.0 2.2
2.0 1.9 1.9 1.9
2 .1 1.8 2.0 2.0 2.0 2.3 2.2 2.1 2.2 2.1 2.6 2 .0 2.4 2.1 2.2 2.1 2.3 2.3 2.3 2.1 1.8 2 .0 2.1
1.9 2.3 2.1 2.2 2.0 2.2
2.0 1.9 1.9 1.9
2.1 1.8 2.0 2.0 2.0 2.3 2.2 2.1 2.2 2.1 2.6 2.0 2.4 2.1 2.2 2.1 2.3 2.3 2.3 *2.1 , 1.8 2.0 2.1
1.9 2.3 2.1 2.2 2.0 2.2
2.0 1.9 1.9 1.9
2 .1 1.8 2.0 2.0 2.0 2.3 2.2 2.1 2.2 2.1 2.6 2.0 2.4 2.1 2.2 2.1 2.3 2.3 2.3 2.1 1.8 2.0 2.1
1.9 2.3 2.1 2.3 2.1 2.3
2.0 2.0 1.9 1.9
2.1 1.9 2.1 2.1 2.0 2.4 2.1 2.2 2.4 2.2 2.8 2.2 2.5 2.1 2.3 2.2 2.4 2.4 2.5 2.2 1.9 2.0 2.2
D ay 43
1.9 2.3 2.1 2.3 2.1 2.3
2.0 2.0 1.9 1.9
2.1 1.9 2.1 2.1 2.0 2.4 2.1 2.2 2.4 2.2 2.8 2.2 2.5 2.1 2.3 2.2 2.4 2.4 2.5 2.2 1.9 2.0 2.2
D ay 44
1.9 2.3 2.1 2.3 2.1 2.3
2.0 2.0 1.9 1.9
2.1 1.9 2.1 2.1 2.0 2.4 2.1 2.2 2.4 2.2 2.8 2.2 2.5 2.1 2.3 2.2 2.4 2.4 2.5 2.2 1.9 2.0 2.2
DuPont-5386
D ay 45
1.9 2.3 2.1 2.3 2.1 2.3
2.0 2.0 1.9 1.9
2 .1 1.9 2.1 2.1 2.0 2.4 2.1 2.2 2.4 2.2 2.8 2.2 2.5 2.1 2.3 2.2 2.4 2.4 2.5 2.2 1.9 2.0 2.2
545
Company Sanitized. Does not contain TSCA CBf
)
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
D ay 46
D ay 47
F e m a le , IV - 25 mg/k g /d a y
643390 643396 643380 643433 643389 643410 643321 643324 643458 643364 643483 643411 643379 643391 643437 643399 643334 643464 643369 643490 643342 643438 643445 643418 643325 643479 643403 643376 643422 643452 643475 643372 643400 643395 643457
1.9 2.3 2.1 2.3 2.1 2.3
2.0 2.0 1.9 1.9
2.1 1.9 2.1 2 .1 2.0 2.4 2.1 2.2 2.4 2,2 2 .8 2.2 2.5 2 .1 2.3 2.2 2.4 2.4 2.5 2.2 1.9 2.0 2.2
1.9 2.3 2.1 2.3 2.1 2.3
2.0 2.0 1.9 1.9
2.1 1.9 2.1 2.1 2.0 2.4 2.1 2.2 2.4 2.2 2.8 2.2 2.5 2.1 2.3 2.2 2.4 2.4 2.5 2.2 1.9 2.0 2.2
D ay 48
1.9 2.3 2.1 2.3 2.1 2.3
2.0 2.0 1.9 1.9
2.1 1.9 2.1 2.1 2.0 2.4 2.1 2.2 2.4 2.2 2.8 2.2 2.5 2.1 2.3 2.2 2.4 2.4 2.5 2.2 1.9 2.0 2.2
INDIVIDUAL DOSE VOLUMES (mL)
Day 4 9
D a y 50
D ay 51
52
2.0 2.3 2.2 2.3 2.1 2.3
2.1 2.0 2.0 2.0
2.3 1.9 2.1 2.2 2.1 2.4 2.3 2.2 2.4 2.2 2.9 2.2 2.5 2.2 2.4 2.2 2.5 2.4 2.5 2.0 1.9 2.1 2.2
2.0 2.3 2.2 2.3 2.1 2.3
2.1 2.0 2.0 2.0
2.3 1.9 2.1 2.2 2.1 2.4 2.3 2.2 2.4 2.2 2.9 2.2 2.5 2.2 2.4 2.2 2.5 2.4 2.5 2.0 1.9 2.1 2.2
2.0 2 .3 2.2 2.3 2 .1 2.3
2.1 2.0 2.0 2.0
2.3 1.9 2.1 2.2 2.1 2.4 2.3 2.2 2.4 2.2 2.9 2.2 2.5 2.2 2.4 2.2 2.5 2.4 2.5 2.0 1.9 2.1 2.2
2.0 2.3 2.2 2.3 2.1 2.3
2 .1 2.0 2.0 2.0
2.3 1.9 2.1 2.2 2.1 2.4 2.3 2.2 2.4 2.2 2.9 2.2 2.5 2.2 2.4 2.2 2.5 2.4 2.5 2.0 1.9 2.1 2.2
D ay 53
2.0 2.3 2.2 2.3 2.1 2.3
2.1 2.0 2.0 2.0
2.3 1.9 2.1 2.2 2.1 2.4 2.3 2.2 2.4 2.2 2.9 2.2 2.5 2.2 2.4 2.2 2.5 2.4 2.5 2.0 1.9 2.1 2.2
D ay 54
2.0 2.3 2.2 2.3 2.1 2.3
2.1 2.0 2.0 2.0
2.3 1.9 2.1 2.2 2.1 2.4 2.3 2.2 2.4 2.2 2.9 2.2 2.5 2.2 2.4 2.2 2.5 2.4 2.5 2.0 1.9 2.1 2.2
DuPont-5386
D ay 55
2.0 2.3 2.2 2 .3 2.1 2.3
2.1 2.0 2.0 2.0
2 .3 1.9 2.1 2.2 2.1 2.4 2.3 2.2 2.4 2.2 2.9 2.2 2.5 2.2 2.4 2.2 2.5 2.4 2.5 2.0 1.9 2.1 2.2
546
Company Sanitized. Does not contain TSCA CBT
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
D ay 56
D ay 57
F e m a le / IV - 25 mg/k g /d a y
643390 643396
643380 643433 643389 643410 643321 643324 643458 643364 643483 643411 643379 643391 643437
643399 643334 643464 643369 643490 643342
643438 643445 643418 643325 643479 643403 643376 643422 643452 643475 643372 643400 643395 643457
2.1 2.4 2.4 2.4 1 .8 2.4
2.2 2.1 2.0 1.9
2.2 2.0 2.1 2.2 2.1 2.4 2.3 2.3 2.5 2.2 2 .9 2.2 2.7 2.2 2.4 2.3 2.6 2.5 2.4 2.2 2.0 2.1 2.2
2.1 2.4 2.4 2.4 1.8 2.4
2.2 2 .1 2.0 1.9
2.2 2.0 2.1 2.2 2.1 2.4 2.3 2.3 2.5 2.2 2.9 2.2 2.7 2.2 2.4 2.3 2.6 2.5 2.4 2.2 2 .0 2.1 2.2
INDIVIDUAL DOSE VOLUMES (mL)
58 D ay 59 D ay 60 D ay 61
62
2.1 2.4 2.4 2.4 1.8 2.4
2.2 2.1 2.0 1.9
2.2 2.0 2.1 2.2 2.1 2.4 2.3 2.3 2.5 2.2 2.9 2.2 2.7 2.2 2.4 2.3 2.6 2.5 2.4 2.2 2.0 2.1 2.2
2 .1 2.4 2.4 2.4 1.8 2.4
2.2 2 .1 2.0 1.9
2.2 2.0 2.1 2.2 2.1 2.4 2.3 2.3 2.5 2.2 2.9 2.2 2.7 2.2 2.4 2.3 2.6 2.5 2.4 2.2 2.0 2.1 2.2
2 .1 2.4 2.4 2.4 1.8 2.4
2.2 2 .1 2.0 1.9
2.2 2.0 2.1 2.2 2.1 2.4 2.3 2.3 2.5 2.2 2.9 2.2 2.7 2.2 2.4 2.3 2.6 2.5 2.4 2.2 2.0 2.1 2.2
2 .1 2.4 2.4 2.4 1.8 2 .4
2.2 2.1 2.0 1 .9
2.2 2 .0 2.1 2.2 2.1 2.4 2 .3 2.3 2.5 2.2 2.9 2.2 2.7 2.2 2.4 2.3 2.6 2.5 2.4 2.2 2.0 2.1 2.2
2.1 2.4 2.4 2.4 1.8 2.4
2.2 2.1 2.0 1.9
2.2 2.0 2.1 2.2 2.1 2.4 2.3 2.3 2.5 2.2 2.9 2.2 2.7 2.2 2.4 2.3 2.6 2.5 2.4 2.2 2.0 2.1 2.2
D a y 63
2.1 2.5 2.3 2.5 2.2 2.3
2.2 2.1 2.1 2.0
2.3 2.1 2.2 2.2 2.2 2.5 2.3 2.2 2.5 2.3 2.9 2.2 2.7 2.3 2.4 2.3 2.7 2.6 2.5 2.2 2.0 2.2 2.3
D ay 64
2.1 2.5 2.3 2.5 2.2 2.3
2.2 2.1 2.1 2.0
2.3 2.1 2.2 2.2 2.2 2.5 2.3 2.2 2.5 2.3 2.9 2.2 2.7 2.3 2.4 2.3 2.7 2.6 2.5 2.2 2.0 2.2 2.3
DuPont-5386
D ay 65
2.1 2.5 2.3 2.5 2.2 2.3
2.2 2 .1 2.1 2.0
2.3 2.1 2.2 2.2 2.2 2.5 2.3 2.2 2.5 2.3 2.9 2.2 2.7 2.3 2.4 2.3 2.7 2.6 2.5 2.2 2.0 2.2 2.3
547
Sanitized. Does not contain TSCACBI
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
D ay 66
D ay 67
F e m a le , IV - 25 mg/k g /d a y
643390 643396 643380 643433 643389
643410 643321 643324
643458 643364 643483 643411 643379 643391 643437 643399 643334 643464 643369 643490 643342 643438
643445
643418 643325 643479 643403 643376 643422 643452 643475 643372 643400 643395 643457
2 .1 2.5 2.3 2.5 2.2 2.3
2.2 2.1 2.1 2.0
2.3 2.1 2.2 2.2 2.2 2.5 2.3 2.2 2.5 2.3
2.2 2.7 2.3 2.4 2.3 2.7 2.6 2.5 2.2 2.0 2.2 2.3
CO
to
2.1 2.5 2.3 2.5 2.2 2.3
2.2 2.1 2.1 2.0
2.3 2.1 2.2 2.2 2.2 2.5 2.3 2.2 2.5 2.3
2.9 2.2 2.7 2.3 2.4 2.3 2.7 2.6 2.5 2.2 2.0 2.2 2.3
D ay 68
2.1 2.5 2.3 2.5 2.2 2.3
2.2 2.1 2.1 2.0
2.3 2.1 2.2 2.2 2.2 2.5 2.3 2.2 2.5 2.3 2.9 2.2 2.7 2.3 2.4 2.3 2.7 2.6 2.5 2.2 2.0 2.2 2.3
INDIVIDUAL DOSE VOLUMES (mL)
D ay 69
D ay 70
D ay 71
D ay 72
2.1
2 .1
2.1
2.1
2.5 2.6 2.6 2.6
2.3 2.4 2.4 2.4
2.5 2.6 2.6 2.6
2.2 2.3 2.3 2.3
2.3 2.4 2.4 2.4
2.2 2.2 2.2 2.2
2.1 2.2 2.2 2.2
2.1 2.1 2.1 2.1
2.0
2 .0
2.0
2.0
2.3 2.3 2.3 2.3 2.1 2.1 2.1 2.1
2.2 2.3 2.3 2.3 2.2 2.3 2.3 2.3 2.2 2.2 2.2 2.2 2.5 2.5 2.5 2.5 2.3 2.4 2.4 2.4 2.2 2.3 2.3 2.3 2.5 2.5 2.5 2.5 2.3 2.4 2.4 2.4
2.9 3.0 3.0 3.0
2.2 2.3 2.3 2.3
2.7
2 .7
2.7
2.7
2.3 2.2 2.2 2.2
2.4 2.4 2.4 2.4
2.3 2.3 2.3 2.3
2.7 2.7 2.7 2.7
2.6
2.6
2.6
2.6
2.5 2.5 2.5 2.5
2.2 2.3 2.3 2.3
2.0 2.0 2.0 2.0
2.2 2.2 2.2 2.2
2.3 2.3 2.3 2.3
DuPont-5386
D ay 73
D a y 74
D ay 75
2.1 2.6 2.4 2.6 2.3 2.4
2.2 2.2 2.1 2.0
2.3 2.1 2.3 2.3 2.2 2.5 2.4 2.3 2.5 2.4
3.0 b 2.3 2.7 2.2 2.4 2.3 2.7 2.6 2.5 2.3 2.0 2.2 2.3
2.1 2.6 2.4 2.6 2.3 2.4
2.2 2.2 2.1 , 2.0
2.3 2.1 2.3 2.3 2.2 2.5 2.4 2.3 2.5 2.4
3.0 2.3 2.7 2.2 2.4 2.3 2.7 2.6 2.5 2.3 2.0 2.2 2.3
2 .1 2 .e
2 .4 2 .6 2 .3 2 .4
2 .2 2 .2
2 .1 2 .0
2 ..3
2 ..1
2 .3
548
Company Sanitized. Does not contain TSCA CBI
H -24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
D ay 76
D ay 77
F e m a le , IV - 25 mg/k g /d a y
643390 643396 643380 643433 643389 643410 643321 643324 643458 643364 643483 643411 643379 643391 643437 643399 643334 643464 643369 643490 643342
643438 643445 643418 643325 643479 643403 643376 643422 643452 643475 643372 643400 643395 643457
2.1 2.6 2.4 2 .6 2.3 2.4
2.2 2.2 2.1 2.0
2 .3 2 .1 2.3
2.2 2.7 2.4 2.6 2.2 2.4
2.2 2.3 2.2 2.0
2.3 2.1 2.2
D ay 78
2.2 2.7 2.4 2.6 2.2 2.4
2.2 2.3 2.2 2.0
2.3 2.1 2.2
INDIVIDUAL DOSE VOLUMES (mL)
D ay 79
D ay 80
D ay 81
D ay 82
2.2 2.2 2.2 2.2 2.7 2.7 2.7 2.7 2.4 2.4 2.4 2.4 2.6 2.6 2.6 2.6 2.2 2.2 2.2 2.2 2.4 2.4 2.4 2.4
2.2 2.2 2.2 2.2 2.3 2.3 2.3 2.3 2.2 2.2 2.2 2.2 2.0 2.0 2.0 2.0
2 .3
2.3
2.3
2.3
2.1 2.1 2.1 2.1
2.2 2.2 2.2 2.2
D ay 83
2.2 2 .7 2.4 2.6 2.2 2.4
2.2 2.3 2.2 2.0
2.3 2.1 2.2
DuPont-5386
D ay 84
D ay 85
2.2 2.7 2.5 2.6 2.2 2.4
2 .3 2.2 2.2 2.0
2.3 2.1 2 .3
2 .2
2 .7
2 2
..56
2 .2
2 .4
2 .3 2 .2 2 .2 2 .0
2 .3 2 .1 2 .3
549
Company Sanitized. Does not contain TSCA CBI
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
D ay 86
D ay 87
F e m a le , IV - 25 mg/k g /d a y
643390 643396 643380 643433 643389 643410 643321 643324
643458 643364 643483 643411 643379 643391 643437 643399 643334 643464 643369 643490 643342 64343B 643445 643418 643325 643479 643403 643376 643422 643452 643475 643372 643400 643395 643457
2.2 2.7 2.5 2.6 2.2 2.4
2 .3 2.2 2.2 2 .0
2.3 2 .1 2.3
2.2 2.7 2.5 2.6 2.2 2.4
2.3 2.2 2.2 2.0
2.3 2.1 2.3
D ay 88
INDIVIDUAL DOSE VOLUMES (mL)
D ay 89
D a y 90
D a y 91
D ay 92
2.2 2.7 2.5 2.6 2.2 2.4
2.3 2.2 2.2 2.0
2.3 2 .1 0.3
2.2 2.7 2.5 2.6 2.2 2.4
2.3 2.2 2.2 2 .0
2.3 2.1 2.3
2.2 2.7 2.5 2.6 2.2 2.4
2.3 2.2 2.2
2.2 2.7 2.5 2 .7 2.2 2.4
2.3 2.3 2.2
2.2 2.7 2.5 2.7 2.2 2.4
2.3 2.3 2.2
DuPont-5386
550
Company Sanitized. Does not contain TSCA CBI
\)
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5386
Day 0
Day 1
F e m a le , V I - 100 mg/k g /d a y
643322 643489 643409 643366 643367 643461 643462 643392
643472 643323 643412 643382 643381 643360 643373 643320 643488 643428 643439 643353 643385 643339 643473 643337
643416 643407 643357 643331 643427 643470 643434 643349 643454 643333
643460
1.9 1.8 1.7 1.7 1 .9 2.1 2.0 1.6
1.7 1.7 1.8 1 .8 1.8 1.6 1.9 1.8 1.8 2.2 1.9 1.9 2.0 1.8 1.8 2.1 1.8 2.1 1.7
1.9 1.9 1.9 2.0 2.0 2.0 1.8 1.9
1.9 1.8 1.7 1.7 1.9 2.1 2.0
1.6
1.7 1.7 1.8 1.8 1.8 1.6 1.9 1.8 1.8 2.2 1 .9 1.9 2.0
- 1.8 1.8 2.1 1.8 2.1 1.7 1.9 1 .9 1.9 2.0 2.0 2.0 1.8
1.9
Day 2
1.9 1.8 1.7 1.7 1.9 2.1 2 .0 1.6 1.7 1.7 1.8 1.8 1.8 1.6 1.9 1.8 1.8 2.2 1.9 1.9 2.0 1.8 1.8 2.1 1.8 2.1
1.7 1.9 1.9 1.9 2.0 2.0 2.0 1.8 1.9
Day 3
1.9 1.8 1.7 1.7 1.9 2 .1 2.0 1.6 1.7 1.7 1.8 1.8 1.8 1.6 1.9 1.8 1.8 2.2 1.9 1 .9 2.0 1.8 1.8 2.1 1.8 2.1 1.7 1.9 1.9
1.9 2.0 2.0 2.0 1.8 1.9
INDIVIDUAL DOSE VOLUMES (mL)
Day 4
Day 5
Day 6
Day 7
1.9 1.8 1.7 1.7
1.9 2.1 2.0 1.6
1.7
1.7 1.8 1.8 1 .8 1.6 1.9 1 .8 1.8 2.2 1.9 1.9 2.0 1.8 1.8 2.1 1.8 2.1 1.7 1.9 1.9 1.9 2.0 2.0 2.0
1.8 1.9
1.9 1.8 1.7 1.7 1.9 2.1 2.0 1.6 1.7
1.7 1.8 1.8 1.8 1.6 1.9 1.8 1.8 2.2 1.9 1.9 2.0 1.8 1.8 2.1
1.8 2.1 1.7 1.9 1.9 1.9 2.0 2.0 2.0 1.8 1.9
1.9 1.8 1.7 1.7 1.9 2.1 2.0 1.6 1.7
1.7 1.8 1.8 1.8 1.6 1.9 1.8 1.8 2.2 1.9 1.9 2.0 1.8 1.8 2.1 1.8 2.1 1.7 1.9 1.9 1.9 2.0 2.0 2.0
1.8 1.9
2.1
2.0
2.0 2.0 2.2 2.6 2.3 1.8 2.0
1.9 2.1 2.0 2.1 1.8 2.3 2 .1 2.1 2.4 2.2 2.2 2.2 2.1 2.0 2.4 2.1 2.2 2.0 2.1 2.1 2.0 2.2 2.2
2.2 2.1 2.2
Day 8
Day 9
2 .1 2.0 2.0 2.0 2.2 2.6 2.3 1.8
2.0
1.9 2.1 2.0 2.1 1.8 2.3 2 .1 2.1 2.4
2.2 2.2 2.2 2.1 2.0 2.4
2.1 2.2 2.0 2.1 2.1 2.0 2.2 2.2
2.2 2 .1 2.2
2.1 2.0 2.0 2.0 2.2 2.6 2.3 1.8 2.0
1.9 2.1 2.0 2.1 1.8 2.3 2 .1 2.1 2.4 2.2 2.2 2.2 2.1 2.0 2.4 2.1 2.2 2.0 2.1 2.1 2.0 2.2 2.2 2.2
2.1 2.2
Day 10
2.1 2.0 2.0 2.0 2.2 2.6 2.3 1.8 2.0
1.9
2.1 2.0 2.1 1.8 2.3 2.1 2.1 2.4 2.2 2.2 2.2 2.1 2.0 2.4 2.1 2.2 2.0 2.1 2.1 2.0 2.2 2.2 2.2 2.1
2.2
D ay 11
2.1 2.0 2.0 2.0 2.2 2.6 2.3 1.8 2.0 1.9 2.1 2.0 2.1 1.8 2.3 2.1 2.1 2.4 2.2 2.2 2.2 2.1 2.0 2.4 2.1 2.2 2.0 2 .1
2.1 2.0 2.2 2.2 2.2 2.1 2.2
551
Company Sanitized. Does not contain TSCA CBI
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5386
INDIVIDUAL DOSE VOLUMES (mL)
D ay 12
D ay 13
D ay 14
D ay 15
D ay 16
D ay 17
D ay 18
D ay 19
D ay 20
Day 21
D ay 22
D ay 23
F e m a le , V I - 100 mg/k g /d a y
643322 643489 643409 643366 643367 643461 643462 643392
643472 643323 643412 643382
643381 643360 643373 643320 643488 643428 643439 643353 643385 643339 643473 643337 643416 643407 643357 643331 643427
643470 643434 643349 643454 643333
643460
2.1 2.0 2.0 2.0 2.2 2.6 2.3 1.8
2.0 1.9 2.1 2.0 2.1 1.8 2.3 2.1 2.1 2.4 2.2 2.2 2.2 2.1 2.0 2.4
2.1 2.2 2.0 2.1 2.1 2.0 2.2 2.2 2.2 2.1 2.2
2.1
2.0 2.0 2.0 2.2
2.6 2.3 1.8
2.0 1.9 2.1 2.0 2.1 1.8 2.3
2.1 2.1 2.4 2.2 2.2 2.2 2.1 2.0 2.4 2.1 2.2 2.0 2.1 2.1 2.0 2.2 2.2 2.2
2.1 2.2
2.3 2.2 2.2 2.1 2.3 2.8 2.5 2.0
2.1 2.1 2.3 2.1 2.2 2.0 2.4 2.3 2.2 2.8 2.4 2.3 2.5 2.3 2.2 2.6 2.3 2.5 2.1 2.3
2.3 2.3 2.3 2.5 2.4 2.3 2.5
2.3 2.2 2.2 2.1 2.3 2.8 2.5 2.0
2.1 2.1 2.3 2.1 2.2 2.0 2.4 2.3 2.2 2.8 2.4 2.3 2.5 2.3 2.2 2.6 2.3 2.5
2.1 2.3 2.3 2.3 2.3 2.5 2.4 2.3 2.5
2.3 2.2 2.2 2.1 2.3 2.8 2.5
2.0 2.1 2.1 2.3 2.1 2.2 2.0 2.4 2.3 2.2 2.8 2.4 2.3 2.5 2.3 2.2 2.6 2.3
2.5 2.1 2.3 2.3 2.3 2.3 2 .5 2.4 2.3 2.5
2.3 2.2 2.2 2.1 2.3 2.8 2.5
2.0 2.1 2.1 2.3
2.1 2.2 2.0 2.4 2.3 2.2 2.8 2 .4 2.3 2.5 2.3 2.2 2.6 2.3 2.5 2.1 2.3 2.3
2.3 n2 .1J 2 .5 2.4 2 .3 2.5
2.3 2.2 2.2 2.1 2.3 2.8 2.5
2.0 2.1 2 .J. 2.3 2.1 2.2 2.0 nA
2 .J *2>. 2*5 2.8 2 .4 2.3 2.5 2.3 2.2 2.6 2.3 2.5 2.1 2 A 23 2.3 2.3 2.3 2.4
2.3 2.5
2.3 2.2 2.2 2.1 2.3 2.8 2.5 2.0 2.1 2.1 2.3 2.1 2.2 2.0 2.4 2.3 2.2 2.8 2.4
2.3 2 .5 2.3 2.2 2.6 2 .3 2.5 2.1 2.3 2.3 2.3 2.3 2.5 2.4 2.3 2.5
2.3 2.2 2.2 2.1 2.3 2.8 2.5 2.0 2.1 2.1 2.3 2.1 2.2 2.0 2.4 2.3 2.2 2.8 2 .4 2.3
2.5 2.3 2.2 2.6 2.3 2.5 2.1 2.3 2.3 2.3 2.3 2.5 2.4 2.3 2.5
2.5 2.4 2.3 2.3 2.6 2.9 2.7
2.1 2.2
2.3 2.5 2.3 2.4 2.2 2.7 2.5 2.4 2.8 2.5 2.4 2.7 2.3 2.3 2.9 2.4 2.7 2.2
2.4 2.5 2.4 2.5 2.6 2.5 2.4 2.6
2.5 2.4 2.3 2.3 2.6 2.9 2.7
2.1 2.2
2.3 2.5 2.3 2.4 2.2 2.7 2.5 2.4 2.8 2.5 2.4 2.7 2.3 2.3 2.9 2.4 2.7 2.2
2.4 2.5 2.4 2.5 2.6 2.5 2.4 2.6
2.5 2.4 2.3 2.3 2.6 2.9 2.7
2.1 2.2 2.3 2.5 2.3 2.4 2.2 2.7 2.5 2.4 2.8 2.5 2.4 2.7 2.3 2.3 2.9 2.4 2.7
2.2 2.4 2.5 2.4 2.5 2.6 2.5 2.4 2.6
552
Company Sanitized. Does not contain TSCA CBI
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5386
D ay 24
D ay 25
F e m a le , V I - 100 mg/k g /d a y
643322 643489 643409 643366 643367 643461 643462 643392
643472 643323 643412 643382 643381 643360 643373 643320 643488 643428 643439 643353 643385
643339 643473 643337 643416
643407
643357 643331 643427 643470 643434 643349 643454 643333 643460
2.5
2.4 2.3 2.3 2.6 2.9 2.7 2 .1
2.2 2.3 2.5 2.3 2.4 2.2 2.7
2.5 2.4 2.8 2.5 2.4 2.7
2.3 2.3 2.9 2.4
2.7
2.2 2.4 2.5 2.4 2.5 2.6 2.5 2.4 2.6
2.5 2.4 2.3 2.3 2.6 2 .9 2.7
2.1 2.2 2.3 2.5 2.3 2.4 2.2 2.7 2.5 2.4 2.8 2.5 2.4 2.7
2.3 2.3 2.9 2.4
2.7
2.2 2.4 2.5 2.4 2.5 2.6 2.5 2.4
2.6
INDIVIDUAL DOSE VOLUMES (mL) 26 D a y 27 D a y 28 D a y 29 D a y 30 D a y 31 D a y 32 D a y 33 Day 34 Day 35
2 .5 2.4 2 .3 2 .3 2 .6 2 .9 2 .7 2 .1 2.2 2 .3 2 .5 2 .3 2 .4 2.2 2 .7 2 .5 2.4 2 .8 2 .5 2.4 2 .7
2 .3 2 .3 2 .9 2.4
2 .7
2 .2 2 .4 2 .5 2 .4 2 .5 2 .6 2 .5 2 .4 2.6
2.5 2.4 2.3 2.3 2.6 2 .9 2.7 2.1 2.2 2 .3 2.5 2.3 2.4 2.2 2.7 2 .5 2.4 2 .8 2 .5 2.4 2.7
2.3 2 .3 2.9 2.4
2.7
2.2 2.4 2 .5 2.4 2.5 2.6 2.5 2.4
2.6
2.6 2.4 2.5 2.5 2.7 3.0 2.8 2.2
2.3 2.4 2.5 2.0 2.4 2.3 2 .8 2.6 2.6 3.0 2.6 2.6 2 .8 2.6 2.4 3.1 2.6
2.9
2.5 2.6 2.5 2.6 2.6 2.8 2.6 2.4
2.8
2.6 2.4 2.5 2.5 2.7 3.0 2.8 2.2
2.3 2.4 2.5 2.0 2.4 2.3 2.8 2.6 2.6 3 .0 2.6 2.6 2.8 2.6 2.4 3.1 2.6
2.9
2.5 2.6 2.5 2.6 2.6 2.8 2.6 2.4 2.8
2.6 2.4
2.5 2.5 2.7 3.0 2.8 2.2 2.3 2.4 2 .5 2.0 2.4 2.3 2.8 2.6 2.6 3 .0 2.6 2.6 2.8 2.6 2.4
3.1 2.6
2.9 2.5 2.6 2.5 2.6 2.6 2 .8 2.6 2.4
2.8
2.6 2.4
2.5 2.5 2.7 3.0 2.8 2.2 2.3 2.4 2.5 2.0 2.4 2.3 2.8 2.6 2.6 3.0 2.6 2.6 2.8 2.6
2.4 3.1 2.6
2.9
2.5 2.6 2.5 2.6 2.6 2.8 2.6 2.4 2.8
2.6 2.4 2.5 2.5 2.7 3.0 2.8 2.2
2.3 2.4 2.5 2.0 2.4 2.3 2.8 2.6 2.6 3.0 2.6 2.6 2.8 2.6 2.4 3.1 2.6
2.9
2.5 2.6 2.5 2.6 2.6 2 .8 2.6 2.4 2.8
2.6 2.4 2 .5 2 .5 2 .7 3 .0 2 .8 2 .2 2 .3 2.4 2 .5 2 .0 2 .4 2 .3 2 .8 2 .6 2 .6 3 .0 2 .6 2 .6 2 .8
2 .6 2 .4 3 .1 2 .6
2 .9
2 .5 2 .6 2 .5 2 .6 2 .6 2 .8 2 .6 2 .4 2 .8
2.6 2.4 2.5 2.5 2.7 3.0 2.8 2.2 2.3 2.4 2.5 2.0 2.4 2.3 2.8 2.6 2.6 3.0 2.6 2.6 2.8 2.6
2.4
3.1 2.6
2.9
2.5 2.6 2.5 2.6 2.6 2.8 2.6 2.4 2.8
2.7
2.6 2.6 2.6 2.8 3.2 2.9 2.4 2.4
2.5 2.6 2.0 2.5 2.2 2.8 2.8 2.6 3.1 2.8 2.7
2.9 2.7
2.5 2.8 2.6
3.0
2.5 2.7 2.7 2.7 2.7 2.9 2.8 2.6 2.9
553
Company Sanitized. Does not contain TSCA CBl
H -24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
D ay 36
D ay 37
F e m a le , VI - 100 mg/k g /d a y
643322 643489 643409 643366 643367
643461 643462 643392 643472 643323 643412 643382 643381 643360 643373 643320 643488 643428 643439 643353 643385
643339 643473 643337 643416 643407 643357 643331 643427 643470 643434 643349 643454 643333 643460
2.7 2.6 2.6 2.6 2.8 3.2 2.9 2.4 2.4 2.5 2.6 2 .0
2.5 2.2 2 .8 2.8 2.6 3.1 2.8 2.7
2.9 2.7 2.5 2.8 2.6 3.0 2.5 2.7 2.7 2.7 2.7
2.9 2.8 2.6 2.9
2.7 2.6 2.6 2.6 2.8 3.2 2.9 2.4 2.4 2.5 2.6 2.0 2.5 2.2 2.8 2.8 2.6 3 .1 2.8 2.7 2.9 ' 2.7 2.5 2.8 2.6
3.0 2.5 2.7 2.7 2.7 2.7 2 .9 2.8 2.6 2.9
D ay 38
2.0 2.0 2.0 2.0 2.1 2.4 2.2 1 .8 1.8 1 .9 1.9 1.5 1.9 1.7 2.1 2.1 2 .0 2 .3 2 .1 2.1 2.2 2 .0 1 .9 2.1 2.0 2.2
1 .9 2 .0 2 .0 2 .0 2 .1 2.2 2 .1 2 .0 2.2
INDIVIDUAL DOSE VOLUMES (mL)
D ay 39
D ay 40
D ay 41
D ay 42
2.0 2.0 2.0 2.0 2.1 2.4 2.2 1.8
1.8 1.9 1 .9 1.5 1.9 1.7 2.1 2.1 2.0 2.3 2.1 2.1 2.2 2.0 1 .9 2 .1 2.0 2.2 1.9 2.0 2.0 2.0 2 .1 2.2 2.1
2.0 2.2
2.0 2.0 2.0 2.0 2.1 2.4 2.2 1.8 1.8 1.9 1.9 1.5 1.9 1.7 2 .1 2.1 2 .0 2.3 2.1 2.1 2.2 2.0 1.9 2.1 2.0
2.2 1.9 2.0 2.0 2.0 2.1 2.2 2.1 2.0 2.2
2.0 2.0 2.0 2 .0 2.1 2.4 2.2 1.8
1.8 1.9 1.9 1.5 1.9 1.7 2.1 2.1 2.0 2 .3 2.1 2.1 2.2 2.0 1.9 2.1 2.0 2.2 1.9 2.0 2.0 2.0 2.1 2.2 2.1
2.0 2.2
2.1 2.0 2.0 2.1 2.1 2.5 2.2 1.9 1.9 2.0 2.0 1.4 2.0 1.9 2.3 2.2 2.1 2.4 2.1 2.1 2.2
2.1 2.0 2.1 2.0 2.3 2.0 2.1 2.1 2 .1 2.1 2.3 2.2 2.0 2.3
D ay 43
2.1 2.0 2.0 2.1 2.1 2.5 2.2 1.9 1.9 2.0 2.0 1.4 2.0 1.9 2.3 2.2 2.1 2.4 2.1 2.1 2.2 2.1 2.0 2.1 2.0
2.3 2.0 2.1 2.1 2.1 2.1 2.3 2.2 2.0 2.3
D ay 44
2.1 2.0 2.0 2.1 2.1 2.5 2.2 1.9 1.9 2.0 2.0 1.4 2.0 1.9 2.3 2.2 2.1 2.4 2.1 2.1 2.2 2.1 2.0 2.1 2.0 2.3
2.0 2.1 2.1 2.1 2.1 2.3 2.2 2.0 2.3
DuPont-5386
D ay 45
2.1 2 .0 2.0 2 .1 2.1 2.5 2.2 1.9 1.9 2.0 2 .0 1.4 2 .0 1 .9 2 .3 2.2 2.1 2.4 2 .1 2.1 2.2 2 .1 2.0 2 .1 2.0 2.3
2.0 2 .1 2.1 2.1 2 .1 2 .3 2 .2 2 .0 2.3
554
Conpany Sanitized. Does not contain TSCA cg(
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations ___________
INDIVIDUAL DOSE VOLUMES (mL)
D ay 46
D ay 47
D ay 48
D ay 49
D ay 50
D ay 51
D ay 52
F e m a le , V I - 100 mg/k g /d a y
643322
643489 643409 643366 643367 643461 643462 643392 643472 643323 643412 643382 643381 643360 643373 643320 643488 643428 643439 643353 643385
643339 643473 643337 643416 643407 643357 643331 643427 643470 643434 643349 643454 643333 643460
2 .1 2.0 2.0 2.1 2.1 2.5 2.2 1.9
1 .9 2.0 2.0 1.4 2.0
1.9 2.3 2.2 2.1 2.4 2.1 2.1 2.2
2 .1 2.0 2.1 2.0 2.3 2.0 2.1 2.1 2.1 2.1 2.3 2.2 2.0 2.3
2.1 2.0 2.0 2.1 2.1 2.5 2.2 1.9
1.9 2 .0 2.0 1.4 2 .0 1.9 2.3 2.2 2.1 2.4
2.1 2.1 2.2
2.1 2.0 2.1 2.0 2.3 2.0 2.1 2.1 2.1 2.1 2.3 2.2 2.0 2.3
2.1 2.0 2 .0 2.1 2 .1 2.5 2.2 1.9
1.9 2.0 2.0 1.4 2.0 1.9 2.3 2.2 2.1 2.4 2.1 2.1 2.2 2.1 2.0 2.1 2.0 2.3 2.0
2.1 2.1 2.1 2.1 2.3 2.2 2.0 2.3
2.1 2 .1 2.0 2.1 2.2 2.4 2.2 1.9 1.9 1.9 2.0 1.7 2.0 1.9 2.3 2.2 2.1 2.4 2.2 2.3
2.3 2.2 2.0 2.3 2.1 2.4 2.1
2.2 2.2 2.3 2.3 2.1 2.3
2.1 2.1 2.0 2.1 2.2 2.4 2.2 1.9 1.9 1.9 2.0 1.7 2.0 1.9 2.3 2.2 2.1 2.4 2.2
2.3 2.3
2.2 2.0 2.3 2.1 2.4 2.1 2.2 2.1 2.2 2.2 2.3 2.3 2.1 2.3
2.1 2.1 2.0 2.1 2.2 2.4 2.2 1.9 1.9 1.9 2.0 1.7 2.0 1.9 2.3 2.2 2.1 2.4 2.2
2.3 2.3 2.2 2.0 2 .3 2.1 2.4 2.1 2.2 2.1 2.2 2.2 2 .3 2.3 2.1 2.3
2.1 2.1 2.0
2.1 2.2 2.4
2.2
1.9 1.9 1.9 2.0 1.7 2.0 1.9 2.3 2.2
2.1 2.4 2.2 2.3 2.3
2.2 2.0 2.3
2.1 2.4
2.1 2.2
2.1
2.2
2.2
2.3 2.3 2.1 2.3
D a y 53
2.1 2.1 2.0 2.1 2.2 2.4 2.2 1.9 1.9 1.9 2.0 1.7 2.0 1.9 2.3 2.2 2.1 2.4 2.2 2.3
2.3 2.2 2.0 2.3 2.1 2.4 2.1 2.2 2.1 2.2 2.2 2.3 2.3 2.1 2.3
Day 54
2.1 2.1 2.0 2.1 2.2 2.4 2.2 1.9 1.9 1.9 2.0 1.7 2.0 1.9 2.3 2.2 2.1 2.4 2.2 2.3
2.3 2.2 2.0 2.3 2.1 2.4 2.1 2.2 2.1 2.2 2.2 2.3 2.3 2.1 2.3
DuPont-5386
Day 55
2.1 2.1 2.0 2.1 2.2 2.4 2.2 1.9 1.9 1.9 2.0 1.7 2.0 1.9 2.3 2.2 2.1 2.4 2.2 2.3
2.3 2.2 2.0 2.3 2.1 2.4 2.1 2.2 2.1 2.2 2.2 2.3 2.3 2.1 2.3
555
D o e s n o t c o n ta in T S C A C B I
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations_________ _
INDIVIDUAL DOSE VOLUMES (mL)
D ay 56
D ay 57
F e m a le , V I - 100 mg/k g /d a y
643322 643489 643409 643366 643367
643461 643462 643392 643472 643323 643412 643382 6 4 3 3 B1 643360 643373 643320 643488 643428
643439 643353 643385
643339 643473 643337 643416 643407 643357 643331 643427 643470 643434 643349 643454 643333 643460
2.1 2.2 2.0 2.1 2.2 2.4 2.3 1.9 1.9 2.0 2.1 1.7 2.0 1.9 2.2 2.3 2.1 2.3 2.2 2.3 2.3 2.2 2 .1
2.3 2.1 2.4 2.1 2.3 2.2 2.2 2.2 2.4 2.3 2.0 2.3
2.1 2.2 2.0 2.1 2.2 2.4
2.3 1.9 1.9 2.0 2.1 1.7 2.0 1 .9 2.2 2.3 2.1 2 .3 2.2 2.3 2.3 2.2 2 .1 2.3 2.1 2.4 2.1 2.3
2.2 2.2 2.2 2.4 2.3 2.0 2 .3
D ay 58
2.1 2.2 2.0 2.1 2.2 2.4 2.3 1.9 1.9 2.0 2.1 1.7 2.0 1.9 2.2 2.3 2.1 2.3 2.2 2.3 2.3 2.2
2.1 2.3 2.1 2.4 2.1 2.3 2.2 2.2 2.2 2.4 2.3 2.0 2.3
D ay 59
2.1 2.2 2.0 2.1 2.2 2.4 2.3 1.9 1.9 2.0 2.1 1.7 2.0 1.9 2.2 2.3 2.1 2.3 2.2 2.3 2.3 2.2 2.1 2.3
2.1 2.4 2.1 2.3 2.2 2.2 2.2 2.4 2.3 2.0 2.3
D ay 60
2.1 2.2 2.0
22.. 21
2.4 2.3 1.9 1.9 2 .0 2.1 1.7 2.0 1.9 2.2 2.3 2.1 2.3 2.2 2.3 2.3 2.2 2.1 2.3 2.1 2.4 2 .1
2.3 2.2 2.2 2.2 2.4 2.3 2.0 2.3
D ay 61
2.1 2.2 2.0 2.1 2.2 2.4 2.3 1.9 1.9 2.0 2.1 1.7 2.0 1.9 2.2 2.3 2.1 2.3 2.2 2.3 2.3 2.2
2.1 2.3 2.1 2.4 2.1 2.3 2.2 2.2 2.2 2.4 2.3 2.0 2.3
62
2.1 2.2 2.0 2.1 2.2 2.4 2.3 1.9 1.9 2.0 2.1 1.7 2.0 1.9 2.2 2.3 2.1 2.3 2.2 2.3 2.3 2.2
2.1 2.3 2.1 2.4 2.1 2.3 2.2 2.2 2.2 2.4 2.3 2.0 2.3
D ay 63
2.2 2.2 2.0 2.2 2.2 2.5 2.3 2.0 2.0 2.1 2.1 1.8 2.1 1 .9 2.3 2.3 2.2 2.4 2.2 2.3 2.3 2.2
2.0 2.4 2.1 2.5 2.1 2.3 2.1 2.3 2.1 2.4 2.3 2.1 2.4
D ay 64
2.2 2.2 2.0 2.2 2.2 2.5 2.3 2.0 2.0 2.1 2.1 1.8 2.1 1.9 2.3 2.3 2.2 2.4 2.2 2.3 2.3 2.2
2.0 2.4 2.1 2.5 2.1 2.3 2.1 2.3 2.1 2.4 2.3 2.1 2.4
DuPont-5386
D ay 65
2.2 2.2 2.0 2.2 2.2 2.5 2.3 2.0 2.0 2.1 2.1 1.8 2.1 1.9 2.3 2.3 2.2 2.4 2.2 2.3 2.3 2.2 2.0
2.4 2.1 2.5 2.1 2.3 2.1 2.3 2.1 2.4 2.3 2.1 2.4
556
Company Sanitized. Does not contain TSCA CBI
J
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations______________ .
D ay 66
D ay 67
F e m a le , V I - 100 mg/k g /d a y
643322 643489 643409 643366 643367
643461 643462 643392
643472 643323 643412 643382 643381 643360 643373 643320 643488 643428 643439 643353 643385
643339 643473 643337 643416 643407 643357
643331 643427
643470 643434 643349 643454 643333 643460
2.2
2.2 2.0 2.2 2.2 2.5 2.3 2.0
2.0 2.1 2.1 1.8 2.1 1.9 2.3 2.3 2.2 2.4 2.2 2.3 2.3 2.2 2.0 2.4 2.1 2.5 2.1 2.3 2.1 2.3 2.1
2.4 2.3 2.1 2.4
2.2 2.2 2 .0 2.2 2.2 2.5 2.3 2.0 2.0 2.1 2 .1 1 .8 2 .1 1.9 2 .3 2.3 2.2 2.4 2.2 2.3 2.3 2.2 2.0 2.4
2.1 2.5 2.1 2.3 2.1 2.3 2.1 2.4 2.3 2.1 2.4
D ay 68
2.2 2.2 2.0 2.2 2.2 2.5 2.3 2.0 2.0 2.1 2.1 1.8 2.1 1.9 2.3 2.3 2.2 2.4 2.2 2.3 2.3 2.2 2.0 2.4 2.1
2.5 2.1 2.3 2.1 2.3 2.1 2.4 2.3 2.1 2.4
INDIVIDUAL DOSE VOLUMES (mL)
D ay 69
D ay 70
D ay 71
D ay 72
2.2 2.2 2 .0 2.2 2.2 2.5 2.3 2.0 2.0 2.1
2.1 1.9
2.2 2.4 2.2 2.3 2.3 2.2
2.1 2.5 2.1 2.3 2.1 2.3 2.1 2.4 2.3 2.1 2.4
2.2
2.3 2.0 2.3 2.3 2.4 2.4 2.1 2 .0 2.2
2.2
1.9 2.1 2.0 2.3 2.4
2.2 2.4 2.2 2.4 2.4 2.3
2.1 2.5
2.1 2.4 2.2 2.4
2.2 2.3 2.1 2.4 2.4
2.1 2.4
2.2 2.3
2.0 2.3 2.3 2.4 2.4
2.1
2.0
2.2
2.2 1.9 2.1
2.0 2.3 2.4 2.2 2.4 2.2 2.4 2.4 2.3 2.1 2 .5
2.1 2.4
2.2 2.4 2.2 2.3
2.1 2.4 2.4
2.1 2.4
2.2
2.3 2.0 2.3 2.3 2.4 2.4
2.1 2.0 2.2 2.2 1.9 2.1 2.0 2.3 2.4 2.2 2.4 2.2 2.4 2.4 2.3
2.1 2.5 2.1 2.4
2.2 2.4 2.2
2.3 2.1 2.4 2 .4
2.1 2.4
D ay 73
2.2 2.3 2.0 2 .3 2.3 2.4 2.4 2.1
2.0 2.2 2.2 1.9 2.1 2.0 2.3 2.4 2.2 2.4 2.2 2.4 2.4 2.3 2.1 2.5 2.1 2.4 2.2 2.4 2.2 2.3 2.1 2.4 2.4
2.1 2.4
D a y 74
2.2 2.3 2.0 2.3 2.3 2.4 2.4 2.1 2.0 2.2 2.2 1.9 2 .1 2.0 2.3 2.4 2.2 2.4 2.2 2.4 2.4 2.3 2.1 2.5 2.1 2.4 2.2
2.4 2.2 2.3 2.1 2.4 2.4 2.1 2.4
DuPont-5386
D ay 75
2.2 2.3 2.0 2.3 2.3 2.4 2.4 2.1 2.0 2.2 2.2 1.9 2.1 2.0 2.3
557
Company Sanitized. Does not contain TSCA CBI
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction E v a l u a t i o n s ____________ _
D ay 76
D ay 77
D ay 78
INDIVIDUAL DOSE VOLUMES (mL)
D ay 79
D ay 80
D ay 81
D ay 82
F em ale, VI
643322 643489 643409 643366 643367 643461 643462 643392 643472
643323 643412 643382 643381 643360 643373 643320 643488 643428 643439 643353 643385 643339 643473 643337 643416 643407 643357 643331
643427 643470 643434 643349 643454 643333 643460
- 100 mg/k g /d a y
2.2 2.3 2.0 2.3 2.3 2.4 2.4 2.1 2.0
2.2 2.2 1.9 2.1 2.0 2.3
2.2
2.4 2.1 2.3 2.3 2.4 2.4 2.1 2.0 2.2
2.0 2.4
2.2 2.4 2.1 2.3 2.3 2.4 2.4
2.1 2.0
2.2 2.2 1.9
2.1 2.0 2.4
2.2 2.4 2.1 2.3 2.3 2.4 2.4
2.1 2.0
2.2
2.0 1.9 2.1 2.0 2.4
2.2 2.4 2.1 2.3 2.3 2.4 2.4
2.1 2.0
2.2 b
2.2 1.9
2.1
2.0 2.4
2.2 2.4 2.1 2.3 2.3 2.4 2.4
2.1 2.0
2.2
2.2 1.9 2.1 2.0 2.4
2.2 2.4 2.1 2.3 2.3 2.4 2.4 2.1 2.0
2.2 2.2 1.9 2.1
2.0 2.4
D ay 83
2.2 2.4 2.1 2.3 2.3 2.4 2.4 2.1 2.0
2.2 2.2 1.9 2.1 2.0 2.4
Day 84
2.2 2.4
2.3
2.3 2.4
2.0 2.0
2.2 2.3 1.9 2.2 2.0 2.3
DuPont-5386
Day 85
2.4 2.1 2.3 2.3 2.4 2.4 2.0 2.0
2.2 2.3 1.9 2.2 2.0 2.3
558
Company Sanitized. Does not contain TSCA CBI
H -24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
D ay 86
D ay 87
F e m a le , V I - 100 mg/k g /d a y
643322
643489 643409 643366 643367 643461 643462 643392
643472 643323 643412 643382 643381 643360 643373 643320 643488 643428 643439 643353 643385 643339 643473 643337
643416 643407 643357 643331 643427
643470 643434 643349 643454 643333 643460
2.2 2.4 2.1 2.3 2.3 2.4 2.4 2.0
2.0 2.2 2.3 1.9 2.2 2.0 2.3
2.2 2.4 2.1 2.3
2.3 2.4 2.4 2.0
2.0 2.2 2.3 1.9 2.2 2.0 2.3
D ay 88
INDIVIDUAL DOSE VOLUMES (mL)
D ay 89
D a y 90
D ay 91
D ay 92
2.2 2.4 2.1 2.3 2.3 2.4 2.4
2.0 2.0 2.2 2.3 1.9
2.2 2 .0 2.3
2.2 2.4 2.1 2.3 2.3 2.4 2.4 2.0
2.0
2.2 2.3 1.9 2.2
2.0 2.3
2.2 2.4
2.1 2.3 2.3 2.4 2.4 2.0 2.0
2.2
2.2 2.4 2.1 2.3 2.4 2.5 2.4 2.1
2.0
2.1
2.2 2.4
2.1 2.3 2.4 2.5 2.4 2.1 2.0
2.1
DuPont-5386
559
Company Sanitized. Does not contain TSCA CBf
,)
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5386
Day 0
Day 1
Day 2
Day 3
INDIVIDUAL DOSE VOLUMES (mL)
Day 4
Day 5
Day 6
Day 7
Day 8
Day 9
D ay 10
D ay 11
F e m a le , V III - 250 mg/k g /d a y
643341 643370 643446 643435 643466 643332 643404 643408 643359 643340 643487
643356 643329 643388 643450 643467 643443 643417
643413 643338 643335 643468 643440
643430 643431 643368 643326 643365 643375 643328 643348 643346 643449 643429 643424 643347 643456 643423 643345 643351 643358
643444 643474 643441 643481
1.9 2.0 2.0 1.8 1.7 1.7 1.7 1.9 1.8 2 .0 1.7 2.0 1.8 1.6 2.2 2.0 1.8 2.2
1.8 2.0 2.1 1.8 2.1 1.8
1.9 1.9 2.0 2.1 2 .1 2.0 1.7 1.9 2.2 2.0
1.9 1.8 2.1 1.9 1.8 1.9 1.9
2.0 1.7 1.9 1.7
1.9 2.0 2.0 1.8 . 1.7 1.7 1.7 1.9 1.8 2.0 1.7 2.0 1.8 1.6 2.2 2.0 1.8 2.2 1.8 2.0 2.1 - 1.8
2.1 1.8 1.9 1.9 2.0 2.1 2 .1 2.0 1.7 1.9 2.2 2.0
1.9 1.8 2.1 1.9 1.8 1.9 1.9
2.0 1.7 1.9 1.7
1.9 2.0 2.0 1.8 1.7 1.7 1.7
1.9 1.8 2.0 1.7 2.0 1.8 1.6 2.2 2.0 1.8 2.2 1.8 2.0 2.1 1.8 2.1 1.8 1.9
1.9 2.0 2.1 2.1 2.0 1.7 1.9 2.2 2.0
1.9 1.8 2.1
1.9 1.8
1.9
1.9 2.0 1.7
1.9 1.7
1.9 2.0 2.0 1.8 1.7 1.7 1.7
1.9 1.8
2.0 1.7
2.0 1.8
1.6 2.2 2.0 1.8 2.2 1.8 2.0 2.1 1.8 2.1 1-8 1.9
1.9 2.0 2.1 2.1 2.0 1.7 1.9 2.2 2.0
1.9 1.8
2.1
1.9 1-8
1-9
1.9 2.0 1.7
1.9 1.7
1-9 2.0 2.0 1.8 1.7 1.7 1.7
1.9 1.8 2.0 1.7 2.0 1.8 1.6 2.2 2.0 1.8 2.2 1.8 2.0 2.1 1.8 2.1 1.8 1.9
1-9 2.0 2.1 2.1 2.0 1.7 1.9 2.2 2.0
1-9 1.8 2.1
1-9 1.8
1.9
I -9 2.0 1.7
1.9 1.7
1.9 2.0 2.0 1.8 1.7 1.7 1.7
1.9 1.8 2.0 1.7
2.0 1.8 1.6 2.2 2.0 1.8 2.2 1.8 2.0
2.1 1.8 2.1 1.8 1.9 1.9 2.0 2.1 2.1 2.0 1.7 1.9 2.2 2.0
1.9 1.8 2.1 1.9 1.8 1.9 1.9
2.0 1.7 1.9 1.7
1.9 2.0 2.0 1.8 1.7 1.7 1.7
1.9 1.8 2.0 1.7 2.0 1.8 1.6 2.2 2.0 1.8 2.2 1.8 2.0 2.1 1.8 2.1 1.8 1.9 1.9 2.0 2.1
2.1 2.0 1.7 1.9 2.2 2.0 1.9
1.8 2.1 1.9 1.8 1.9 1 .9
2.0 1.7
1 .9 1.7
2.1 2.4 2.2 2.0 1.9 1.9 1.9 2.1 2.1 2.1 1.9 2.2 2.1 1.9 2.5 2.3 2.0 2.5 2.1 2.2 2.3
2.0 2.3 2.0 2.2 2.2 2.3 2.5 2.5 2.3 2.0 2.2 2.4 2.3
2.1 2.0 2.5 2.1 2.0 2.1 2.2
2.3 1.9 2.2 1.9
2.1 2.4 2.2 2.0 1.9 1.9 1.9 2.1 2.1 2.1 1.9 2.2 2.1 1.9 2.5 2.3 2.0 2.5 2.1 2.2 2.3
2.0 2.3 2.0 2.2 2.2 2.3 2.5 2.5 2.3 2.0 2.2 2.4 2.3
2.1 2.0 2.5 2.1 2.0 2.1 2.2
2.3 1.9 2.2 1.9
2.1 2.4 2.2 2.0 1.9 1.9 1 .9 2.1 2.1 2.1 1.9 2.2 2.1 1.9 2.5 2.3 2.0 2.5 2.1 2.2 2.3
2.0 2.3 2.0 2.2 2.2 2.3 2.5 2.5 2.3 2.0 2.2 2.4 2.3
2.1 2.0 2.5 2.1 2.0 2.1 2.2
2.3 1.9 2.2 1.9
2.1 2.4 2.2 2.0 1.9 1.9 1.9 2.1 2.1 2.1 1.9 2.2 2.1 1.9 2.5 2.3 2.0 2.5 2.1 2.2 2.3 2.0
2.3 2.0 2.2 2.2 2.3 2.5 2.5 2.3 2.0 2.2 2.4 2.3 2.1 2.0 2.5
2.1 2.0 2.1 2.2
2.3 1.9 2.2 1.9
2.1 2.4 2.2 2.0 1.9 1.9 1.9 2.1 2.1 2.1 1.9 2.2 2 .1 1.9 2.5 2.3 2.0 2.5 2.1 2.2 2.3 2 .0
2.3 2.0 2.2 2.2 2.3 2 .5 2.5 2.3 2.0 2.2 2.4 2.3 2.1 2.0 2.5 2.1 2.0 2.1 2.2
2.3 1.9 2.2 1.9
560
Company Sanitized. Does not contain TSCA C8I
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5386
D ay 12
D ay 13
D ay 14
D ay 15
INDIVIDUAL DOSE VOLUMES (mL)
D ay 16
D ay 17
D ay 18
D ay 19
D ay 20
D ay 21
D ay 22
D ay 23
F e m a le , V I I I - 250 mg/k g /d a y
643341 643370 643446 643435 643466 643332 643404 643408 643359 643340 643487 643356 643329 643388 643450 643467 643443 643417 643413 643338
643335 643468 643440 643430 643431 643368 643326 643365 643375 643328 643348 643346 643449 643429 643424 643347 643456 643423 643345
643351 643358 643444 643474 643441
643481
2.1 2.4 2.2 2.0 1.9 1.9 1.9 2.1 2.1 2.1 1.9 2.2 2.1 1 .9 2.5 2.3 2.0 2.5 2.1 2.2 2.3 2.0 2.3 2.0
2.2
2.2 2.3 2.5 2.5 2.3 2.0 2.2 2.4 2.3 2.1 2.0 2.5 2.1 2.0 2.1 2.2
2.3 1.9 2.2 1.9
2.1 2.4 2.2 2.0 1.9 1.9 1.9 2.1 2 .1 2.1 1.9 2.2 2.1 1 .9 2.5 2.3 2.0 2.5 2 .1 2.2 2.3 - 2.0 2 .3
2.0 2.2 2.2 2.3 2.5 2.5 2.3 2.0 2.2 2.4 2.3 2.1 2.0 2.5 2.1 2.0 2.1 2.2
2.3 1 .9 2.2 1.9
2.3 2.6 2.5 2.2 2.2 2.0 2.1 2.4 2.4 2.4 2.1 2.4 2.2 2.0 2.7 2.4 2.1 2.8 2.2 2.3 2.4 2.2 2.6 2.2
2.4 2.3
2.5 2.7 2.8 2.6 2.2 2.3 2.8 2.6 2.3 2.2 2.7 2.3 2.3 2.3 2.4
2.4 2.2 2.4 2.2
2.3 2.6
2.5 2.2 2.2 2.0 2.1 2.4 2.4 2.4 2.1 2.4 2.2 2.0 2.7 2.4 2.1 2.8 2.2 2.3 2.4 2.2 2.6 2.2 2.4 2.3
2.5 2.7 2.8 2.6 2.2 2.3 2.8 2.6 2.3 2.2 2.7 2.3 2.3 2.3 2.4
2.4 2.2
2.4 2.2
2.3 2.6 2.5 2.2 2.2 2.0 2.1 2.4 2.4 2.4 2.1
2.4 2.2 2.0 2.7 2.4 2.1 2.8 2.2 2.3 2.4 2.2 2.6 2.2 2.4 2.3
2.5 2.7 2.8 2.6 2.2 2.3 2.8 2.6 2.3 2.2 2.7 2.3 2.3 2.3 2.4
2.4 2.2 2.4 2.2
2.3 2.6 2.5 2.2 2.2 2.0 2.1 2.4
2.4 2.4
2.1 2.4 2.2 2.0 2.7 2.4
2.1 2.8 2.2 2.3 2.4 2.2 2.6 2.2 2.4 2.3 2.5 2.7 2.8 2.6 2.2 2.3 2.8 2.6 2.3
2.2 2.7 2.3 2.3 2.3 2.4 2.4 2.2 2.4 2.2
2.3 2.6 2.5 2.2 2.2 2.0 2.1 2.4
2.4 2.4
2.1 2.4 2.2 2.0 2.7 2.4
2.1 2.8 2.2 2.3 2.4
2.2 2.6 2.2 2.4 2.3 2.5 2.7 2.8 2.6 2.2 2.3 2.8 2.6 2.3 2.2 2.7 2.3 2.3 2.3 2.4 2.4 2.2 2.4 2.2
2.3 2.6 2.5 2.2 2.2 2.0 2.1 2.4
2.4 2.4
2.1 2.4 2.2 2.0 2.7 2.4
2.1 2.8 2.2 2.3 2.4 2.2 2.6 2.2 2.4 2.3 2.5 2.7 2.8 2.6 2.2 2.3
2.8 2.6 2.3 2.2 2.7 2.3 2.3 2.3 2.4 2.4 2.2 2.4 2.2
2.3 2.6 2.5 2.2 2.2 2.0 2.1 2.4 2.4 2.4 2.1 2.4 2.2 2.0 2.7 2.4 2.1 2.8 2.2 2.3 2.4 2.2 2.6
2.2 2.4 2.3 2.5 2.7 2.8 2.6 2.2 2.3 2.8 2.6
2.3 2.2
2.7 2.3 2.3 2.3 2.4
2.4 2.2 2.4 2.2
2.4 2.9 2.6 2.2 2.3 2.3 2.3 2.6 2.5 2.5 2.3 2.5 2.3 2.2 2.9 2.5 2.3 3.0 2.4 2.5 2.6 2.4 2.8 2.4
2.6 2.4 2.6 2.9 2.9 2.7 2.4 2.5 2.9 2.7
2.5 2.2
2.9 2.3 2.4 2.4 2.5
2.6 2.2 2.6 2.3
2.4 2.9 2.6 2.2 2.3 2.3 2.3 2.6 2.5 2.5 2.3 2.5 2.3 2.2 2.9 2.5 2.3 3.0 2.4 2.5 2.6 2.4 2.8 2.4
2.6 2.4 2.6 2.9 2.9 2.7 2.4 2.5 2.9 2.7
2.5 2.2
2-9 2.3 2.4 2.4 2.5
2.6 2.2 2.6 2.3
2.4 2.9 2.6 2.2
2.3 2.3 2.6 2.5 2.5 2.3 2.5 2.3 2.2
2.3 3.0 2.4 2.5 2.6 2.4 2.8 2.4 2.6 2.4 2.6 2.9 2.9 2.7 2.4 2.5 2.9 2.7 2.5 2.2
2.4
2.6 22.. 62
2.3
561
Company Sanitized. Does not contain TSCA CBI
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
D ay 24
D ay 25
D ay 26
F e m a le , V I I I - 250 mg/k g /d a y
643341 643370 643446 643435 643466 643332
643404 643408 643359 643340 643487 643356 643329 643388 643450 643467 643443 643417
643413 643338 643335 643468 643440 643430 643431
643368 643326 643365 643375 643328 643348 643346 643449 643429
643424 643347 643456 643423 643345 643351 643358 643444 643474 643441 6 4 3 4 B1
2.4 2.9 2.6 2.2 2.3 2.3 2.3 2.6 2.5 2.5 2.3
2.5 2.3 2.2 2 .9 2.5 2.3 3.0 2.4 2.5 2.6 2.4 2.8 2.4 2.6 2.4 2.6 2.9 2.9 2.7 2.4 2.5 2.9 2.7
2.5 2.2 2.9 2.3 2.4 2.4 2.5 2.6 2.2 2.6 2.3
2.4 2.9 2.6 2.2 2.3 2 .3 2.3 2.6 2.5 2.5 2.3 2.5 2.3 2.2 2.9 2.5 2.3 3 .0 2.4 2.5 2.6 - 2.4 2.8 2.4 2.6
2.4 2 .6 2.9 2.9 2 .7 2.4 2.5 2.9 2.7
2.5
2.2 2.9 2.3 2.4 2.4 2.5 2.6 2.2 2.6 2.3
2.4 2.9 2.6 2.2
2.3 2.3 2.3 2.6 2.5 2.5 2.3 2.5 2.3 2.2 2 .9 2.5 2.3 3.0 2.4 2.5 2.6 2.4 2.8 2.4 2.6 2.4 2.6 2.9 2.9 2.7 2.4 2.5 2.9 2.7
2.5 2.2 2.9 2.3 2.4 2.4 2.5 2.6 2.2 2.6 2.3
INDIVIDUAL DOSE VOLUMES
27 D ay 28 D ay 29 D ay 30
2.4 2.9 2.6 2.2 2.3 2.3 2.3
2.6 2.5 2.5 2.3 2.5 2.3 2.2 2.9 2.5 2.3 3.0 2.4
2.5 2.6 2.4
2.8 2.4 2.6 2.4 2.6 2.9 2.9 2.7 2.4 2.5 2 .9 2.7
2.5
2.2 2.9 2.3 2.4 2.4 2.5 2.6 2.2 2.6 2.3
2.5 2.9 2.7 2.3 2.5 2.3 2.4 2.7
2.8 2.7 2.4 2.6 2.4 2.4 3.0 2.7 2.5 3.1 2.5 2.7 2.8 2 .5 2 .9 2.5 2.7 2.6 2,8 3.1 3.1 2 .8 2.5 2.5 3.0 2.9
2.5 2.3 2.9 2.5 2.5 2.4 ' 2.6
2.8 2.3 2.7 2.5
2.5 2.9 2.7 2.3 2.5 2.3 2.4 2.7
2.8 2.7 2.4 2.6 2.4 2.4 3.0 2.7 2.5 3 .1 2.5 2.7 2.8 2.5 2.9 2.5 2.7 2.6 2.6 3.1 3.1 2.8 2.5 2.5 3.0 2.9 2.5
2.3 2.9 2.5 2.5 2.4 2.6 2.8 2.3 2.7 2.5
2.5 2.9 2.7 2.3 2.5 2.3 2.4
2.7 2.8 2.7 2.4 2.6 2.4 2.4 3.0 2.7 2.5 3 .1 2.5 2.7 2.8 2.5 2.9 2.5 2.7 2.6 2.8 3.1 3.1 2.8 2.5 2.5 3.0 2.9 2.5 2.3 2.9 2.5 2.5 2.4 2.6 2.8 2.3 2.7
2.5
562
i
> (m L ) D ay 31
D ay 32
D a y 33
D ay 34
DuPont-5386
D ay 35
2.5 2.9 2.7 2.3
2.5 2.3 2.4 2.7
2.8 2.7 2.4 2.6 2.4 2.4 3.0 2.7 2.5 3.1 2.5 2.7 2 .8 2.5 2.9 2.5 2.7
2.6
2.8 3.1 3.1
2.8
2.5 2.5 3.0 2.9 2.5
2.3 2.9 2.5 2.5 2 .4 2.6
2.8 2.3 2.7 2.5
2.5 2.9 2.7 2.3 2.5 2.3 2.4 2.7
2.8
2.7 2.4
2.6 2.4 2.4 3.0 2 .7 2.5 3.1
2.5 2.7
2.8 2.5 2.9 2.5
22 .. 76
2.8
3.1 3.1
2.8
2.5 2.5 3.0 2.9 2.5
2.3 2.9 2.5 2.5 2.4
2.6
2.8 2.3 2.7 2.5
2.5 2.9 2.7 2.3 2.5 2.3 2.4 2.7
2.8 2.7 2.4 2.6 2.4 2.4 3.0 2.7 2.5 3.1 2.5 2.7
2.8 2.5 2.9 2.5 2.7 2.6
2.8 3.1 3.1
2.8 2.5 2.5 3.0 2.9 2.5 2.3 2.9 2.5 2.5 2.4 2.6
2.8 2.3 2.7 2.5
2.5 2.9 2 .7 2.3 2.5 2.3 2.4 2.7
2.8 2.7
22 ..46
2.4 2.4 3.0 2.7 2.5 3.1 2.5 2.7
2.8 2.5 2.9 2.5 2.7 2.6 2.8 3.1 3.1
2.8 2.5 2.5 3.0 2 .9 2.5 2.3 2.9 2.5 2.5 2.4 2.6
2.8 2.3 2.7 2.5
2.7
23 .. 28
2.4
2.6
2.5 2.6 2.7 2.9 2 .0 2.5 2.6
2.6 2.4 3.1
2.8 2.5 3.1 2.6
2.8
3.0 2.6
32 .. 06
2.9 2.7
2.9 3.2 3.3
23 .. 06 2.8
3.1 3.0 2.6 2.4 3.1 2.6 2.5 2.5 2.7
2.8
22 .. 48
2.5
Company Sanitized. Does not contain TSCA CM
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
D ay 36
D ay 37
D ay 38
F e m a le , V III - 250 mg/k g /d a y
643341 643370
643446 643435 643466 643332
643404 643408 643359 643340 643487 643356 643329 643388 643450 643467 643443 643417 643413 643338 643335 643468 643440 643430 643431 643368 643326 643365 643375 643328 643348 643346 643449 643429 643424 643347 643456
643423 643345 643351 643358 643444 643474 643441 643481
2.7 3.2 2.8 2.4 2.6 2.5 2.6 2.7 2.9 2.8 2.5 2.6 2.6 2.4 3.1 2.8 2.5 3.1 2.6 2.8 3.0 2.6 3.0 2.6 2 .9 2.7 2.9 3.2 3.3 3.0 2.6
2.8 3.1 3.0
2.6 2.4 3.1 2.6 2.5 2.5 2.7
2.8 2.4 2.8 2.5
2.7 3.2
2.8 2.4 2.6 2.5
2.6 2 .7 2.9
2.8
2.5 2.6 2.6 2.4 3.1
2.8 2.5 3 .1 2.6 2 .8 3.0
2.6
3 .0 2 .6 2.9 2.7 2.9 3.2 3.3 3 .0
2.6
2.8
3.1 3.0 2.6 2.4
23 .. 16
2.5 2.5 2.7
2.8 2.4
2.8
2.5
2.0 2.4 2.1 1.8 1.9 1.9
1.9 2.0
2.2 2.1 1.9 2.0 1.9 1.8 2.3 2.1 1.9 2.4 1.9 2.1 2.2 2.0 2.2 1.9 2.2 2.0 2.2 2.4 2.4 2.3 1.9 2.1 2.3 2.2
2.0 1.8 2.3 1.9 1.9 1.9 2.0
2.1 1.8 2.1 1.9
INDIVIDUAL DOSE VOLUMES (mL)
Day 39
Day 40
D ay 41
D ay 42
2.0 2.4 2 .1 1.8
1.9 1.9 1.9 2 .0 2.2 2.1 1.9 2.0 1.9 1.8 2.3 2.1 1.9 2.4 1.9 2.1 2.2
2.0 2.2 1.9 2.2 2.0 2.2 2.4 2.4 2.3 1.9 2.1 2.3 2.2 2.0 1.8 2.3 1.9 1.9 1.9 2.0
2.1 1.8 2.1
1.9
2.0 2.4 2 .1
1.8
1.9 1.9 1.9
2.0 2.2 2.1 1.9
2.0 1.9
1.8
2.3 2.1 1.9 2.4 1.9 2.1 2.2 2.0 2.2 1.9
2.2 2.0 2.2 2.4 2.4 2.3 1.9 2.1 2.3 2.2 2.0 1.8 2.3 1.9 1.9 1.9
2.0
2.1 1.8 2.1 1.9
2.0 2.4 2.1 1.8 1.9 1.9 1.9 2.0 2.2 2.1 1.9 2.0 1.9 1.8 2.3 2.1 1.9 2.4 1.9 2.1 2.2
2.0 2.2 1.9 2.2 2.0 2.2 2.4 2.4 2.3 1.9 2.1 2.3 2.2 2.0 1.8 2.3 1.9 1.9 1.9 2.0
2.1 1.8 2.1 1.9
2.1 2.5 2.2 1.9 2.1
2.0 2.0 2.1
2.2 2.1 1.9 2.0 2.1 1.9 2.4 2.2 2.0 2.4 2.0 2.1 2.3 2.0 2.3 1.9 2.3 2.1 2.2 2.4 2.5 2.3 2.0 2.1 2.4 2.3 2.0
1.9 2.4 2.0 2.0 1.9 2.1 2.3 1.9 2.2 2.0
Day 43
D ay 44
2.1 2.5
2.2 1.9 2.1 2.0 2.0 2 .1
2.2 2.1 1.9 2.0 2.1 1.9 2.4
2.2
2.0 2.4 2.0 2.1 2.3 2.0 2.3 1.9 2.3 2.1 2.2 2.4 2.5 2.3 2.0 2.1 2.4 2.3 2.0 1.9 2.4
2.0 2.0 1.9 2.1 2.3 1.9
2.2
2.0
2.1 2.5 2.2 1 .9 2 .1 2.0 2.0 2.1 2.2 2.1 1.9 2.0 2.1 1.9 2.4 2.2 2.0 2.4 2.0 2.1 2.3 2.0 2.3 1.9 2.3 2.1 2.2 2.4 2.5 2.3 2.0 2.1 2.4 2.3 2.0
1.9 2.4 2.0 2.0 1.9 2.1
2.3 1.9 2.2 2.0
DuPont-5386
D ay 45
2.1 2.5 2.2 1.9 2.1 2.0 2.0 2.1 2.2 2.1 1.9 2.0 2.1 1.9 2.4 2.2 2.0 2.4 2.0 2.1 2.3 2.0 2.3 1.9 2.3 2.1 2.2 2.4 2.5 2.3 2.0 2.1 2.4 2.3 2.0
1.9 2.4 2.0 2.0 1.9 2 .1 2.3 1.9 2.2 2.0
563
Company Sanitized. Does not contain TSCA CBt
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Day 46
D ay 47
F e m a l e , V I I I - 2 5 0 m g/ k g / d a y
643341 643370 643446 643435 643466 643332
643404 643408 643359 643340 643487 643356 643329 643388 643450 643467 643443 643417 643413 643338 643335 643468 643440 643430 643431 643368 643326 643365 643375 643328 643348 643346 643449 643429 643424 643347
643456 643423 643345 643351 643358 643444 643474 643441 643481
2.1 2.5 2.2 1.9 2.1 2.0
2.0 2.1 2.2 2.1 1.9 2.0 2.1 1.9 2.4 2.2 2.0 2.4 2.0 2.1 2.3 2.0 2.3 1.9 2.3 2.1 2.2 2.4 2.5 2.3 2.0 2.1 2.4 2.3 2 .0
1.9 2.4 2.0 2.0 1.9 2.1 2.3 1.9 2.2 2.0
2.1 2.5 2.2 1.9 2.1 2.0 2.0 2 .1 2.2
2.1 1.9 2.0 2.1 1.9 2.4 2.2 2.0 2.4 2 .0 2.1 2 .3 2.0 2.3 1 .9 2 .3 2.1 2.2 2.4 2.5 2.3 2.0 2.1 2.4
2.3 2.0 1.9 2.4 2.0 2.0 1.9 2.1 2.3 1.9 2.2 2.0
INDIVIDUAL DOSE VOLUMES (mL)
48 D ay 4 9 D ay 50
51 D ay 52
2.1 2.5 2.2 1.9 2.1 2.0 2.0 2.1 2.2 2 .1 1.9 2.0 2.1 1.9 2.4 2.2 2.0 2.4 2.0 2.1 2.3 2.0 2.3 1.9 2.3 2.1 2.2 2.4
2.5 2.3 2.0 2.1 2.4 2.3 2.0 1.9 2.4 2.0 2.0 1.9 2.1 2.3 1.9 2.2
2.0
2.1
2.5 2.2 1.9 2.0 2.0 2.0 2.1 2.3 2.2 2.0 2.1 2.2 1.8 2.4 2.1 2.0 2.5 2.0 2.2 2.4 2.1 2.4 2.1 2.4 1.7 2.2 2.5 2.5 2.3 2.0 2.2 2.4
2.4 2.1 1.9 2.2 1.6 2.0 1.9 2.2 2.3 1.9 2.3 2.0
2.1 2.5 2.2 1.9 2.0 2.0 2.0 2.1 2.3 2.2 2.0 2.1 2.2 1.8 2.4 2.1 2.0 2.5 2.0 2.2 2.4 2 .1 2.4 2.1 2.4 1.7 2.2 2.5 2.5 2.3 2.0
2.2 2.4 2.4 2.1 1.9 2.2 1.6 2.0 1.9 2.2 2.3 1.9 2.3 2.0
2.1 2.5 2.2 1.9 2.0 2.0 2.0 2.1 2.3 2.2 2.0 2.1 2.2 1.8 2.4 2.1 2.0 2.5 2.0 2.2 2.4 2.1 2.4 2.1 2.4 1.7 2.2 2.5 2.5 2.3 2.0
2.2 2.4 2.4
2.1 1.9 2.2 1.6 2.0 1.9 2.2 2.3 1.9 2.3 2.0
2.1 2.5 2.2 1.9 2.0 2.0 2.0 2.1 2.3 2.2 2.0 2.1 2.2 1.8 2.4 2.1 2.0 2.5 2.0 2.2 2.4 2.1 2.4 2.1 2.4 1.7 2.2 2.5 2.5 2.3 2.0
2.2 2.4 2.4 2.1 1.9 2.2 1.6 2.0 1.9 2.2 2.3 1.9 2.3 2.0
D ay 53
D ay 54
2.1 2.5 2.2 1.9 2.0 2.0 2.0 2.1 2.3 2.2 2.0 2.1 2.2 1.8 2.4 2.1 2.0 2.5 2.0 2.2 2.4 2.1 2.4 2.1 2.4
AK TEST 2.2 2.5 2.5 2.3 2.0 2.2 2.4 2.4 2.1 1.9 2.2 1.6 2.0 1.9 2.2
2.3 1.9 2.3 2.0
2.1
2.5
2.2
1.9
22 .. 00
2.0
2.1 2.3 2.2 2.0 2.1 2.2
1.8 2.4 2.1 2.0 2.5
2.0 2.2 2.4 2.1 2.4 2.1 2.4
53
2.2 2.5 2.5 2.3 2.0
2.2 2.4 2.4 2.1 1.9 2.2
12.. 06
1.9 2.2
2.3 1.9 2.3
2.0
DuPont-5386
D ay 55
2.5 2.2
12 .. 90
2.0 2.0 2.1 2.3
2.2 2.0 2.1 2.2 1.8 2.4 2.1 2.0 2.5 2.0 2.2 2.4 2.1 2.4 2.1 2.4
2.2 2.5 2.5 2.3 2.0
2.4 2.4 2.1
1.9
2.2 1.6 2.0
1.9
2.2 2.3
1.9
2.3 2.0
564
Company Sanitized. Does not contain TSCA CBI
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
D ay 56
D ay 57
F e m a le , V I I I - 250 mg/k g /d a y
643341 643370 643446 643435 643466 643332 643404 643408
643359 643340 643487 643356 643329 643388 643450 643467 643443 643417 643413 643338 643335
643468 643440 643430 643431 643368 643326 643365 643375 643328 643348 643346 643449 643429 643424 643347 643456 643423 643345 643351 643358 643444 643474
643441 643481
2.1 2.5 2.3 1.9 2.2 1.9 2.0 2.1 2.3 2.3 2.0 2.1 2.1 1.3 2 .5 2.1 2.0 2.5 2.0 2.2 2.4 2.0
2.2 2.0 2.4
2.2 2.5 2.5 2.2 2.0 2.2 2.4 2.3 2.1 1.9 1.8 1.7 1.8 1.9 2 .1 2.3 1.9 2.2 2.0
2.1 2.5 2 .3 1 .9 2.2 1.9 2.0 2.1
2.3 2.3 2.0 2.1 2.1 1.3 2.5 2.1 2.0 2.5 2.0 2.2 2.4 2.0 2.2 2.0 2.4
2.2 2.5 2.5 2.2 2.0 2.2 2.4 2.3 2.1 1.9 1.8 1.7 1.8 1.9 2.1 2.3 1.9 2.2 2.0
D ay 58
2.1 2.5 2 .3 1 .9 2.2 1.9 2.0 2.1 2.3 2.3 2.0 2.1 2.1 1.3 2.5 2 .1 2 .0 2.5 2.0 2.2 2.4 2.0 2.2
2.0 2.4
2.2 2.5 2.5 2.2 2.0 2.2 2.4 2.3 2.1 1.9 1.8 1.7 1.8 1.9 2.1 2.3 1.9 2.2 2.0
INDIVIDUAL DOSE VOLUMES (mL)
D ay 59
D ay 60
D ay 61
D ay 62
2.1 2.5 2.3 1.9
2.2
12 .. 90
2.1 2.3 2.3
2.0 2.1 2.1 1.3 2.5
2.1
2.0 2.5 2.0 2.2 2.4
2.0
2.2 2 .0 2.4
2 .2 2 .5 2 .5 2.2 2 .0 2 .2 2.4 2 .3 2.1 1 .9 1 .8 1.7 1 .8 1 .9 2 .1 2.3 1 .9 2.2 2.0
2.1 2.5 2.3 1.9
2.2
12 .. 90
2.1 2.3 2.3
2.0 2.1 2.1 1.3 2.5
2.1 2.0 2.5
2.0
2.2 2.4
2.0
2.2 2.0 2.4
2.2 2.5 2.5 2.2 2.0 2.2 2.4 2.3 2.1 1.9 1.8 1.7 1.8 1.9 2.1 2.3 1.9 2.2 2.0
2.1 2.5 2.3 1.9
2.2
21 .. 90
2.1 2.3 2.3 2.0 2.1 2.1 1.3 2.5
22 .. 10
2.5
2.0
2.2 2.4
2.0
2.2 2.0 2.4
2.2 2.5 2.5 2.2 2.0 2.2 2.4 2.3 2.1 1.9 1.8 1.7 1.8 1.9 2.1 2.3 1.9 2.2 2.0
2.1 2.5 2.3 1.9
2.2
12 .. 90
2.1 2.3 2.3
2.0 2.1 2.1 1.3 2.5 2.1 2.0
22 ..50
2.2 2.4 2.0 2.2 2.0 2.4
2.2 2.5 2.5 2.2 2.0 2.2 2.4 2.3 2.1 1.9 1.8 1.7 1.8 1.9 2.1 2.3 1 .9 2.2 2.0
D ay 63
2.1 2.3 2.3 1.9 2.1 1.9
22 .. 00
2.4
22.. 01
2.2 2.2 1.8 2.5 2.1 2.0 2.4 2.1 2.2 2.3 2.0 -a 2.0 2.5
1.9 2.5 2.5 2.1 1.9 2.3 2.4 2.3 2.1 2.0 2.3 1.9 2.0 1.6 2.2 2.0 1.9 2.0 2.0
D ay 64
2.1 2.3 2.3 1.9 2.1
122 ... 900
2.4
22 .. 10 2.2
2.2 1.8 2.5
22 .. 10
2.4 2.1 2.2 2.3 2.0 x.a 2.0 2.5
1.9 2.5 2.5 2.1 1.9 2.3 2.4 2.3 2.1 2.0 2.3 1.9 2.0 1.6 2.2 2.0 1.9 2.0 2.0
DuPont-5386
D ay 65
2.1 2.3 2.3 1.9 2.1
2.1 2.0 2.2 2.2 1.8 2.5 2.1 2.0 2 .4 2.1 2.2
22 .. 30
2.0 2.5
1.9 2.5 2 .5 2.1 1.9 2.3 2.4 2.3 2.1 2 .0 2.3 1.9 2.0 1 .6 2 .2 2.0 1 .9 2 .0 2.0
565
Company Sanitized. Does not contain TSCA CBI
J. w'
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
D ay 66
D ay 67
F e m a le , V III - 250 mg/k g /d a y
643341 643370 643446 643435 643466 643332 643404 643408
643359 643340 643487 643356 643329 643388 643450 643467 643443 643417 643413 643338 643335 643468 643440 643430 643431 643368 643326 643365 643375 643328 643348 643346
643449 643429 643424 643347 643456 643423 643345 643351 643358 643444 643474 643441
643481
2.1 2.3 2.3 1.9 2.1 1.9 2.0 2.0 2.4 2.1 2.0 2.2 2.2 1.8 2.5 2.1 2.0 2.4 2.1 2.2 2.3 2.0
l.B 2.0 2.5
1.9 2.5 2.5 2.1 1.9 2.3 2.4 2.3 2.1 2.0 2.3 1.9 2.0 1.6 2.2
2.0 1 .9 2.0 2.0
2.1 2.3 2.3 1.9 2.1 1.9 2 .0 2.0 2.4 2.1 2.0 2.2 2.2 1.8 2.5 2.1 2.0 2.4 2.1 2.2 2.3 2.0 1.8 2.0 2.5
1.9 2 .5 2.5 2.1 1.9 2.3 2.4 2.3 2.1 2.0 2.3 1.9 2.0 1.6 2.2 2.0 1 .9 2 .0 2.0
D ay 68
2.1 2.3 2.3 1.9 2.1 1.9 2.0 2.0 2.4 2.1 2.0 2.2 2.2 1 .8 2.5 2.1 2.0 2.4 2.1 2.2 2.3 2.0 1 .8 2.0 2.5
1.9 2.5 2.5 2.1 1.9 2.3 2.4 2.3 2.1 2.0 2.3 1.9 2.0 1.6 2.2 2.0 1.9 2.0 2.0
INDIVIDUAL DOSE VOLUMES (mL)
D ay 69
D ay 70
D ay 71
D ay 72
2 .1 2.3 2.3 1.9 2.1
1.9 2.0 2.0 2.4
FD TEST 2.0 2.2 2.2 1 .8 2.5 2.1 2.0 2.4 2.1 2.2 2.3 2.0 1.8 2.0 2.5
DAY
2.1 2.2 2.3 1.9 2.2 2.0 2.1 2.1 2.4
69 1.9 2.2 2.2 1.9 2.6 1.7 1.9 2.4 2.1 2.2 2.2 1.5 1.5 1.7 2.1
1 .9 2.5 2.5 2.1 1.9 2.3 2.4 2.3 2 .1 2.0 2.3 1.9 2.0 1.6 2.2
2.0 1.9 2.0
2.2 2.4 2.4 2.2 2.0 2.4 2.5 2.1
2.0 2.0 2.4 1.9 2.0 2.0 2.2
2.0 2.0 2.2 2.1
to
o
2 .1 2.2 2.3 1.9 2.2 2.0 2 .1 2.1 2.4
1.9 2.2 2.2 1.9 2.6 1.7 1.9 2.4 2.1 2.2 2.2 1.5 1.5 1.7 2.1
2.2 2.4 2.4 2.2 2.0 2.4 2.5 2.1 2.0 2.0 2.4 1.9 2.0 2.0 2.2 2.0 2.0 2.2 2.1
2.1 2.2 2.3 1.9 2.2 2.0 2.1 2.1
2.4
1.9 2.2 2.2
12 .. 96
1.7 1.9 2.4 2.1 2.2 2.2 1.5 1.5 1.7
2.1
2.2 2.4 2.4 2.2 2.0 2.4 2.5 2.1 2.0 2.0 2.4 1.9 2.0 2.0 2.2
2.0 2.0 2.2 2.1
INDIVIDUAL DOSE VOLUMES (mL)
D ay 73
2.1 2.2 2.3 1.9 2.2 2.0 2.1 2.1 2.4
1.9 2.2 2.2
1.9
2.6 1.7 1.9 2.4 2.1 2.2 2.2 1.5 1.5 1.7 2.1
2.2 2.4 2.4 2.2 2.0 2.4 2.5 2.1 2.0 2.0 2.4 1.9 2.0 2.0 2.2 2.0 2.0 2.2 2.1
D ay 74
2.1 2.2 2.3 1.9 2.2 2.0 2.1 2.1 2.4
1.9 2.2 2.2
12 ..96
1.7 1.9 2.4 2.1 2.2 2.2 1.5 1.5 1.7 2.1
2.2 2.4 2.4 2.2 2.0 2.4 2.5 2.1 2.0 2.0 2.4 1.9 2.0 2.0 2.2 2.0 2.0 2.2 2.1
DuPont-5386
D ay 75
2.1 2.2 2 .3 1.9 2.2 2.0 2.1 2.1 2.4 1.9 2.2 2.2 1.9
2.6
2.0
2.4 1.9 2.0 2.0 2.2 2.0 2.0 2.2 2.1
566
Company Sanitized Does not contain TSGA CBI
H -24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
D ay 76
D ay 77
D ay 78
D ay 79
D ay 80
F e m a le , V I I I - 250 mg/k g /d a y
643341 643370 643446 643435 643466 643332 643404
643408
643359 643340 643487
643356
643329 643386 643450 643467 643443 643417 643413 643338 643335 643468 643440 643430 643431 643368 643326 643365 643375 643328 643348 643346 643449 643429 643424 643347
643456 643423 643345 643351 643358 643444 643474 643441 643481
2.1 2 .2 2.3 1.9 2.2 2.0 2.1 2.1 2.4
1.9 2.2 b 2.2 1.9 2.6
2.0 2.2 2.3 1.9 2.1 2.0 2.0 2.1 2.5
1.7
2.2 1.9 1.8 2.1
2.0 2.0 2.4 2.4 1.9 1.9 2.0 2.0 2.0 2.1 2.2 2.2 2.0 2.1 2.0 1.8 2.2 2.3 2.1 1.9
2.0 2.2 2.3 1.9 2.1 2.0 2.0 2.1 2.5 1.7 2.2 1.9 1.8 2.1
2.0 2.4 1.9 2.0 2.1 2.2 2.1 1.8 2.3 1.9
2.0 2.2 2.3 1.9 2.1 2.0 2.0 2.1 2.5 1.7 2.2 1.9 1.8 2.1
2.0 2.4 1.9 2.0 2.1 2.2 2.1 1.8 2.3 1.9
2.0 2.2 2.3 1.9 2.1 2.0 2.0 2.1 2.5 1.7 2.2 1.9 1.8 2.1
2.0 2.4 1.9 2.0 2.1 2.2 2.1 1.8 2.3 1.9
4
DuPont-5386
01 D a y 82 D ay 03 D a y 84 D a y 85
2.0 2.0 2.0 2.2 2.2 2.2 2.2 2.2 2.5 2.5
2.3 2.3 2.3 2.4 2.4
1.9 1.9 1.9 1.9 1.9
2.1 2.1 2.1 2.2 2.2
2.0
2.0
2 .0
2.1
2.1
2.0 2.0 2.0 2.1 2.1
2.1 2.1 2.1 2.3 2.3 b
2.5 2.5 2.5 2.5 2.5
to to
1.7 1.7 1.7 2.0 2.0
2.2 2.2 2.3 2.3 1.9 1.9 1.9 2.3 2.3 1.8 1.8 1.8 2.0 2.0 2.1 2.1 2.1 2.5 2.5
2.0 2.0 2.0 2.0 2.0 2 .4 2.4 2.4 2.6 2.6 1.9 1.9 1.9 2.1 2.1 2.0 2.0 2.0 2.2 2.2 2.1 2.1 2.1 2.1 2.1 2.2 2.2 2.2 2.3 2.3 2.1 2.1 2.1 2.3 2.3 1.8 1.8 1.8 2.0 2.0 2.3 2.3 2.3 2.5 2.5 1.9 1.9 1.9 2.1 2.1
Company Sanitized. Does not contain TSCA CBI
H-24516: Subchronic Toxicity
D ay 86
D ay 87
F e m a le , V III - 250 mg/k g /d a y
643341 643370 643446 643435 643466 643332 643404 643408 643359 643340 643487 643356
643329 643388 643450 643467
643443 643417 643413 643338 643335 643468 643440 643430 643431 643368 643326 643365 643375 643328 643348 643346 643449 643429 643424 643347 643456
643423 643345 643351 643358
643444 643474 643441 643481
2.2 2.5 2.4 1.9 2.2 2.1 2.1 2.3 2.5 2.0 2.3 2.3 2.0 2.5
2.0
2.6
2.1 2.2 2.1 2.3 2.3 2.0 2.5 2.1
2.2 2.5 2.4 1.9 2.2 2.1 2.1 2.3 2.5 2 .0 2.3 2.3 2.0 2.5
2 .0
2.6
2.1 2.2 2.1 2.3 2.3 2.0 2.5 2.1
D ay 88
2.2 2.5 2.4
2.5 2.0 2.3 2.3 2.0 2.5
2.0 2.6 2.1 2.2 2.1 2.3 2.3 2.0 2.5 2.1
D ay 89
2.2
2.5 2.4 1.9 2.2 2.1 2.1 2.3 2.5 2.0 2.3 2.3 2.0 2.5
2.0 2.6 2.1 2.2 2.1 2.3 2.3 2.0 2.5 2.1
Li D O S E V O L U M E S (m L )
90 D ay 91 D ay 92
2.2 2.2 2.2 2.5 2.6 2.6 2.4 2.2 2.2 1 . 9 1 . 9 1 .9 2.2 2.2 2.2 2.1 2.1 2.1 2.1 2.0 2.0 2.3 2.3 2.3 2.5 2.6 2.6
DuPont-5386
568
Company Sanitized. Does not contain TSCA CBI
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5386
APPENDIX C INDIVIDUAL BODY WEIGHTS
569
Company Sanitized. Does not contain TSCA CBl
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
INDIVIDUAL BODY WEIGHTS
EXPLANATORY NOTES
DuPont-5386
Critical Dates
Day 74 Male and female rats designated for reproduction evaluations were co-housed. Body weights
collected during the cohabitation and post-mating periods are reported in the Reproductive Toxicology section. Day 91 Male rats designated for the 90-day exposure period were sacrificed. Day 93 Female rats designated for 90-day exposure period were sacrificed. Day 119 Last day of non-fasted body weight data collection for rats designated for the one-month recovery period. Day 125 Male and female rats designated for the one-month recovery period were sacrificed Day 175 Last day of non-fasted body weight data collection for rats designated for the 3-month recovery penod. Day 181 Male and female rats designated for 3-month recovery period were sacrificed.
Abbreviations
AK Accidentally Killed FD Found Dead SE Sacrificed in extrem is
570
Company Sanitized. Does not contain TSCA CBI
H -24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Day 0
M a le , I - 0 mg/k g /d a y
643241 643300 643143 643205 643235 643288
643150 643189 643185 643210 643268 643232 643265 643239 643270 643148 643284 643229 643196 643176 643218 643207 643280 643271 643211 643163 643197 643242 643251 643155 643147 643276 643237 643226 643195 643246 643253 643262 643172 643303 643304 643162 643254 643145 643204
278.0 237.5 237.1 262.8 282.1
246.7 235.8
253.6 254.9 254.0 264.6 263.0 244.5 274.2 236.7 246.4 277.8 237.8 207.6 249.3 265.9 243.4 231.5 257.2 253.4 268.6 252.9 244.2 244.9 240.4 251.3 281.7 236.4 245.1 242.2 298.8 243.1 254.1 256.0 227.0 211.2 227.3 220.3 248.7 265.6
Day 7
347.0 296.9 291.5 313.3 345.3 311.5 290.4 323.7 320.6 304.8 321.1 309.7 292.8 336.3 291.4 296.4 341.8 282.6 255.6 300.5 311.9 285.4 279.3 317.0 306.4 335.4 315.7 307.5 295.6 294.8 313.7 352.7 277.9 290.7 300.1 357.6 297.0 311.4 315.6 286.3 261.4 284.3 268.7 291.4 322.1
D ay 14
409.3 347.2 340.0 356.7 409.6 361.6 340.4 383.9 377.6 350.2 377.0 338.8 342.8 383.7 343.2 345.3 391.5 316.6 298.9 347.8 359.0 326.2 336.3 382.3 351.0 393.3 364.9 356.2 350.4 348.8 358.7 422.7 321.0 336.3 346.6 426.4 352.7 372.2 370.4 343.9 303.5 331.6 305.7 334.6 370.7
INDIVIDUAL BODY WEIGHTS (g)
D ay 21
D ay 28
D ay 35
451.2 392.9 381.3 409.0 459.2
413.8 362.3 431.3 422.4 392.1 433.9 381.3 396.9 429.6 384.1 382.5 432.3 352.1 330.0 392.6 402.9 359.2 375.5 425.2 392.3 443.0 415.5 401.4 389.9 389.5 396.8 466.9 360.2 367.4 380.9 467.6 404.2 421.4 426.6 389.2 338.4
365.0 334.2 369.7 407.6
497.6 423.9 419.4 447.6 511.4
459.6
383.1 468.9 , 459.8 427.6 468.7 396.6 416.7 464.4 414.4 412.6 473.6 371.3 351.7 427.3 434.6 389.8 407.6 470.9 423.7 482.2 445.2 434.9 417.9 415.4 434.0 502.7 390.9 396.2 407.6 501.7 431.4 452.5
463.9 433.7 370.3 391.1 366.5 397.1 447.8
522.6 455.5 442.7 473.2 535.6 488.3 409.2 492.0 483.3 444.7 504.2 410.7 440.4 489.6 438.3 445.1 501.1 388.2 373.4 451.9 456.5 420.4 442.7 499.1 445.2 524.1 473.0 464.8 435.3 432.1 464.8 542.2 406.0 413.9 426.8 533.1 456.5 493.0 490.3 471.4
391.1 415.9 396.8 433.7 468.8
D ay 42
549.7 483.5 463.6 504.0 571.7 514.2 426.9 520.1 512.9 471.0 524.6 428.1 475.7 522.0 461.4 459.8 535.2 410.2 403.1 480.0 478.7 434.9 472.2 531.5 464.3 548.7 493.2 497.1 455.0 454.4 486.7 565.8 429.5 440.8 460.0 562.4 490.6 517.7 516.2 502.6 418.0 426.5 420.8 459.3 494.1
D ay 49
571.4 501.2 474.5 517.2 584.1 521.8 430.0 515.9 515.0 492.5 545.3 450.8 489.4 542.2 474.4 481.2 555.9 422.3 412.5 493.7 506.2 455.5 489.0 558.3 488.8 574.8 514.0 525.7 478.1 490.8 502.6 600.1 446.6 474.4 479.3 577.3 510.1 543.6 534.6 531.3 436.4 436.8 437.4 481.9 500.7
DuPont-5386
D ay 56
589.6 530.7 492.2 538.3 599.1 549.9 443.8 545.3 539.1 492.2 561.8 452.3 489.5 564.1 491.5 498.7 578.0 437.6 428.9 503.9 529.5 461.7 516.2 583.4 507.0 600.3 539.2 545.5 495.4 528.8 526.7 620.2 463.8 495.9 501.9 592.1 537.3 560.1 569.2 549.6 450.9 416.9 455.2 477.8 521.4
571
Comparii Sanitized. Ones not contain ISCA CBI
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations_________________ _
INDIVIDUAL BODY WEIGHTS (g)
M ale, I
643241 643300 643143 643205 643235 643288 643150 643189 643185 643210 643268 643232 643265 643239 643270 643148 643284 643229 643196 643176 643218 643207 643280 643271 643211 643163 643197 643242 643251 643155 643147
643276 643237 643226 643195 643246 643253 643262 643172 643303 643304 643162 643254 643145 643204
D ay 63
D ay 70
0 mg/k g /d a y
607.0 554.5 496.9 546.8 622.4
565.9 461.8 568.6 556.6 512.5 558.0 476.2 489.4
582.8 502.5 508.0 597.3 452.8 442.9 525.7 548.2 480.5 536.5 606.7 518.8 619.7 553.9 571.0 514.1 551.5 539.4 646.7 479.4 515.0 523.1 609.6
545.9 573.9 586.1 568.3 466.6 401.9 471.1 495.0 542.5
621.5 570.0 508.2 563.6 632.0
584.2 474.4 583.2 566.5 528.8 583.0 490.3 501.0 600.6 508.3 509.9 620.1 463.8 451.8
. 533.9 558.2 506.4 557.2 628.5 533.2 643.8 568.9 589.1 524.1 568.0 564.1 676.8 490.4 530.2 540.0 634.0 570.3 592.2 607.0 579.8 480.7 416.8
481.9 504.0 557.6
D ay 74
603.0 510.3 512.4 629.2 469.0 458.8 534.3 568.8 504.9 563.1 624.9 531.3 644.0 573.1 586.3 531.5 593.7 562.4 682.3
478.3
D ay 77
625.0 582.2 516.7 575.1 640.7 596.8 475.8 600.7 582.7 532.8 575.4 505.9 511.4
D ay 84
637.6 594.8 522.5 584.9 657.5 607.1 485.5 613.5 600.6 551.0 589.5 524.7 511.0
505.6 544.4 545.0 641.7 579.1 600.4 620.8 594.0 496.4 378.9
,
495.6 564.4
507.0 550.0 559.9 643.8 599.8 598.8 629.3 607.2 504.3 402.4
515.2 590.1
D a y 90
640.6 601.4 524.1 593.0 665.2 602.7 492.0 628.9 610.2 546.8 573.8 530.6 '5 2 2 . 9
510.5 557.8 572.6 661.1 605.5 608.8 634.6 616.0 508.2 413.3 522.0 595.4
D a y 98
560.0 609.2 547.9 523.9
525.6 577.0 577.3 685.8 637.0 632.1 649.7 640.5 522.5 448.1 536.6
D ay 105
576.6 631.3 533.8 528.2
526.7 594.0 591.4 696.6 645.3 654.2 663.2 657.4 532.4 417.3 544.3
DuPont-5386
D ay 112
587.3 648.2 546.4 533.8
533.0 602.7 618.6 700.1 654.4 664.3 673.9 667.9 544.0 448.3 554.5
572
Company Sanitized. Does not contain TSC C8I
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
INDIVIDUAL BODY WEIGHTS (g)
M ale, I
643241 643300 643143 643205 643235 643288 643150 643189 643185 643210 643268 643232 643265 643239 643270 643148 643284 643229 643196 643176 643218 643207 643280 643271 643211 643163 643197 643242 643251 643155
643147 643276 643237 643226 643195 643246 643253 643262 643172 643303 643304 643162 643254 643145 643204
D ay 119
D ay 126
0 mg/k g /d a y
596.0 601.4 547.3 533.8
578.7 622.5 548.2 538.2
536.4 609.3 '6 2 1 . 1 702.0 661.4 678.7 673.0 671.7 539.2 434.2
555.3
549.0
D ay 133
600.9 636.3 556.5 548.9
569.0
Day 140
600.0 657.5 578.8 553.5
573.0
Day 147
610.7 672.6 593.0 569.2
546.0
D ay 154
616.7 678.3 601.7 579.6
558.4
D ay 161
620.1 693.2 606.0 579.4
573.3
D ay 168
618.8 697.8 621.4 574.1
583.2
DuPont-5386
D ay 175
' 632.6 720.7 644.4 585.5
594.1
573
Company Sanitized. Does not contain TSCA CBI
H -24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
INDIVIDUAL. BODY WEIGHTS (g)
D ay 181
M a le , X - 0 mg/k g /d a y
643241 643300 643143 643205
643235
643288 643150 643189 643185 643210 643268 643232 643265 643239 643270 643148 643284 643229 643196 643176 643218 643207 643280 643271 643211 643163 643197 643242 643251 643155 643147 643276 643237 643226
643195 643246 643253 643262 643172 643303
643304 643162 643254 643145 643204
606.2 687.8 617.5 576.9
557.8
DuPont-5386
574
CwnPany Sanitized. Does not contain TSCA CBI
H -24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
INDIVIDUAL BODY WEIGHTS (g)
Day 0
Day 7
Male, I I I - 25 mg/kg/day
643173 643290 643272
643292
643228
643308
643264
643240
643180 643179
643202
643310
643306 643305 643293
643287 643188 643230 643170
643144 643277 643214
643261 643166 643153
643177 643198
643291
643184
643167 643223 643233 643183
643219 643263
239.1 214.9 227.0
246.5
276.0
259.3
273.4
254.7
240.6
261.6
229.4
259.8 216.0 272.6
245.5
205.8 263.6 261.9 258.0 192.6
251.8 261.5 261.6
231.5 242.3 242.7
273.5
256.8
241.7 252.6 255.0 241.1
262.6 269.4 228.7
302.6 272.0 277.8
300.7
346.4
326.3
332.3 302.4
302.8
313.9 281.6
316.0 259.7
319.4
299.3
255.4
331.6 310.9 322.2
243.1 309.3 325.0 320.0
278.3 292.7
305.5 340.7
318.7
297.3
315.8 312.5 287.6
322.4 327.0 282.5
Day 14
350.3 323.6 325.4 345.8 407.7 386.4 390.6 359.8 362.0 370.9 327.0 364.2 301.6 368.2 352.5 302.0 396.0 350.4 374.9 294.6 365.3 374.6 384.2 337.7 347.4 357.8 402.4 379.9 340.9 377.2 355.7 329.5 368.7 383.1 323.1
Day 21
384.9 357.9 354.9 386.2 450.9 424.1 429.0 377.9 395.4 410.4 356.7 413.5 331.0 401.3 391.4 337.8 438.5 380.0 412.6 329.2 415.2 415.9 421.9 372.1 375.3 402.5 447.9 418.5 369.5 420.1 391.5 358.1 404.3 416.9 356.1
Day 28
423.0 397.1 394.8 424.0 493.7 464.8 465.1 411.6 437.0 443.9 384.8 449.6 365.6 421.8 422.9 369.6 479.3 410.3 449.1 366.6 455.3 460.9 449.8 411.4 416.0 439.7 489.6 459.9 384.5 451.4 418.2 381.9 444.8 456.9 388.9
Day 35
470.2 433.2 412.3 457.9 540.2 498.7 504.4 433.6 478.1 462.1 411.0 475.5 388.1 456.8 461.6 397.0 505.2 433.9 478.6 385.9 487.5 487.4 487.0 443.3 453.5 474.8 522.3 490.4 396.2 487.2 440.8 409.5 480.5 489.3 416.2
Day 42
477.0 462.5 434.7 483.0 560.1 520.4 527.8 446.3 509.5 479.6 428.5 494.6 407.9 468.8 479.7 412.1 522.5 444.8 498.5 409.2 516.2 505.8 503.9 457.3 460.1 492.0 536.6 513.4 413.5 500.3 462.4 422.4 505.7 511.2 430.1
Day 49
490.5 472.6 444.7 489.0 570.3 529.1 536.6 445.4 518.4 480.8 446.9 502.0 407.3 487.3 499.0 422.8 547.8 461.7 513.0 424.6 535.8 510.3 524.0 486.6 470.1 513.4 563.7 531.7 420.6 508.6 475.0 428.4 530.2 532.8 456.4
DuPont-5386
Day 56
51.6 502.0 459.8 502.5 601.8 553.1 564.2 457.0 534.6 497.9 444.1 522.3 420.1 496.7 522 4 436.0 582.7 473.4 523.3 438.4 553.3 531.7 546.0 506.9 492.3 532.3 582.2 551.9 436.4 520.8 488.9 392.3 547.5 549.3 470.9
575
Company Sanitized. Does not contain TSCA CBI
H -24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
INDIVIDUAL BODY WEIGHTS (g)
D ay 63
D ay 70
M a le , XXI - 25 m g/k g / d a y
643173 643290 643272 643292
643228 643308 643264 643240 643180 643179 643202 643310 643306 643305 643293 643287 643188 643230 643170 643144 643277 643214 643261 643166 643153 643177 643198 643291 643184 643167 643223 643233 643183
643219 643263
524.4 513.5 487.6 520.8 625.8
564.5 589.3 468.4 554.5 495.5 448.4 535.0 426.4 512.2 540.9 448.0 602.5 489.3 546.0 456.7 582.8 548.6 569.2 526.3 511.4 549.2 589.5 568.2 433.2 537.4 502.2 440.6 565.1 572.6 479.7
528.6 529.0 504.8 534.8
646.0 588.3 603.8 482.3 553.3 514.6 459.8 554.8 438.1 530.6 553.4
466.8 614.3 495.6 564.5 474.3 600.0 557.6 591.6 552.5 525.4 562.8 605.3 591.3 441.2 553.7 516.6 460.8 576.7 586.0 493.3
D ay 74
464.4 627.9 498.8 562.9 469.4 604.5 574.2 594.0 559.7 536.0 566.0 624.1 593.3 461.8 555.7 523.6 480.3 585.6 587.9 495.4
D ay 77
544.9 544.5 520.7 537.5 663.3 600.9 622.6 488.9 557.5 525.3 466.6 553.1 444.8 537.2 547.1
'
D a y 84
540.5 561.0 538.4 536.4 685.3 625.9 635.0 499.6 576.5 541.1 471.6 565.6 461.3 543.1 553.5
D ay 90
514.0 573.3 549.4 541.3 699.3 630.5 651.5 507.7 573.7 543.5 483.2 567.1 464.0 549.6 562.8
D ay 98
489.9 581.8 482.5 564.1 579.5
D ay 105
500.1 597.1 485.5 578.7 587.6
DuPont-5386
D ay 112
508.4 580.5 490.4 597.1 607.7
576
Company Sanitized. Does not contain TSCA CBI
H -24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations __________________ _______________________________________ DuPont-5386
INDIVIDUAL BODY WEIGHTS (g)
D ay 119
Day 126
M a le , I I I - 25 mg/k g /d a y
643173 643290 643272 643292 643228 643308 643264 643240 643180 643179 643202 643310 643306 643305 643293 643287 643188 643230 643170 643144 643277 643214 643261 643166 643153 643177 643198 643291 643184 643167 643223 643233 643183 643219 643263
509.3 565.5 471.9 609.8 606.0
509.9 572.8 479.5 590.0 574.3
D ay 133
521.6 595.9 503.7 581.0 603.1
D ay 140
518.4 605.8 503.3 604.0 617.6
D ay 147
525.8 623.0 514.4 617.7 628.8
D ay 154
532.0 620.3 511.9 630.9 637.5
D ay 161
534.7 626.3 517.1 638.6 644.0
D ay 168
541.9 635.2 529.6 653.5 650.3
D ay 175
550.2 640.2 531.8 672.8 653.7
577
Company Sanitized. Does not contain TSCA CBI
H -24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
INDIVIDUAL BODY WEIGHTS (g)
D ay 181
M a le , I I I - 25 mg/k g /d a y
643173 643290 643272 643292 643228 643308 643264 643240 643180 643179 643202
643310 643306 643305 643293 643287 643188 643230 643170 643144 643277 643214 643261 643166 643153 643177 643198 643291 643184 643167 643223 643233 643183 643219 643263
523.6
618.7 514.8 644.7 620.2
DuPont-5386
578
Company
Does not contain TSCA CBS
H -24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
INDIVIDUAL.BODY WEIGHTS (g)
Day 0
Day 7
M a le , V - 100 mg/k g /d a y
643250 643243
643311 643318 643247
643175
643314
643275 643257 643224 643169 643159 643286 643181 643206 643313 643182 643146 643312 643199 643267
643216 643244
643245 643301 643200 643255 643157 643238 643227 643164 643154 643156 643208 643190
229.7 230.7
236.3 260.0
280.3 260.0 263.1
271.8 236.3 253.3 231.9 267.5 210.0 280.8 239.5 206.6 248.0 275.5 244.2 241.3 248.4 271.2 249.9 231.1 255.1 244.3 256.6 241.6 257.0 262.7 250.5 243.9 266.4 245.0 273.7
275.3 288.5 297.5 321.5 353.1
321.8 328.2
323.6 302.8 302.9 277.3 306.7 252.5 333.0 286.7 266.7 310.5 327.6 303.7 311.3 310.4 337.7 303.2
276.2 311.6 307.8 314.2 295.0 307.2 330.3 325.4 297.9 330.2 302.6 333.5
D ay 14
311.4 347.9 355.8 373.2 413.5 370.2 371.5 365.2 347.1 341.1 326.1 356.6 286.5 377.1 324.4 315.4 372.2 373.7 347.0 373.9 370.9 398.3 356.6 313.6 361.5 361.8 372.5 347.0 349.9 380.1 382.1 340.4 381.4 347.3 384.1
Day 2 1 ,
D ay 28
352.4 386.2 385.5 428.9 449.9
423.3 410.1 407.2 387.3 374.5 367.6 394.2 327.5 409.5 366.0 356.1 421.5 420.0 383.5 422.1 418.1 450.8 392.8 348.4
403.0 402.1 420.5 387.2 396.5 411.4 426.5 387.0 428.0 390.3 422.4
. ,
385.1 420.0 418.7 462.6 477.0
453.1
431.8 447.9 408.9 404.5 400.8 431.5 361.4 437.5 384.6 394.4 463.8 , 452.0 403.6 466.4 451.2 488.1 426.7 . 378.3 439.3 442.9 460.7 421.9 411.0 448.5 471.1 415.0 467.0 411.9 450.4
D ay 35
395.5 447.4 444.2 494.4 496.7 480.4 452.1 469.6 436.2 420.0 420.2 466.1 389.5 462.1 397.7 420.1 496.5 479.7 418.1 482.0 483.7 522.6 447.3 391.4 466.3 466.1 480.4 453.2 434.9 469.4 499.8 437.8 492.5 433.8 481.2
D ay 42
408.9 469.2 466.3 512.8 526.4 503.8 477.8 488.0 451.8 436.4 439.8 480.7 411.9 490.6 4 1 8 .0 ' 442.7 513.6 495.2 433.0 488.3 501.5 545.1 469.6 403.4 484.5 496.6 513.1 478.9 460.5 500.7 519.7 459.2 518.3 458.8 502.1
D ay 49
422.1 481.1 475.2 523.8 480.4 509.0 492.6 500.2 459.5 446.2 449.4 498.9 435.9 518.5 443.3 466.4 528.5 512.3 439.0 507.9 533.6 565.4 490.9 418.6 504.1 511.8 539.6 503.9 488.2 531.6 546.4 480.6 549.9 481.7 521.2
DuPont-5386
D ay 56
440.1 496.8 481.7 538.3 504.2 532.2 505.1 521.0 474.9 450.1 447.0 515.8 447.5 533.3 440.1 485.4 548.9 527.2 463.6 519.5 535.7 578.5 494.6 437.0 521.7 529.4 557.6 522.3 511.5 548.9 566.2 494.2 574.7 500.5 538.7
579
Company Sanitized, Ones not contain TSCA CBI
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
INDIVIDUAL BODY WEIGHTS (g)
D ay 63
D ay 70
M a le , V - 100 mg/k g /d a y
643250 643243 643311 643318 643247 643175 643314
643275 643257 643224 643169 643159 643286
643181 643206 643313 643182 643146 643312 643199 643267
643216 643244 643245 643301 643200 643255 643157 643238 643227 643164 643154 643156 643208 643190
458.6 520.0 494.5 549.9 527.4 526.3 516.8 541.3 485.0 467.1 448.5 532.6 471.8 541.8 460.9 502.2 567.2 544.7 486.8 529.0 545.3
597.9 520.1 459.4 540.3 546.4 583.6 555.1 528.7 561.0 581.6 509.0 598.7 519.4 567.0
472.1 532.4 508.7 563.5
545.3 454.6 531.0
560.5 496.1 471.5 469.4 536.5 484.2 570.7 473.7 511.2 582.9 573.3 502.0 544.7 568.2
607.6 514.6 469.9 559.1 564.3 601.7 575.1 547.4 577.4 602.5 516.2 615.1 529.6 562.5
D a y 74
514.2 588.1 573.8 513.4 551.5 570.1 605.8 508.5 468.8 561.0 570.6 612.3 576.5 547.3 589.1 602.9 514.9 610.9 529.4 561.8
D ay 77
D a y 84
D ay 90
470.0 543.5 511.3 570.8 555.9 397.4 538.2 562.2 501.5 480.8 475.8 544.8 490.8 590.3 472.9
485.1 548.3 519.3 575.6 562.6 AK TE ST DAY 77 476.3
542.8 513.3 491.0 486.1 534.0 501.8 599.8 489.0
492.6 554.5 526.4 593.3 572.4
529.3 541.2 520.6 490.7 488.4 532.7 498.4 599.1 496.3
D a y 98
506.9 545.3 496.8 588.8 501.8
D ay 105
514.8 427.7 509.2 613.1 502.8
DuPont-5386
D ay 112
515.4 463.3 513.5 638.1 496.8
580
Company Sanitized Does not contain TSCA CBI
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
INDIVIDUAL BODY WEIGHTS (g)
D ay 119
D ay 126
M a le , V - 100 mg/k g /d a y
643250 643243 643311 643318
643247
643175 643314 643275 643257 643224 643169 643159 643286 643181 643206 643313 643182 643146 643312 643199 643267 643216 643244 643245 643301 643200 643255 643157 643238 643227 643164 643154 643156 643208 643190
497.5 515.1 503.2 636.4 506.4
517.7 539.7
461.5 631.3 505.3
D ay 133
510.3 555.0 504.4 635.1 520.8
D ay 140
523.2 574.0 527.3 657.0 521.1
D ay 147
535.0 587.4 544.4 676.0 532.0
D ay 154
548.3 609.0 556.8 688.4 533.0
D ay 161
555.9 611.1 557.1 706.6 542.4
D ay 168
569.3 620.0 563.7 738.4 548.5
DuPont-5386
D ay 175
574.5 626.5 579.6 757.2 555.4
581
Company Sanitized Does not contain TSCA CBI
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
___________________________________________________ DuPont-5386
INDIVIDUAL BODY WEIGHTS (g)
D ay 181
M a le , V - 100 mg/k g /d a y
643250 643243 643311 643318
643247
643175 643314 643275 643257 643224 643169 643159 643286 643181 643206 643313 643182 643146 643312 643199 643267 643216 643244 643245 643301 643200 643255 643157
643238 643227 643164 643154 643156 643208 643190
555.3 608.8 558.5 729.9 534.3
582
Company Sanitized. Poes not contain TSCA CBS
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
INDIVIDUAL BODY
Day 0
Day 7
M a le , V II - 250 mg/k g /d a y
643194 643252 643260 643315
643215 643193 643298 643201 643259 643174 643283 643149 643178 643152 643295 643289 643171 643158 643249 643161 643309 643248 643285 643278 643299 643274 643192 643222
643160 643191 643203 643282 643302 643317 643225 643296 643258 643316 643220 643236 643165 643266 643151 643234 643281
238.2 224.4 230.1 236.0 267.2 265.5 251.8 266.4 242.1 275.9 238.2 261.9 226.2 286.4 250.2 211.8 263.8 264.8 249.1 255.7 285.9 256.2 249.3 235.1 239.6 237.1 261.3 260.1 244.4 273.4 252.4 277.8 246.7 250.3 263.9 274.6 234.0 236.7 249.0 246.7 239.2 248.3 234.2 281.8 239.4
296.9 287.0 281.8 289.8
326.9 335.0 325.1 334.3 294.4 348.3 294.3 313.8 274.0 353.0 303.9 268.2 334.8 337.4 307.1 319.2 367.2 310.3 307.8 293.7 300.4 298.9 322.5 321.7 297.8 335.9 315.5 349.2 303.2 302.3 326.3 340.6 301.5 296.6 311.4 312.8 299.5 312.4 284.8 343.2 299.2
D ay 14
336.6 332.4 320.5 330.8 372.9 383.2 379.6 379.8 344.4 394.7 342.9 356.5 306.3 412.6 340.2 307.3 394.0 388.3 355.1 362.8 419.8 350.0 350.4 337.6 350.8 348.7 374.0 366.1 331.5 381.9 366.7 410.4 353.5 350.8 371.9 391.8 352.8 350.5 360.1 362.7 354.3 367.0 326.3 384.9 342.7
D ay 21
382.6 372.1 352.4 372.3 417.5 433.3 424.0 429.6 392.9 449.4 371.5 400.3 338.0 464.9 381.6 350.7 452.4 435.2 390.6 418.9 472.0 392.0 386.0 378.3 391.3 390.7 419.7 413.4 375.7 423.0 417.0 472.5 393.9 393.4 407.9 438.5 401.4 398.2 401.7 410.4 399.1 412.8 364.6 427.2 387.8
D ay 28
410.4 404.1 379.5 402.8 448.1 461.1 452.9 462.1 427.9 485.4 398.4 438.8 293.0 504.9 406.6 380.3 481.7 463.2 421.9 453.0 504.2 419.9 418.6 408.7 418.1 422.9 459.2 444.6 401.0 443.7 . 453.8 510.6 423.4 423.0 433.1 469.3 431.7 429.9 432.6 445.4 432.0 451.1 396.0 458.1 422.6
583
WEIGHTS (g)
D ay 35
D ay 42
432.4 433.9 395.6 428.6
468.1 479.9 478.7 494.2 451.3 519.7 419.7 466.9 318.3 531.9 432.8 404.3 509.5 494.3 462.4 486.5 529.5 442.6 440.5 427.5 441.2 453.2 491.9 471.4 422.8
460.0 481.1 536.8 445.5 446.3 454.4 495.8 456.2 455.8 447.4 453.8 460.5 482.7 415.6 494.4 451.1
448.2 454.7 412.4 447.8 478.6 501.6 492.4 515.9 473.5 531.7 429.6 497.5 357.7 551.7 452.6 420.2 538.4 512.5 491.5 499.0 546.7 460.5 453.6 455.7 465.2 472.4 514.7 490.6 435.8
476.8 497.0 557.7 463.3 464.2 475.2 507.4 391.0 471.5 460.5 466.9 475.4 504.1 426.2 505.0 459.7
D ay 49
463.5 440.2 410.4 447.5 473.4 503.5 496.8 502.7 471.6 534.4 420.4 509.1 354.8 570.6 456.0 426.6 543.2 533.8 498.0 511.7 558.3 457.8 460.7 449.7 477.0 484.5 523.2 495.6 450.4 488.8 505.9 586.7 474.5 473.1 477.6 518.9 439.6 485.6 471.7 481.2 458.4 519.9 437.9 525.8 483.8
DuPont-5386
D ay 56
480.8 454.9 426.4 451.1 493.0 417.0 523.4 510.7 ,, 461.7 545.2 430.5 515.7 369.1 570.5 391.6 383.9 544.4 549.3 513.0 517.0 499.3 470.7 468.7 478.5 490.5 495.0 527.8 510.3 464.1 495.0 510.0 583.4 481.8 479.3 481.7 534.8 456.7 496.6 462.3 505.3 458.2 525.5 448.8 525.9 496.5
Company Sanitised. Does not contain TSCA CBI
H -24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
INDIVIDUAL BODY WEIGHTS (g)
D a y 63
D ay 70
M a le , V II - 250 mg/k g /d a y
543194 643252 643260 643315 643215
643193
643298 643201 643259 643174 643283 643149 643178 643152 643295 643289 643171 643158 643249 643161 643309 643248 643285 643278 643299 643274 643192 643222 643160 643191 643203 643282 643302 643317 643225 643296 643258 643316 643220 643236
643165 643266 643151 643234 643281
487.4 477.1 445.3 473.8 497.7
470.9
532.0 532.0 469.7 568.0 423.1 514.8 368.7 587.5 389.3 398.5 548.8 558.9 514.5 482.2 531.7 426.0 457.2 444.8
489.0 501.4 507.5 494.7 473.8 508.7 519.4 5 7 9 .0. 458.2 477.3 497.9 539.4 479.0 505.6 437.7 481.6
434.2 534.5 431.8 489.4 508.1
501.3 369.1 446.4 489.8
426.3 485.5
537.0
532.0 495.7 578.6 394.7 523.6 369.4 595.6 337.8 423.4 453.0 573.0 457.9 478.4 487.8 396.8 439.9 474.1
480.2 502.0 518.2 520.8 480.4 511.1 530.9 499.3 375.0 393.0 511.2 427.7 480.1 504.8 444.3 500.0 460.8 537.4 427.7 437.7 510.8
D ay 74
D ay 77
D ay 84
373.5 513.8 561.0 491.4 462.4 AK T E ST DAY 70 430.7 434.7 488.8 438.6 454.9 529.3 515.9 472.5 512.5 487.3 559.5 414.4 459.2
511.7
502.9 451.7 453.5 463.5 487.2 506.9 492.7 549.4 453.6 580.3 440.3 527.4 351.7 595.9 420.7
509.0 515.4 416.0 502.3 455.7 485.3 393.2 525.3 396.1 504.5
518.8 502.2 458.6 497.2 515.2 537.3 530.1 564.4 498.0 590.3 443.4 547.2 386.9 624.5 432.9
528.1 563.5 473.8 521.7 470.0 518.5 481.1 549.2 454.6 512.2
D ay 90
532.9 530.3 463.6 501.1 533.1 562.2 544.4 576.8 509.9 596.3 471.1 543.9 394.5 628.3 456.8
545.3 581.2 498.5 528.7 476.1 543.5 508.2 564.1 458.5 503.6
D a y 98
482.4 549.7 408.2 643.9 454.9
555.1 593.9 512.8 538.2 483.6 545.0 536.6 576.8 476.0 536.2
D ay 105
497.2 543.2 407.9 661.0 457.9
568.1 610.2 532.9 557.9 485.4 553.3 532.6 580.3 477.6 548.4
DuPont-5386
D ay 112
*
471.8 548.0 413.9 678.4 454.9
570.1 618.5 537.0 568.4 498.2 578.2 544.9 593 .2 482.1 550.9
584
Company Sanitized. Dees netcontain TSCA CBl
H -24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
INDIVIDUAL BODY WEIGHTS (g)
D ay 119
D ay 126
M a le , V II - 250 mg/k g /d a y
643194 643252 643260 643315 643215
643193 643298 643201 643259 643174 643283 643149 643178 643152 643295 643289 643171 643158 643249 643161 643309 643248 643285 643278 643299 643274 643192 643222 643160 643191 643203 643282 643302 643317 643225 643296 643258 643316 643220 643236 643165 643266 643151 643234
643281
483.5 554.9 411.6 694.2 466.1
576.3 627.0 539.7 575.0 515.5 570.9 560.3 591.6 495.6 566.1
493.1 550.8 421.1 708.0 477.0
D ay 133
511.7 574.8 429.9 726.3 487.8
D ay 140
526.6 582.0 446.5 728.7 499.4
D ay 147
547.4 609.1 454.5 743.7 513.4
D ay 154
560.7 610.6 460.9 750.7 528.9
D ay 161
567.8 622.9 470.7 756.5 551.5
D ay 168
585.2 637.2 479.4 782.9 554.0
DuPont-5386
D ay 175
5 9 6 . 1 643.6 484.4 782.6 546.5
585
Company Sanitized Poes not contain TSCA CBI
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
INDIVIDUAL BODY WEIGHTS (g)
D ay 181
M a le , V I I - 250 ntg/k g / d a y
643194 643252 643260 643315 643215 643193
643298 643201 643259 643174 643283 643149 643178 643152 643295 643289 643171 643158 643249 643161 643309 643248 643285 643278 643299
643274 643192 643222 643160 643191
643203 643282 643302 643317 643225 643296 643258 643316 643220 643236 643165 643266 643151 643234 643281
5 7 5 .2 619.1 4 5 7 .7 770.5 522.5
DuPont-5386
586
Company Sanitised. Coes not contain TSCA CBI
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
INDIVIDUAL BODY WEIGHTS (g)
Day 0
Day 7
F e m a le , I I - 0 mg/k g /d a y
643477 643374 643406 643486 643361 643463
643398 643436 643362 643354 643402 643383 643465 643484 643384 643352 643343 643459 643394 643480 643319 643350 643363 643397 643421 643420 643419 643414 643401 643455 643378 643393 643447 643478 643386 643405 643425 643448 643426 643415 643453 643330 643336 643387
643377
173.9 184.0 161.9 1 8 1 .9 189.3 224.2
1 7 4 .1
1 8 2 .1 184.2 162.0 178.9 167.2 2 1 3 .8 177.2 190.9 185.0 170.9 2 1 2 .5 188.6 197.8 197.9 186.0 2 0 2 .8 185.6 184.2 2 0 7 .1 209.9 2 0 9 .5 176.5
191.1 221.0 1 9 4 .8 ' 191.3 177.5 183.8 214.9 2 0 2 .5 209.3 183.1 205.4 2 0 3 .0 172.6 201.4 191.5 197.9
202.3 212.6 185.0 185.2 2 1 4 .0 2 4 3 .9
188.9 201.4 2 0 8 .4 173.4 193.2 1 8 9 .9 219.3 194.5 215.3 214.3 185.4 228.4 226.2 226.6 228.3 206.9 234.0 225.3 2 0 3 .9 234.3 2 4 3 .5 246.8 183.6 213.2 2 4 1 .8 2 2 8 .2 224.8 201.2 216.5 2 4 0 .1 231.0 2 2 9 .9 2 0 7 .8 2 4 3 .7 2 2 3 .1 188.2 216.4 2 1 1 .0
2 1 7 .5
D a y 14
213.3 2 3 0 .6 2 0 7 .7 190.6 222.4 265.8 209.5 225.0 236.4 191.7 221.3 204.0 243.7 2 1 0 .7 2 3 6 .1 2 2 9 .7 210.4 248.5 2 3 8 .0 2 3 9 .1 241.9 2 1 9 .7 256.4 249.2 2 1 5 .5 250.7 263.2 261.6 2 0 4 .5 223.4 272.9 2 4 4 .9 240.8 209.6 224.3 2 6 5 .7 2 4 3 .4 2 2 9 .8 231.4 256.1 252.2 206.3 247.9 236.9 237.7
D ay 21
236.3 2 4 0 .1 2 1 6 .1 208.4 2 5 8 .1 2 6 8 .1 2 2 9 .0 243.1 2 5 3 .7 2 1 0 .1 2 3 3 .9 2 2 0 .5 266.7 2 1 6 .6 2 4 9 .1 2 5 3 .6 2 2 8 .8 2 5 7 .1 2 5 1 .0 253.8 268.5 229.4 2 6 1 .7 2 6 2 .7 234.4 279.8 2 8 6 .5 2 7 9 .7 2 0 5 .7 2 4 0 .7 2 8 6 .9 257.4 257.0 227.7 239.7 283.8 266.5 245.3 259.8 2 7 3 .9 269.6 2 2 0 .9 265.0 2 5 4 .7 264.4
Day 28
2 3 9 .5 246.9 226.2 2 0 8 .0 2 7 2 .6 292.2 243.0 2 5 8 .1 258.8 2 1 7 .9 239.9 219.5 278.2 233.0 261.6 262.2 2 4 1 .5 2 7 3 .3 2 6 6 .2 2 7 0 .1 2 7 3 .2 243.2 288.6 2 7 0 .7 238.9 28 5 ,.6 305.0 2 9 1 .4 227.2 255.4 300.7 286.9 269.9 236.6 2 5 1 .7 304.6 2 7 8 .5 270.4 2 7 3 .1 301.4 279.1 239.0 290.6 274.2 2 7 3 .5
D ay 35
2 6 4 .5 256.5 243.6 2 2 1 .8 284.2 305.4 262.2 2 7 1 .7 276.8 226.2 248.3 2 3 8 .0 274.2 236.7 279.6 280.2 2 6 2 .6 285.3 2 7 7 .0 2 8 6 .8 2 9 3 .7 253.5 302.6 277.2 253.9 319.5 324.2 307.3 234.0 257.2 321.8 300.3 289.4 243.3 2 5 4 .8 318.5 2 9 2 .7 281.9 291.4 2 9 6 .6 290.8 254.1 2 9 8 .5 294.2 285.9
D ay 42
271.1 268.4 245.8 226.2 2 9 3 .1 309.4 2 6 0 .7 274.1 282.4 2 4 3 .8 251.4 244.3 287.1 239.9 271.6 284.2 263.2 303.4 277.3 284.5 303.7 262.0 2 9 7 .6 287.7 266.3 331.2 336.5 319.6 239.8 2 6 4 .7 3 2 2 .6 309.3 2 9 9 .1 2 4 8 .7 2 6 5 .8 340.3 2 9 8 .9 2 8 2 .5 2 9 7 .1 3 0 7 .6 3 0 7 .7 2 6 1 .8 311.8 2 9 3 .1 299.4
Day 49
272.7 279.9 255.2 237.6 318.8 308.3 272.0 276.8 285.2 259.4 267.0 2 5 9 .7 2 9 7 .7 2 4 9 .6 2 8 4 .3 295.4 274.4 316.6 2 9 1 .1 2 8 9 .9 3 0 9 .9 274.8 3 1 5 .1 3 0 1 .9 2 7 0 .9 347.8 349.3 330.3 244.3 272.6 3 4 4 .7 319.4 307.8 2 6 1 .0 2 6 9 .7 3 5 4 .6 307.3 2 8 0 .5 301.9 315.4 315.2 266.3 3 1 8 .1 307.0 309.7
DuPont-5386
D ay 56
2 7 0 .8 2 8 2 .6 2 5 9 .8 2 5 6 .2 3 3 1 .0 3 2 7 .7 2 8 8 .1 2 9 5 .9 2 9 2 .0 2 6 5 .0 2 6 4 .8 2 7 5 .1 305.4 2 4 6 .7 281.9 300.6 282.9 321.1 2 8 0 .6 3 0 0 .3 319.1 285.7 335.0 293.6 275.6 352.1 359.1 340.8 264.2 274.3 336.3 329.8 3 1 1 .8 2 6 9 .2 280.3 357.7 3 1 7 .8 3 0 0 .5 3 1 8 .9 3 2 6 .1 3 1 9 .1 2 7 0 .6 3 1 5 .9 317.8 3 2 2 .5
587
Company Sanitized. Does not contain TSCA CBi
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
D ay 63
D ay 70
F e m a le , I I - 0 mg/k g /d a y
643477 643374 643406 643486 643361 643463 643398
643436 643362 643354 643402 643383 643465 643484 643384 643352 643343 643459 643394 643480 643319 643350 643363 643397 643421 643420 643419 643414 643401 643455 643378 643393 643447 643478 643386 643405 643425 643448 643426 643415 643453 643330 643336 643387 643377
281.2 292.0 269.3 260.1 342.4 333.9 296.2 288.4
303.9 272.8 270.0 278.4 301.6 251.9 295.6 2 9 8 .5 270.5 3 1 3 .1 287.6 2 9 8 .5 316.1 288.8 328.8 296.3 279.2 358.5 360.0 344.4 2 4 9 .6 2 7 6 .1 343.3 333.1 320.0 271.9 282.2 3 5 4 .1 316.2 310.2 321.8 347.8 320.1 276.1 3 2 9 .7 323.0 338.8
2 8 5 .9 3 0 4 .5 276.6 264.3 353.0 336.2
2 9 7 .9 2 9 8 .9 305.2 2 8 0 .0 2 7 4 .9 2 9 0 .1 314.4 2 5 5 .6 2 9 9 .1 306.6 2 8 8 .4 323.6 2 9 3 .9 294.6 318.4 2 9 2 .4 327.9 3 0 4 .9 2 8 6 .5 358.2 358.2 355.4 263.0 278.1 342.8 335.7 325.9 268.0 282.2 367.3 3 2 6 .1 310.7 333.9 373.1 333.4 281.3 3 2 9 .7 333.3 338.4
D ay 74
307.9 2 7 7 .6 320.8 2 8 7 .6 302.6 321.2 294.2 323.5 306.4 284.3 354.9 361.2 3 5 1 .7 2 6 5 .9 2 7 6 .5 345.5 332.8 325.0 267.4 277.0
INDIVIDUAL BODY WEIGHTS (g)
D ay 77
D a y 84
D ay 91
2 8 4 .0 313.1 273.0 263.3 359.9 336.7 295.6
301.7 309.7 283.8 271.2 297.3 314.8
260.0 303.2
'
286.8 313.7 272.5 257.9 378.1 341.3 303.8 307.2 315.8 284.8 286.0 2 9 6 .9 3 2 4 .1
2 6 8 .0 311.0
2 9 7 .9 327.7 2 8 0 .6 2 4 9 .7 395.0 351.3 309.2 323.9 312.4 286.8 280.1 3 0 1 .1 324.8
267.4 299.3
358.9 324.2 310.6 3 4 1 .8 381.4 330.6
2 7 9 .8 328.3 330.3 342.4
3 6 0 .0 325.4 312.6 349.9 395.9 334.7
288.5 332.9
339.9 339.6
365.3 333.7 315.4 351.7 400.2 332.0 234.3 328.2 339.4 346.1
D ay 98
2 8 0 .8 282.9 329.8 2 6 6 .7 319.0
377.7 333.3 346.0 359.8 4 1 8 .5 352.3 269.3 346.5 349.8 349.0
DuPont-5386
D ay 105
D ay 112 .
2 9 0 .0 2 6 3 .4 330.2 2 7 4 .8 316.7
2 9 5 .5 2 7 9 .6 3 3 9 .4 2 8 3 .7 3 1 3 .3
3 8 5 .9 347.2 3 5 0 .7 373.3 426.3 355.3
287.3 3 2 6 .1 367.2 361.7
389.2 374.8 3 5 0 .0 387.4 447.5 3 6 4 .9 301.3
SE T E S T DAY 369.0 374.0
588
CompanySanitized. Doesnotcontain TSCA CB1
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
D ay 119
D ay 126
F e m a le , I I - 0 mg/k g /d a y
643477 643374 643406 643486 643361
643463 643398 643436 643362 643354 643402 643383 643465 643484 643384 643352 643343 643459 643394 643480 643319 643350 643363 643397 643421 643420 643419 643414 643401 643455 643378 643393 643447 643478 643386 643405 643425 643448 643426 643415 643453 643330 643336
643387
643377
2 8 7 .9 280.1 318.3 287.1 319.1
278.4 281.8 3 1 9 .5 281.6 301.8
3 8 9 .5 384.6 350.9 395.3 4 5 0 .3 368.2 301.9 SE T E ST DAY 105
3 6 5 .1
378.5
D ay 133
293.4 296.8 331.6 296.9 323.4
INDIVIDUAL BODY WEIGHTS (g)
D ay 140
D ay 147
D ay 154
2 9 3 .8 303.9 329.2 290.9 321.1
298.5 313.5 334.5 302.0 328.0
295.0 322.1 349.1 295.1 320.2
D ay 161
2 9 9 .2 3 2 2 .7 352.3 3 1 4 .9 325.3
D ay 168
3 0 5 .0 340.6 3 5 6 .5 311.9 334.0
DuPont-5386
D ay 175
303.8 3 3 4 .0 3 5 5 .8 3 1 4 .1 333.0
589
Company Sanitized. Does not contain TSCA CBI
H -24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
D ay 181
F e m a le , IX - 0 mg/k g /d a y
643477 643374 643406 643486 643361 643463 643398 643436 643362 643354 643402 643383 643465 643484 643384 643352 643343 643459 643394 643480 643319 643350 643363 643397 643421 643420 643419 643414 643401 643455 643378 643393 643447 643478 643386 643405 643425 643448 643426 643415 643453 643330 643336 643387 643377
294.9 312.7 345.9 294.6 315.0
INDIVIDUAL BODY WEIGHTS (g)
DuPont-5386
590
Company Sanitized. Does not contain TSCA CBI
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Day 0
Day 7
D ay 14
F e m a l e , XV - 25 m g/ k g / d a y
643390 643396 643380 643433 643389 643410
643321
643324 643458 643364 643483 643411 643379 643391 643437 643399 643334 643464 643369 643490 643342 643438 643445 643418 643325 643479
643403 643376 643422 643452
643475 643372 643400 643395 643457
175.0 2 0 1 .1 174.8 193.5 184.4 194.5
193.2
175.9 179.6 175.9 184.6 173.3 208.1 168.6 192.5 183.9 169.8 2 0 8 .9 200.3 2 0 5 .8 2 0 2 .8 196.6 225.8 185.1 2 2 4 .1 194.4
194.4 190.4 195.7 205.7 2 1 7 .1 2 0 4 .9 1 6 5 .8 ' 189.6 198.5
189.2 2 3 1 .6 194.6 218.3 2 0 7 .5
2 2 8 .9 2 0 8 .1
202.3
194.8 1 8 6 .6 2 0 2 .4 AK T E ST DAY 0 224.3
187.7 204.3 196.2 185.7 2 3 7 .1 218.2 225.2 230.0 215.2 262.3 206.4 2 5 1 .8 2 1 9 .9
228.8 2 1 9 .8 230.4 2 1 8 .5 2 5 1 .8 2 2 3 .3 189.0 209.2 2 2 5 .8
2 0 1 .5 254.6 2 3 3 .7 240.2 215.6 238.2 209.3 219.8 216.2 2 0 9 .7 2 1 4 .9
239.8 205.8 2 2 3 .1 227.6 214.4 255.4 2 3 7 .1 247.8 2 5 4 .8 237.3 2 7 3 .5 226.6 270.8 228.9 251.3 237.0 2 5 6 .1 244.2 249.4 242.0 199.8 230.4 245.3
INDIVIDUAL BODY WEIGHTS (g)
D ay 21
D ay 28
D ay 35
D ay 42
2 2 3 .6 2 8 4 .1 247.0 268.4 236.2 264.3 233.8 242.6 230.8 2 2 7 .7 225.2
269.2 218.0 246.3 242.2 239.4 275.7 2 5 8 .7 2 6 6 .7 2 7 4 .1 249.4 302.3 242.2 2 9 8 .1 256.2 2 7 3 .9 2 5 6 .7 2 7 6 .5 2 7 4 .0 2 7 6 .7 263.6 212.9 253.0 255.0
240.3 283.8 265.5 285.2 240.3 274.9 236.7
256.0 244.4 239.4 228.9
270.0 231.8 253.8 256.1 247.4 2 9 1 .9 291.2 2 7 8 .7 2 8 7 .5 279.3 314.5 2 6 1 .8 305.3 264.5 282.1 268.8 300.1 3 0 0 ..6 288.2 276.4 .2 2 8 . 2 256.8 267.1
249.5 303.4 275.9 294.2 262.0 288.1
SE T E ST DAY 29 270.0 258.1 248.0 247.9
257.3 3 0 7 .5 2 8 2 .5 305.4 2 7 5 .2 301.2
266.3 264.3 2 5 8 .9 254.2
279.4 239.2 260.0 268.5 260.8 304.4 294.0 284.8 299.1 286.0 351.5 270.4 319.3 278.4
296.8 274.4 313.3 305.0 303.7 285.2 241.3 2 6 8 .9 2 7 5 .1
2 8 3 .5 2 5 3 .1 2 7 5 .6 2 8 0 .0 273.3 314.2 2 8 5 .1 295.3 317.5 2 9 8 .1 366.9 2 8 9 .1 3 3 4 .5 285.4 306.4 2 9 3 .5 325.4 3 1 5 .9 329.3 2 9 0 .5 247.3 2 7 1 .0 2 8 9 .3
D ay 49
2 7 0 .2 312.3 293.3 308.7 2 8 0 .6 3 1 2 .6
2 7 8 .5 2 6 6 .4 2 6 7 .1 2 6 0 .4
303.0 2 5 4 .4 2 8 1 .5 2 8 7 .8 2 7 7 .8 3 2 4 .0 3 1 1 .8 2 9 9 .6 3 2 4 .0 297.6 380.6 2 9 9 .1 3 3 6 .9 2 8 9 .3 3 2 2 .7 2 9 6 .5 3 3 5 .0 323.2 336.5 2 6 7 .3 2 5 1 .2 2 8 2 .9 291.5
DuPont-5386
D ay 56
27413 3 2 1 .1 3 1 6 .6 3 2 2 .5 245.9 3 1 5 .2
2 8 7 .1 284.4 ,2 7 1 . 2 2 5 4 .0
296.1 265.7 283.3 290.5 281.0 319.8 3 0 1 .9 3 0 3 .1 327.3 299.3 3 8 7 .5 297.5 3 5 4 .2 2 9 8 .4 3 2 0 .1 305.3 3 4 9 .6 3 2 9 .0 3 2 2 .6 2 9 8 .2 2 6 3 .4 2 8 2 .3 2 9 2 .7
591
Sanitized. Does notcontain TSCA CBI
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
D ay 63
D ay 70
F e m a l e , XV - 25 m g/ k g / d a y
643390 643396 643380 643433 643389 643410 643321 643324
643458 643364 643483 643411 643379 643391 643437 643399 643334 643464 643369 643490 643342 643438 643445 643418 643325 643479 643403 643376 643422 643452 643475 643372 643400 643395 643457
2 8 3 .6 334.4 304.9 330.6 2 9 2 .7 312.4
290.8 279.5 274.3 268.7
308.4 275.7 289.3 2 8 9 .7 2 8 7 .8 3 2 7 .6 309.2 2 9 8 .6 330.8 302.6 392.2 296.2 355.4 301.4 3 1 7 .5 3 0 5 .7 3 5 5 .1 344.7 339.2 2 9 8 .9 2 7 2 .4 . 2 8 7 .6 300.2
2 8 1 .6 349.3 319.6 3 4 1 .4 306.2
3 1 6 .7
2 8 9 .9 295.4 285.8 2 7 1 .5
312.3 282.5 303.5 302.5 2 9 4 .6 328.9 314.2 309.9
335.1 313.8 398.6 305.9 365.2 2 9 5 .7 318.8 3 0 7 .8 3 5 6 .7 343.7 331.6 305.3 266.8 293 .4 3 1 0 .1
.
D ay 74
301.2 292.5 328.3 312.9 306.0 337.8 305.3 395.9 3 0 2 .5 368.6 307.5 274.5 311.1 360.7 341.2 341.2 310.8 269.0 2 9 4 .6 303.2
INDIVIDUAL BODY WEIGHTS (g)
D ay 77
D ay 84
D ay 91
288.3 355.7 322.6 3 4 9 .5 298.3 319.8
2 9 4 .8 300.6 295.2 2 6 7 .6
3 0 4 .9 2 7 8 .7 298.3
2 9 1 .1 361.8 3 3 1 .7 348.7 295.8 3 2 5 .7
304.5 299.7 299.8 273.0
304.7 2 8 4 .7 300.4
286.8 359.1 328.6 353.5 2 9 0 .1 323.4
303.1 303.1 296.5 280.9
312.6 294.6 302.8
D a y 98
2 8 8 .4 330.0 2 9 4 .7 309.3
D ay 105
2 8 3 .7 3 2 9 .7 297.8 319.4
DuPont-5386
D ay 112
,
290.3 339.8 312.3 325.9
592
Company Sanitized- Does not contain TSCA CBI
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
D ay 119
D ay 126
F e m a le , IV - 25 mg/k g /d a y
643390 643396 643380 643433 643389 643410
643321
643324 643458 643364 643483 643411 643379 643391 643437 643399 643334 643464 643369 643490 643342 643438 643445 643418 643325 643479 643403 643376 643422 643452 643475 643372 643400 643395 643457
2 9 3 .3
3 4 6 .9 3 1 7 .0 325.5
2 8 9 .2
345.8 315.7 320.1
D ay 133
298.2 358.8 321.9 3 3 0 .6
INDIVIDUAL BODY WEIGHTS (g)
D ay 140
D ay 147
D ay 154
294.8
3 6 5 .1 3 2 9 .7 344.4
307.3
376.2 3 2 6 .5 344.8
314.6
371.9 340.6 3 4 9 .9
D ay 161
309.8 380.4 334.1 353.0
D ay 168
313.3 3 8 7 .9 337.7 355.6
DuPont-5386
D ay 175
3 1 9 .4 389.6 343.4 3 5 1 .5
593
Company Sanitized. Does not contain TSCA CBi
H -24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
D ay 181
F e m a le , IV - 25 mg/k g /d a y
643390 643396 643380 643433 643389 643410
643321 643324
643458 643364 643483 643411 643379 643391 643437 643399 643334 643464 643369 643490 643342 643438 643445 643418 643325 643479 643403 643376 643422 643452 643475 643372 643400 643395 643457
2 9 9 .7
3 6 8 .1 326.8 3 4 3 .1
INDIVIDUAL BODY WEIGHTS (g)
DuPont-5386
594
Company Sanitized. Does not contain TSCA CBI
H -24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Day 0
Day 7
F e m a le , V I - 100 mg/k g /d a y
643322
643489 643409 643366 643367 643461
643462 643392
643472 643323 643412 643382
643381 643360 643373 643320 643488 643428 643439 643353 643385 643339 643473 643337 643416 643407 643357 643331 643427 643470
643434 643349 643454 643333 643460
186.5 184.6 171.5 173.6 194.9
214.8 203.2 164.8
174.8 166.7 184.6 180.3 184.9 161.6 192.7 179.7 178.2 2 1 8 .7 1 9 3 .5 186.8 2 0 2 .1 177.0 175.8 2 0 8 .5 183.3 2 1 0 .7 166.3 192.8 187.4 185.5
199.9 201.3 2 0 0 .7 184.6 194.0
212.9 2 0 3 .1 1 9 8 .5 202.4 220.2 255.4 2 2 8 .9
180.3 197.1
191.8 213.6 202.4 206.0 184.6 2 2 6 .1 2 1 2 .1 206.3 2 3 7 .1 216.6 215.2 222.8 205.0 2 0 0 .8 2 4 0 .9 2 0 6 .6 220.8 196.0 2 1 1 .6 210.6 198.9 2 2 0 .0 2 2 1 .1 2 1 9 .1 206.3 224.8
D ay 14
230.5 221.6 221.2 213.3 234.2 276.3 250.1 197.1 207.6 2 1 2 .9 2 3 2 .9 207.8 218.5 201.6 2 3 6 .1 2 3 3 .1 2 2 3 .6 2 7 5 .6 2 3 6 .5 2 3 1 .0 253.3 229.4 218.6 259.5 2 2 8 .8 2 5 3 .6 2 1 3 .2 227.4 2 3 2 .6 226.9 228.4 2 4 9 .5 244.1 2 2 9 .1 2 4 8 .5
INDIVIDUAL BODY WEIGHTS (g)
D ay 21
D ay 28
D ay 35
247.8 2 4 3 .7 2 3 0 .7 2 3 3 .0 258.0 2 9 4 .8 272.3 2 1 4 .9 2 1 9 .9
234.8 2 5 0 .0 2 3 4 .6 2 3 6 .7 2 2 2 .1 2 6 6 .0 2 5 2 .5 2 3 9 .9 278.4 2 5 2 .6 241.2 2 6 7 .7 2 3 4 .1 2 2 6 .0 2 8 5 .9 244.2 2 7 3 .9 2 1 9 .7 2 4 0 .7 248.6 2 4 0 .9
2 5 0 .6 261.8 253.5 2 3 9 .7 261.3
261.8 240.7 2 4 6 .6 2 4 8 .9 2 6 8 .4 300.1 282.4 223.3 2 3 2 .9 243.8 253.0 198.4 2 4 4 .1 233.0 2 7 9 .9 2 6 3 .7 2 6 0 .9 300.3 2 6 3 .9 2 6 1 .5 280.8 2 6 2 .1 243.6 311.0 257.9 2 9 3 .9 2 4 5 .7 256.8 251.8 2 6 1 .5 2 6 2 .9 2 8 1 .6 2 6 3 .6 2 4 3 .9 2 7 5 .1
271.3 262.6 262.5 264.0 279.4 324.3 287.8 236.7 242.0 248.0 259.9 196.4 249.2 222.3 279.0 278.5 263.9 307.3 275.1
273.7 293.4 267.5 251.3 284.4 264.2 297.9 254.1 270.6 270.3 269.2 273.5 294.9 279.9 260.7 289.0
D ay 42
2 8 0 .8 262.8 2 6 1 .6 283.5 2 7 9 .6 331.7 2 9 4 .8 2 5 5 .7 2 5 9 .0 266.2 2 7 0 .9 188.6 2 6 3 .6 2 4 8 .7 300.4 2 9 6 .5 275.4 3 1 9 .7 283.2 277.8 292.4 2 8 3 .5 267.8 275.3 269.3 310.8 2 7 3 .1 2 8 4 .7 282.3 285.2 277.2 300.6 2 9 6 .4 263.3 302.4
D ay 49
278.3 2 8 4 .1 2 6 9 .5 2 8 5 .5 287.3 3 1 4 .7 2 9 9 .7 2 5 1 .1 250.8 2 5 5 .7 2 7 3 .0 2 2 4 .8 2 6 8 .6 2 5 6 .5 3 0 7 .0 2 9 6 .9 2 8 3 .0 322.4 2 8 9 .5 303.2 3 1 0 .7 2 9 0 .7 267.3 3 0 8 .9 2 7 5 .6 317.0 2 7 4 .9 2 9 9 .4 2 8 2 .3 2 8 9 .4 2 9 3 .2 306.8 305.5 2 7 5 .0 310.4
DuPont-5386
D ay 56
279.'6 2 9 3 .3 2 6 8 .8 2 8 4 .5 2 9 6 .8 323.3 3 0 3 .5 249.5 257.7 267.3 275.0 231.8 269.2 259.9 293 .4 306.1 284.9 311.2 296.2 304.0 308.3 290.5 2 7 5 .8 304.4 283.8 321.2 284.0 300.6 287.6 291.3 292.5 313 .4 309.1 272.2 311.5
CM pa"1,Sanl,i" ` D e s not contain t sc a c b ,
H -24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
D ay 63
D a y 70
F e m a le , V I - 100 mg/k g /d a y
643322 643489 643409 643366 643367 643461 643462
643392 643472 643323 643412 643382 643381 643360 643373 643320 643488 643428 643439 643353 643385 643339 643473 643337 643416 643407 643357 643331 643427 643470 643434 643349 643454 643333 643460
2 8 9 .7 290.2 2 7 2 .4 2 9 7 .5 2 9 2 .2
327.7 3 0 5 .1
264.3 262.5 274.2 2 8 5 .9 2 3 8 .9 274.3 2 5 1 .7 3 0 7 .2 3 0 5 .6 2 9 0 .1 318.3 2 9 3 .9 309.2 308.6 299.4 2 6 9 .8 319.2 2 8 4 .1 330.6 2 8 5 .5 3 0 7 .5 2 8 4 .5 305.4 2 8 4 .7
3 1 6 .7 304.0 275.8 317.1
290.8 3 1 2 .1
272.6 3 0 5 .7 304.5 320.5 315.7
274.5 264.9
290.8 2 9 6 .4 252.4 2 8 2 .7 2 6 4 .8 300.3 316.3 293.2 315.6 292.5 3 1 3 .7 315.1 3 0 6 .1 2 7 8 .1 338.6 280.4 325.5 288.0 317.3 290.3 308.8 2 8 1 .6 313.4 313.6 2 8 4 .2 316.9
D a y 74
316.2 296.9 314.7 290.6 310.0 323.7 311.0 274.0 298.5 274.5 327.7 291.0 317.5 286.8 310.7 291.6 315.1 309.9 280.5 315.3
INDIVIDUAL BODY WEIGHTS (g)
D ay 77
D a y 84
D a y 91
295.4 315.7 278.2 307.6 302.7 324.3 314.9
2 7 5 .9 2 6 3 .4 290.4 2 9 3 .6 257.3 284.2 2 6 0 .8 317.6
294.0
315.0 2 7 6 .7 311.5 3 0 5 .7 316.9 320.3 271.2 2 7 0 .1 293.3 302.8 . 254.5 298.9 261.2 311.3
295.7 319.2 281.9 313.0 315.0
328.1 318.3 277.0 270.6 2 8 6 .1 300.7 258.5 2 9 6 .6 261.3 314.5
D a y 98
306.2 270.7 2 9 8 .2 256.5 301.6
D ay 105
3 0 6 .5 276.0 301.9 2 6 7 .9 3 0 5 .8
DuPont-5386
D ay 112
'3 1 8 .8 2 7 0 .9 3 1 1 .1 227.2 3 1 4 .1
596
Company Sanitized. Does not contain TSCA CBS
H -24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
D ay 119
D ay 126
F e m a le , V I - 100 mg/k g /d a y
643322 643489 643409 643366 643367 643461 643462 643392 643472
643323 643412 643382 643381 643360 643373 643320 643488 643428 643439 643353 643385 643339 643473 643337 643416 643407 643357 643331 643427 643470 643434 643349 643454 643333 643460
321.8 2 2 0 .9 312.3 2 4 2 .5 313.6
317.8 263.9 311.3 248.1 325.1
D ay 133
317.5 277.8 329.7 2 6 5 .7 316.3
INDIVIDUAL BODY WEIGHTS (g)
D ay 140
D ay 147
D ay 154
3 2 3 .5 2 7 8 .1 321.6 265.2 327.2
3 3 3 .9 2 8 1 .1 327.2 269.6 3 4 2 .7
334.4 281.5 342.6 283.6 338.3
D ay 161
339.7 2 9 1 .7 3 3 8 .9 280.0 3 4 8 .5
D ay 168
3 4 1 .4 2 9 3 .1 3 4 2 .1 2 8 1 .5 3 5 1 .7
DuPont-5386
D ay 175
3 4 8 .0 294.2 342.2 2 8 3 .3 364.6
597
Company Sanitized. Does not contain TSCA CBi
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
D ay 181
F e m a le , V I - 100 mg/k g /d a y
643322 643489 643409 643366 643367 643461 643462 643392
643472
643323 643412 643382 643381 643360 643373 643320 643488 643428 643439 643353
643385 643339 643473 643337
643416 643407 643357 643331 643427 643470 643434 643349 643454 643333 643460
327.2 286.1 328.1 277.7 356.8
INDIVIDUAL BODY WEIGHTS (g)
DuPont-5386
598
Company Sanitized. Does not contain TSCA CBI
H -24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Day 0
Day 7
F e m a l e , V I I I - 250 mg/kg/day
643341 643370 643446 643435 643466 643332 643404
643408 643359 643340 643487 643356 643329 643388 643450 643467 643443 643417 643413 643338 643335 643468 643440 643430 643431 643368
643326 643365 643375 643328 643348 643346 643449 643429 643424 643347 643456 643423 643345 643351 643358 643444 643474 643441
643481
186.4 202.6 195.9 181.0 168.9 173.1 166.9 191.2 184.7 196.2 1 6 9 .0 1 9 6 .1 180.8 164.2 2 2 4 .7 197.0 1 8 1 .1 2 1 7 .9 1 8 1 .7 197.2 2 0 5 .9 175.6 211.6 181.8 190.6
188.2 196.4 209.8 2 0 6 .8 2 0 1 .9
172.8 193.0 2 1 6 .0. 204.2 189.5 175.6 205.8 188.1 178.2 186.6 1 8 9 .9 2 0 3 .8 168.8 192.9
171.0
212.8 2 3 9 .1 2 2 1 .5 198.5 192.0
187.3 190.0 211.5 212.0 213.7 194.4 215.4 210.2 185.1 246.4 2 2 6 .2 201.7 250.1 2 0 8 .0 2 2 0 .0 230.4 196.4 2 3 4 .6 198.0 2 2 0 .0 215.3 227.8 245.4 2 5 3 .5 233.3 196.1 215.4 2 3 7 .4 2 2 7 .7 213.7 197.7 251.0 210.9 203.9 207.0 215.8 2 2 9 .6 189.3 2 2 1 .5 190.9
D ay 14
2 3 3 .2 2 6 1 .6 2 4 6 .1 216.8 217.0 202.0 211.3 240.5 2 3 9 .1 2 4 4 .9 210.4 236.2 220.6 204.0 2 6 6 .1 240.3 213.8 278.8 2 2 1 .6 2 3 4 .7 244.6 223.4 261.2 223.5 243.6 234.9 249.3 271.6 275.5 256.6 217.5 232.4 275.6 258.2 2 3 2 .5 224.4 2 7 4 .7 230.8 2 2 7 .9 2 2 6 .9 235.4 244.6 217.8 244.5 220.3
INDIVIDUAL BODY WEIGHTS (g)
D ay 21
D ay 28
D ay 35
2 4 4 .7 2 9 4 .3 2 5 6 .2 2 2 4 .9 234.4 2 2 7 .1 227.2 257.6 249.3 2 5 2 .2 231.3 2 5 0 .6 227.3 222.6 291.6 252.2 230.6 298.3 242.8 2 5 1 .0 2 6 4 .1 2 3 7 .1 2 8 4 .3 235.3 2 6 1 .0 2 3 7 .1 261.7 2 9 3 .6 292.2 268.0 236.5 2 5 0 .4 2 8 8 .9 2 7 2 .6 2 4 5 .3 2 2 2 .7 2 8 8 .9 230.3 242.4 235.8 2 5 4 .4 255.8 221.8 2 5 6 .7 230.8
2 5 2 .1 289.3 268.3 234.3 2 5 1 .6 232.4 2 4 4 .1 2 6 8 .5 278.2 2 6 9 .5 240.8 2 5 9 .1 236.8 238.4 300.9 2 7 0 .5 245.8 314.8 2 5 1 .7 265.5 281.5 2 5 0 .6 290.3 246.3 2 7 4 .8 259.4 281.8 310.1 313.9 2 7 6 .1 253.8 2 5 3 .1 2 9 9 .7 289.3 249.2 232.8 2 8 9 .7 2 5 2 .4 2 4 6 .9 2 3 5 .6 2 6 2 .5 275.1 230.0 2 7 0 .1 2 4 5 .1
266.7 318.3 282.7 241.2 257.1 2 5 1 .3 257.4 2 7 0 .6 289.4 282.0 2 5 2 .7 262.6 2 5 5 .5 2 4 0 .6 310.2 278.2 251.6 314.6 257.9 278.4 2 9 6 .5 261.7 2 9 8 .1 2 5 7 .8 2 8 8 .5 2 6 7 .9 2 9 0 .7 321.3 326.1 301.4 259.6 275.3 310.2 297.3 2 6 3 .1 2 4 1 .7 3 1 2 .7 259.2 2 5 1 .5 2 4 7 .7 2 6 9 .1
284.2 2 3 5 .1 2 8 0 .7 2 5 4 .0
D ay 42
2 7 6 .0 334.2 2 8 9 .1 248.6 279.8 268.7 260.3 285.3 294.2 280.0 259.7 267.0 275.6 253.4 320.1 287.0 2 6 1 .6 322.6 262.1 283.2 306.4 2 7 0 .6 308.5 256.3 304.4 2 8 0 .4 2 8 7 .5 325.2 330.2 306.8 2 6 3 .7 284.8 316.6 309.1 266.1 251.5 318.8 264.2 269.6 250.9 276.5 300.4 2 5 0 .6 2 8 7 .8 2 6 6 .9
DuPont-5386
D ay 49
D ay 56
2 7 4 .7 338.0 2 9 2 .7 2 5 2 .3 2 7 2 .8 261.3 266.3 2 8 5 .7 307.0 2 9 7 .1 2 6 4 .4 2 7 4 .7 2 9 4 .6 239.3 3 2 6 .5 2 8 6 .1 2 6 2 .2 339.8 2 7 0 .1 2 8 8 .6 3 2 0 .1 2 7 4 .9 314.8 2 7 3 .7 315.4 2 3 2 .2 2 9 4 .8 3 3 6 .7 333.2 311.8 269.2 297.3 3 1 7 .1 3 1 5 .5 2 8 3 .6 2 5 9 .9 287.3 2 1 9 .7
2 7 2 .0 2 5 8 .3 2 8 9 .9 3 1 3 .1 2 5 7 .1 305.0 269.6
2 7 9 '.5 329.9 3 0 2 .5 254.3 287.5 252.4 269.5 2 8 6 .6 3 1 0 .1 3 0 0 .5 271.3 2 7 3 .7 2 7 6 .4 178.9 333.3 2 8 4 .9 2 6 1 .4 3 3 6 .5 2 7 1 .6 292.2 3 1 9 .9 269.2 2 9 0 .1 2 6 8 .3 325.4
AK TEST DAY
2 9 7 .2 334.2 3 3 1 .9 292.2 2 6 6 .6 2 9 9 .4 3 2 3 .9 3 0 5 .6 2 8 1 .0 2 5 6 .4 2 3 8 .7 2 3 0 .1 2 3 5 .9 2 5 5 .3 2 8 1 .8 3 1 2 .1 2 5 1 .5 2 9 3 .1 2 7 1 .4
599
Company Sanitized. Does not contain TSCA CBt
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
D a y 63
D ay 70
D a y 74
F e m a le , V I I I - 250 mg/k g /d a y
643341 643370 643446 643435 643466
643332 643404
643408 643359 643340 643487 643356 643329 643388 643450 643467 643443 643417 643413 643338 643335 643468 643440 643430 643431 643368 643326 643365 643375 643328 643348 643346 643449 643429 643424 643347
643456 643423 643345
643351 643358 643444 643474 643441 643481
283.2 3 0 8 .7 307.5 251.8 280.2 246.8 268.6 272.0 3 1 7 .7 274.4 2 6 5 .1 2 8 7 .2 2 9 0 .1 2 3 5 .9 334.5 2 7 5 .8 260.3 323.0 2 7 6 .1 2 9 5 .1 313.1 2 6 7 .2 240.7 269.8 328.3
251.4 332.5 332.0 279.3 2 4 9 .8 310.3 324.1 305.6 279.2 265.8 306.1 249.6 268.3 2 1 0 .5 2 8 8 .1 270.3 254.3 2 6 3 .5 271.8
285.9 2 9 7 .0 307.5 250.0 291.0 2 6 8 .7 274.4 284.0 325.5 FD T E ST DAY 69 252.3 292.4 2 9 1 .1 2 4 7 .5 342.4 231.5 255.4 320.5 279.0 2 9 2 .5 298.3 2 0 4 .8 1 9 5 .7 2 2 9 .9 2 8 1 .5
214.9 229.0 326.6 283.5 2 8 9 .5 283.0 2 6 1 .7 269.0 278.6 325.4
2 9 7 .8 324.5 325.9 2 8 8 .7 261.0 315.7 332.2 2 7 9 .8 2 6 3 .7 2 6 3 .7 324.2 2 4 8 .7 2 6 8 .2 262.0 287.1 262.8 261.6 2 9 9 .5 274.2
310.2 331.4 297.6 2 6 7 .5 2 3 2 .5 316.9 326.0 2 9 7 .9 221.0
INDIVIDUAL BODY WEIGHTS (g)
D ay 77
D ay 84
D ay 91
2 6 9 .9 289.4 3 0 1 .9 2 5 7 .0 2 7 5 .9 264.2 262.7 285.1 328.9
2 3 0 .7 2 8 7 .0 2 5 6 .0 2 4 4 .0 2 8 5 .8
2 9 9 .5 331.1 313.6 257.8 288.9 279.4 278.1 302.7 3 3 9 .7
2 7 2 .7 308.7 300.2 264.3 3 3 0 .1
299.0 348.6 296.9 2 5 4 .5 297.6 2 7 7 .4 268.3 302.8 349.8
274.0 312.3 308.7 261.5 347.9
265.2 319.4 250.2 262.2 276.3 290.8 283.4 2 3 8 .9 307.7 2 5 5 .5
2 6 8 .1 3 4 5 .7 2 7 9 .1 290.0 2 7 5 .6 309.7 3 1 1 .7 2 6 7 .9 328.2 274.3
276.7 3 3 7 .1 283.5 2 8 0 .5 280.0 323.1 313.9 269.3 336.0 2 8 5 .9
D a y 98
2 7 6 .1 2 9 8 .7 317.6 272.7 369.5
2 7 5 .1 329.2 2 8 8 .9 296.9 283.3 3 3 3 .1 303.2 2 8 0 .2 350.7 296.3
D ay 105
280.6 2 9 8 .7 324.0 2 7 1 .5 3 8 4 .6
275.2 335.1 297.0 307.9 2 9 2 .1 3 5 0 .1 307.9 2 7 5 .1 354.2 3 0 1 .9
DuPont-5386
D ay 112
2 8 4 .3 303.2 326.8 2 8 5 .8 398.5
2 7 7 .7 333.4 310.5 328.3 300.2 358.7 308.9 2 8 2 .5 3 6 8 .9 3 1 1 .8
600
Company Sanitized. Does not contain TSCA CB
H -24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
D ay 119
D ay 126
F e m a le , V I I I - 250 mg/k g /d a y
643341 643370 643446 643435 643466 643332
643404
643408
643359 643340 643487 643356
643329 643388 643450 643467 643443 643417 643413 643338 643335 643468 643440 643430 643431 643368 643326 643365 643375 643328 643348 643346 643449 643429 643424 643347 643456 643423
643345 643351 643358 643444 643474 643441 643481
286.2 308.6 3 2 5 .5 2 8 3 .6 404.8
277.7 340.7 309.7 3 2 8 .5 301.5 372.2 3 2 3 .0 2 8 0 .1 382.3 313.6
2 8 0 .8 310.4 3 3 1 .7 2 9 0 .9 4 1 1 .1
D ay 133
288.9 3 3 1 .5 343.4 2 8 9 .1 4 1 6 .6
INDIVIDUAL BODY WEIGHTS (g)
D ay 140
D ay 147
D ay 154
292.1 348.6 335.9 291.3 422.0
305.5 365.2 348.0 2 9 6 .9 4 3 1 .4
318.0 373.2 357.9 2 9 7 .0 437.3
D ay 161
316.4 384.4 364.6 302.4 4 4 2 .6
D ay 168
316.7 363.1 373.9 297.6 444.5
DuPont-5386
D ay 175
3 2 2 .9 3 5 9 .2 3 7 6 .9 2 9 8 .6 4 5 0 .8
601
Company Sanitized. Does not contain TSCA CBI
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
D ay 181
F e m a le , V I I I - 250 mg/k g /d a y
643341 643370 643446 643435 643466 643332 643404 643408
643359 643340 643487 643356 643329 643388 643450 643467 643443 643417 643413 643338 643335 643468 643440 643430 643431
643368 643326 643365 643375 643328 643348 643346 643449 643429 643424 643347 643456
643423 643345 643351 643358 643444 643474 643441 643481
312.0 341.1 3 6 8 .9 2 8 6 .1 4 2 9 .7
INDIVIDUAL BODY WEIGHTS (g)
DuPont-5386
602
Company Sanitized. Does not contain TSCA CBI
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5386
APPENDIX D INDIVIDUAL FOOD CONSUMPTION
603
Company Sanitized Dees not certain TSCA CBI
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
INDIVIDUAL FOOD CONSUMPTION
EXPLANATORY NOTES
DuPont-5386
Critical Dates
Day 74 Male and female rats designated for reproduction evaluations were co-housed.
Last day o f food consumption data collection for rats designated for reproduction evaluation.
Day 83-89 Rats designated for the 3-month recovery period were temporarily housed in metabolism cages for urine and feces collection. Food consumption data was not collected for these animals during this period.
Day 91 Male rats designated for the 90-day exposure period were sacrificed.
Day 93 Female rats designated for 90-day exposure period were sacrificed. Day 119 Last day o f food consumption data collection for animals designated for the one-month recovery
period.
Day 125 Male and female rats designated for the one-month recovery period were sacrificed Day 175 Last day o f food consumption data collection for animals designated for the 3-month recovery
period.
Day 181 Male and female rats designated for 3-month recovery period were sacrificed.
Abbreviations
AK Accidentally Killed FD Found Dead SE Sacrificed in extrem is
604
Company Sanitized. Does notcontainTSCA CBI
^__
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
INDIVIDUAL FOOD CONSUMPTION (g/day)
Day 7
D a y 14
M a le , I - 0 mg/k g /d a y
643241 643300 643143 643205 643235 643288 643150 643189 643185 643210 643268 643232
643265 643239 643270 643148 643284 643229 643196 643176 643218 643207 643280 643271 643211 643163 643197 643242
643251 643155 643147 643276 643237 643226 643195 643246 643253 643262 643172 643303 643304 643162 643254 643145 643204
28.6 25.0 25.4 25.8 29.3 2 6 .5 25.0 29.4 2 7 .7 2 3 .8 2 5 .3 24.0 2 4 .1 28.4 24.3 23.3 2 6 .8 2 2 .9 22.4 2 3 .6 2 6 .0 2 2 .7 2 4 .7 28.6 26.3 29.7 2 6 .5 2 6 .5
25.2 24.4 2 8 .4 29.7 2 1 .5 23.8 2 5 .2 30.0 2 6 .6
24.3 27.3 2 6 .5 2 3 .0 2 5 .3 24.4 23.2 2 7 .7
3 1 .1 26.4 2 7 .7 2 5 .9 30.4 2 8 .6 27.4 33.6 29.4 25.4 27.2 2 2 .1 2 7 .2 2 9 .1 2 7 .0 25.8 2 7 .7 2 2 .6 2 3 .8 2 5 .7 2 5 .3 2 4 .1 27.2 3 1 .8 2 7 .9 32.6 2 7 .7
2 6 .1 26.6 2 5 .8 31.8 33.2 2 3 .0 2 3 .5 2 7 .0 32.9 2 9 .1 27.7 30.4 28.3 2 5 .5 27.0
2 3 .5 2 4 .6 2 8 .2
D ay 21
28.7 27.4 27.0 2 9 .1 3 2 .5 3 0 .5 2 5 .2 32.2 31.7 25.3 29.9 2 5 .7 30.5 31.5 2 8 .8 2 6 .2 29.0 2 4 .7 2 3 .9 2 7 .4 2 7 .0 25.0 2 7 .8 30.6 28.8 33.2 29.0 29.4 2 7 .7 2 8 .9
31.4 32.0 24.9 22.7 25.7 31.8 30.4 2 8 .5 3 1 .7 2 9 .6 2 5 .7 28.2 24.6 26.3 27.4
D ay 28
31.4 27.0 2 8 .8 2 9 .6 33.0 31.2 2 4 .6 31.7 31.2 2 6 .9 30.0 22.2 29.0 3 0 .6 2 7 .6 2 6 .5 30.9 2 4 .1 23.2 28.0 2 6 .9 24.8 28.4 3 1 .7 3 0 .5 32.1 2 8 .7 28.3 26.4 27.0
32.0 32.4 25.3 24.0 2 5 .1 31.0 29.4 2 7 .1 29.4 29.9 24.9 27.4 24.2 2 5 .5 3 0 .3
- 35
D ay 42
D ay 49
31.3 29.2 28.4 29.0 33.6
32.1 25.5 3 0 .9 3 0 .5 2 5 .8 32.3 26.4
29.3 2 9 .5 2 7 .7 26.4 30.3 2 3 .9 23.8 28.2 27.3 2 5 .1 29.2 30.4
2 9 .9 32.8 27.3 2 8 .1 2 5 .2 2 5 .3 30.8 31.9 23.9 23.8 25.2 31.6 28.7 29.2 29.6 3 2 .7 27.2 2 8 .1 2 7 .3 29.2 29.8
31.5 30.1 27.4 30.3 3 4 .6 31.2
2 4 .9 3 1 .7
31.6 2 6 .5 29.8 2 7 .1
2 9 .9
31.1 2 9 .2 2 7 .5 3 0 .0 2 4 .2 25.8 29.3 2 7 .0 2 4 .8 3 0 .1 33.1 27.5 31.6 2 7 .4 2 8 .6 2 4 .8 2 7 .3 31.3 32.4 2 4 .9 2 5 .2 27.2 31.4
2 9 .6 2 7 .7 2 9 .0 33.2 2 8 .0 2 4 .4 25.3 2 7 .2 29.9
2 9 .2 2 6 .5 2 6 .8 2 8 .4
3 0 .1 2 7 .1 25.4 28.8 30.0 28.3 30.4 2 8 .7
3 0 .7 3 2 .8 29.0 2 9 .1 32.0 2 3 .8 2 4 .5 2 7 .7 2 8 .2 2 5 .5 3 1 .2 3 4 .8 3 1 .1 34.3 29.2 31.6 2 7 .6 30.4 31.2 35.9 2 5 .9 27.3 2 7 .7 31.9 30.1 3 0 .1 29.6 32.2 27.2 2 6 .9
26.8 2 9 .4 2 7 .8
DuPont-5386
56
D ay 63
D ay 70
31.2 32.0 2 8 .6 30.8 34.6 3 1 .6 2 6 .8 33.2 3 4 .2 2 5 .1 3 0 .9 27.6
30.0 30.2 27.3 27.6 2 9 .6 2 3 .0 2 5 .1 2 6 .3 2 8 .3 2 4 .0 29.3 33.5 30.0 34.3 29.3 30.6 2 6 .5 3 1 .2 31.2 35.2 2 5 .5 2 6 .5 2 9 .5 30.3
2 9 .9, 2 8 .7 3 1 .2 3 0 .7 2 7 .0 2 4 .0 26.2 27.6 28.8
3 3 .3 3 3 .1 2 9 .4 2 8 .5 37.4
31.3 2 7 .5 34.3 3 3 .8 2 4 .7 2 3 .0 2 6 .6
2 4 .0 31.3 2 6 .5 2 6 .6 2 9 .8 2 2 .8 2 5 .6 2 8 .6 2 8 .5 2 4 .2 2 9 .8
35.0 2 9 .2
34.3 2 8 .8 30.0 2 6 .9 31.0 3 0 .8 35.0 2 6 .5 2 7 .8 2 8 .7 3 3 .1 3 0 .4
2 9 .7 3 0 .1 3 0 .4 2 8 .0 12.8 2 6 .1 2 6 .3 2 9 .9
2 9 .5 3 0 .4 2 6 .9 30.3 33.3 3 2 .5 2 7 .2 33.2 2 9 .9 2 7 .4 29.3 2 5 .4 2 6 .7 3 2 .5 2 6 .9 2 2 .9 3 0 .1 2 3 .5 2 4 .2
2 7 .1 2 7 .8 2 6 .2 2 9 .8 3 4 .2
2 8 .5 3 4 .1 2 8 .9 3 0 .0 2 6 .2 32.2 3 2 .7 3 5 .9 2 5 .9 27.3 2 9 .0 3 2 .6
3 2 .8 2 8 .7 3 0 .6 2 9 .7 2 7 .9 1 9 .9 2 6 .1 2 7 .4 2 8 .5
605
Company Sanitized. Does not contain TSCA CBI
U fr
H -24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
DuPont-5386
D ay 74
D ay 77
M a le , I - 0 mg/k g /d a y
643241
643300 643143 643205 643235 643288 643150 643189 643185 643210 643268 643232 643265 643239 643270 643148 643284 643229 643196 643176 643218 643207 643280 643271
643211 643163 643197 643242 643251 643155 643147 643276 643237 643226 643195 643246 643253 643262 643172 643303 643304
643162 643254 643145 643204
34.0 2 8 .7 3 0 .9 32.2 26.0 2 6 .1 2 7 .7 30.6 27.0 31.2 33.4 2 8 .5 35.6 30.6 3 2 .5 3 0 .1 3 8 .5 3 3 .1 4 0 .3
2 4 .7
3 0 .2 2 8 .6 2 7 .3 30.7 32.5 2 9 .7 2 5 .9 34.2 32.8 27.3 25.2 30.3 2 6 .4
26.4 2 8 .0 28.0 30.4 32.8 2 3 .5 3 0 .1 28.4 26.3 17.3 2 5 .0 2 7 .7
D ay 84
2 9 .0 29.0 2 7 .0 30.7 33.6 2 9 .7 2 6 .3 32.5 32.2 2 6 .7 27.9 30.4 2 5 .9
24.2 26.6 2 7 .8 3 0 .1 32.0 2 4 .9 2 8 .1 28.4 2 6 .9 15.9 24.9 30.4
INDIVIDUAL POOD CONSUMPTION (g/day)
D a y 90
D a y 98
D ay 105
D ay 112
D ay 119
D ay 126
D ay 133
2 8 .5 2 7 .5 2 5 .2 2 8 .3 33.1 2 5 .1 2 5 .5 32.7 31.5 22.9 21.2 27.8 2 4 .6
2 6 .9 31.1 2 7 .9 26.4
27.4 31.0 29.0 27.3
2 3 .6 3 1 .0 2 7 .6 2 6 .0
2 8 .6 17.1 2 5 .8 2 4 .6
2 7 .6 2 8 .5 2 7 .4 2 6 .1
2 7 .4 2 8 .1 2 9 .5 2 5 .0
23.8 2 7 .2 2 8 .2 29.4 29.2 25.6 2 8 .5 2 7 .6 2 4 .6 24.2
2 5 .0 28.8
24.9 27.4 26.3 3 3 .5 33.1 2 8 .7 2 9 .1 30.8 2 6 .8 25.4
27.0
2 4 .0 28.2 2 8 .6 3 2 .6 31.6 31.6 29.6 32.6 2 8 .0 12.4
26.3
2 3 .5 2 7 .8 29.9 31.4 3 2 .5 31.3 2 9 .0 32.3 2 7 .2 2 8 .2
2 8 .7
2 3 .1 27.4 2 9 .7 2 9 .5 3 2 .8 3 0 .8 2 7 .3 30.6 2 5 .4 14.4
2 6 .1
2 7 .1
2 7 .5
606
Company Sanitized. Does not contain TSCA CBI
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
D ay 140
D ay 147
M a le , X - 0 mg/k g /d a y
643241 643300 643143 643205 643235
643288 643150 643189 643185 6 4 3 2 X0 643268 643232 643265 643239 643270 643148 643284 643229 643196 643176 643218 643207 643280 643271 643211 643163 643197 643242
643251 643155 643147
643276 643237 643226
643195 643246 643253
643262 643172 643303 643304 643162 643254 643145
643204
28.3 3 3 .1 2 9 .3 2 1 .3
2 7 .7
29.2 30.7 30.2 2 6 .0
13.9
D ay 154
2 9 .9 31.7 31.4 26.8
32.4
INDIVIDUAL FOOD CONSUMPTION (g/day)
161 D ay 168 D ay 175 D ay 181
33.0 33.9 32.2 28.5
2 9 .7 30.2 3 1 .8 2 7 .5
29.2 3 4 .5 33.1 27.4
2 4 .7 28.8 2 7 .5 24.3
3 4 .7
2 8 .4
2 9 .8
23.7
DuPont-5386
607
Company Sanitized. Does not contain TSCA CBI
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Day 7
D ay 14
M a le , I I I - 25 mg/k g /d a y
643173 643290 643272 643292 643228 643308 643264 643240 643180 643179 643202 643310 643306 643305 643293 643287 643188 643230 643170 643144 643277 643214 643261 643166 643153 643177 643198 643291 643184 643167
643223 643233 643183 643219 643263
2 9 .4 2 3 .2 23.6 25.6 2 3 .8 2 6 .7 27.2 25.0 25.4 2 6 .4 24.4 23.2 2 3 .6 2 3 .5 24.8 1 9 .1 2 9 .3 2 4 .6 2 9 .8 2 2 .1 2 6 .5 2 8 .0 2 8 .9 24.4 2 3 .6 26.3 30.2 28.2 2 7 .7 2 7 .0
26.5 2 3 .0 2 7 .3 2 8 .7 26.0
2 9 .9 2 4 .9 26.6 2 5 .6
3 0 .9 3 0 .9 2 9 .1 24.9 28.6 2 8 .1 25.4 2 7 .9 24.2 2 5 .6 26.4 2 1 .2 32.4 2 5 .4 2 9 .6 2 4 .1 27.8 29.2 3 3 .7 2 7 .7 2 6 .7 28.3 33.2 3 1 .4 2 7 .7 2 9 .6 25.6 2 3 .5 2 8 .7 2 8 .6
27.0
D ay 21
INDIVIDUAL FOOD CONSUMPTION (g/day)
D ay 28
D ay 35
D ay 42
D ay 49
29.3 26.3 25.6 27.7 32.3
31.7 29.3 23.3 29.2 29.3 2 5 .4 31.1 2 4 .1 2 5 .9 27.2 2 1 .5 32.8 2 5 .7 30.4 24.2
29.2 3 1 .1 33.4 2 5 .8 26.0 31.8 3 4 .5 30.3 26.4 29.8 2 5 .2 2 2 .9 2 8 .5 28.0 2 7 .4
2 9 .9 2 6 .6 26.3 28.6 3 2 .7 31.2 2 9 .1 23.6 29.4 2 8 .7 25.0 30.9 2 4 .9 25.4 26.4 21.6 3 2 .1 2 6 .7 3 0 .3 25.5 30.2
31.9 31.6 27.6 2 7 .7 3 0 .1 35.4 3 2 .5 23.7 29.8 24.6 22.6 29.2 28.5 28.0
3 2 .8 2 8 .4 26.0 29.8 35.4
34.0 31.2 26.0 3 2 .1 2 8 .7 26.6 33.3 27.4 2 7 .1 30.4 2 3 .9 31.1 27.0 32.0 24.3 30.6 30.8 32.2 27.4 2 8 .9 32.7 34.0 32.0 19.7 29.8 26.5 24.2 2 9 .5 2 9 .4 28.6
29.0 29.0 27.2 29.2 33.6 34.9 31.7 24.4 32.4 2 8 .1 2 5 .5 33.4
2 8 .1 25.4 28.4 2 2 .9
31.6 25.3 3 1 .1 2 5 .2 3 0 .8 2 9 .0 32.3 2 5 .5 26.0 30.3 3 2 .5 30.8 2 7 .7 2 9 .3 2 7 .0 23 .2 31.2 29.3 28.3
27.4 25.3 2 4 .8 2 6 .1 30.0 2 9 .5 2 8 .6 23.4 2 7 .8 2 5 .6 2 7 .7 3 0 .1 2 2 .0 2 6 .7 2 9 .5 2 2 .9 32.7 2 5 .7 30.4 25.3 31.2 13.2 33.2 2 8 .4 25.2 3 1 .0 3 5 .2 31.9 25.0 2 9 .1 2 7 .8
2 3 .8 3 2 .1 2 9 .5 2 8 .9
D ay 56
30.7 2 9 .7 26.3 2 9 .2 3 5 .5 34.4 33.1 2 5 .1 31.4 2 8 .6 2 5 .1 33.0 25.8 26.3 30.4 2 3 .2 3 4 .0 2 5 .1 2 9 .5 2 6 .0 3 0 .5 2 8 .8 33.1 28.7 2 9 .1 31.4 35.4 32.0 2 4 .9 2 9 .2 2 7 .6
14.2 3 1 .1 2 9 .6 2 9 .2
D ay 63
29.3 2 8 .4 2 7 .8 2 9 .3 3 5 .1 32.5 3 4 .0 2 4 .1 3 0 .1 2 4 .4 23.3 30.5 25.3 2 6 .6 2 9 .9 2 3 .3 3 2 .7 2 6 .0 3 1 .5 2 5 .8 3 1 .8 2 9 .4 32.9 2 7 .7 2 9 .2 3 1 .8 3 3 .8 30.6 2 1 .5 3 0 .8 2 7 .3 2 3 .6
30.8 3 0 .2 2 9 .0
DuPont-5386
D ay 70
2 7 .1 2 8 .6 2 8 .3 2 8 .0 3 3 .3 3 5 .0 3 1 .9 2 2 .8 2 6 .1 2 7 .2 2 4 .8 33 .0 24 .3 2 7 ..4 2 8 .,8 2 3 ..2 3 2 ..1 2 5 ,.0 3 2 ,. 0 2 5 ,. 9 3 2 ,. 0 29 .0 34 .4 28 .5 29 .4 32 .2 32 .8 32 .5 22 .8 30 .6 26 .6 24 .9
30 .2 30 .2 28 .8
608
Company Sanitized. Does not contain TSCA CBI
H -24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
D ay 74
D ai 77
M a le , I I I - 25 mg/k g /d a y
643173 643290 643272 643292
643228 643308
643264
643240 643180 643179 643202 643310 643306 643305 643293 643287 643188 643230 643170 643144 643277 643214 643261 643166
643153 643177 643198 643291 643184 643167 643223 643233 643183 643219 643263
22.3 3 3 .9 25.8 2 9 .7 2 5 .0 3 1 .1 33.3 32.1 30.3
2 9 .7 2 9 .9 36.2 32.8 33.6 32.0 28.8 2 7 .0 31.1 30.9 27.8
29.3 2 8 .9 27.4 2 4 .6 3 3 .0
33.4
30.8
2 2 .X 2 5 .6 2 6 .3 24.2 29.8 2 2 .9 25.3 2 7 .0
D ay 84
2 5 .0 2 9 .7 2 9 .8 26.6 33.8 32.8 30.9 23.2 2 8 .8 2 8 .6 2 4 .4 2 8 .2 24.7 26.1 26.0
INDIVIDUAL FOOD CONSUMPTION (g/day)
D ay 90
D a y 98
D ay 105
D ay 112
20.5 27.9 2 9 .8 2 4 .1 3 0 .6
32.6 30.4
23.4 2 7 .7 26.0 23.2 24.6 22.5 24.8 26.7
24.0 29.3 25.3 2 6 .0 29.3
26.2 31.3 24.4 2 8 .7 2 8 .0
26.3 27.0 25.3 30.3 2 9 .7
D ay 119
2 6 .2 27.0 18.4 2 9 .0 2 8 .9
D ay 126
2 5 .9 27.4 2 5 .0 2 6 .8 2 6 .1
DuPont-5386
D ay 133
2 6 .5 3 2 .7 28.3 1 6 .2 2 8 .9
609
Company Sanitized. Does not contain TSCA CBI
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
D ay 140
D ay 147
M a le , I I I - 25 mg/k g /d a y
643173 643290 643272 643292 643228 643308
643264
643240 643180 643179 643202 643310 643306 643305 643293 643287 643188 643230 643170 643144 643277 643214 643261 643166 643153 643177
643198 643291 643184 643167 643223 643233 643183 643219 643263
2 5 .0 30.6 2 6 .9 31.4 29.6
2 6 .7 3 1 .7 2 7 .7 31.4 30.2
D ay 154
28.6 3 0 .9 2 9 .1 3 1 .9 3 2 .7
INDIVIDUAL FOOD CONSUMPTION (g/day)
Day 161
D ay 168
D ay 175
D ay 181
2 7 .1 2 9 .7 26.9 29.2 31.2
2 6 .9 30.6 27.5 29.7 31.3
2 7 .5 30.2 26.3 30.0 30.9
2 3 .1 27.4 23.0 25.8 25.2
DuPont-5386
610
Company Sanitized. Does not contain TSCA CBI
H -24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Day 7
D ay 14
M a le , V - 100 mg/k g /d a y
643250 643243 643311 643318 643247 643175
643314 643275 643257 643224 643169 643159 643286 643181 643206 643313 643182 643146 643312 643199 643267 643216 643244 643245 643301 643200 643255 643157 643238 643227 643164 643154 643156 643208 643190
23.8 2 5 .9 2 6 .8 2 6 .5 2 9 .5 2 5 .9
2 8 .9 2 8 .0 2 6 .1 2 4 .1 2 2 .4 23.4 20.8 24.6 21.6 23.4 26.3 27.6 2 7 .6 29.3 26.4 2 8 .4 2 4 .9 2 2 .5 2 8 .1 2 7 .8 26.7 25.8 28.3 2 6 .9 27.3 25.5 28.4 26.3 2 8 .0
2 3 .1 30.2 2 9 .5 2 7 .7 32.3 2 8 .0 30.8
27.8 2 6 .9 2 4 .5 2 5 .5 2 7 .1 2 1 .6
2 7 .9 2 2 .8 2 5 .1 3 0 .7 29.2 28.2 31.8 2 9 .1 3 2 .7 2 7 .5 2 4 .4 2 9 .4 30.2 30.0 2 8 .9 26.4 30.1
30.3 27.3 30.0 27.4 30.0
D ay 21
2 5 .3 2 8 .7 2 7 .2 3 0 .4 2 8 .7 2 8 .5 2 9 .6 27.2 26.3 2 4 .9 26.2 27.4 2 2 .9 2 8 .1 2 4 .5 24.9 3 1 .7 29.2 27.8 31.9 29.7 33.5 2 6 .1 24.6 29.8 30.2 30.2 29.4 27.8 28.4 29.4 2 7 .9 2 9 .9 2 6 .1 2 8 .9
INDIVIDUAL FOOD CONSUMPTION (g/day)
D ay 28
D ay 35
D ay 42
D ay 49
'
25.8 28.0 2 8 .1 29.6 29.7 29.7
28.8
2 8 .7 25.4 2 6 .0 2 6 .8 28.3 2 6 .1 2 8 .9 2 4 .0 2 6 .1 32.8 30.6 27.8 35.4 30.3 33.4 2 7 .8 2 4 .2 31.2 30.9 30.9 32.3 28.5
30.1 31.5 28.3 31.6 25.9 29.3
24.4 31.3 29.5 2 9 .6 58.6 29.8
29.0 2 8 .6 2 7 .3 2 4 .8 2 7 .0 30.6 2 7 .3 2 9 .4 24.1 26.5 32.8 30.8 2 8 .1 33.0 31.3 33.6 28.2 24.8 31.5 2 9 .1 30.0 30.6 28.6 28.5
3 1 .1 2 7 .9 32.8 27.7 30.9
2 2 .9 30.0 30.1 29.1 31.8 30.2
31.0 2 8 .4 27.6 2 5 .1 26.4 2 9 .1 2 6 .6 31.6 2 3 .8 27.4 31.7 30.0 27.8 3 2 .1 30.4 33.5 2 9 .4 2 3 .8 30.0 30.3 3 1 .1 3 0 .5 2 8 .0 2 9 .5 3 2 .6 2 7 .1 31.4 2 8 .5 30.2
2 2 .9 2 8 .6 2 6 .4 25.8 15.1 2 7 .4
28.8 2 6 .7 2 4 .5 23.4 2 6 .9 2 9 .7 2 7 .9 3 1 .1 2 8 .4 2 9 .8 3 1 .9 2 9 .5 2 6 .7 3 2 .1 3 0 .9 32.9 2 9 .0 2 5 .4 30.7 30.3 32.4 31.1 31.2
31.2 31.6 2 7 .1 33.3 2 8 .9 30.2
D ay 56
2 4 .5 3 0 .8 2 7 .6 2 8 .8 2 7 .1 31.8 30.8 30.8 26.6 2 6 .1 26.9 2 9 .9 26.8 31.4 25.3 2 7 .0 32.2 30.4 2 8 .5 31.0 30.7 33.9 2 7 .1 25.3 31.4 31.6 31.3 31.0 3 0 .5 30.2 3 0 .6 2 6 .0 3 4 .5 2 9 .8 3 1 .6
DuPont-5386
D ay 63
D ay 70
2 6 .2 30.8 2 8 .8 2 9 .0 3 0 .7 2 7 .7 30.8 31.3 2 5 .6 2 6 .1 2 1 .4 2 8 .3 2 7 .6 2 7 .1 2 5 .4 2 9 .2 3 2 .5 3 0 .7 3 0 .3 2 9 .6 2 9 .5 31.3 27.2 2 7 .6 3 1 .9 3 1 .5 3 3 .7 3 2 .1 2 9 .2 35.5
30.6 2 6 .3 3 4 .1 2 8 .7 3 3 .1
'' 25 3
30 4
28 1
28 0
30 7
8 32
56
30 7
25 6
24 6
26 e
27 8
27 1
30 9
26 3
26 5
31 9
32 8
29 0
30 9
30 9
30 8
25 0
26 ,5
32 .4
31 ,0
33 ,0
33 ,7
31 .5
29 .6
32 .3
26 .4
34 .4
27 .8
29 .7
611
Company Sanitized Does not contain TSCA CBI
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
D ay 74
D ay 77
M a le , V - 100 mg/k g /d a y
643250 643243 643311 643318 643247
643175 643314
643275 643257 643224 643169 643159 643286 643181 643206 643313 643182 643146 643312 643199 643267 643216 643244 643245 643301 643200 643255 643157 643238 643227 643164 643154 643156 643208 643190
2 5 .7 3 2 .1 2 8 .2 2 8 .5 2 8 .8 3 0 .6 2 9 .8 2 3 .5 2 2 .8 30.4 35.5 32.3 2 9 .5 2 9 .6 34.6 20.8 28.5 2 9 .1 30.6 26.4
2 3 .3 30.2 2 6 .7 26.5 2 8 .6
6 .8
32.0
3 0 .1 2 4 .6 2 4 .0 2 6 .6 2 6 .9 2 5 .1 2 9 .7 2 4 .7
D a y 84
INDIVIDUAL FOOD CONSUMPTION (g/day)
D ay 90
D ay 98
D ay 105
D ay 112
23.4 27.3 27.0 25.0 2 7 .9 AK T E ST DAY 77
16.9
24.6 2 4 .5 2 4 .9 2 7 .1 20.0 2 5 .1 31.4 24.8
2 3 .6 2 7 .8 25.8 2 5 .7 2 9 .7
2 6 .8 19.5 23.7 22.5 28.1 20.5 23.7 2 4 .9 2 3 .4
31.1 26.5 21.8 23.0 24.6
2 9 .9 1 .4
24.6 31.2 2 4 .7
2 7 .7 1 8 .5 2 3 .7 32.9 22.2
D ay 119
2 2 .5 2 8 .9 20.5 31.0 2 4 .7
D ay 126
2 9 .1 3 0 .1 15.3 29.4 2 3 .6
DuPont-5386
D ay 133
.
2 7 .1 2 9 .8 2 8 .4 2 4 .6 2 6 .6
612
Company Sanitized. Does not contain TSCA CBI
H -24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
D ay 140
D ay 147
M a le , V - 100 mg/k g /d a y
643250 643243 643311 643318 643247 643175 643314 643275 643257 643224 643169 643159 643286 643181 643206 643313 643182 643146 643312
643199 643267 643216 643244 643245 643301 643200 643255 643157 643238 643227 643164 643154 643156 643208 643190
2 7 .7 13.7 32.5 3 3 .5 2 6 .7
3 0 .6 32.3 31.4 36.3 2 8 .1
D ay 154
30.3 33.8 30.0 35.0 2 6 .9
INDIVIDUAL FOOD CONSUMPTION (g/day)
161
D ay 168
D ay 175
D sy 181
2 9 .6 3 2 .5 2 8 .0 36.4 2 7 .8
30.3 32.2 27.6 40.3 2 7 .8
2 8 .0 30.3 30.0 37.8 2 7 .2
2 4 .2 2 7 .5 26.4 3 2 .1 24.7
DuPont-5386
613
Company Sanitized. Does not contain TSCA CBI
H -24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Day 7
D ay 14
M a le , V II - 250 mg/k g /d a y
643194 643252 643260 643315 643215
643193 643298
643201 643259 643174 643283 643149 643178 643152 643295 643289 643171 643158 643249 643161 643309 643248 643285 643278 643299
643274 643192 643222 643160
643191 643203 643282 643302 643317 643225 643296
643258 643316
643220 643236 643165 643266 643151 643234 643281
26.4 2 5 .9 2 5 .4 2 3 .6 2 6 .6 2 6 .6
2 6 .7
2 8 .3 2 5 .1 3 0 .8 2 3 .8 2 4 .9 2 3 .1 29.0 24.2 23.4 30.7 2 9 .5 2 5 .8 2 5 .6 3 2 .5 2 7 .7 2 5 .0 2 5 .2 26.4
2 4 .7 2 8 .4 2 8 .3 2 8 .0 2 6 .4
2 6 .1 29.2 2 4 .7 2 5 .9 2 7 .5
29.8 2 4 .7 2 4 .7
25.6 2 6 .6 2 5 .4 2 8 .1 2 0 .9 35.7 20.5
2 5 .1 27.5 26.0 24.0 2 7 .5
28.8 29.2
29.8 2 7 .7 33.0 26.3 2 8 .1 25.2 3 1 .1 2 6 .7 25.8 3 3 .5 3 1 .9 2 7 .6 27.7 34.6 2 7 .1 27.3 2 6 .5 28.6 2 6 .9 2 9 .7 27.4 2 7 .7 2 8 .6 2 9 .1 32.8 27.4 2 9 .6 2 9 .3 31.3 28.6 29.2 29.7 28.4 29.6 31.6 22.6 29.9 27.7
D ay 21
INDIVIDUAL FOOD CONSUMPTION (g/day)
D ay 28
D ay 35
D ay 42
D ay 49
2 5 .6 2 6 .6 2 5 .4 2 4 .9 2 6 .9 2 9 .4
2 7 .3 2 8 .7
28.3 32.3 2 4 .8 2 6 .9 2 4 .0 31.7 2 7 .7 2 5 .7 33.1 30.5 2 4 .9 30.5 33.4 28.8 26.4 2 5 .7 2 7 .6 2 6 .9 3 0 .2 2 8 .4 29.2
2 8 .0 29.8 3 4 .7 2 7 .7 29.8 28.0 31.5 28.3 2 7 .8
2 7 .5 2 9 .1 2 7 .9 3 0 .0 2 1 .8 2 9 .9 26.2
25.6 2 9 .1 27.2 2 7 .5 2 8 .5
28.9
27.3
29.5 29.2 32.4 2 5 .6 30.0
9 .1 32.6 27.8 26.8 3 3 .6 30.3 2 7 .4 30.6 32.0 30.3 29.3 26.3 2 7 .6 27.0 2 9 .7 28.8 30.0 26.3 30.6 34.2 27.3 3 0 .7 2 9 .0 32.4 27.6 2 8 .9 26.6 29.8 2 8 .7 31.5 24.4 30.6 2 8 .1
2 5 .1 30.4 26.0 2 6 .0 2 7 .7
2 7 .6 2 7 .5
2 9 .7
3 0 .2 3 4 .1 25.3 31.6 2 0 .7 33.2 29.5 27.8 35.5 31.0 31.5 31.7 33.2 31.4 2 9 .5 28.4 28.4 29.7 30.2 29.2 3 0 .6 2 7 .2 30.3 33.5 26.3 28.8 29.2
31.0 2 7 .2 28.6 26.0 27.8 28.6 3 2 .1 2 3 .6 3 1 .3 2 8 .1
25.0 29.0 26.8 2 6 .0 2 7 .5
2 9 .6 2 7 .1
30.3 3 0 .1 35.1 24.0 32.5 25.5 32.9 29.7 2 7 .6 34.9 31.9 3 0 .7 28.8 31.3 3 0 .7 2 8 .5 2 6 .8 2 8 .3 2 8 .0 3 1 .7 2 9 .5 30.2 26.8 29.1 33.2 26.5 29.0 27.3 2 9 .5 1 2 .7 2 7 .6 2 5 .9 2 7 .6 2 7 .6 2 8 .7 22.4 2 8 .8 28.1
24.8 19.3 2 2 .6 2 1 .1 23.2
2 4 .7 24.2
2 2 .8 2 3 .4
2 6 .5 2 1 .6 2 8 .9 2 0 .8 3 2 .5 2 6 .9 2 5 .6 29.1 32.4 28.2 2 9 .0 2 9 .6 2 7 .0 27.2 2 2 .6 2 5 .9 2 6 .0 2 8 .0 2 8 .0 30.7 2 7 .2 2 7 .1 3 1 .8 2 5 .8 2 6 .1 24.7 3 0 .4 2 4 .5 2 7 .5 2 4 .5 26.4 19.8 30.0 23.0 28.8 2 6 .8
D ay 56
2 7 .5 2 3 .9 2 4 .5 22.8 2 6 .4
9 .9 2 8 .0 2 6 .5 2 3 .1 31.0 24.3 2 9 .2 2 4 .5 31.3 12.5 13.6 32.5 32.4 2 9 .5 27.4 18.4 2 7 .6 2 6 .8 2 9 .5 2 8 .2 2 4 .7 2 7 .0 29.2 30.1 2 5 .2 27.3 2 9 .1 2 5 .1 2 6 .1 26.2 30.9 28.0 2 8 .0 2 1 .8 3 0 .0 2 3 .9 2 8 .7 23.7 2 6 .0 2 8 .7
DuPont-5386
D ay 63
D ay 70
2 7 .0 3 0 .2 2 5 .2 2 6 .4 2 5 .3 23.2
2 7 .9 29.3 2 2 .6 33.4 1 9 .9 2 3 .2 2 3 .4 2 7 .4 14.5 2 3 .5 31.6 2 9 .2 2 5 .3 17.4 2 8 .9 15.8 2 4 .9 2 1 .0
2 2 .9 2 4 .3 19.8 2 2 .5 2 8 .3 2 5 .8 2 7 .5 2 6 .2 1 9 .1 2 0 .6 2 9 .8
2 8 .3 2 7 .1 2 7 .3 18.2 2 2 .2 2 1 .3 2 7 .9 2 0 .7 16.8 28.0
' 29.9 4 .0
2 5 .8 2 7 .5 13.6
2 4 .7 2 7 .2 2 7 .4
3 0 .0 3 1 .1 1 4 .7 2 7 .4 24.4 2 8 .0 12.2 2 8 .0 12.0 2 8 .5 14.6 2 3 .0 2 3 .4 1 4 .0 20.8 2 8 .5 22.2
2 4 .6 2 3 .6 2 7 .9 26.3 2 6 .0 2 6 .4
5 .2 6 .4 6 .4
2 9 .1 4 .4
2 4 .5 2 5 .4 1 9 .6 2 6 .9 2 8 .1 2 6 .0 22.0 12.3 2 5 .8
614
Company Sanitized. Does not contain TSC CBI
H -24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
D ay 74
D ay 77
M a le , V II - 250 tng/k g / d a y
643194 643252 643260 643315 643215 643193
643298 643201 643259 643174 643283 643149 643178 643152
643295 643289 643171 643158 643249 643161 643309 643248 643285 643278 643299 643274 643192 643222 643160 643191 643203 643282 643302 643317 643225 643296 643258 643316 643220 643236 643165 643266 643151 643234 643281
28.8 25.4 25.9 22.8 31.8 21.0
20.0 30.8 18.9 28.8 29.1 28.5 18.6 27.9 28.8 10.1 34.3 27.4 26.7 18.7 AK TE ST DAY 70 27.8 25.3 31.6 15.5 13.5 27.6 27.7 23.2
26.7 16.9 36.4 25.3 37.4
26.2 30.2 11.6 25.6
26.9 22.3 10.4 23.8 13.9 28.0 27.3
D a y 84
INDIVIDUAL FOOD CONSUMPTION (g/day)
D a y 90
D ay 98
D ay 105
D ay 112
26.9 29.5 24.7 26.9 29.1 28.5 27.0
29.0 26.7 27.4 23.0 25.8 20.8 31.4 22.0
27.4 29.9 24.1 21.0 28.8 27.8 23.9 26.7 26.1 27.8 24.5 20.5 18.8 26.4 24.3
24.2 25.5 20.7 30.3 23.4
25.4 23.3 19.4 31.5 25.0
18.9 24.0 19.6 31.7
23.9
26.6 32.4 27.2 26.1 22.9 31.0 31.7 26.5 18.1 29.6
26.0 31.3 26.9 24.0 22.6 29.5 30.0 27.4 20.1 17.5
26.3 30.3 25.1 26.5
22.5 23.5 27.2 27.5
21.1 26.7
27.4 31.3 26.6 29.9 21.0 25.5 25.3 25.1 21.9 25.8
26.7 30.5 23.5 27.8 21.6 27.7 24.8 25.7 20.4 23.1
D ay 119
20.5 24.7 19.5 32.4 22.9
26.8 29.5 23.7 27.3 24.6 24.6 26.7 27.8 23.6 25.8
D ay 126
23.1 26.2 20.7 31.5 24.2
DuPont-5386
D ay 133
,
23.0 27.3 21.3 32.0 25.4
615
Company Sanitized. Does not contain TSCA CBI
H -24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
D ay 140
D ay 147
M a le , V II - 250 mg/k g /d a y
643194 643252 643260 643315 643215 643193 643298
643201 643259 643174 643283 643149 643178 643152 643295 643289 643171 643158 643249 643161 643309 643248 643285 643278 643299 643274 643192 643222 643160 643191
643203 643282 643302 643317 643225 643296
643258 643316 643220 643236 643165
643266
643151 643234 643281
27.0 28.8 24.6 29.9 24.3
28.9 31.0 24.1 31.0 28.8
D ay 154
INDIVIDUAL POOD CONSUMPTION (g/day)
D ay 161
D ay 168
D ay 175
D ay 181
30.5 30.5 24.6 32.4 29.4
30.6 30.5 25.4 35,9 31.0
31.6 31.5 25.7
34.9 30.7
29.2 29.9 23.7 33.1 28.5
25.9 25.8 20.8 31.1 22.8
DuPont-5386
616
Company Sanitized. Does not contain TSCA CBI
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Day 7
D ay 14
F e m a l e , I I - 0 mg/kg/day
643477 643374 643406 643486 643361
643463 643398
643436 643362 643354 643402 643383 643465 643484 643384 643352 643343 643459 643394 643480 643319 643350 643363 643397 643421 643420 643419 643414 643401 643455 643378 643393 643447 643478 643386 643405 643425 643448
643426 643415 643453
643330 643336 643387 643377
18.9 19.8 17.0 14.8 18.3 18.9 16.4
18.7 18.9 15.9 15.4 17.5 17.2 16.8 16.6 18.7 17.3 17.7 20.2 18.6 18.5 17.3 20.0 17.5 18.1 19.8 22.2 19.8 14.6 17.7 21.2 20.7 1 8 .9' 18.4 18.5 22.0 20.1 22.6 19.1 21.8 19.3 21.4 18.8 19.2 18.8
18.5 19.6 17.7 13 . 4 18.9 20.7 18.2
18.9 19.8
16.5 20.5 17.1 20.7 16.9 19.0 20.7 19.8 20.2 20.6 21.4 19.5 18.0 22.0 22.0 19.4 22.1 23.4 22.7 17.8 18.8 23.5 22.8 20.9 19.7 19.1 24.7 22.0 20.9 19.9 24.0 22.2
18.7 21.6 19.9 18.9
D ay 21
INDIVIDUAL FOOD CONSUMPTION (g/day)
D ay 28
D ay 35
D ay 42
D ay 49
19.8 18.3 17.2 15.8 22.3 21.0 18.0 18.6
20.5 18.4 19.0 18.9 20.2 17.9 17.8 21.0 19.5 18.8 19.4 20.8 20.9 12.8 20.6 20.7 18.8 24.7 24.2 21.8 16.7 18.9 22.2 22.5 19.5 18.9 17.7 22.9 21.1 19.6 20.9 22.4 21.4
19.5 22.1 21.2 19.8
18.8 18.0 19.0 14.4 20.1 20.8 18.1
22.3 19.2 16.7 20.3 16.6 19.2 15.3 17.7 20.7 19.1 19.4 18.7 20.0 21.0 17.5 22.6 19.3 17.4 22.2 22.3 19.7 18.0 18.2 20.6 24.6 20.3 16.5 17.1 23.9 21.1 19.5 20.2 24.2 21.0
18.8 22.2 22.4 19.8
21.9 18.5 19.1 15.9 21.5 21.7 20.9 21.3 20.9 17.8 22.2 19.8 20.3 17.9 21.4 22.2 22.3 21.5 21.0 21.7 22.9 18.6 22.7 19.4 18.8 27.6 25.7 22.5 17.9 17.7 22.3 23.4 22.0 17.4 17.4 24.7 19.5 20.7 22.1 22.1 21.8
21.3 21.8 23.4 21.2
20.4 21.9 18.4 17.0 19.8 19.9 18.2
18.4 22.0 19.4 23.0 20.4 19.9 15.6 17.1 20.3 19.8 22.8 18.7 19.7 21.0 18.9 21.4 20.0 20.5 25.9 24.8 22.5 16.9
18.9 21.3 22.6 21.8 17.6 17.5 24.7 21.5 20.8 20.0 21.4 21.1 19.3 21.1 23.1 20.3
18.5 18.2 18.0 16.7 26.1 19.4 18.8 17.6
19.1 20.4 25.2 22.6 21.7 18.1 19.3 21.1 21.1 22.1 21.1 20.7 20.9 18.8 21.9 21.3 18.8 27.2 24.9 23.3 19.3 18.2 22.6 22.7 21.2 18.4 18.5 24.1 20.2 19.7 20.2 20.7 20.8
19.2 21.2 24.0 20.3
D ay 56
18.8 20.1 19.8 20.5 24.4 23.8 22.1 21.4 21.5 21.2 23.1 24.4 22.0 16.9 18.8 20.0 20.5 19.6 17.0 20.7 21.9 20.5 24.7 19.1 20.3 24.2 23.9 22.7 19.9 18.0 20.2 24.0 21.1 17.6 18.5 24.0 20.6 22.5 20.6 21.6 20.5 19.6 20.0 23.5 21.7
DuPont-5386
D ay 63
D ay 70
20.6 22.4 20.6 19.2 24.9 22.7 21.3
18.8 21.9 20.9 20.8 21.9 20.9 17.2 19.8 20.3 16.8 20.1 19.8 20.0 20.6 20.4 22.8 19.0 19.0 24.9 23.3 23.5 18.2 19.2 21.9 22.0 22.7 18.3 19.0 22.0 21.3 23.8 21.3 26.3 21.0
19.9 21.2 22.8 22.8
18.6 22.4 19.2 19.5 24.5 21.5 21.8
20.7 21.0 18.7 22.1 23.6 22.3 18.5 18.9 20.0 19.8 21.1 18.7 20.3 21.4 19.1 21.9 18.8 19.7 22.2 21.2 23.1 18.3 18.5 21.3 23.1 20.3 17.5 18.3 22.8 20.8 20.0 22.9 30.2 20.7
20.3 22.3 22.7 21.5
617
Company Sanitized. Does not contain TSCA CBI
H -24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
D ay 74
D ay 77
F e m a le , XI - 0 mg/k g /d a y
643477 643374 643406 643486 643361 643463 643398 643436
643362 643354 643402 643383 643465 643484 643384 643352
643343 643459 643394 643480 643319 643350 643363 643397 643421 643420 643419 643414 643401 643455
643378 643393 643447 643478 643386 643405 643425 643448 643426 643415 643453 643330 643336 643387 643377
23.4 19.2 21.4 19.0 23.3 22.5 19.8 22.1 23.2 20.5 24.4 24.5 23.9 21.1 19.4
24.5 23.3 23.5 19.8 19.2
17.7 24.2 18.6 16.6 25.0 23.1 23.2 21.0 21.0 20.2 20.5 25.5 20.9 19.0 19.5
20.8 20.8 20.7 21.5 27.8 18.7 19.2 18.7 22.3 21.7
D a y 84
INDIVIDUAL FOOD CONSUMPTION (g/day)
D ay 91
D a y 98
D ay 105
D ay 112
D ay 119
19.2 20.2 33.5 16.2 24.9 21.3 22.7
21.8 20.7 19.9 21.7 21.1 21.2 16.0 18.6
20.0 22.2 18.5 13.3 24.4 19.7 20.4
21.9 19.3 19.9 20.3 20.3 18.5 16.4 16.6
21.0 17.7 21.1 16.2 18.7
20.4 10.7 20.5 18.1 17.5
21.0 18.9 17.5 17.3 18.4
20.8 19.9 16.5 17.2 15.9
21.0 19.8 22.3 22.5 29.5 19.9 19.3 21.6 20.3 19.3
1
21.9 18.6 17.3 18.5 25.4 18.5
7.9 19.2
20.2 19.7
21.4 19.4 25.2 19.6 27.1 21.1 14.2 20.3 22.7 20.1
21.9 23.9 24.3 22.3 27.0 20.8 22.9 15.8 26.8 23.2
21.5
22.5
25.1
24.9
22.7
21.2
23.1
24.1
27.8
27.0
21.3
22.3
22.5
21.2
SE TE ST DAY 105
22.5
20.9
22.6
25.0
D ay 126
21.0 21.3 19.7 19.0 15.9
DuPont-5386
D ay 133
23.9 22.1 20.7 19.3 20.1
618
Company Sanitized. Does not contain TSCA CBi
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations_____________________ _
D ay 140
D ay 147
F e m a le , I I - 0 mg/k g /d a y
643477 643374 643406 643486 643361 643463 643398 643436 643362 643354 643402 643383 643465 643484 643384 643352 643343 643459 643394
643480 643319 643350 643363 643397 643421 643420 643419 643414 643401 643455
643378 643393 643447 643478 643386 643405 643425
643448 643426 643415 643453 643330 643336 643387 643377
21.9 23.1 18.9 17.9 18.9
23.2 23.7 21.9 20.7 19.8
D ay 154
INDIVIDUAL FOOD CONSUMPTION (g/day)
D ay 161
D ay 168
D ay 175
D ay 181
24.1 26.9 24.8 19.7 20.7
25.3 27.1 23.6 23.0 21.9
23.2 27.8 22.8 19.8 19.0
22.0 22.2 21.9 18.7 19.6
21.3 19.3 20.6 15.7 18.7
DuPont-5386
619
Company Sanitized- Does not contain TSCA CBI
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Day 7
D ay 14
F e m a le , IV - 25 mg/k g /d a y
643390 643396 643380 643433 643389 643410 643321
643324 643458 643364 643483 643411 643379 643391 643437 643399 643334 643464 643369 643490 643342 643438 643445 643418 643325 643479 643403 643376 643422
643452 643475 643372 643400 643395 643457
15.8 20.6 18.6 19.3 19.1 19.1 15.4 17.2
15.9 16.2 17.6 AK TE ST DAY 0 19.0 17.1 16.0 16.8 15.5 18.7 17.2 18.4 20.0 18.0 21.9 16.9 22.2 18.6 18.1 17.6 21.2
18.8 22.9 17.7 17.3 17.7 39.0
16.4 22.0 23.1 20.0 18.4 18.1 14.7 17.8 16.3 17.9 17.1
20.1 18.3 17.4 20.2 17.4 19.0 18.7 20.3 21.7 18.9 22.0 17.5 18.7 20.1 19.6 18.3 23.2 21.4 19.9 20.1 17.3 19.0 39.6
D ay 21
INDIVIDUAL FOOD CONSUMPTION (g/day)
D ay 28
D ay 35
D ay 42
D ay 49
18.0 23.6 21.2 23.8 18.9 21.5 18.4 19.4 17.6 18.7 17.9
21.7 18.8 18.7 19.9 18.8 19.6 18.7 20.9 20.2 20.7 23.6 17.5 22.5 22.0 21.7 19.0 24.0 23.5 19.5 21.3 18.9 19.9 40.0
17.5 20.6 22.3 23.2 17.9 21.0 17.0 19.3 16.8 18.9 17.2
20.2 18.5 17.9 19.9 18.0 20.6 21.1 21.3 21.4 22.5 24.6 19.4 22.2 21.8 18.2 17.9 24.1 23.2 20.0 19.7 18.5 17.9 39.9
18.6
20.4
23.8
21.5
23.1
22.0
22.2
22.7
20.0
21.7
21.5
22.8
SE T E ST DAY 29
21.0
19.9
19.3
18.7
20.8
20.6
20.1
19.0
20.3 18.3 18.8 21.7 19.2 21.4 20.1 21.7 20.9 20.9 28.4 20.1 21.7 20.7 19.2 18.3 22.2
22.7 21.0 20.2 19.2 18.0 37.4
20.5 21.2
18.9 20.2 18.4 22.2 17.8 22.0 22.1 23.3 27.8 19.8 22.8 21.1 20.9 18.3 22.9 21.5 22.7 20.9 19.1 18.4 36.7
19.5 20.4 23.0 19.7 19.3 21.7
21.7 18.0 18.0 19.6
22.0 19.6 18.1 20.5 17.6 20.2 21.9 21.4 20.9 19.3 26.1 20.7 24.7 22.0 22.5 18.5 24.2 21.8 23.1
8.3 20.1 18.2 38.6
D ay 56
20.0 23.3 25.7 22.5 12.6 21.6
20.7 23.6 19.8 19.1
20.7 19.7 26.0 19.9 18.4 19.8 18.5 20.0 21.5 18.1 23.3 17.7 23.9 22.1 20.0 18.6 24.3 21.1 19.2 22.9 19.9 18.6 38.3
DuPont-5386
D ay 63
D a y 70
21.0 23.7 23.4 21.7 17.7 21.7
21.1 20.7 21.3 20.5
22.0 20.4 19.6 18.8 18.7 20.3 19.0 20.3 21.8 18.1 22.6 19.5 24.7 23.7 18.9 18.0 23.0 22.4 21.9 21.1 20.9 19.7 20.3
. 20.2 28.7 24.2 21.9 20.5 20.4
21.3 21.4 20.9 18.9
20.9 20.1 19.3 20.5 17.3 17.5 19.8 19.6 20.7 19.2 21.6 18.2 23.5 20.7 18.3 16.6 22.2 20.9 20.4 20.3 18.0 18.6 18.5
620
Company Sanitized. Does not contain TSCA CBI
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
D ay 74
D ay 77
F e m a le , IV - 25 mg/k g /d a y
643390 643396 643380 643433 643389 643410 643321
643324
643458 643364 643411 643483 643379 643391 643437 643399 643334 643464 643369 643490 643342 643438 643445 643418 643325 643479 643403 643376 643422 643452 643475 643372 643400 643395 643457
21.1 19.8 19.6 21.0 21.0 23.0 18.4 21.9 20.3 24.9 25.5
8.8 19.8 25.9 22.6 26.8 22.5 21.9 21.5 20.0
20.5 28.5 22.6 21.2 18.6 21.1
22.1 21.5 20.3
17.9 19.1 19.7 18.1
D ay 84
20.0 29.1 24.4 21.6 16.4 20.4
21.6 19.6 20.3
19.5 18.9 20.0 18.5
INDIVIDUAL FOOD CONSUMPTION (g/day)
D ay 91
D ay 98
D ay 105
D ay 112
17.0 23.8 21.5 20.0 16.0 18.8
19.8 21.6 18.3
18.2 17.7 18.6 15.6
18.7 21.4 18.5 17.5
18.6 21.2 20.6 19.7
19.0 22.5 21.5 19.9
D ay 119
19.8 22.0 20.9 18.8
D ay 126
19.8 22.5 21.7 18.5
DuPont-5386
D ay 133
18.7 22.7 20.9 19.3
621
Company Sanitized. Does not contain TSCA CBI
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
INDIVIDUAL FOOD CONSUMPTION (g/day)
D ay 140
D ay 147
F e m a le , IV - 25 mg/k g /d a y
643390 643396 643380 643433 643389 643410 643321 643324 643458 643364 643411 643483 643379 643391 643437 643399 643334 643464
643369 643490 643342 643438 643445 643418 643325 643479 643403 643376 643422 643452 643475 643372 643400 643395 643457
20.0 23.4 22.5 22.1
22.5
24.0 21.2 21.2
D ay 154
22.2 24.4 23.6 22.1
D ay 161
20.9 23.7 20.6 20.0
D ay 168
20.8 23.6 22.0 20.5
D ay 175
21.2 23.9 21.6 17.7
D ay 181
16.7 20.3 18.4 17.4
DuPont-5386
622
Company Sanitized. Does not contain TSCA CBI
H -24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Day 7
D a y 14
F e m a le , V I - 100 mg/k g /d a y
643322 643489 643409 643366 643367 643461 643462
643392 643472 643323 643412 643382
643381 643360 643373 643320 643488 643428 643439 643353 643385 643339 643473 643337 643416 643407 643357 643331 643427 643470 643434
643349 643454 643333 643460
18.6 17.5 16.1 18.9 18.5 21.7
17.7
13.5 16.4 16.9 17.1 16.0 17.4 15.1 17.7 18.3 18.6 20.4 17.8 17.8 17.0 17.9 18.1 21.5 17.9 17.7 17.8 17.1 18.5 18.0 17.9 18.0 20.3 18.6 19.7
18.9 16.7 17.4 19.1 19.5 21.7
18.9
15.5 16.1 18.1 18.6 16.5 17.4 16.1 17.2 19.1 20.0 21.5 19.4 18.5 18.9 19.5 17.3 20.9 19.9
19.9 16.7 17.0 18.3 20.0 17.7 18.5 19.6 18.1 19.7
D ay 21
19.1 18.9 17.8 20.0 20.9 22.2 19.3 16.0 16.7 19.8 20.5 19.8 19.5 17.7 20.5 21.2 22.7 20.2 19.9 19.3 19.7 19.0 19.3 22.9 21.3 23.7 17.9 18.4 20.2 20.4 19.6 19.4 20.6 19.8 20.7
INDIVIDUAL FOOD CONSUMPTION (g/day)
D ay 28
D ay 35
D ay 42
D ay 49
19.7 17.5 17.1 21.6 21.9 22.3
19.5 17.4 18.1 21.3 19.3
6.6 19.1 16.8 21.5 23.0 21.2 22.3 19.3 19.7 18.3 21.6 19.4 24.3 22.2
22.2 20.1 18.7 19.9 21.0 19.1 21.4 20.4 18.2 20.9
19.6 19.0 18.9 21.8 19.4 23.1
17.9 17.2
16.6 19.1 18.0
9.7 18.8 15.8 20.2 22.2 19.9 22.8 18.2 21.3 19.2 21.2 18.6 18.2 19.8
21.7 18.1 19.5 20.3 20.7 19.4
19.8 20.6 18.9 21.2
17.9 17.4 16.7 21.8 18.8 20.2
18.1 17.4 17.6 20.1 17.0 10.5 18.5 17.6 19.1 21.7 20.1 20.3 19.3 20.0 18.5 20.3 19.3
7.0 19.2
19.1 19.1 18.6 18.7 19.9 18.3 19.0 21.4 17.2 19.8
16.3 21.4 18.1 19.8 18.6 16.5
17.0 14.6 16.5 17.9 18.9 17.1 18.9
19.9 21.8 22.2 19.8 21.6 19.5 22.9 19.8 21.7 19.2 25.2 21.0 23.4 20.6 20.2 19.5 21.9 22.0 21.6 24.1 19.0 22.7
D ay 56
19.3 22.7 17.4 21.9 22.5 21.9 18.9 16.9 19.0 21.0 21.1 22.7 19.1 18.7 19.3 23.3 20.7 20.0 18.8 21.1 19.3 21.6 19.1 19.9 21.2 24.2 20.2 20.9 19.7 20.3 19.8 20.2 23.4 19.3 21.1
D ay 63
20.3 20.6 19.4 21.8 19.8 20.4 19.6 17.0 18.2 20.8 20.5 12.1 17.2 16.2 21.3 20.5 18.7 20.2 18.0 21.1 18.0 23.4 18.0 22.4 18.9 20.8 18.1 20.2 18.0 22.4 17.6 19.8 21.2 20.0 20.7
DuPont-5386
D ay 70
. 18.0 23 .2 18.9 22.0 20.3 16.1 19.2 17.5 18.0 21.8 20.6 21.0 18.0 19.7 20.4 21.9 19.5 19.8 17.1 21.5 19.6 21.4 18.8 24.5 18.5 20.8 17.4 19.6 18.4 21.8 17.4 19.0 22.5 19.7 19.4
623
Company Sanitized. Does not contain TSCA CBi
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
D ay 74
D a y 77
F e m a le , V I - 100 mg/k g /d a y
643322 643489 643409 643366 643367
643461 643462 643392 643472
643323 643412 643382 643381 643360 643373 643320 643488 643428 643439 643353 643385 643339 643473 643337 643416
643407 643357 643331 643427 643470
643434 643349 643454 643333 643460
21.0 20.9 18.9 17.6 21.2 21.1 23.8 19.2
9.8 19.1
22.3 20.5 21.2 19.2 24.2
21.4 20.3 22.2 20.2 20.9
18.5 20.5 18.6 22.7 19.6 18.4 17.2 17.8 17.4 20.1 20.8 16.5 19.5 16.9 23.9
D a y 84
INDIVIDUAL FOOD CONSUMPTION (g/day)
D ay 91
D ay 98
D ay 105
D ay 112
18.2 19.1 17.3 20.5 21.5 15.5
18.9 17.4 17.3 19.8 22.2 17.9
19.9 17.7 20.4
16.6 20.9 16.7 19.3 21.0 18.8
17.9 14.5 15.3 15.4 17.1 15.7
17.6 15.0 18.1
17.7 18.2 17.0 14.2 18.1
19.3 15.3 19.5 17.8 19.3
20.9 16.4 20.2 10.1 21.8
D ay 119
20.9 7.4
20.6 15.5 20.3
D ay 126
20.1 23.4 19.5 16.8 23.2
DuPont-5386
D ay 133
19.2 19.0 22.5 18.2 22.6
624
Company Sanitized. Does not contain TSCA CSS
H -24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
D ay 140
D ay 147
F e m a le , V I - 100 mg/k g /d a y
643322 643489 643409 643366 643367 643461 643462 643392 643472
643323 643412 643382 643381 643360 643373 643320 643488 643428 643439 643353 643385 643339 643473 643337 643416 643407
643357 643331 643427 643470 643434 643349 643454 643333 643460
22.6 30.7 20.0 18.5 22.2
22.4 29.3 23.0 21.0 26.6
D ay 154
21.0 18.4 23.6 20.4 23.2
INDIVIDUAL FOOD CONSUMPTION (g/day)
D ay 161
D ay 168
D ay 175
D ay 181
22.9 25.6 21.3 18.4 24.9
22.8 20.5 21.1 18.0 24.2
21.7 18.0 20.7
18.8 25.8
18.4 32.5 19.0 19.2 23.7
DuPont-5386
625 Company Sanitized. Does not contain TSCA CB!
H -24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
Day 7
D a y 14
F e m a le , V I I I - 250 mg/k g /d a y
643341 643370 643446 643435 643466 643332
643404 643408 643359 643340 643487 643356 643329 643388 643450 643467 643443 643417 643413 643338 643335 643468 643440 643430 643431 643368 643326 643365 643375 643328 643348 643346 643449 643429 643424 643347 643456 643423 643345 643351 643358
643444 643474 643441 643481
17.5 21.3 17.7 16.7 15.8 15.8
15.6 18.1 16.7 16.7 16.3 16.8 17.6 15.4 19.7 20.0 15.1 19.9 17.3 18.2 18.9 17.2 19.6 16.5 18.5 18.0 19.0 22.3 21.4 20.8 17.2 18.4 19.3 17.9 17.6 16.0 20.9 17.1 19.2 14.9 18.6
17.9 16.7 20.1 17.9
18.2 22.6 19.1 20.0 16.9 18.3 17.9 20.4 19.0 19.7 17.0 18.2 18.5 20.9 18.2 23.3 21.2 21.1 18.9 18.6 20.0 19.0 21.3 19.0 19.2 18.4 19.4 23.3 22.5 19.8 18.2 18.8 22.0 19.7 18.9 17.7 20.9 17.6 18.8 18.3 18.5
18.5 17.4 19.2 18.0
D ay 21
19.0 25.9 20.3 19.1 19.1 18.1 18.3 20.3 19.0 19.3 17.8 19.0 18.1 19.6 23.2 20.6 17.0 20.4 19.5 19.6 22.5 22.3 25.4 22.0 21.6 19.7 22.4 26.2 23.9 22.4 22.1 22.0 24.4 21.9 21.4 16.2 23.3 17.8 21.6 19.4 22.1 21.5 17.8 20.9 21.5
INDIVIDUAL FOOD CONSUMPTION (g/day)
D ay 28
D ay 35
D ay 42
D ay 49
17.6 23.3 19.5 17.7 20.4 17.9
20.0 20.4 21.4 20.3 17.9 18.5 20.1 19.9 21.5 21.5 17.8 20.6 19.7 19.2 21.8 19.0 21.2 19.4 19.4 20.2 20.8 26.8 25.7 21.9 20.4 18.7 23.0 20.5 17.9 17.3 20.5 18.4 18.5 18.5 19.4
20.6 16.4 18.6 18.7
18.9 24.3 19.2 17.2 19.2
20.3 20.5 19.9 20.9 21.6 17.7 17.8 22.3 19.6
23.3 22.9 18.6 19.7 19.6 19.5 23.2 19.3 22.1 20.6 21.5 19.0 21.6 26.6 25.1 24.2 20.5 20.3 22.9 21.8 21.1 17.9 22.9 17.7 20.2 18.2 18.4
21.2 17.8 19.7 19.3
18.0 23.8 17.4 18.2 20.1 18.8
17.9 20.7 18.7 19.8 17.4 14.9 22.4 19.7 21.6 22.7 16.6 20.4 18.7 19.3 21.6 17.9 20.2 18.8 22.1 19.1 19.2 24.2 24.6 20.1 19.5 18.4 20.1 20.4 18.7 16.7 21.0 16.5 20.7 16.2 17.7
22.5 17.5 20.2 19.9
17.6 23.1 17.7 16.6 17.4
15.3 16.8
20.3 20.0 21.3 16.1 17.2 23.6 14.5 21.3 21.0 18.3 21.6 20.3 20.3 22.5 19.2 19.8 20.8 22.0 10.2 19.1 25.8 22.7 21.6 18.4 20.2 21.4 20.5 22.2 18.4 15.6
6.8 16.9 18.1 18.9 22.9 17.3 19.8 19.0
D ay 56
D ay 63
18.5
19.0
20.6
15.8
21.0
19.0
17.5
18.1
21.3
19.8
17.3
15.2
21.6
19.7
19.3
15.7
21.5
22.3
24.5
12.4
18.7
15.8
19.5
32.8
20.2
22.4
2.5 19.4
23.8
21.6
21.3
15.4
18.2
16.2
22.7
17.7
20.1
19.1
21.1
19.1
23.2
19.0
17.3
14.6
16.1
6.4
21.5
18.4
22.8
19.9
AK T E ST DAY 53
19.8
12.8
26.8
25.7
24.6
21.9
17.0
13.3
19.3
12.6
22.2
21.4
22.0
18.9
19.2
18.8
21.0
19.8
18.9
18.0
7.3 21.9
12.3
20.5
11.4
19.5
17.5
10.3
18.8
21.2
24.7
11.4
18.9
17.6
16.1
10.5
19.4
18.5
DuPont-5386
D ay 70
18.7 11.0 18.7 17.2 18.5 19.6 18.9 19.2 21.3 FD T E S T DAY 69 12.6 18.6 20.9 17.0 21.0
9.7 14.7 15.4 18.5 18.1 13.0
1.8 1.9 10.2 12.1
26.8 24.7 19.4 17.7 18.9 19.5 18.0 10.0 15.4 17.1 25.8 16.6 17.3 21.8 17.9
9.7 16.8 16.4 19.4
626
Company Sanitized. Does not contain TSCA CBI
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
D ay 74
D ay 77
F e m a le , V I I I - 250 mg/k g /d a y
643341 643370 643446 643435 643466 643332
643404 643408
643359 643340 643487 643356 643329 643388 643450 643467 643443 643417 643413 643338 643335 643468 643440 643430 643431 643368 643326 643365 643375
643328 643348 643346 643449 643429 643424 643347 643456 643423 643345 643351 643358 643444 643474 643441 643481
6.8 9.5 18.2 20.6 20.0 16.3 25.5 28.3 22.6 40.1
52.1 26.2 14.4 13.1
8.4 21.0 18.2 20.6
4.0
15.8 15.4 17.8 17.4 16.3 16.2 14.8 18.9 23.6 12.9 15.5 10.6 16.8
5.1
19.1 20.3 12.2 17.7 20.9 19.1 17.4 13.4 26.3 14.8
D ay 84
21.6 29.2 20.1 16.9 19.8 24.6 25.3 22.9 23.4 19.7 22.1 23.1 20.9 24.3
21.4 24.2 23.3 23.3 17.3 22.1 29.2 21.3 25.3 21.3
INDIVIDUAL FOOD CONSUMPTION (g/day)
D ay 91
D a y 98
D ay 105
D ay 112
18.4 25.7 14.0 14.1 16.9 18.5 15.5 18.9 24.4
16.6 17.7 20.4 17.1 24.3
16.9 15.6 19.9 17.6 26.9
17.0 14.8 21.1 17.1 27.2
16.8 14.8 17.4 20.1 25.8
18.1 18.1 18.0 18.0 16.1 20.7 20.2 16.8 23.4 18.1
24.7 19.1 18.3 20.7 16.4 21.0 16.7 16.8 24.3 20.4
24.2 18.7 18.5 21.4 18.8 23.1 20.0 16.4 26.2 20.4
20.4 17.6
18.3 20.9 17.8 20.1 18.3 16.9 22.1 19.2
D ay 119
16.9 16.4 18.6 18.5 24.0
12.1 19.1 19.0 22.9 17.3 23.0 21.0 17.3 22.3 20.2
D ay 126
16.2 17.4 18.0 18.2 22.9
DuPont-5386
D ay 133
,
15.8 19.6 18.9 16.4 21.0
627
Company Sanitized. Does not contain TSCA CBI
H-24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations
D ay 140
D ay 147
F e m a le , V III - 250 mg/k g /d a y
643341 643370 643446 643435 643466 643332
643404
643408 643359 643340 643487 643356 643329 643388 643450 643467 643443 643417 643413 643338 643335 643468 643440 643430 643431 643368 643326 643365 643375 643328
643348 643346 643449 643429 643424 643347 643456 643423 643345 643351 643358 643444 643474 643441 643481
17.4 24.5 17.1 21.6 21.3
19.7 25.2 19.9 22.8 23.7
D ay 154
21.3 25.7 21.5 20.1 26.0
INDIVIDUAL FOOD CONSUMPTION (g/day)
D ay 161
D ay 168
D ay 175
D ay 181
20.1 26.5 21.1 21.3 23.8
20.4 22.4 22.6 20.9 24.9
19.5 18.4 22.7 19.3 23.3
19.0 19.4 18.5 18.3 22.0
DuPont-5386
628
Company Sanitized. Does not contain TSCA CBI